data_1yxe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yxe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.035 0.445 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.426 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.054 0.454 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 411' ' ' ILE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.426 ' CG ' ' HA ' ' A' ' 326' ' ' VAL . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 418' ' ' CYS . 42.4 t . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.48 ' HB ' ' HD3' ' A' ' 324' ' ' PRO . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.295 0.569 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.462 ' CE1' ' CG1' ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 320' ' ' CYS . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 33.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.436 ' CB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.422 HG11 ' CG ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.097 0.475 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.437 HD11 ' CD1' ' A' ' 329' ' ' PHE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.422 ' CG ' HG11 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 76.0 m . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.181 0.515 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.164 0.507 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.451 ' CD1' ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.451 ' CZ3' ' CD1' ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 407' ' ' GLN . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.14 0.495 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 323' ' ' ILE . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.045 0.45 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.158 0.504 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 121.391 0.615 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 426' ' ' ILE . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.561 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.097 0.475 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.501 HG21 HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' SER . . . . . 0.418 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 426' ' ' ILE . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.419 0.628 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.109 0.481 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . 0.413 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.466 HG22 HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.272 0.558 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 mp . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 399' ' ' TRP . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . 0.421 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 426' ' ' ILE . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.156 0.503 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.433 ' N ' HD12 ' A' ' 323' ' ' ILE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 426' ' ' ILE . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.335 0.588 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.112 0.482 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.4 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.43 ' CG ' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.42 HG11 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.408 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.42 ' CG ' HG11 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.351 0.596 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 10.1 tt . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.109 0.48 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.08 0.467 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.425 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.43 ' O ' ' CZ2' ' A' ' 399' ' ' TRP . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.415 ' HA ' ' CZ3' ' A' ' 399' ' ' TRP . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.176 0.512 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.425 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.479 HG21 HD11 ' A' ' 420' ' ' ILE . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 323' ' ' ILE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.9 m120 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.996 0.427 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.227 0.537 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 340' ' ' LEU . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . 0.442 ' CG1' ' CH2' ' A' ' 399' ' ' TRP . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . 0.417 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.132 0.491 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.442 ' CH2' ' CG1' ' A' ' 341' ' ' VAL . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.097 0.475 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.5 mt . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.059 0.457 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.419 ' CG ' HG13 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.136 0.493 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -146.2 78.89 1.53 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -135.75 173.96 21.56 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.0 m -131.41 -169.39 2.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.919 . . . . 0.0 110.024 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.23 124.6 28.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.709 . . . . 0.0 110.086 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -82.59 164.32 20.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -161.07 172.34 17.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.564 -0.71 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -147.78 47.4 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.578 -0.701 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -110.78 -159.65 0.69 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.571 -0.706 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -108.03 151.1 26.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.605 -0.684 . . . . 0.0 110.226 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.85 -142.69 4.49 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 74.2 m -105.15 -65.11 1.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.54 -0.976 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -72.0 -28.37 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.24 -47.23 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.697 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -141.62 -164.39 1.77 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.584 -0.697 . . . . 0.0 110.327 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.426 ' CZ ' HG12 ' A' ' 323' ' ' ILE . 49.2 t80 -150.09 80.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.026 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.89 -159.16 8.66 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.18 -178.99 6.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.656 -0.908 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.431 ' CE3' HG21 ' A' ' 316' ' ' VAL . 1.3 p-90 -81.95 172.01 13.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.431 HG21 ' CE3' ' A' ' 315' ' ' TRP . 34.1 m -48.4 171.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.526 -0.734 . . . . 0.0 111.454 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -52.82 147.43 8.99 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.659 0.742 . . . . 0.0 111.304 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.91 -116.24 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -113.49 -30.53 6.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.593 -0.945 . . . . 0.0 110.216 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t -110.22 92.98 4.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.63 -0.669 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.426 HG12 ' CZ ' ' A' ' 312' ' ' PHE . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.426 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -98.4 -23.99 15.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 53.7 p -57.76 -28.91 64.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.46 -0.775 . . . . 0.0 110.418 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.24 84.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.0 t -98.2 10.63 40.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -59.26 -39.76 83.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.163 -0.961 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.17 80.77 63.27 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.56 -0.713 . . . . 0.0 110.366 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.24 -46.46 0.37 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.427 1.225 . . . . 0.0 110.315 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.18 -169.02 1.53 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.654 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -62.21 98.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.631 -0.668 . . . . 0.0 110.185 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.4 28.89 8.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.069 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -104.3 -27.93 11.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.8 65.16 0.89 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.368 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -109.85 18.26 20.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.72 -28.75 69.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.367 -0.833 . . . . 0.0 110.064 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 4.2 m -81.65 1.89 31.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.514 -0.741 . . . . 0.0 111.039 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.79 -16.31 32.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.36 -31.12 29.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.22 63.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.478 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -83.84 6.39 21.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.472 -0.768 . . . . 0.0 111.244 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 7.5 tp -64.75 -28.8 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -20.71 50.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.608 -0.683 . . . . 0.0 110.582 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.26 19.33 12.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -0.851 . . . . 0.0 110.609 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.06 -30.13 76.88 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -103.66 22.49 14.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.597 -0.943 . . . . 0.0 110.567 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -54.29 -25.95 26.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 109.696 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -76.39 -139.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -147.63 8.89 0.9 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.884 -1.135 . . . . 0.0 111.703 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -59.16 -26.49 64.81 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.854 -1.154 . . . . 0.0 110.675 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.07 -25.95 64.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.797 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 12.9 t -101.08 -28.34 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.461 -0.774 . . . . 0.0 110.563 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 378' ' ' ALA . 4.8 mmt -87.56 9.74 20.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 111.127 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -41.19 -58.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.362 -0.837 . . . . 0.0 113.098 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.05 -27.11 0.86 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.46 -0.775 . . . . 0.0 111.984 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.2 47.62 0.83 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.44 -0.788 . . . . 0.0 110.126 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 374' ' ' MET . . . -83.69 102.35 12.18 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.894 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.12 88.09 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 3.4 mt -41.31 99.55 0.2 Allowed Pre-proline 0 N--CA 1.506 2.367 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.68 60.78 3.49 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.519 1.273 . . . . 0.0 109.944 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 43.0 m -78.37 58.4 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 110.501 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -160.74 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -65.21 -75.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.679 -0.895 . . . . 0.0 109.7 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -91.14 42.46 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.497 -0.752 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -68.1 -26.7 65.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.265 -0.897 . . . . 0.0 110.421 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.86 -6.33 48.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.483 -0.761 . . . . 0.0 110.612 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.66 -28.58 58.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.285 -0.885 . . . . 0.0 111.308 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -72.97 62.79 0.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.328 -0.858 . . . . 0.0 110.812 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.55 70.34 10.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 109.75 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -66.14 -162.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.624 -0.673 . . . . 0.0 110.26 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.5 p -82.51 60.03 4.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.742 . . . . 0.0 109.878 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -50.29 -26.32 4.67 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.562 -0.711 . . . . 0.0 110.94 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.02 -30.92 78.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -114.92 52.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.93 . . . . 0.0 109.955 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -132.25 79.34 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.41 ' O ' ' CE2' ' A' ' 399' ' ' TRP . 13.4 m-85 -56.73 -21.91 31.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.623 -0.928 . . . . 0.0 110.808 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -90.82 130.27 36.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.337 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.41 ' CE2' ' O ' ' A' ' 397' ' ' TYR . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 411' ' ' ILE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.426 ' CG ' ' HA ' ' A' ' 326' ' ' VAL . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -58.39 137.68 57.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 1.7 m -155.44 156.25 34.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.7 p -61.14 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.677 -0.639 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.49 66.22 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.62 -0.675 . . . . 0.0 110.455 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.49 -68.54 0.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.419 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 84.0 p -83.9 141.27 31.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.01 61.97 54.51 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 -169.41 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.403 1.212 . . . . 0.0 110.425 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 435' ' ' ILE . 50.7 mm -76.97 -28.53 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.65 -0.656 . . . . 0.0 110.122 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.445 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -85.7 89.06 7.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.613 -0.68 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -84.21 125.27 7.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 60.4 p -94.84 -35.59 12.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.576 -0.955 . . . . 0.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.9 -36.54 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.565 -0.71 . . . . 0.0 110.175 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.47 146.8 51.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -120.67 147.97 44.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.597 -0.689 . . . . 0.0 110.222 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -135.17 103.62 5.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.63 -0.669 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.42 52.28 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.554 -0.716 . . . . 0.0 110.1 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.16 157.41 29.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.625 -0.672 . . . . 0.0 110.035 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -149.9 179.46 26.64 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.5 p -123.97 175.81 6.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.229 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -140.59 -69.58 0.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 110.285 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -148.41 -161.41 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -132.9 85.83 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.604 -0.685 . . . . 0.0 110.282 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 323' ' ' ILE . 28.6 t80 -106.35 44.63 1.03 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.64 27.49 1.06 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 14.8 tp -144.66 160.0 41.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 110.161 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -171.78 148.57 2.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 110.26 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.1 p -96.34 89.49 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.559 -0.713 . . . . 0.0 109.797 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -169.29 -63.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 110.915 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -106.54 -101.44 2.72 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -152.28 -45.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.628 -0.925 . . . . 0.0 109.856 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 418' ' ' CYS . 42.4 t -150.85 159.07 44.79 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.48 ' HB ' ' HD3' ' A' ' 324' ' ' PRO . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp -72.57 -22.5 60.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 11.3 t -57.07 -27.09 61.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.349 -0.845 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.41 0.4 49.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.728 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 52.4 p -94.74 10.68 34.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.125 -0.985 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -25.15 64.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.175 -0.953 . . . . 0.0 110.577 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -52.08 108.24 1.03 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.341 -0.849 . . . . 0.0 111.01 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.879 0 O-C-N 123.036 1.019 . . . . 0.0 110.736 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -60.68 -76.46 0.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.541 -0.724 . . . . 0.0 110.354 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.79 94.43 0.82 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.502 -0.749 . . . . 0.0 110.018 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 354' ' ' GLU . 27.8 p90 -93.24 -25.73 17.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.595 -0.69 . . . . 0.0 110.343 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.43 ' N ' ' CD1' ' A' ' 353' ' ' TYR . 9.0 tt0 -128.68 -79.35 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.52 -156.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -91.1 19.4 5.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.4 mp -52.0 -21.08 2.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.161 -0.962 . . . . 0.0 111.68 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 56.1 m -49.04 -64.1 0.91 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.077 -1.015 . . . . 0.0 111.264 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.39 -15.59 13.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.591 -0.693 . . . . 0.0 111.67 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.99 2.27 43.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.186 -0.946 . . . . 0.0 112.287 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -30.93 21.95 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.894 -1.129 . . . . 0.0 111.265 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -61.98 -32.26 72.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.297 -0.877 . . . . 0.0 109.785 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.21 -19.53 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.748 -0.595 . . . . 0.0 110.255 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.49 -24.82 19.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.867 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.22 -28.72 63.14 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.45 85.14 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.58 96.28 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 0.0 110.307 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 35.46 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.67 -0.644 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -114.01 -63.32 1.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.309 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -120.31 119.99 34.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.569 -0.707 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.19 -28.34 13.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.685 . . . . 0.0 110.267 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.75 65.43 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 110.478 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -102.56 10.79 38.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.628 -0.67 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.3 ttt -105.5 -24.66 12.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.688 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.17 -60.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.787 . . . . 0.0 111.157 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.68 -24.57 5.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.402 -0.811 . . . . 0.0 111.259 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.7 p -58.58 -26.15 63.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -158.94 52.61 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.53 -0.731 . . . . 0.0 110.23 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -96.16 39.11 1.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.61 -0.681 . . . . 0.0 110.212 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 380' ' ' LEU . 10.1 mp -109.29 73.89 0.61 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 110.5 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.81 66.35 3.16 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.206 1.108 . . . . 0.0 110.298 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.9 p -108.67 -83.54 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 0.0 110.439 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 179.2 51.13 0.08 OUTLIER Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -90.11 10.54 23.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.509 -0.995 . . . . 0.0 111.092 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.58 -30.49 17.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.258 -0.901 . . . . 0.0 110.457 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.07 -18.92 25.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.629 -0.669 . . . . 0.0 110.976 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.83 -15.89 45.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.21 141.64 34.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 110.872 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 152.61 39.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 390' ' ' TYR . 50.2 p90 -68.29 128.84 38.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.727 . . . . 0.0 110.526 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.37 -44.21 0.17 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.738 . . . . 0.0 110.404 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.3 p -83.52 57.35 4.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -66.99 -30.77 70.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.607 -0.683 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -124.8 54.88 0.73 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 155.96 32.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.469 -1.018 . . . . 0.0 110.218 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 397' ' ' TYR . . . -144.53 23.73 2.01 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 396' ' ' GLY . 38.3 m-85 -140.73 93.38 2.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -1.047 . . . . 0.0 109.523 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -107.76 111.25 23.33 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.562 -0.711 . . . . 0.0 110.97 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.438 ' CD1' ' CG2' ' A' ' 428' ' ' THR . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.462 ' CE1' ' CG1' ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 320' ' ' CYS . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 425' ' ' TYR . . . -167.36 90.1 0.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.438 ' CG2' ' CD1' ' A' ' 399' ' ' TRP . 40.0 p -59.87 -77.37 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.347 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 49.8 m -160.39 115.76 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.73 41.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -77.91 111.85 14.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 110.076 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.4 t -116.96 107.04 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.257 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 10.5 p80 -154.07 70.15 6.31 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 -178.91 3.77 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.343 1.181 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 51.0 mm -91.59 48.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.593 -0.692 . . . . 0.0 109.945 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.187 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.931 0.396 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.93 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -132.88 139.89 11.35 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.5 t -119.49 155.83 31.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.493 -1.004 . . . . 0.0 110.203 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -92.32 -173.86 3.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 110.251 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.75 152.65 29.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -129.6 -49.49 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 110.144 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.68 -27.37 66.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.204 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -74.71 -30.88 61.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.533 -0.729 . . . . 0.0 110.297 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -122.14 83.82 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -148.86 45.82 0.7 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 t -125.65 67.87 1.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.992 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 25.7 p30 -71.47 161.43 31.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.633 -0.667 . . . . 0.0 110.337 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -169.72 38.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.602 -0.686 . . . . 0.0 110.138 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -146.45 28.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -118.89 -65.55 1.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.238 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.38 157.11 27.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 39.0 mt -143.54 117.51 9.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.452 -1.028 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.403 ' CD1' ' HB3' ' A' ' 321' ' ' GLU . 1.5 p-90 -150.11 163.06 39.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.859 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.1 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.71 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -177.67 -44.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 109.602 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -171.61 -100.59 0.14 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -149.45 19.71 0.94 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.564 -0.962 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 33.7 t -150.74 138.79 20.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 315' ' ' TRP . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.436 ' CB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.422 HG11 ' CG ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.437 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.46 -24.5 13.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.9 t -57.41 -40.5 78.45 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.476 -0.765 . . . . 0.0 110.664 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.08 17.29 24.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.532 -0.73 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 40.1 t -98.31 -33.94 10.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 0.0 110.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.73 -40.22 14.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 110.441 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -151.51 147.07 19.58 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.222 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.07 155.25 52.55 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.322 1.17 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -108.4 -67.17 0.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.27 90.37 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 110.121 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -136.69 34.1 2.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 110.324 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.45 -76.86 0.34 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.615 -0.678 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -168.61 32.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.335 -0.853 . . . . 0.0 110.374 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -85.41 -24.83 27.34 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.419 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.66 -21.42 18.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.497 -0.752 . . . . 0.0 111.068 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 54.6 m -51.23 -49.44 61.08 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.189 -0.944 . . . . 0.0 111.307 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.7 -16.99 13.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 0.0 111.454 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -91.35 0.65 57.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.224 -0.922 . . . . 0.0 111.726 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -19.53 65.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.08 -1.013 . . . . 0.0 110.75 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -65.79 -12.93 58.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -0.832 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 37.3 pt -55.76 -33.31 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.125 -0.984 . . . . 0.0 110.682 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 1.6 ptmt -57.31 -25.35 59.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 110.673 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -84.68 -22.55 29.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.547 -0.721 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -135.96 51.35 0.82 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 367' ' ' PHE . 26.2 t80 -97.28 27.43 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.511 -0.993 . . . . 0.0 110.154 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -27.62 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -170.08 30.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -110.17 -30.41 7.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.455 -0.778 . . . . 0.0 109.981 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -62.41 -20.16 64.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.694 -0.628 . . . . 0.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.46 58.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.3 -0.875 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.6 m -105.28 -45.42 4.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 111.003 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 4.7 ppp? -54.01 -25.54 21.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.436 -0.79 . . . . 0.0 111.276 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.94 -29.34 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.362 -0.836 . . . . 0.0 110.0 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -20.95 12.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.2 m -98.13 -27.96 13.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.353 -0.842 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -97.06 34.12 1.8 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 110.248 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.09 -57.0 2.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 110.056 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 28.2 mt -127.46 154.3 77.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.72 . . . . 0.0 110.208 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.31 -26.83 14.11 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.392 1.206 . . . . 0.0 110.493 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.7 m -127.12 75.56 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 110.05 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -118.57 40.85 2.16 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -59.95 -26.57 66.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.53 -0.982 . . . . 0.0 110.36 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -27.39 68.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -77.77 -22.2 50.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.569 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.69 -13.51 54.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -0.795 . . . . 0.0 110.842 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.109 -0.995 . . . . 0.0 110.609 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -68.83 -75.66 0.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.739 . . . . 0.0 110.117 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -81.56 151.16 27.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.336 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -152.53 0.5 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.563 -0.71 . . . . 0.0 110.249 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.0 p -83.55 57.13 3.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.483 ' CE1' ' CD1' ' A' ' 397' ' ' TYR . 59.9 t-80 -65.89 -43.53 88.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 110.428 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -62.48 -34.81 90.56 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 38.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.533 -0.98 . . . . 0.0 110.499 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 54.58 0.08 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.483 ' CD1' ' CE1' ' A' ' 393' ' ' HIS . 66.2 t80 -130.71 -38.45 1.3 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.596 -0.944 . . . . 0.0 110.877 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -96.93 107.71 20.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.468 -0.77 . . . . 0.0 110.813 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.458 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.437 HD11 ' CD1' ' A' ' 329' ' ' PHE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.422 ' CG ' HG11 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.422 ' N ' ' CD2' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -160.87 102.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.3 p -94.62 136.18 35.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.705 . . . . 0.0 109.771 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.2 m -59.53 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.668 . . . . 0.0 110.404 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -60.69 -26.07 66.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.636 -0.665 . . . . 0.0 110.426 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 431' ' ' LEU . 0.0 OUTLIER -153.99 174.99 13.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.522 -0.736 . . . . 0.0 110.623 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 8.3 t -83.61 -74.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -161.83 163.02 19.94 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 -28.74 12.83 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.477 1.251 . . . . 0.0 110.404 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.42 40.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.667 . . . . 0.0 109.998 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.771 -179.899 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 10.0 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.048 0.451 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -165.05 -58.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.686 . . . . 0.0 110.269 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -137.63 76.16 0.37 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 p -114.37 168.41 9.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.523 -0.987 . . . . 0.0 110.214 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.28 34.62 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.547 -0.721 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -150.53 158.72 44.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.65 -0.656 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . 0.418 ' CE1' ' HB2' ' A' ' -4' ' ' HIS . 0.0 OUTLIER -59.84 -174.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.647 -0.658 . . . . 0.0 110.864 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 81.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.618 -0.676 . . . . 0.0 111.012 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . 0.418 ' HB2' ' CE1' ' A' ' -6' ' ' HIS . 25.4 t60 -115.16 169.92 8.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.388 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -146.0 138.41 25.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.636 -0.665 . . . . 0.0 110.138 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.38 -159.92 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 t -81.0 160.29 24.62 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.938 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.37 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 110.241 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -166.66 170.92 12.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -156.61 -51.77 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.63 -0.669 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -134.47 117.03 15.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.146 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -91.56 94.81 1.98 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.35 135.22 17.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.953 . . . . 0.0 110.153 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.428 ' CE3' HG12 ' A' ' 316' ' ' VAL . 3.1 p-90 -108.73 170.44 8.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 0.0 109.648 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.428 HG12 ' CE3' ' A' ' 315' ' ' TRP . 9.8 p -56.39 128.74 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.438 -0.788 . . . . 0.0 110.25 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.83 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 0.0 110.718 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.427 ' HA3' ' CH2' ' A' ' 315' ' ' TRP . . . -115.24 -29.41 2.54 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -149.45 -43.82 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.483 -1.01 . . . . 0.0 110.755 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t -97.53 159.5 14.88 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . 0.412 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.03 -46.89 4.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.6 t -68.21 -24.77 64.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.588 -0.695 . . . . 0.0 110.283 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -89.78 14.64 11.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 0.0 111.035 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.4 m -95.0 -28.45 15.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.281 -0.887 . . . . 0.0 110.013 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.63 -26.5 14.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.613 -0.68 . . . . 0.0 110.186 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.33 92.67 7.12 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.05 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.86 -20.36 22.52 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.392 1.206 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -58.37 -59.39 5.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.317 -0.864 . . . . 0.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -60.06 -26.36 66.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.521 -0.737 . . . . 0.0 110.629 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.14 -28.84 68.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.441 -0.787 . . . . 0.0 110.477 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -101.21 55.3 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.73 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -144.65 15.81 1.61 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 110.977 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -110.6 -29.58 7.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.13 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -81.81 -16.6 50.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 110.913 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 7.6 m -101.77 -23.6 14.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.821 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 -47.1 3.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.26 1.39 28.69 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.592 -0.692 . . . . 0.0 111.357 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.68 6.18 18.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.135 -0.978 . . . . 0.0 111.469 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 25.2 pt -89.92 -25.59 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.436 -0.79 . . . . 0.0 110.633 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -28.56 67.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.438 -0.789 . . . . 0.0 110.658 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.04 -23.36 55.12 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.743 . . . . 0.0 110.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -107.24 76.63 0.23 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.18 52.1 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.538 -0.977 . . . . 0.0 110.403 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -24.82 11.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.562 -0.711 . . . . 0.0 110.254 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -162.12 104.92 1.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 110.034 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 155.13 8.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.507 -0.746 . . . . 0.0 110.501 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -94.85 -23.18 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -51.44 -25.48 6.44 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.337 -0.852 . . . . 0.0 111.012 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.8 p -79.84 -23.64 41.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.597 -0.69 . . . . 0.0 110.481 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -29.49 17.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 110.561 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 375' ' ' ILE . 46.9 mm -63.79 -42.71 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.493 -0.754 . . . . 0.0 110.167 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -26.19 61.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.63 -0.669 . . . . 0.0 110.517 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.0 t -90.9 -26.48 19.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -130.55 75.24 1.64 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.496 -0.752 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -117.92 30.69 7.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.405 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 5.9 mt -57.03 -56.15 36.49 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.493 -0.755 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 52.4 Cg_endo -75.41 60.4 5.73 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.2 1.105 . . . . 0.0 110.601 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.8 m -160.77 92.42 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -58.53 -20.44 45.79 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -64.01 -12.89 42.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.387 -1.066 . . . . 0.0 111.222 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -54.74 -30.27 55.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.05 -1.031 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -59.85 -25.6 65.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.589 -0.694 . . . . 0.0 110.504 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.16 -12.13 59.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.549 -0.719 . . . . 0.0 110.544 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.86 159.04 4.3 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.195 -0.94 . . . . 0.0 110.612 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 67.89 0.67 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.36 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.38 -74.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -112.66 169.82 8.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.648 -0.658 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 34.4 t -84.97 55.83 3.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.253 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -140.74 21.07 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.502 -0.749 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -163.65 28.15 0.23 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -77.3 132.79 38.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.356 -1.085 . . . . 0.0 109.871 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.4 60.95 0.14 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -161.96 28.81 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.508 -0.995 . . . . 0.0 110.358 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.39 140.72 52.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.69 . . . . 0.0 109.835 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.426 ' HB2' ' CD1' ' A' ' 315' ' ' TRP . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -109.1 95.15 5.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 79.5 p -59.39 -62.81 1.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.595 -0.691 . . . . 0.0 110.229 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 88.6 m -160.37 110.69 1.82 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.748 . . . . 0.0 110.276 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.74 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 110.29 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.7 pp -148.27 151.42 35.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.365 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.88 70.17 0.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -76.3 -58.29 1.24 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.237 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.12 130.84 20.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.043 1.022 . . . . 0.0 110.364 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.68 -59.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.66 . . . . 0.0 110.11 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.442 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.146 0.498 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -107.91 -43.21 4.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.538 -0.726 . . . . 0.0 110.235 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -159.69 112.75 0.54 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 15.1 m -108.57 -55.89 2.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.926 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -162.6 133.48 4.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.644 -0.66 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.57 36.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -149.45 105.11 3.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -142.04 171.22 14.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.215 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -155.64 -60.04 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -129.24 -171.01 2.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -96.54 39.99 2.68 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 p -153.0 139.03 18.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.642 -0.916 . . . . 0.0 109.962 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -107.19 117.18 33.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 0.0 110.443 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -111.56 134.99 52.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.682 -0.636 . . . . 0.0 109.904 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -159.02 -43.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.487 -0.758 . . . . 0.0 109.928 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.431 ' CD1' ' N ' ' A' ' 313' ' ' GLY . 7.5 t80 -136.41 154.7 50.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.643 -0.661 . . . . 0.0 110.394 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . 0.431 ' N ' ' CD1' ' A' ' 312' ' ' PHE . . . -115.67 82.55 0.32 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.415 HD11 ' CZ3' ' A' ' 315' ' ' TRP . 0.5 OUTLIER -104.52 160.06 15.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.934 . . . . 0.0 110.358 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.425 ' CZ2' ' HB2' ' A' ' 320' ' ' CYS . 0.1 OUTLIER -51.92 170.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.411 -0.805 . . . . 0.0 110.443 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.38 166.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.692 -0.63 . . . . 0.0 109.99 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -63.58 97.83 0.16 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.682 . . . . 0.0 110.267 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -101.15 -86.7 1.94 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -150.24 30.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.939 . . . . 0.0 110.116 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.425 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 76.0 m -140.49 169.89 16.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.7 . . . . 0.0 110.37 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.411 ' CE1' ' OG ' ' A' ' 345' ' ' SER . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt -66.37 -26.31 67.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' SER . . . . . 0.411 ' OG ' ' CE1' ' A' ' 342' ' ' PHE . 4.6 p -78.38 -36.22 46.21 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.557 -0.714 . . . . 0.0 110.405 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -91.87 -37.4 12.93 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.547 -0.72 . . . . 0.0 110.334 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 5.0 m -88.73 10.83 19.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.61 -0.681 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.49 -27.82 64.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.167 -0.958 . . . . 0.0 110.349 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -87.08 127.35 59.71 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.72 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.21 -54.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.198 1.104 . . . . 0.0 110.455 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.11 176.2 8.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.472 -0.768 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -146.23 160.42 42.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.662 . . . . 0.0 110.256 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.18 -27.2 63.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.0 110.293 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.17 29.47 7.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -166.21 42.61 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.23 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -109.8 -28.53 8.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 360' ' ' TYR . 9.0 tt -66.21 -25.22 66.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.752 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 52.2 m -104.52 6.19 34.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.418 -0.801 . . . . 0.0 111.106 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.9 -28.56 13.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.139 -0.976 . . . . 0.0 111.599 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.415 ' CE2' ' O ' ' A' ' 357' ' ' LEU . 13.6 p90 -80.34 -22.6 41.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.235 -0.916 . . . . 0.0 110.98 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.38 -24.57 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 110.686 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 -10.61 21.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.461 -0.775 . . . . 0.0 111.474 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 9.1 tt -58.47 -24.21 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.12 -0.988 . . . . 0.0 110.76 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -92.75 -30.43 15.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.428 -0.795 . . . . 0.0 110.373 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.25 20.74 17.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.536 -0.728 . . . . 0.0 110.772 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.27 65.18 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -98.01 20.83 11.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.525 -0.985 . . . . 0.0 110.993 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -59.55 -36.77 76.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -113.44 -110.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.633 -0.667 . . . . 0.0 109.896 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -171.17 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.612 -1.305 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -76.3 -32.96 59.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.623 -0.673 . . . . 0.0 110.291 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.22 -28.66 69.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.648 -0.657 . . . . 0.0 110.278 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.6 m -101.47 -19.95 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.607 -0.683 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -38.76 73.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.427 -0.795 . . . . 0.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.6 pt -130.61 -113.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.496 -0.752 . . . . 0.0 109.616 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -133.82 60.86 1.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.558 -1.338 . . . . 0.0 109.94 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -25.18 8.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.536 -0.727 . . . . 0.0 110.546 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -59.12 -31.81 69.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.94 -53.29 8.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.569 -0.707 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.07 126.02 41.76 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 110.001 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.45 62.77 4.47 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.051 1.027 . . . . 0.0 110.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.6 t -169.11 71.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -0.769 . . . . 0.0 110.246 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -91.35 -34.14 7.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.99 -27.97 68.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.592 -0.946 . . . . 0.0 110.306 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.95 -26.22 65.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -79.63 -25.86 41.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.528 -0.732 . . . . 0.0 110.464 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.36 -11.8 58.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 0.0 110.665 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.99 -64.56 0.84 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.0 110.789 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -55.07 -176.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.525 -0.734 . . . . 0.0 111.171 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -90.9 114.69 27.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.909 -0.495 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -41.42 1.68 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 12.5 t -66.9 -27.85 67.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.499 -0.751 . . . . 0.0 110.22 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -69.99 84.1 0.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.589 -0.694 . . . . 0.0 110.184 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 179.73 -47.79 0.08 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 133.44 55.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.973 . . . . 0.0 109.577 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -155.66 28.17 0.6 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -150.96 172.5 15.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.966 . . . . 0.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -85.25 142.39 29.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.455 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -112.61 -27.95 8.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 58.1 p -60.71 -71.61 0.13 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.592 -0.693 . . . . 0.0 110.281 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.5 p -147.89 115.91 6.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.619 -0.675 . . . . 0.0 110.243 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -105.86 157.22 17.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -109.92 84.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.236 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 8.6 t -154.99 161.5 41.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.171 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -82.91 152.02 65.03 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.93 120.3 6.56 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.431 1.227 . . . . 0.0 110.37 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.466 HG22 HD12 ' A' ' 435' ' ' ILE . 0.1 OUTLIER -84.55 -37.95 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.685 . . . . 0.0 109.868 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 20.2 mtt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.113 0.483 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 8.9 ptt85 -164.18 34.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -152.66 71.4 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 32.0 m -104.23 -35.41 8.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.524 -0.986 . . . . 0.0 110.169 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -138.29 35.04 2.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.498 -0.751 . . . . 0.0 110.331 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -106.19 -58.41 1.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.613 -0.68 . . . . 0.0 110.197 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -158.29 118.92 3.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 110.286 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -144.33 39.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -167.47 145.56 4.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.563 -0.71 . . . . 0.0 110.311 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -92.91 -42.22 9.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.688 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.3 -117.6 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.2 m -118.44 -158.62 0.72 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.633 -0.922 . . . . 0.0 110.187 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.21 146.44 34.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.712 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -154.84 49.59 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.09 55.97 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 3.9 t80 -112.44 71.94 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.489 -0.757 . . . . 0.0 110.311 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.21 143.53 10.81 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 3.0 pp -145.99 159.76 42.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.621 -0.929 . . . . 0.0 110.063 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -70.82 135.78 48.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.0 110.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.99 88.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.815 0.817 . . . . 0.0 110.055 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.27 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.57 -0.706 . . . . 0.0 109.962 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.62 -115.38 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.81 21.66 9.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.58 -0.953 . . . . 0.0 110.824 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 47.2 t -89.2 128.06 35.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.189 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.44 ' CD1' ' CZ ' ' A' ' 312' ' ' PHE . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.434 ' CD2' ' N ' ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 386' ' ' LYS . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.451 ' CD1' ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER -103.84 5.22 35.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 12.6 p -50.99 -25.62 4.94 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.985 -1.072 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.62 -12.42 59.96 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.6 t -86.58 10.54 15.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.206 -0.934 . . . . 0.0 111.179 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -58.16 -23.11 54.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.098 -1.001 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -56.21 109.87 1.95 Allowed Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.412 -0.805 . . . . 0.0 110.528 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.73 159.91 47.47 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.196 1.103 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.54 -74.38 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 110.314 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.48 -28.14 17.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.0 110.308 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -57.15 -26.14 60.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.567 -0.708 . . . . 0.0 110.553 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -122.76 81.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 0.0 110.192 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.67 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.601 -0.687 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -59.07 -24.61 63.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.23 -37.02 76.51 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.457 -0.777 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 3.7 m -103.97 -26.73 12.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 110.261 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -59.7 -28.09 67.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.776 . . . . 0.0 110.311 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -77.06 -4.67 45.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.722 . . . . 0.0 111.072 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -91.19 -27.57 18.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.155 -0.966 . . . . 0.0 110.175 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -64.71 -25.62 68.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.607 -0.683 . . . . 0.0 110.594 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 7.6 tp -57.89 -40.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -100.38 -18.77 16.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.681 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.8 20.51 17.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.02 -31.37 57.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -74.81 -14.41 60.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.53 -0.982 . . . . 0.0 111.105 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -69.58 -23.19 63.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.06 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.2 86.89 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -114.47 -30.34 6.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -69.96 -37.63 75.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.289 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.64 65.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.642 -0.661 . . . . 0.0 110.504 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 t -105.29 -14.77 15.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.067 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.06 -37.76 6.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 110.926 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 375' ' ' ILE . 84.9 mt -96.21 -59.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.44 -0.787 . . . . 0.0 110.542 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -59.52 -30.43 68.58 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.622 -0.674 . . . . 0.0 110.493 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -26.46 27.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.568 -0.708 . . . . 0.0 110.349 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.0 -64.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.536 -0.727 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -70.93 96.06 1.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.646 -0.659 . . . . 0.0 110.332 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 10.2 tp -75.64 -58.87 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.559 -0.713 . . . . 0.0 109.814 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.72 65.05 2.37 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.02 1.01 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 10.3 m -87.33 -29.55 21.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 110.253 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -168.69 87.26 0.09 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -58.89 -20.09 48.25 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.453 -1.028 . . . . 0.0 110.74 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -25.12 59.39 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.359 -0.838 . . . . 0.0 110.486 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 342' ' ' PHE . 39.0 mmtt -78.47 -0.94 31.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.38 -0.825 . . . . 0.0 111.185 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.51 -12.26 61.0 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.135 -0.978 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -55.0 -175.93 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.227 -0.92 . . . . 0.0 110.967 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 128.12 35.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.56 -0.713 . . . . 0.0 110.571 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -90.34 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 0.0 110.362 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -119.01 145.78 45.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.3 p -90.45 58.29 3.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -64.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 109.948 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -105.86 61.73 0.35 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.15 4.42 17.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.956 . . . . 0.0 110.527 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -96.51 51.62 1.56 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -139.58 -170.43 2.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 110.24 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -119.73 133.87 55.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.451 ' CZ3' ' CD1' ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 407' ' ' GLN . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.428 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -170.4 43.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.406 ' OG1' ' CD1' ' A' ' 399' ' ' TRP . 27.1 m -72.68 -65.85 0.74 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.712 . . . . 0.0 110.303 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 2.0 p -157.56 136.75 11.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.701 . . . . 0.0 110.115 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -77.86 -170.33 1.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.686 . . . . 0.0 110.111 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.37 105.28 15.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.133 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.52 -28.98 7.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.282 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -122.4 160.38 48.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.52 -171.03 0.66 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.468 1.247 . . . . 0.0 110.396 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.67 -29.32 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 109.976 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.212 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.096 0.474 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -85.7 156.88 20.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 0.0 110.202 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -142.15 -88.24 0.11 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 1.2 m -141.47 -50.95 0.42 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.942 . . . . 0.0 110.156 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -168.26 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -84.73 90.48 7.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.678 . . . . 0.0 110.305 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -118.45 -59.0 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.639 -0.663 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.11 -175.39 5.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' -4' ' ' HIS . 4.9 p-80 -66.58 150.17 49.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -82.55 -28.65 30.86 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.311 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.45 110.35 3.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -91.92 -46.67 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.941 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.91 -21.8 31.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -55.97 107.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.342 -0.848 . . . . 0.0 110.599 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -104.72 -157.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.662 . . . . 0.0 110.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.23 55.75 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.57 -0.706 . . . . 0.0 110.068 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -151.13 64.99 0.38 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.01 147.34 27.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.42 -1.047 . . . . 0.0 110.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.406 ' CG ' ' O ' ' A' ' 419' ' ' LEU . 0.2 OUTLIER -56.18 170.43 0.33 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 111.06 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.02 89.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.771 -0.581 . . . . 0.0 109.824 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.4 -62.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.511 -0.743 . . . . 0.0 110.486 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -63.17 -111.7 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -119.01 41.5 3.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.973 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 39.0 m -148.9 127.36 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.851 -0.531 . . . . 0.0 109.956 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.14 -19.65 46.73 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.2 t -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.37 -0.831 . . . . 0.0 110.622 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.14 17.53 23.91 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.509 -0.744 . . . . 0.0 110.948 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.3 p -90.14 -36.18 14.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.238 -0.914 . . . . 0.0 110.459 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -43.97 5.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.504 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.74 160.49 66.2 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.537 -0.727 . . . . 0.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.55 144.82 40.94 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.46 1.242 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -120.23 160.68 22.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 110.556 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.52 -19.39 59.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.7 -0.625 . . . . 0.0 110.47 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -52.86 -24.12 8.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.58 49.66 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 110.195 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -81.49 106.33 13.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -109.65 -26.34 9.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.599 -0.688 . . . . 0.0 110.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.83 -27.1 62.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 110.465 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.9 m -63.04 -25.81 68.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.617 -0.677 . . . . 0.0 110.36 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -28.69 66.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.486 -0.759 . . . . 0.0 110.429 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -66.11 -14.43 61.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -72.16 -13.96 61.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.235 -0.915 . . . . 0.0 110.664 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -77.63 1.08 20.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.0 111.743 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 68.4 mt -60.41 -28.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.986 -1.071 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -73.83 -23.3 59.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.0 110.59 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.2 20.82 16.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.4 -0.812 . . . . 0.0 110.64 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.1 38.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -98.59 20.54 12.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.551 -0.97 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -87.99 -26.15 22.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -86.9 61.59 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 110.656 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -72.55 162.34 29.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -80.64 -21.49 41.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.02 64.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 69.8 m -105.63 6.47 32.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.651 -0.656 . . . . 0.0 110.984 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.0 ttp -105.39 0.73 27.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.177 -0.952 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.49 -77.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.099 -1.0 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -54.16 -27.22 32.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.253 -0.905 . . . . 0.0 110.432 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 m -114.55 -124.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -165.21 109.83 0.89 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.602 -1.312 . . . . 0.0 110.27 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -92.74 -24.68 18.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 110.559 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 380' ' ' LEU . 0.0 OUTLIER -151.66 157.67 34.5 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 110.932 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.1 -47.49 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.263 1.138 . . . . 0.0 110.548 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.4 m -154.89 -43.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.72 -0.613 . . . . 0.0 110.539 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -154.72 67.25 0.31 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -82.97 -14.62 53.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.955 . . . . 0.0 110.639 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.89 -31.28 64.7 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -83.52 -24.69 31.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.2 -11.82 58.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.546 -0.721 . . . . 0.0 110.575 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -153.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.344 -0.847 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -50.65 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.226 -0.921 . . . . 0.0 111.38 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -72.96 148.88 43.84 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.736 -0.602 . . . . 0.0 110.366 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -55.46 164.11 1.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.715 . . . . 0.0 110.915 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.2 m -78.44 58.5 2.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.675 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 394' ' ' GLY . 32.7 p-80 -83.42 -39.65 20.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.632 -0.667 . . . . 0.0 110.027 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.434 ' N ' ' CD2' ' A' ' 393' ' ' HIS . . . -127.45 53.77 0.79 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 173.66 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.647 -0.914 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -99.07 30.83 9.07 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -122.84 73.92 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.615 -0.932 . . . . 0.0 109.948 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -79.81 156.82 27.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.406 ' O ' ' CG ' ' A' ' 315' ' ' TRP . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -161.74 40.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.9 p -76.44 -56.91 4.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.558 -0.714 . . . . 0.0 110.038 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.3 p -127.38 121.97 32.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 110.26 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -103.69 -46.92 4.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.05 146.61 53.85 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.185 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.2 t -152.9 -44.56 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.621 -0.675 . . . . 0.0 110.246 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -127.49 105.19 21.41 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.616 -0.678 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.83 172.15 15.93 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.352 1.185 . . . . 0.0 110.19 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.1 tt -100.87 46.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.46 -0.775 . . . . 0.0 110.128 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.883 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 15.4 mmm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.107 0.48 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -130.61 -54.93 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 110.315 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.68 -45.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 93.0 p -75.38 142.73 43.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.484 -1.01 . . . . 0.0 110.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.96 -173.24 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -128.16 45.93 2.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.238 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -152.15 47.75 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.211 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -88.63 -49.14 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -142.01 -66.71 0.4 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.638 -0.664 . . . . 0.0 110.162 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -161.21 -174.62 4.42 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.597 -0.689 . . . . 0.0 110.283 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -118.61 64.67 0.4 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.2 m -136.63 127.3 27.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.6 -0.941 . . . . 0.0 110.285 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -152.14 -179.38 7.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.659 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -104.42 118.24 36.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.559 -0.713 . . . . 0.0 110.151 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -168.73 -41.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.012 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -89.71 -154.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.613 -0.68 . . . . 0.0 109.604 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -115.2 56.98 0.49 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 88.8 mt -111.39 137.78 48.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.563 -0.963 . . . . 0.0 110.256 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -66.9 170.01 7.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.378 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.54 89.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.613 -0.679 . . . . 0.0 110.234 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.72 -67.21 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -91.23 -104.31 1.34 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -151.05 95.1 2.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.756 -0.849 . . . . 0.0 110.167 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 52.8 t -89.95 158.17 17.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.475 HD12 HG23 ' A' ' 323' ' ' ILE . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.34 -32.58 9.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.3 t -67.65 -35.45 78.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.551 -0.718 . . . . 0.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.75 17.53 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.643 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 61.6 p -65.82 -53.85 34.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.64 -39.41 6.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 110.377 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -168.73 149.03 4.12 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.622 -0.674 . . . . 0.0 110.187 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.18 -165.08 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.434 1.229 . . . . 0.0 110.402 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -77.75 -173.82 3.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.524 -0.735 . . . . 0.0 110.13 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 354' ' ' GLU . 0.4 OUTLIER -144.39 -75.2 0.24 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.568 -0.707 . . . . 0.0 110.478 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 352' ' ' GLN . 16.1 m-85 3.78 63.23 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 352' ' ' GLN . 51.6 mt-10 2.1 69.45 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.88 -38.37 3.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -110.24 -61.69 1.62 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.489 -0.757 . . . . 0.0 110.445 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 pp -51.13 -50.0 59.7 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.463 -0.773 . . . . 0.0 111.5 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 89.0 m -59.37 -19.07 44.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.447 -0.783 . . . . 0.0 110.794 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.15 -16.63 46.63 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 111.272 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -56.41 -31.67 64.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.111 -0.993 . . . . 0.0 110.75 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.36 6.15 49.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.556 -0.715 . . . . 0.0 111.201 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -89.36 -29.09 19.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.96 . . . . 0.0 110.127 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 pt -58.55 -27.95 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.57 -0.706 . . . . 0.0 110.363 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -96.87 -20.38 18.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 367' ' ' PHE . 4.1 tp10 -68.54 -36.35 78.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.366 -0.834 . . . . 0.0 110.43 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 2.45 63.18 0.0 OUTLIER Glycine 1 N--CA 1.521 4.367 0 C-N-CA 124.398 0.999 . . . . 0.0 114.143 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 379' ' ' PHE . 26.3 p90 -84.99 9.46 14.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.762 -0.846 . . . . 0.0 111.323 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -61.31 -35.09 76.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.74 28.32 5.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.734 -0.604 . . . . 0.0 110.209 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -115.04 144.86 42.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -100.07 -28.21 13.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.612 -0.68 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -50.82 -26.1 5.3 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.353 -0.842 . . . . 0.0 111.056 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 44.4 t -104.53 -23.54 13.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.614 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.54 9.63 15.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.245 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 73.3 mt -112.66 -70.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.072 -1.018 . . . . 0.0 110.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -79.56 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.518 -0.739 . . . . 0.0 110.862 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.2 t -178.67 44.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.037 -1.04 . . . . 0.0 110.592 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -61.16 -54.62 42.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.14 -0.975 . . . . 0.0 109.986 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 367' ' ' PHE . 0.8 OUTLIER -108.1 86.47 2.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 109.809 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 6.8 mp -50.5 107.1 0.73 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.544 -0.722 . . . . 0.0 111.23 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.88 56.35 5.59 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.179 1.094 . . . . 0.0 110.487 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.6 t -107.0 39.43 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.447 -0.783 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -132.35 31.47 2.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -84.87 -28.46 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.66 -0.906 . . . . 0.0 110.325 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -60.89 -32.9 72.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -59.77 -20.21 55.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.646 -0.659 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.97 -10.45 53.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.416 -0.803 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -49.74 153.5 1.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.133 -0.979 . . . . 0.0 111.384 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -78.21 -16.05 58.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.683 -0.635 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -49.86 106.03 0.1 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.271 -0.893 . . . . 0.0 111.076 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -21.54 34.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 t -83.41 56.42 3.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -113.9 -33.66 5.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 109.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.45 -29.96 17.62 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 86.04 4.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.979 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -89.77 -27.9 20.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.402 ' CG ' ' O ' ' A' ' 427' ' ' ALA . 48.8 m-85 -94.06 151.45 19.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.953 . . . . 0.0 110.419 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -100.97 156.72 17.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 110.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.454 ' CE1' ' CG2' ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . 0.454 ' CG2' ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -113.75 25.24 11.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 68.2 p -86.5 -53.32 5.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.47 -0.769 . . . . 0.0 110.164 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 6.1 t -168.15 89.62 0.27 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.468 -0.77 . . . . 0.0 110.219 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -171.25 -165.48 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.47 -0.769 . . . . 0.0 110.093 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.23 125.9 43.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.008 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 49.8 m -118.65 164.49 15.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.726 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -102.79 102.67 28.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 110.16 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.9 -12.73 28.76 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.254 1.134 . . . . 0.0 111.247 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.55 -52.84 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.065 0.459 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -37.75 3.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.571 -0.706 . . . . 0.0 110.161 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -68.45 -36.48 84.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 22.6 t -116.01 -173.09 2.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.931 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -138.16 -168.25 2.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.558 -0.713 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -113.42 -170.97 1.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.287 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -60.01 131.53 51.14 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.581 -0.699 . . . . 0.0 110.389 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -62.82 179.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.566 -0.709 . . . . 0.0 110.194 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -90.25 162.62 15.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.56 -0.713 . . . . 0.0 110.152 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -107.38 -178.7 3.71 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.693 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -177.81 173.78 46.32 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.4 m -132.33 131.32 41.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.572 -0.958 . . . . 0.0 110.253 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -112.91 -28.58 7.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.525 -0.735 . . . . 0.0 110.34 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.24 115.14 19.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.257 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -127.71 -172.4 2.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.639 -0.663 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 323' ' ' ILE . 34.1 t80 -114.0 25.53 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.721 . . . . 0.0 110.463 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.38 92.82 0.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.95 160.32 43.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.582 -0.952 . . . . 0.0 110.82 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.423 ' CH2' HD11 ' A' ' 419' ' ' LEU . 0.1 OUTLIER -88.6 170.07 11.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.515 -0.741 . . . . 0.0 110.36 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.03 94.0 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -168.79 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 110.284 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -90.58 -89.68 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -139.99 36.29 1.95 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.95 . . . . 0.0 110.294 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.1 112.15 13.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.538 -0.726 . . . . 0.0 110.095 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.417 HG23 HD12 ' A' ' 323' ' ' ILE . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . 0.402 ' CD2' ' HD3' ' A' ' 351' ' ' LYS . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.0 tp -90.75 5.14 49.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.4 m -52.14 -28.56 18.41 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.0 110.55 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.69 -27.79 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.719 -0.613 . . . . 0.0 109.767 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.2 t -87.71 10.3 18.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.577 -0.702 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.52 8.64 43.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 111.1 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -56.82 149.55 42.38 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.39 118.91 5.82 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.514 1.271 . . . . 0.0 110.578 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . 0.402 ' HD3' ' CD2' ' A' ' 325' ' ' HIS . 5.0 mtpt -124.67 -64.64 1.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.605 -0.685 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.61 91.79 2.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 353' ' ' TYR . 32.0 p90 -140.31 24.77 2.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.518 -0.739 . . . . 0.0 110.583 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -169.79 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.433 -0.792 . . . . 0.0 110.096 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -62.59 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.56 -0.712 . . . . 0.0 110.24 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -68.06 -39.83 82.92 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.65 -27.69 68.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.505 -0.747 . . . . 0.0 110.188 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 20.2 m -99.32 -27.09 13.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.619 -0.676 . . . . 0.0 110.385 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.56 -25.11 53.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.573 -0.704 . . . . 0.0 110.373 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -81.49 -20.76 39.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.495 -0.753 . . . . 0.0 110.61 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -101.87 6.58 41.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.339 -0.851 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.45 -24.43 23.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.116 -0.99 . . . . 0.0 111.735 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 363' ' ' ILE . 0.2 OUTLIER -50.83 -23.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.23 -0.918 . . . . 0.0 111.508 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -24.37 21.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.385 -0.822 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 20.29 9.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -91.49 -50.11 2.83 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -169.19 32.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.958 . . . . 0.0 110.23 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -86.26 -29.7 22.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.639 -0.663 . . . . 0.0 110.242 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.75 105.55 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -106.16 -29.52 9.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.603 -0.685 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -93.78 -39.24 10.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.559 -0.713 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.31 -26.04 66.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.9 p -83.9 -22.88 31.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 110.641 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.79 -21.13 15.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.346 -0.846 . . . . 0.0 111.026 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.413 HG22 HD12 ' A' ' 375' ' ' ILE . 83.3 mt -116.27 -66.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.62 -41.84 82.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.698 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -76.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 110.277 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -150.88 -161.19 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -152.92 -45.33 0.1 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.45 85.68 7.42 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.57 -0.706 . . . . 0.0 110.798 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.67 71.33 1.99 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.276 1.145 . . . . 0.0 109.85 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.6 m -115.15 73.15 0.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -89.66 52.61 3.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -66.85 -11.31 55.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.685 -0.891 . . . . 0.0 110.397 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.03 -28.76 40.48 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.189 -0.945 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -66.44 -20.95 66.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.589 -0.694 . . . . 0.0 110.331 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.85 48.4 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.375 -0.828 . . . . 0.0 111.097 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.37 -165.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.15 -0.969 . . . . 0.0 110.76 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.5 mmt-85 -58.05 -25.74 61.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.558 -0.714 . . . . 0.0 110.531 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -52.1 -24.59 7.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 111.068 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -136.25 -43.54 0.63 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.2 t -83.93 57.63 4.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.548 -0.72 . . . . 0.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -91.41 45.69 1.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.607 -0.683 . . . . 0.0 110.493 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 108.32 17.68 10.47 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.7 149.76 50.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 -38.41 0.07 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.66 -36.38 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.499 -1.0 . . . . 0.0 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -47.58 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.435 -0.791 . . . . 0.0 111.797 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.423 HD11 ' CH2' ' A' ' 315' ' ' TRP . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 426' ' ' ILE . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 4.0 p -60.04 -35.72 75.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.564 -0.71 . . . . 0.0 110.344 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 40.7 p -99.99 91.84 4.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -165.0 -42.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.546 -0.721 . . . . 0.0 110.352 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 10.2 tt -81.36 -30.81 33.62 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.639 -0.663 . . . . 0.0 110.277 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.5 t -80.69 -28.65 36.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.55 -0.719 . . . . 0.0 110.29 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -155.95 162.49 27.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 110.277 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 143.4 37.49 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.447 1.235 . . . . 0.0 110.351 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.0 mt -70.64 -32.11 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.619 -0.675 . . . . 0.0 109.854 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.752 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -64.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.576 -0.702 . . . . 0.0 110.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.39 147.35 17.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 5.9 m -144.63 -63.07 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.966 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -83.05 139.03 33.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 110.171 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -116.05 -72.24 0.7 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -145.14 -44.61 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.562 -0.711 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -78.62 148.79 33.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.552 -0.717 . . . . 0.0 110.134 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -133.21 176.19 8.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.567 -0.708 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -126.44 163.68 22.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 110.168 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.22 -84.58 0.73 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.9 m -128.38 155.1 45.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.583 -0.951 . . . . 0.0 110.178 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -135.56 14.02 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -101.53 -179.54 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -152.04 29.1 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.649 -0.657 . . . . 0.0 110.216 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -144.84 -77.15 0.21 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.681 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.12 -69.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.42 153.92 25.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.981 . . . . 0.0 110.267 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.29 168.26 19.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.688 -0.632 . . . . 0.0 110.346 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.86 88.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.73 0.776 . . . . 0.0 109.933 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -175.75 34.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.659 -0.65 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.07 -117.18 0.93 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.07 20.93 0.87 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.45 -1.029 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t -93.43 169.97 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.919 . . . . 0.0 110.109 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.2 -3.15 26.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.06 -35.92 10.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.123 -0.986 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.46 18.02 22.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.728 -0.608 . . . . 0.0 110.66 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.79 10.53 11.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 111.421 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.52 -72.24 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.98 -1.075 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.93 54.63 0.25 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.468 -0.77 . . . . 0.0 110.61 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.85 111.23 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.296 1.156 . . . . 0.0 110.475 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -146.95 -74.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.662 -0.649 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -162.42 165.93 25.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 0.0 109.914 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -155.55 -44.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 31.9 5.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.675 . . . . 0.0 110.108 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.47 170.44 1.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.552 -0.718 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -82.44 -30.99 29.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.405 ' O ' ' CE2' ' A' ' 360' ' ' TYR . 2.1 mm? -61.13 -24.5 66.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.622 -0.674 . . . . 0.0 110.36 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 63.0 m -101.57 5.76 41.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.483 -0.761 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.94 -21.52 21.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.405 ' CE2' ' O ' ' A' ' 357' ' ' LEU . 26.2 p90 -99.97 -24.33 14.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.206 -0.934 . . . . 0.0 111.036 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.46 -16.35 60.37 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.465 -0.772 . . . . 0.0 111.02 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.05 -27.22 52.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 5.2 tp -100.12 -22.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.629 -0.67 . . . . 0.0 110.342 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -90.01 -27.7 19.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 110.224 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -93.02 20.29 6.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.565 -0.709 . . . . 0.0 110.805 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.55 -27.24 63.32 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -56.33 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.493 -1.004 . . . . 0.0 110.494 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -96.23 25.13 5.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -112.8 18.3 18.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.736 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -102.87 -33.22 9.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.039 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -100.07 -28.3 13.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.738 -0.601 . . . . 0.0 110.261 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.86 48.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.47 -0.769 . . . . 0.0 110.76 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.6 t -82.49 -23.52 34.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.598 -0.689 . . . . 0.0 110.347 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 14.1 mtt -79.91 -26.37 40.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.414 -0.803 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 375' ' ' ILE . 45.7 mm -59.13 -50.19 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.806 . . . . 0.0 110.03 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.46 -24.08 64.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.711 -0.618 . . . . 0.0 110.398 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.47 23.44 11.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.473 -0.767 . . . . 0.0 110.352 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -85.02 131.32 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.488 -0.758 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -64.83 81.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.717 -0.614 . . . . 0.0 110.132 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 7.4 mt -77.74 -57.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.69 . . . . 0.0 110.82 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 47.6 Cg_endo -73.28 -27.08 13.9 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.144 1.076 . . . . 0.0 110.711 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.9 p -94.86 -36.1 11.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.2 29.11 11.92 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -90.51 -24.31 20.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.947 . . . . 0.0 110.64 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.08 -21.53 54.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 110.986 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -89.65 -25.6 21.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.307 -0.871 . . . . 0.0 110.639 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.28 55.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 110.817 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -52.09 -54.24 32.79 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.156 -0.965 . . . . 0.0 111.866 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -122.27 111.49 16.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.329 -0.857 . . . . 0.0 111.138 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -91.31 46.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.774 -0.579 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -92.07 -22.45 19.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.5 p -58.53 -19.19 35.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.949 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -94.47 29.91 2.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.0 14.61 2.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -67.65 165.61 16.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.209 -1.171 . . . . 0.0 110.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -156.62 -60.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.421 ' CD2' ' HA ' ' A' ' 428' ' ' THR . 0.2 OUTLIER -128.98 -155.32 0.69 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.576 -0.955 . . . . 0.0 110.076 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -135.84 119.39 17.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.502 -0.749 . . . . 0.0 110.332 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . 0.418 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.501 HG21 HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.402 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . 0.418 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 426' ' ' ILE . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . 0.414 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -169.24 71.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' THR . . . . . 0.421 ' HA ' ' CD2' ' A' ' 397' ' ' TYR . 82.6 p -59.87 -52.74 64.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.415 -0.803 . . . . 0.0 110.226 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 10.2 p -137.25 101.48 4.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.0 110.146 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.13 -72.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.58 -0.7 . . . . 0.0 110.291 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -117.41 134.6 54.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.646 -0.659 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -115.34 28.81 8.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 11.6 p80 -169.5 76.02 0.69 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.79 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 64.0 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.3 1.158 . . . . 0.0 110.465 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.7 tp -76.56 -25.48 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.073 179.875 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 17.5 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.084 0.469 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -92.44 -66.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.618 -0.676 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -146.73 134.57 5.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.9 t -128.96 132.19 47.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.663 -0.904 . . . . 0.0 110.279 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -148.99 47.22 1.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.566 -0.708 . . . . 0.0 110.223 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -86.5 -36.38 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -126.0 -165.28 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -71.8 127.85 33.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -86.52 136.06 33.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 110.256 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -87.95 52.98 2.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.18 109.47 0.43 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 94.9 p -102.41 33.17 3.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.593 -0.945 . . . . 0.0 110.16 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -121.32 -71.46 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.696 . . . . 0.0 110.197 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -168.02 -176.3 2.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.626 -0.671 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -172.39 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.512 -0.742 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 314' ' ' LEU . 21.7 t80 -134.58 170.47 15.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.772 -0.58 . . . . 0.0 109.46 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -95.19 31.6 6.89 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.427 ' HB2' ' CE2' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -150.17 146.77 27.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -1.075 . . . . 0.0 110.17 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.411 ' CE2' HD23 ' A' ' 419' ' ' LEU . 12.9 p-90 -143.3 171.32 14.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.607 . . . . 0.0 109.669 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.405 ' O ' ' CD2' ' A' ' 315' ' ' TRP . 59.9 t -50.42 134.17 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.54 126.65 24.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.49 -43.56 0.02 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.28 -40.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -1.0 . . . . 0.0 110.901 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t -89.33 170.26 10.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.49 -0.757 . . . . 0.0 110.465 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.19 4.62 37.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.4 t -53.64 -29.22 37.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.094 -1.004 . . . . 0.0 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.8 -31.48 72.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.655 . . . . 0.0 109.674 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -98.22 10.5 40.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.654 -0.654 . . . . 0.0 110.897 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.42 8.97 40.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.195 -0.941 . . . . 0.0 111.116 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -102.48 98.43 10.79 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.207 -0.933 . . . . 0.0 110.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.13 -19.1 26.6 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.4 1.21 . . . . 0.0 110.931 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -55.92 -69.73 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.323 -0.86 . . . . 0.0 110.735 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.75 103.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.597 -0.689 . . . . 0.0 110.433 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.44 -50.34 1.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.694 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -149.32 77.75 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.609 -0.682 . . . . 0.0 110.343 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -165.21 -42.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.411 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -99.99 18.56 18.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.37 -40.59 96.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.421 -0.799 . . . . 0.0 110.057 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.4 m -60.24 -24.81 65.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.638 -0.664 . . . . 0.0 110.431 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -92.75 -25.85 18.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -0.771 . . . . 0.0 110.462 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.1 -27.94 35.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.524 -0.735 . . . . 0.0 110.526 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.85 -20.52 61.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.512 -0.742 . . . . 0.0 110.647 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -97.73 10.59 39.67 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.382 -0.824 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.68 -26.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -60.42 -32.83 71.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.404 -0.81 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -109.97 20.11 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.667 -0.646 . . . . 0.0 110.571 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.67 80.1 0.3 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.21 76.46 8.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.555 -0.968 . . . . 0.0 110.144 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -125.79 34.72 4.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.508 -0.745 . . . . 0.0 110.402 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -137.86 29.76 2.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.616 -0.677 . . . . 0.0 110.135 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -88.87 -157.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.585 -0.697 . . . . 0.0 110.172 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -79.26 -35.4 41.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.66 69.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.627 -0.671 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.9 t -94.63 -28.84 15.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 3.9 mtt -60.45 -27.32 67.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.563 -0.711 . . . . 0.0 110.28 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.63 -28.65 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.96 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -81.07 -27.28 35.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 7.4 m -99.1 -41.77 7.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.566 -0.709 . . . . 0.0 110.323 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -97.07 108.13 20.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.719 -0.613 . . . . 0.0 110.301 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -83.36 76.53 9.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.681 -0.637 . . . . 0.0 110.16 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -165.87 92.28 0.84 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.11 64.1 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.331 1.174 . . . . 0.0 110.378 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 17.6 p -80.29 -31.95 38.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.526 -0.734 . . . . 0.0 110.22 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -139.7 51.89 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -79.74 -28.19 40.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.682 -0.893 . . . . 0.0 110.277 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.96 -25.83 68.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.61 -0.681 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -19.94 44.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.432 -0.792 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.59 -19.26 36.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.415 -0.803 . . . . 0.0 110.688 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -57.01 -20.86 26.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.258 -0.901 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -55.3 135.98 49.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.337 -0.852 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -77.3 172.87 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.588 -0.695 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -52.4 -47.42 66.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 0.0 111.328 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.2 p -63.0 -27.18 69.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.599 -0.688 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -97.51 29.92 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.494 -0.754 . . . . 0.0 110.334 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -114.55 -38.08 1.12 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 396' ' ' GLY . 11.0 mttp -94.89 -70.85 0.69 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.272 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 395' ' ' LYS . . . 3.01 65.76 0.0 OUTLIER Glycine 1 N--CA 1.519 4.194 0 C-N-CA 124.722 1.153 . . . . 0.0 113.976 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 395' ' ' LYS . 65.9 t80 -146.98 62.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.732 . . . . 0.0 110.049 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -95.86 133.38 40.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.647 -0.658 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.419 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . 0.413 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.466 HG22 HD12 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.411 HD23 ' CE2' ' A' ' 315' ' ' TRP . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -147.34 104.63 3.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.4 p -80.13 -66.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 59.2 m -157.82 90.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.52 -0.737 . . . . 0.0 110.185 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.11 -74.93 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.238 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.4 pp -143.42 138.17 29.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 110.446 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.2 p -112.96 65.5 0.64 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.709 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . 0.402 ' HB3' ' HD3' ' A' ' 434' ' ' PRO . 4.5 t60 -75.61 -57.63 1.56 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.486 -0.759 . . . . 0.0 109.97 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 433' ' ' HIS . 46.0 Cg_endo -70.43 -166.27 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 122.962 0.98 . . . . 0.0 110.418 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.8 tp -162.51 -40.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 110.438 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.755 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.075 0.464 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -114.01 -26.06 8.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -143.34 155.27 25.96 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.9 p -147.46 -67.71 0.25 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.953 . . . . 0.0 110.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -134.43 165.93 24.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.697 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.95 -162.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.586 -0.696 . . . . 0.0 110.046 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.29 167.18 2.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.721 . . . . 0.0 110.243 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' -5' ' ' HIS . 16.5 m-70 -91.37 155.51 18.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.0 110.212 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -91.94 165.51 13.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . 0.414 ' CD2' ' HB1' ' A' ' 346' ' ' ALA . 32.5 m170 -137.48 -177.59 4.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.373 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -165.05 -159.14 11.03 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.1 t -169.12 92.28 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.508 -0.995 . . . . 0.0 110.25 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.13 147.59 4.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -160.03 173.2 16.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.595 -0.69 . . . . 0.0 110.12 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.37 -161.63 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.543 -0.723 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.428 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 3.9 t80 -150.25 94.63 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.636 -0.665 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -106.26 133.6 11.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.84 -165.51 1.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.647 -0.913 . . . . 0.0 110.066 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.43 ' CZ2' ' CB ' ' A' ' 320' ' ' CYS . 0.3 OUTLIER -162.78 170.56 18.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 33.9 m -68.62 170.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.565 -0.709 . . . . 0.0 110.039 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -57.74 117.74 4.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.458 -0.776 . . . . 0.0 110.577 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -144.51 -124.7 1.78 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -127.18 24.84 6.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.0 110.515 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.43 ' CB ' ' CZ2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -91.56 170.84 9.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.425 -0.797 . . . . 0.0 110.006 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.428 ' CD1' ' CZ ' ' A' ' 312' ' ' PHE . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.434 HG13 ' CD1' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . 0.415 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 mp -103.31 -42.66 5.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 61.4 m -89.89 -2.69 58.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.666 -0.646 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' A' ' -3' ' ' HIS . . . -86.53 9.15 19.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 39.8 t -60.8 -29.0 69.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.14 8.43 43.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.12 112.11 4.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 -169.01 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.178 1.094 . . . . 0.0 110.439 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.9 165.49 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 110.376 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -81.59 101.66 10.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.69 . . . . 0.0 110.019 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.92 -29.88 69.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.551 -0.718 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.18 -70.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.712 . . . . 0.0 110.204 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -168.33 -172.99 1.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -110.07 18.42 20.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.552 -0.718 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.84 -28.53 10.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' THR . . . . . 0.43 ' HA ' ' CE2' ' A' ' 360' ' ' TYR . 23.0 m -83.6 4.14 29.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 111.171 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.07 -17.73 28.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.198 -0.939 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.43 ' CE2' ' HA ' ' A' ' 358' ' ' THR . 23.6 p90 -55.37 -22.64 20.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.115 -0.991 . . . . 0.0 110.918 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.19 -17.72 54.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.379 -0.826 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -73.87 -4.23 33.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 111.547 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 35.5 pt -56.66 -25.71 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.964 -1.085 . . . . 0.0 110.447 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -17.9 22.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 110.558 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.6 20.67 6.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.353 -0.842 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.2 -27.83 63.34 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.88 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -1.062 . . . . 0.0 110.484 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 pttt -115.63 42.39 2.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.688 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -106.2 -29.93 9.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.581 -0.699 . . . . 0.0 110.079 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -105.23 -28.75 10.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 110.15 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -86.63 -32.1 20.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.624 -0.672 . . . . 0.0 110.405 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.66 68.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 t -105.02 5.07 32.27 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.574 -0.704 . . . . 0.0 111.178 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 15.1 mtt -105.16 -26.33 12.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 110.398 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 4.5 mp -134.33 -60.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -0.763 . . . . 0.0 109.899 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -55.91 -26.09 45.97 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.783 -0.573 . . . . 0.0 110.684 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.93 78.08 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.8 -47.62 4.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.749 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -103.72 91.24 3.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.679 -0.638 . . . . 0.0 109.633 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 380' ' ' LEU . 0.0 OUTLIER -128.08 52.31 8.5 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.661 -0.65 . . . . 0.0 111.144 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 47.8 Cg_endo -71.99 64.19 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.388 1.204 . . . . 0.0 110.331 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.0 t -165.44 71.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 110.131 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -60.15 -27.77 65.59 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.28 8.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.58 -0.953 . . . . 0.0 110.565 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -90.64 44.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.475 -0.766 . . . . 0.0 110.677 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 26.5 ttmt -90.42 -24.1 20.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.69 -18.88 34.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.471 -0.768 . . . . 0.0 110.649 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.64 -50.06 7.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 33.3 mtt85 -70.78 -23.02 62.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.682 -0.636 . . . . 0.0 110.524 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.61 154.85 1.77 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.376 -0.828 . . . . 0.0 110.955 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.44 175.19 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.599 -0.688 . . . . 0.0 110.214 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.4 m -89.98 52.26 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.55 -0.718 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -59.58 -21.14 59.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.616 -0.677 . . . . 0.0 110.663 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -78.53 -1.01 81.45 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -55.89 144.24 28.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.885 -1.362 . . . . 0.0 110.697 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.9 -62.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 397' ' ' TYR . 51.3 m-85 -137.1 -161.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.545 -0.973 . . . . 0.0 109.537 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -113.49 58.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.52 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.442 HD11 ' CD1' ' A' ' 399' ' ' TRP . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 412' ' ' PHE . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.421 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.401 ' HB2' ' CD1' ' A' ' 315' ' ' TRP . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 426' ' ' ILE . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -164.83 133.62 3.47 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 75.3 m -59.07 -81.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.251 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 1.1 p -160.11 97.28 1.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.61 70.78 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.721 . . . . 0.0 110.079 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.47 123.88 4.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.649 -0.657 . . . . 0.0 110.105 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 14.5 t -127.35 -179.03 4.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.557 -0.714 . . . . 0.0 110.372 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -86.34 147.26 44.17 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.51 -0.744 . . . . 0.0 110.124 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.0 -46.39 0.31 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.409 1.215 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.29 -32.42 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.702 -0.624 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.289 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.082 0.467 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -127.3 155.91 42.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.246 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -111.57 42.77 1.87 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 63.9 m -85.35 153.13 22.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.689 -0.889 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -71.8 129.91 39.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.541 -0.725 . . . . 0.0 110.322 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -157.61 -73.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -168.94 140.46 2.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -171.85 1.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.545 -0.722 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -151.86 -57.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 110.217 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -132.36 173.53 11.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.16 68.16 0.19 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -123.33 -158.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.525 -0.985 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.55 -33.2 23.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.582 -0.699 . . . . 0.0 110.055 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -142.56 179.41 6.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.587 -0.696 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.76 -46.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.715 . . . . 0.0 109.454 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.463 ' CG ' HD13 ' A' ' 323' ' ' ILE . 0.3 OUTLIER -113.92 -147.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -134.11 36.05 2.15 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.1 -164.91 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.929 -0.747 . . . . 0.0 110.239 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.424 ' CZ2' ' HA3' ' A' ' 318' ' ' GLY . 0.1 OUTLIER -51.64 146.05 8.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.258 -0.902 . . . . 0.0 111.339 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.51 92.03 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.882 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -169.35 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.424 ' HA3' ' CZ2' ' A' ' 315' ' ' TRP . . . -61.66 -108.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -149.39 17.41 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.972 . . . . 0.0 111.284 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.66 86.12 6.93 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.157 -0.964 . . . . 0.0 109.934 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.463 HD13 ' CG ' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.27 4.31 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.5 p -83.22 -31.57 26.97 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.241 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.38 -30.36 63.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.619 -0.675 . . . . 0.0 110.14 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.9 p -98.02 10.54 40.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.984 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.58 -26.3 13.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.171 -0.955 . . . . 0.0 110.425 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -110.82 76.22 1.17 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.432 -0.792 . . . . 0.0 110.241 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.18 -165.52 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -106.5 -71.3 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.619 -0.676 . . . . 0.0 110.234 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -106.35 169.55 8.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 0.0 110.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -75.63 -22.96 56.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.69 . . . . 0.0 110.565 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.59 27.14 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.407 -0.808 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -150.46 104.99 3.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.237 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -110.03 -25.86 10.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.55 -23.98 59.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.379 -0.825 . . . . 0.0 110.57 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 6.8 m -63.32 -15.64 57.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.399 -0.813 . . . . 0.0 110.962 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -54.39 -22.68 13.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.272 -0.892 . . . . 0.0 111.084 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -55.61 -22.63 23.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -10.89 57.22 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -74.18 -3.98 33.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.216 -0.928 . . . . 0.0 111.36 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 53.1 mt -58.88 -25.71 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.075 -1.016 . . . . 0.0 110.138 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -27.76 66.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.562 -0.711 . . . . 0.0 110.287 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -26.46 15.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.286 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -89.48 75.34 1.86 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.93 98.07 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.623 -0.928 . . . . 0.0 110.039 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.9 pttt -55.09 -22.36 16.11 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.466 -0.771 . . . . 0.0 111.094 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.58 -22.62 19.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.82 . . . . 0.0 111.068 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -104.75 -25.19 12.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.318 -0.864 . . . . 0.0 110.786 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -58.53 -27.85 64.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.436 -0.79 . . . . 0.0 110.629 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.63 93.39 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.509 -0.744 . . . . 0.0 110.494 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.3 t -105.18 13.82 30.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.652 -0.655 . . . . 0.0 111.041 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 6.6 tpt -105.15 -31.36 9.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.26 -0.9 . . . . 0.0 110.484 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 375' ' ' ILE . 81.9 mt -119.24 -52.0 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 110.208 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -66.61 -28.79 68.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.192 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 58.19 1.78 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.212 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.32 100.79 11.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.56 -0.713 . . . . 0.0 110.237 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -113.79 -27.16 7.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.406 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 5.5 mt -58.56 -56.38 36.17 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 46.8 Cg_endo -73.54 -29.54 10.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.311 1.163 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.96 83.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 109.929 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -115.91 -27.58 2.94 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.9 -18.74 24.85 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.984 . . . . 0.0 111.237 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.44 18.07 5.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.163 -0.96 . . . . 0.0 111.169 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -82.56 -24.39 34.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.27 -18.05 46.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.48 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.36 -166.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -100.98 -170.91 1.91 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.676 -0.64 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.11 162.61 9.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 110.144 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -158.61 0.88 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.66 -0.65 . . . . 0.0 110.087 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 66.5 m -90.17 53.03 2.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -59.93 -27.42 66.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.554 -0.716 . . . . 0.0 110.389 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -115.2 43.84 1.6 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.85 171.62 1.15 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.963 . . . . 0.0 110.336 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -163.24 38.11 0.33 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -83.52 -170.71 3.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.899 . . . . 0.0 110.237 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -105.84 152.42 23.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.624 -0.672 . . . . 0.0 110.081 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.414 HD21 ' CD1' ' A' ' 315' ' ' TRP . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . 0.46 HD12 HG22 ' A' ' 426' ' ' ILE . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -165.12 66.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 12.6 p -99.9 -51.99 3.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.61 -0.681 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 14.1 p -134.25 109.85 9.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.737 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.59 157.97 25.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.622 -0.674 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.61 39.51 1.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 90.9 p -165.33 -170.98 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.737 . . . . 0.0 110.269 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -96.01 151.94 38.61 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 110.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 126.9 11.79 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.368 1.194 . . . . 0.0 110.368 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 tp -151.11 61.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.113 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.085 0.469 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -168.53 48.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.98 119.35 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 m -141.08 37.58 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.974 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.2 84.99 2.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.189 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . 0.405 ' O ' ' CD2' ' A' ' -7' ' ' HIS . 0.6 OUTLIER -164.75 67.13 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.623 -0.673 . . . . 0.0 110.37 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -76.6 -71.78 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -166.32 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.714 . . . . 0.0 110.185 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -83.82 165.3 18.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.609 -0.682 . . . . 0.0 110.212 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -164.45 -167.04 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.74 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -159.22 172.21 35.86 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 t -119.24 51.41 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.498 -1.001 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.05 -153.69 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 109.866 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.03 128.93 38.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.457 -0.777 . . . . 0.0 109.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -168.81 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 0.0 109.661 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 2.3 t80 -129.2 -146.13 0.31 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.784 -0.572 . . . . 0.0 109.655 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -146.05 28.51 1.7 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.51 -163.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.56 -0.965 . . . . 0.0 110.095 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.45 ' CZ2' ' HB2' ' A' ' 320' ' ' CYS . 0.4 OUTLIER -165.9 160.12 16.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 110.005 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.46 87.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -178.65 -148.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -150.56 65.44 0.38 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.1 22.48 0.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.478 -1.013 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.45 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 85.3 m -135.9 170.43 16.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.722 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.436 ' CD1' ' CZ ' ' A' ' 312' ' ' PHE . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.43 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.54 2.54 25.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.5 p -60.06 -34.38 73.34 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.033 -1.042 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -89.72 -28.59 19.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.541 -0.725 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 27.5 m -89.39 10.54 22.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.506 -0.747 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -58.65 -33.39 70.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.128 -0.983 . . . . 0.0 110.428 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.36 135.94 13.51 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.39 179.19 6.11 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.237 1.125 . . . . 0.0 110.471 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -108.11 158.08 17.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.551 -0.718 . . . . 0.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -140.8 139.28 34.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.596 -0.69 . . . . 0.0 110.241 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -62.69 -44.45 96.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.679 . . . . 0.0 109.984 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -170.59 65.68 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.41 -73.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.534 -0.728 . . . . 0.0 110.054 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -99.35 18.29 18.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -88.75 -40.04 13.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.932 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -27.92 22.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.707 . . . . 0.0 110.353 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.39 -30.42 68.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.545 -0.722 . . . . 0.0 110.327 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -84.62 -15.71 44.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.11 -30.43 13.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -65.07 -16.77 63.83 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.533 -0.73 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.28 -30.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.247 -0.908 . . . . 0.0 110.732 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -100.02 -14.71 18.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.57 -0.706 . . . . 0.0 110.949 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.81 -23.22 28.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.184 -0.948 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.95 65.27 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -56.77 100.91 0.05 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -1.03 . . . . 0.0 110.57 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -48.89 -28.05 3.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.604 -0.685 . . . . 0.0 110.575 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.38 53.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -45.79 121.49 3.18 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.759 -0.588 . . . . 0.0 111.787 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -99.66 -9.04 23.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.741 -0.599 . . . . 0.0 110.755 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.99 51.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.99 . . . . 0.0 110.461 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 67.5 m -59.88 -32.81 71.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.558 -0.714 . . . . 0.0 110.065 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 5.1 mtt -98.36 -32.32 11.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.432 HD13 HG23 ' A' ' 375' ' ' ILE . 84.1 mt -72.43 -28.19 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.637 -0.665 . . . . 0.0 110.029 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -56.34 -27.64 56.51 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.517 -0.74 . . . . 0.0 110.473 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.9 m -85.14 -30.48 23.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.67 . . . . 0.0 109.972 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -121.35 90.74 3.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.66 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.28 -25.86 62.29 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 99.3 mt -124.35 95.74 42.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.514 -0.741 . . . . 0.0 110.241 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.6 -48.79 0.29 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.345 1.182 . . . . 0.0 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.6 m -159.55 -63.89 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.737 -0.602 . . . . 0.0 110.404 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -145.85 74.42 0.3 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -89.97 14.68 11.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.947 . . . . 0.0 110.681 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -90.18 -29.74 18.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.875 . . . . 0.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -80.36 -23.61 40.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.681 -0.637 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.69 44.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.35 -0.844 . . . . 0.0 110.397 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.78 -168.84 0.5 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.448 -0.783 . . . . 0.0 110.267 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -126.03 23.92 7.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.69 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -55.54 -23.4 26.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.324 -0.86 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.22 172.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.341 -0.85 . . . . 0.0 110.6 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 t -86.78 55.8 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.623 -0.673 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -104.45 76.85 1.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 127.76 -29.39 4.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.49 114.12 2.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.352 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -168.8 -53.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -67.42 -177.09 0.66 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.968 . . . . 0.0 110.402 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -119.27 139.59 51.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.4 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.43 ' CG ' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -167.22 109.71 0.67 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -37.87 88.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.597 -0.689 . . . . 0.0 110.086 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 7.5 t -143.66 110.99 5.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.363 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -118.71 -158.84 0.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.575 -0.703 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.27 63.99 2.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.072 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.3 m -150.14 102.6 3.11 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -129.31 67.04 78.13 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.725 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 -27.95 14.24 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.341 1.179 . . . . 0.0 110.507 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -62.27 -43.57 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.645 -0.659 . . . . 0.0 109.951 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.137 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.091 0.472 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -106.52 80.7 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.576 -0.703 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -128.56 118.25 2.72 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 17.5 t -86.04 -43.72 12.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.935 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.2 29.36 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.521 -0.737 . . . . 0.0 110.273 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -116.8 158.64 23.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -109.48 43.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.592 -0.692 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -102.69 131.08 49.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.526 -0.734 . . . . 0.0 110.246 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -137.25 168.82 18.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -135.58 58.83 1.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.687 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.51 148.11 43.19 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -124.71 178.74 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -160.03 136.52 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.61 -0.681 . . . . 0.0 110.288 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -146.21 61.34 1.24 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.563 -0.711 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.22 173.98 6.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.525 -0.734 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -144.77 64.66 1.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.327 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -110.9 90.43 0.57 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.81 -165.57 1.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.954 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.403 ' CD1' ' O ' ' A' ' 419' ' ' LEU . 68.2 t-105 -143.89 134.12 24.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.68 . . . . 0.0 109.467 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.23 89.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.566 -0.709 . . . . 0.0 109.877 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.58 -43.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -85.92 -90.96 0.89 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -149.94 26.74 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.572 -0.958 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m -89.34 170.71 10.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 110.671 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.42 HG11 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.35 -27.6 64.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.8 t -80.49 -25.94 38.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.752 . . . . 0.0 110.489 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.84 68.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.457 -0.777 . . . . 0.0 110.364 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 m -95.23 10.51 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.624 -0.673 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.98 -33.74 15.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.09 73.95 13.48 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.501 -0.749 . . . . 0.0 110.382 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.69 -29.54 15.74 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.355 1.187 . . . . 0.0 110.204 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -95.62 -169.8 2.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -81.03 73.16 8.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.552 -0.718 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.81 28.0 7.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.085 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -139.04 27.03 2.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.677 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.23 152.77 45.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.751 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 360' ' ' TYR . 34.7 m-70 -107.45 18.66 21.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.6 -0.688 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.79 -27.46 66.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.315 -0.866 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.9 m -77.53 -28.02 51.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.526 -0.734 . . . . 0.0 110.331 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 -27.13 16.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 356' ' ' HIS . 3.5 m-85 -80.47 1.32 29.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.538 -0.726 . . . . 0.0 111.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -56.51 -26.79 55.55 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.977 -1.077 . . . . 0.0 110.538 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -87.0 10.23 17.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.583 -0.698 . . . . 0.0 111.251 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.9 -21.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.189 -0.944 . . . . 0.0 110.775 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -54.99 -38.45 67.85 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 110.811 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.97 -25.81 18.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.702 -0.624 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.38 71.12 0.27 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -90.24 15.65 10.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.59 -0.947 . . . . 0.0 111.11 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -115.2 32.2 6.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -114.56 -40.21 3.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.596 -0.69 . . . . 0.0 110.164 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.412 ' HE2' ' CE1' ' A' ' 360' ' ' TYR . 26.0 mttt -69.33 -35.09 75.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.555 -0.716 . . . . 0.0 110.03 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.57 -28.74 69.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 110.187 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.69 73.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.115 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 41.1 t -104.98 -15.84 15.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.672 -0.642 . . . . 0.0 110.837 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 11.3 mtt -85.62 9.61 15.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 111.317 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 375' ' ' ILE . 87.4 mt -59.75 -30.85 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.096 -1.003 . . . . 0.0 109.757 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -65.05 -28.98 69.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.71 -0.619 . . . . 0.0 110.233 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.8 t -134.75 33.42 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.265 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -93.6 44.39 1.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -155.75 27.77 0.38 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.621 -0.674 . . . . 0.0 110.223 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.18 56.64 0.59 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.259 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.41 63.85 3.63 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.4 1.21 . . . . 0.0 110.529 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.5 m -127.66 -41.96 1.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.518 -0.739 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -126.29 52.44 0.81 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.55 -21.15 36.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.642 -0.916 . . . . 0.0 110.779 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -59.39 -60.5 3.75 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -86.23 -26.61 24.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.654 . . . . 0.0 110.264 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -65.09 -13.85 59.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.71 . . . . 0.0 110.584 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.63 166.3 3.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.212 -0.93 . . . . 0.0 110.286 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 -176.95 4.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.671 -0.643 . . . . 0.0 110.285 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.5 113.01 1.13 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 0.0 110.749 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.47 -162.37 0.4 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.16 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 m -83.37 58.37 4.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.589 -0.695 . . . . 0.0 110.064 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.69 76.28 0.19 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.71 -0.619 . . . . 0.0 110.155 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 170.72 -45.41 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 73.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.707 -0.878 . . . . 0.0 110.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -127.9 -55.6 0.12 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -141.75 -174.01 3.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.976 . . . . 0.0 110.081 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -90.63 149.58 22.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.583 -0.698 . . . . 0.0 110.088 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.408 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.42 ' CG ' HG11 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . 0.403 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -131.07 135.2 47.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.8 m -60.92 -48.34 82.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 0.0 110.16 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 9.1 m -154.03 98.28 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.528 -0.733 . . . . 0.0 110.226 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.69 153.83 9.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.55 -0.719 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -91.16 123.59 34.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.56 -0.713 . . . . 0.0 110.068 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 43.1 t -116.06 108.46 16.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -144.54 53.64 2.27 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 134.49 21.88 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.314 1.165 . . . . 0.0 110.468 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.5 tt -123.42 58.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.594 -0.691 . . . . 0.0 110.129 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.154 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.055 0.455 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -94.34 107.88 19.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 110.162 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.77 124.9 1.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.8 m -85.15 -37.42 20.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.947 . . . . 0.0 110.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -167.56 168.63 12.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.697 . . . . 0.0 110.249 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' -7' ' ' HIS . 4.6 p80 -148.39 60.46 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.676 . . . . 0.0 110.248 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.87 91.82 6.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.473 -0.767 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -118.56 -60.09 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.615 -0.678 . . . . 0.0 110.104 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -102.27 164.98 11.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.677 -0.639 . . . . 0.0 110.18 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -91.66 143.38 26.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.557 -0.714 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -103.99 51.54 0.81 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.2 p -166.76 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.913 . . . . 0.0 110.14 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.23 -29.14 69.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.61 113.78 2.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.581 -0.7 . . . . 0.0 110.122 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -107.75 -26.65 10.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.685 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -104.71 -79.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.485 -0.759 . . . . 0.0 110.231 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.34 -64.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.4 167.78 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.931 . . . . 0.0 110.764 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 170.11 16.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 110.112 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.66 87.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.522 -0.736 . . . . 0.0 109.574 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -178.16 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 109.987 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.81 -117.85 0.71 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -145.3 40.08 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.506 -0.996 . . . . 0.0 110.761 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t -89.53 158.06 17.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 10.1 tt -101.9 -28.29 12.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.1 m -86.53 -28.25 23.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.53 -0.731 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.54 82.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 110.286 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 p -93.74 10.53 32.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.499 -0.751 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.96 -27.92 16.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.47 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -153.55 89.62 3.51 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.572 -0.705 . . . . 0.0 110.48 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.14 -20.24 21.81 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.458 1.241 . . . . 0.0 110.701 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -53.13 -54.81 30.28 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.334 -0.854 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -48.73 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.661 -0.649 . . . . 0.0 111.507 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -103.27 -31.83 9.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.695 -0.628 . . . . 0.0 109.596 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -121.63 65.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.706 -0.621 . . . . 0.0 109.727 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 97.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.509 -0.744 . . . . 0.0 111.308 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -110.11 -29.19 8.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.767 . . . . 0.0 109.999 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 6.7 mp -78.3 -15.63 58.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.636 -0.665 . . . . 0.0 111.002 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 29.0 m -51.52 -24.27 5.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.162 -0.961 . . . . 0.0 111.203 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.01 -18.07 62.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.733 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -98.05 1.75 48.06 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 111.589 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -10.85 55.14 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.087 -1.008 . . . . 0.0 111.112 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -50.93 -24.26 3.49 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.027 -1.046 . . . . 0.0 111.271 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.43 -38.15 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.284 -0.885 . . . . 0.0 110.664 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.64 -22.89 14.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.546 -0.721 . . . . 0.0 109.788 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 367' ' ' PHE . 0.6 OUTLIER -96.19 23.07 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 110.411 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.68 80.43 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 365' ' ' GLU . 1.6 m-85 -77.2 106.7 9.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.68 -0.894 . . . . 0.0 108.929 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -39.69 -31.49 0.11 Allowed 'General case' 0 N--CA 1.511 2.588 0 CA-C-O 121.281 0.562 . . . . 0.0 111.929 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -98.42 43.77 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 109.448 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -79.34 -55.35 5.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.654 -0.654 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.81 7.09 13.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 111.69 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.65 -42.99 12.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.163 -0.961 . . . . 0.0 110.295 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.5 m -106.15 -19.8 13.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 111.459 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 17.5 mmt -78.89 0.51 27.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.229 -0.919 . . . . 0.0 111.554 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.32 -29.45 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 109.662 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -101.49 -23.81 14.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.722 -0.611 . . . . 0.0 110.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 t -115.53 26.04 10.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.453 -0.78 . . . . 0.0 110.716 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . 0.406 ' O ' ' CG ' ' A' ' 379' ' ' PHE . . . -71.2 65.49 0.4 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.493 -0.755 . . . . 0.0 110.26 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.406 ' CG ' ' O ' ' A' ' 378' ' ' ALA . 10.2 m-85 -161.27 91.24 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.504 -0.747 . . . . 0.0 110.076 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 380' ' ' LEU . 0.0 OUTLIER -153.15 51.92 0.78 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.633 -0.667 . . . . 0.0 110.98 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 46.5 Cg_endo -73.73 -29.31 10.71 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.29 1.153 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.7 m -92.91 -24.78 18.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . 0.416 ' HA2' ' CE2' ' A' ' 385' ' ' PHE . . . -136.33 59.35 0.64 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -56.86 -24.0 48.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.562 -0.964 . . . . 0.0 110.495 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 386' ' ' LYS . 25.5 p90 -69.32 -25.96 64.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 385' ' ' PHE . 11.7 tttp -87.52 5.38 39.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.709 . . . . 0.0 111.258 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.37 -26.94 67.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.189 -0.945 . . . . 0.0 110.241 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.64 144.43 43.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.353 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -76.97 -64.6 1.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.589 -0.695 . . . . 0.0 110.009 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -87.5 -168.98 2.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 110.113 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -45.55 2.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 109.885 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.5 m -90.13 50.73 1.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.57 -0.706 . . . . 0.0 110.284 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -118.65 79.3 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 110.192 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 129.32 -39.59 1.82 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -75.78 67.42 2.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.551 -0.97 . . . . 0.0 110.096 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -131.57 40.95 1.57 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -149.89 -171.68 3.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.513 -0.992 . . . . 0.0 110.27 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.82 139.82 30.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.637 -0.664 . . . . 0.0 110.129 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.501 HD11 HG21 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -151.72 42.16 0.7 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 5.7 m -61.67 -28.06 69.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.519 -0.738 . . . . 0.0 110.219 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 6.1 m -135.25 136.44 41.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.56 -0.712 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -62.87 -28.31 69.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.553 -0.717 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 9.0 tt -73.36 134.32 44.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.479 -0.763 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 60.4 m -117.61 -74.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -145.63 59.87 6.15 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.73 -28.35 13.95 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.338 1.178 . . . . 0.0 110.267 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.9 81.74 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.641 -0.662 . . . . 0.0 109.914 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.186 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.098 0.475 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.64 169.86 18.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.282 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -71.54 161.73 54.23 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.21 176.18 12.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.923 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -130.15 71.39 1.45 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.549 -0.72 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' -5' ' ' HIS . 2.2 p-80 -119.11 -167.68 1.44 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.519 -0.738 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -63.84 -73.36 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' -7' ' ' HIS . 23.1 p80 -143.39 -172.9 3.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.26 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -62.6 122.54 16.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.645 -0.659 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -130.14 -44.5 1.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.142 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.8 42.04 2.07 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 m -114.11 -64.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.693 -0.886 . . . . 0.0 110.151 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -88.34 -29.78 20.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -120.84 -167.51 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -148.41 29.1 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.413 ' CE1' HG13 ' A' ' 323' ' ' ILE . 1.9 t80 -113.52 86.21 2.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -125.87 126.34 5.81 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.76 161.34 30.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.534 -0.98 . . . . 0.0 110.438 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 320' ' ' CYS . 0.0 OUTLIER -57.56 168.85 0.75 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.1 t -65.04 163.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.598 -0.689 . . . . 0.0 109.954 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -61.43 91.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.589 -0.694 . . . . 0.0 110.205 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -96.38 -93.33 1.82 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -123.19 25.51 8.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.962 . . . . 0.0 110.429 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . 0.42 ' HB3' ' CH2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -150.06 154.61 38.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.515 -0.741 . . . . 0.0 110.112 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.413 HG13 ' CE1' ' A' ' 312' ' ' PHE . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.425 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.43 ' O ' ' CZ2' ' A' ' 399' ' ' TRP . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.415 ' HA ' ' CZ3' ' A' ' 399' ' ' TRP . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . 0.405 ' CD2' ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? -92.12 6.75 45.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.9 t -97.8 -35.31 10.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.44 67.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 31.4 m -63.31 -28.41 69.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.506 -0.746 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.25 -65.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -158.37 155.48 25.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 110.298 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.97 122.64 7.82 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.396 1.208 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -121.98 -65.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.58 -0.7 . . . . 0.0 110.155 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -84.96 113.18 21.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.67 -48.19 3.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 0.0 110.305 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.74 65.99 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.601 -0.687 . . . . 0.0 110.507 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.78 -160.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.0 110.038 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -90.54 18.35 6.39 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.32 -0.862 . . . . 0.0 111.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -26.7 14.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.328 -0.857 . . . . 0.0 110.198 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 60.3 m -89.46 -24.33 21.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.756 . . . . 0.0 110.584 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -75.11 -28.73 60.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.424 -0.798 . . . . 0.0 110.483 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -74.66 -39.62 61.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.578 -0.702 . . . . 0.0 110.239 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.65 6.64 23.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.46 -27.26 46.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 110.663 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 31.0 pt -100.14 -28.26 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 111.099 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -100.63 -26.53 13.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 110.307 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 367' ' ' PHE . 5.4 tt0 -111.76 -4.29 14.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.553 -0.717 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 4.89 56.8 0.0 OUTLIER Glycine 1 N--CA 1.523 4.471 0 C-N-CA 124.422 1.01 . . . . 0.0 114.403 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 365' ' ' GLU . 43.7 p90 -61.53 102.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.965 0.888 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -23.39 12.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -106.26 40.9 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -104.65 -76.6 0.6 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -85.37 -39.04 18.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.583 -0.698 . . . . 0.0 110.154 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.49 -21.94 60.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.713 -0.617 . . . . 0.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 18.2 t -76.83 -52.06 10.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.495 -0.753 . . . . 0.0 109.989 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -67.85 0.42 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.615 -0.678 . . . . 0.0 109.731 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 4.5 pt -152.06 -110.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.715 . . . . 0.0 109.529 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -115.17 -33.88 5.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.674 -1.266 . . . . 0.0 109.951 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.39 107.29 3.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.594 . . . . 0.0 109.717 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -60.1 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.655 -0.653 . . . . 0.0 110.758 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 379' ' ' PHE . 60.0 t80 -138.77 94.26 2.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 380' ' ' LEU . 7.6 mp -103.22 96.87 8.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.723 . . . . 0.0 110.682 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.44 -26.8 16.6 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.381 1.201 . . . . 0.0 110.194 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.3 t -128.67 77.34 1.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.732 . . . . 0.0 109.809 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -93.56 48.34 2.33 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.57 40.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.951 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -55.47 -26.68 43.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.298 -0.876 . . . . 0.0 110.55 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -65.74 -13.95 60.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.576 -0.703 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.95 -20.9 18.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.934 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -23.75 8.88 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.304 -0.872 . . . . 0.0 111.041 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.85 153.48 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.488 -0.757 . . . . 0.0 110.331 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.34 -74.93 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.406 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -114.52 159.65 20.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.575 -0.703 . . . . 0.0 110.324 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.1 m -90.21 49.88 1.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.597 -0.689 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -86.96 80.33 8.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.489 -0.757 . . . . 0.0 110.316 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 81.12 45.97 7.27 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 15.69 2.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.589 -0.948 . . . . 0.0 110.9 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -137.9 69.67 0.49 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 397' ' ' TYR . 6.7 p90 -170.54 100.79 0.25 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -1.024 . . . . 0.0 110.15 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -169.65 -40.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.507 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.425 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.479 HG21 HD11 ' A' ' 420' ' ' ILE . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -156.81 77.5 0.9 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -34.9 75.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.437 -0.789 . . . . 0.0 110.024 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 21.5 p -146.59 93.91 2.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.695 . . . . 0.0 110.242 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.38 -165.17 1.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.38 98.77 0.07 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.606 -0.684 . . . . 0.0 110.264 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 15.4 p -150.28 128.76 12.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 110.298 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 433' ' ' HIS . 4.5 p80 -150.71 67.06 7.8 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.596 -0.69 . . . . 0.0 110.215 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.29 -28.88 11.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.381 1.201 . . . . 0.0 110.508 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -104.42 74.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.514 -0.741 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.769 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.063 0.459 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -88.87 -64.81 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.589 -0.695 . . . . 0.0 110.112 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -75.36 103.41 1.6 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.37 -177.82 3.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.58 -0.953 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.48 -169.53 2.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 110.211 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 91.04 2.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.763 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -88.5 95.54 10.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.614 -0.679 . . . . 0.0 110.231 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -120.26 72.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.595 -0.691 . . . . 0.0 110.239 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -114.46 -61.32 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.18 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -148.47 34.15 0.79 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.3 165.71 19.55 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.7 m -83.95 -57.67 3.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.556 -0.967 . . . . 0.0 110.129 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -86.21 136.36 33.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.525 -0.735 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.99 -73.25 0.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.501 -0.749 . . . . 0.0 110.196 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -151.36 166.63 30.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.54 -0.725 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.436 ' CD1' ' HA ' ' A' ' 324' ' ' PRO . 3.9 t80 -106.1 114.78 29.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.807 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -124.48 125.17 5.67 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.05 157.91 43.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.654 -0.909 . . . . 0.0 110.248 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.405 ' CD1' ' O ' ' A' ' 315' ' ' TRP . 6.5 t-105 -74.92 103.14 5.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.01 117.5 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.693 -0.629 . . . . 0.0 110.714 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -168.13 -74.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 179.58 38.64 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -149.85 -35.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.628 -0.925 . . . . 0.0 111.502 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m -88.67 169.86 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.484 HD13 HG21 ' A' ' 323' ' ' ILE . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . 0.436 ' HA ' ' CD1' ' A' ' 312' ' ' PHE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.411 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.411 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -103.16 4.33 36.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.5 t -52.83 -26.87 15.9 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.094 -1.004 . . . . 0.0 110.737 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.51 -22.37 64.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.56 -0.712 . . . . 0.0 110.232 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' SER . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 412' ' ' PHE . 60.7 p -86.35 10.06 16.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 111.199 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -87.45 9.32 21.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 111.041 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -50.73 167.26 0.27 Allowed Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.063 -1.023 . . . . 0.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.74 -167.18 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.425 1.224 . . . . 0.0 110.316 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -92.54 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.673 -0.642 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.38 -26.58 67.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.77 -24.57 51.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.492 -0.755 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.2 69.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.489 -0.757 . . . . 0.0 110.248 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.28 49.05 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.43 -0.794 . . . . 0.0 110.286 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -108.88 18.93 20.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.819 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.63 -38.73 82.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 15.2 m -62.54 -28.44 69.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.504 -0.747 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -97.58 -18.1 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.597 -0.689 . . . . 0.0 110.702 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.41 1.03 52.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -57.28 -23.84 50.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -89.07 -19.52 25.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.393 -0.817 . . . . 0.0 110.727 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -75.66 -22.15 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.33 -0.856 . . . . 0.0 110.599 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.08 65.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -20.77 21.69 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.562 -0.711 . . . . 0.0 110.747 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.93 85.53 0.89 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.8 -5.6 41.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.946 . . . . 0.0 111.458 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -26.39 68.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -147.51 92.67 2.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.745 . . . . 0.0 110.237 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.94 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.205 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -100.21 -4.24 29.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.15 73.35 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.4 t -105.22 12.97 31.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 111.12 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.5 ttt -105.21 -29.81 10.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.557 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.79 -54.32 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 110.319 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -57.33 -25.9 60.1 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.607 -0.683 . . . . 0.0 110.692 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.2 m -84.34 -25.93 28.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 110.319 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.73 97.73 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.418 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.58 -77.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.715 -0.616 . . . . 0.0 109.705 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . 0.459 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 13.9 mt -107.55 -65.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 111.161 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 55.4 Cg_endo -73.81 76.6 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.619 0.799 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 8.4 t -80.88 57.26 2.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.487 -0.758 . . . . 0.0 110.447 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -148.0 74.17 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.36 27.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.557 -0.967 . . . . 0.0 110.852 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.22 -69.9 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.402 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -78.74 -22.24 46.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.95 -16.3 50.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 110.664 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -73.76 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.189 -0.945 . . . . 0.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 65.88 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.606 -0.684 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 390' ' ' TYR . 26.4 p90 -81.78 145.01 30.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.5 -0.75 . . . . 0.0 110.268 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.09 -167.08 1.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.417 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.91 52.92 2.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.13 -22.43 13.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.619 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -59.52 -50.17 70.66 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -60.54 134.85 57.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.535 -0.979 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -165.7 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.48 177.85 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.96 . . . . 0.0 110.184 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -74.62 130.0 38.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 109.987 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 347' ' ' SER . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -127.98 100.49 5.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 9.9 p -60.73 -38.08 83.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 8.0 t -144.66 116.66 8.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.598 -0.689 . . . . 0.0 110.245 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -57.89 165.46 1.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 6.8 mt -88.65 -165.67 1.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.184 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 33.9 t -81.15 -155.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.597 -0.689 . . . . 0.0 110.174 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.5 156.57 22.21 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.437 -0.789 . . . . 0.0 110.411 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.44 -29.91 10.63 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.377 1.199 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . 0.421 HD12 HG22 ' A' ' 435' ' ' ILE . 81.0 mt -72.97 79.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.055 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.302 -179.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.7 ptp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.079 0.466 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 40.3 mtm-85 -123.01 -177.4 3.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.592 -0.692 . . . . 0.0 110.155 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -151.18 125.48 1.9 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 6.9 m -110.21 -29.95 7.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.587 -0.949 . . . . 0.0 110.183 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . 0.459 ' CD2' ' N ' ' A' ' -8' ' ' HIS . 0.4 OUTLIER -62.0 -164.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.583 -0.698 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -57.91 -56.36 23.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.558 -0.714 . . . . 0.0 110.693 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.31 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.515 -0.74 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -79.13 -50.51 10.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.0 110.302 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -119.72 -169.13 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.537 -0.727 . . . . 0.0 110.285 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -125.13 46.97 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.41 158.94 27.9 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 43.9 t -88.82 171.96 9.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.84 115.93 27.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . . . -170.15 164.58 9.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.62 -0.675 . . . . 0.0 109.959 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 0.75 71.34 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.193 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.407 ' CE2' HG22 ' A' ' 323' ' ' ILE . 8.5 t80 -146.83 -61.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.668 -0.645 . . . . 0.0 109.379 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.72 23.56 1.04 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.8 mt -123.48 157.82 32.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -1.09 . . . . 0.0 110.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -165.3 173.7 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.659 -0.65 . . . . 0.0 109.654 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 90.8 t -45.75 167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.692 -0.63 . . . . 0.0 111.23 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -43.78 112.14 0.36 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.526 -0.734 . . . . 0.0 112.147 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -128.62 -115.39 1.85 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -150.22 30.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.966 . . . . 0.0 110.454 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.19 137.88 34.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.516 -0.74 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.407 HG22 ' CE2' ' A' ' 312' ' ' PHE . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.416 ' CE1' HD12 ' A' ' 340' ' ' LEU . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . 0.442 ' CG1' ' CH2' ' A' ' 399' ' ' TRP . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt -81.32 4.87 19.1 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.5 p -89.83 -43.32 10.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.34 -26.1 16.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.356 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.1 t -78.97 -19.56 51.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.841 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.05 -31.62 65.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.288 -0.882 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 132.63 78.02 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.108 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.18 157.59 46.04 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.18 1.095 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -103.33 -58.55 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.582 -0.699 . . . . 0.0 110.121 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.05 105.81 8.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 110.25 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -150.62 28.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 110.354 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.73 -29.48 6.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.549 -0.72 . . . . 0.0 110.344 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -87.56 -24.73 23.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -92.12 18.34 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.416 -0.802 . . . . 0.0 110.913 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tp -76.4 -19.87 57.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.285 -0.884 . . . . 0.0 110.666 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.96 -26.04 14.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -0.82 . . . . 0.0 110.646 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.69 -19.0 46.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.08 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -56.24 -24.59 43.36 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.61 -53.79 42.0 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.438 -0.788 . . . . 0.0 111.064 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -59.26 -15.48 15.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.706 -0.621 . . . . 0.0 111.968 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 47.0 mm -57.21 -37.64 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -29.72 70.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.443 -0.785 . . . . 0.0 110.095 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -97.8 21.02 11.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.672 -0.642 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -56.01 -26.69 49.35 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.35 53.17 2.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.989 . . . . 0.0 110.381 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 369' ' ' ASN . 4.7 pttm -103.19 56.96 0.75 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 368' ' ' LYS . 5.8 t30 2.09 68.31 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -139.69 -50.87 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -58.42 -27.9 64.75 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.888 -0.507 . . . . 0.0 110.601 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.45 67.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.577 -0.702 . . . . 0.0 110.459 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.4 t -105.19 14.48 29.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -26.85 12.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 71.0 mt -102.79 -63.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.115 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.27 58.84 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.64 -0.662 . . . . 0.0 110.424 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.9 t -169.97 -40.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.24 -59.58 2.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.642 . . . . 0.0 110.305 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -124.98 71.13 1.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.601 -0.687 . . . . 0.0 110.222 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 8.5 mt -58.83 110.86 2.96 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 110.089 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.22 -55.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.215 1.113 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.6 t -170.64 78.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.313 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -60.81 -30.51 73.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -61.64 -24.06 66.46 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.569 -0.959 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -90.82 22.92 3.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.391 -0.818 . . . . 0.0 111.105 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -84.02 5.08 27.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.29 -0.881 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.132 -0.98 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -55.36 -24.1 27.67 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.378 -0.826 . . . . 0.0 110.946 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -56.66 -24.21 47.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 110.772 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.2 -75.28 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -0.787 . . . . 0.0 110.538 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -129.46 -39.95 1.46 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 110.711 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.5 m -84.83 53.79 2.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.418 -0.801 . . . . 0.0 110.72 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 393' ' ' HIS . 0.7 OUTLIER -89.01 61.63 5.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.32 39.36 0.8 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -58.49 -25.21 62.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.637 -0.92 . . . . 0.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -97.49 27.14 20.03 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 396' ' ' GLY . 64.1 m-85 -153.77 27.76 0.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.467 -1.019 . . . . 0.0 110.302 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . 0.417 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 -87.98 76.2 8.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.442 ' CH2' ' CG1' ' A' ' 341' ' ' VAL . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.442 ' N ' ' CD1' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.406 ' CD2' HG11 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.75 69.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.9 p -75.74 124.83 27.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 110.074 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.9 p -63.58 89.68 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.07 151.05 47.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.708 . . . . 0.0 110.164 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.28 -45.87 11.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.571 -0.706 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 77.5 p -168.26 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.715 . . . . 0.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -105.95 126.49 30.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.583 -0.698 . . . . 0.0 110.206 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -76.94 59.43 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.127 1.067 . . . . 0.0 110.651 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.51 -44.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 109.936 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.515 -179.96 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.253 0.549 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -117.41 38.08 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -125.95 61.69 0.62 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 18.4 p -124.8 151.82 44.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.982 . . . . 0.0 110.265 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -164.22 -178.33 5.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.589 -0.694 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.18 123.26 42.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -88.19 135.82 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 110.143 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -116.53 144.74 43.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.501 -0.749 . . . . 0.0 110.252 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -130.37 46.85 2.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.172 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -146.78 155.14 42.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -166.97 -68.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.8 m -105.09 156.91 17.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.601 -0.941 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.78 -51.78 5.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.147 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.15 140.26 51.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -156.14 128.42 7.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 0.0 110.254 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -94.32 44.46 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -126.63 -173.88 13.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 2.0 pp -150.15 117.59 6.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.646 -0.914 . . . . 0.0 110.198 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' TRP . . . . . 0.413 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 1.0 OUTLIER -55.86 125.44 21.37 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 110.731 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.49 90.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -149.75 -62.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.72 . . . . 0.0 110.324 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -77.36 -112.11 0.16 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.36 27.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.905 . . . . 0.0 110.179 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t -96.93 95.6 7.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.689 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.419 HG13 ' CG ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.5 mt -77.83 -29.63 50.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -25.59 65.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.589 -0.694 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.76 -32.28 23.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.47 -0.769 . . . . 0.0 110.256 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.4 t -72.52 -21.5 61.18 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.6 -0.688 . . . . 0.0 110.585 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.28 -20.63 29.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 110.955 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -51.74 149.5 8.44 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.93 -166.98 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.414 1.218 . . . . 0.0 110.573 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -98.53 -168.68 1.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 110.237 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -77.99 117.94 19.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -155.47 30.09 0.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.529 -0.732 . . . . 0.0 110.117 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -133.05 -64.44 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -145.07 -169.52 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -109.69 -30.78 7.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.656 -0.653 . . . . 0.0 110.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.37 -29.44 17.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.516 -0.74 . . . . 0.0 110.321 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.7 m -58.36 -26.18 62.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.78 -20.45 42.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 110.66 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.57 -25.93 18.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.683 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -90.73 -20.29 22.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.45 -0.781 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -63.08 -18.05 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -0.848 . . . . 0.0 110.791 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.11 -26.92 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.314 -0.866 . . . . 0.0 109.917 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -91.56 -30.86 16.15 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.08 20.53 18.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.531 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -78.92 83.46 1.27 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -80.11 80.95 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.552 -0.969 . . . . 0.0 110.071 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -156.46 28.85 0.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 110.435 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -87.09 -39.44 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -168.87 -67.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.561 -0.712 . . . . 0.0 110.321 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -53.91 -23.84 14.12 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.698 -0.626 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.78 -34.84 73.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.477 -0.764 . . . . 0.0 110.302 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 73.2 m -104.93 13.09 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.782 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 12.7 mmt -104.48 -12.44 16.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.297 -0.877 . . . . 0.0 110.817 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.18 -31.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.278 -0.889 . . . . 0.0 109.931 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -94.71 -32.62 13.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 56.9 p -114.36 33.8 5.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.772 -0.58 . . . . 0.0 109.968 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -57.63 113.22 1.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.715 -0.616 . . . . 0.0 110.727 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.31 86.05 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.584 -0.698 . . . . 0.0 109.802 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 9.4 mt -53.57 124.15 40.27 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.22 -26.89 17.25 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.127 1.067 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 36.8 p -61.03 -29.16 69.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.5 42.64 1.06 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -85.46 -28.22 25.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 110.333 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.62 -39.97 90.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.521 -0.737 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -90.29 -20.88 22.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.705 -0.622 . . . . 0.0 110.727 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.71 -19.24 38.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.77 142.75 52.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.424 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -124.09 -157.46 0.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.666 -0.646 . . . . 0.0 110.312 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.47 179.33 6.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.509 -0.744 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -107.28 -38.02 6.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.612 -0.68 . . . . 0.0 110.339 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 59.7 p -85.63 -28.11 24.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.235 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -85.13 82.01 8.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.586 -0.696 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 110.58 34.67 2.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.72 126.72 28.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.545 -0.973 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.79 56.29 0.14 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.1 32.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.94 . . . . 0.0 110.189 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -135.67 129.93 33.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 110.067 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 411' ' ' ILE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.419 ' CG ' HG13 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -129.31 58.1 1.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.5 p -124.89 -46.34 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.553 -0.717 . . . . 0.0 110.129 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 6.4 t -151.67 104.22 3.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.58 -0.7 . . . . 0.0 110.183 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.02 151.83 20.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.59 -20.15 9.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.566 -0.709 . . . . 0.0 110.776 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -26.83 13.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -70.36 -56.74 6.41 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.445 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.82 171.85 16.54 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.155 1.082 . . . . 0.0 110.363 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 16.7 tt -60.56 -27.74 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 110.306 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.275 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.035 0.445 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 323' ' ' ILE . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.468 ' HG3' HG21 ' A' ' 420' ' ' ILE . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.614 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.56 ' CD1' HD23 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 340' ' ' LEU . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 340' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.054 0.454 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 404' ' ' THR . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.67 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.67 ' N ' HD13 ' A' ' 411' ' ' ILE . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 324' ' ' PRO . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 324' ' ' PRO . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 332' ' ' ILE . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.601 ' O ' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 339' ' ' LYS . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 341' ' ' VAL . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.669 ' N ' HD21 ' A' ' 398' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.295 0.569 . . . . 0.0 110.97 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.911 ' HA3' HD13 ' A' ' 411' ' ' ILE . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 404' ' ' THR . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.911 HD13 ' HA3' ' A' ' 400' ' ' GLY . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.824 ' CD1' HG12 ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.656 HG21 HG11 ' A' ' 326' ' ' VAL . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.501 ' N ' HG23 ' A' ' 417' ' ' THR . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 419' ' ' LEU . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 426' ' ' ILE . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.636 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 418' ' ' CYS . 33.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLU . . . . . 0.632 ' O ' HD11 ' A' ' 420' ' ' ILE . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.644 HG12 ' CB ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 409' ' ' CYS . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 332' ' ' ILE . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 343' ' ' GLU . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 340' ' ' LEU . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.097 0.475 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 331' ' ' ALA . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 411' ' ' ILE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.644 ' CB ' HG12 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.429 ' C ' HG23 ' A' ' 414' ' ' VAL . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 415' ' ' LYS . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 414' ' ' VAL . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 417' ' ' THR . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 420' ' ' ILE . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 321' ' ' GLU . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 326' ' ' VAL . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ASN . . . . . 0.433 ' O ' HD23 ' A' ' 340' ' ' LEU . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 338' ' ' ASN . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 341' ' ' VAL . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.533 ' HA ' HD13 ' A' ' 426' ' ' ILE . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' ' CD1' ' A' ' 411' ' ' ILE . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 404' ' ' THR . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.401 ' CD1' ' HA3' ' A' ' 400' ' ' GLY . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 419' ' ' LEU . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 418' ' ' CYS . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 399' ' ' TRP . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 320' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 417' ' ' THR . 76.0 m . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 420' ' ' ILE . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 416' ' ' PRO . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 411' ' ' ILE . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.681 HD13 ' HB2' ' A' ' 409' ' ' CYS . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 335' ' ' PHE . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.424 ' CE2' HD22 ' A' ' 334' ' ' LEU . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 340' ' ' LEU . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 342' ' ' PHE . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.181 0.515 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.662 HG21 ' CB ' ' A' ' 408' ' ' LYS . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 404' ' ' THR . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLN . . . . . 0.442 ' H ' HG23 ' A' ' 406' ' ' THR . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.662 ' CB ' HG21 ' A' ' 404' ' ' THR . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.681 ' HB2' HD13 ' A' ' 332' ' ' ILE . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.438 ' C ' HG23 ' A' ' 411' ' ' ILE . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 414' ' ' VAL . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' PRO . . . . . 0.41 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 320' ' ' CYS . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 419' ' ' LEU . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 323' ' ' ILE . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 410' ' ' GLU . 57.7 m-20 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.164 0.507 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 332' ' ' ILE . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 332' ' ' ILE . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 334' ' ' LEU . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' CYS . . . . . 0.499 ' O ' HG21 ' A' ' 411' ' ' ILE . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.419 ' HB3' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 344' ' ' LEU . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.847 HD11 ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.847 ' CZ3' HD11 ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.721 ' CA ' HG22 ' A' ' 411' ' ' ILE . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 422' ' ' ASN . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 406' ' ' THR . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.721 HG22 ' CA ' ' A' ' 400' ' ' GLY . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 418' ' ' CYS . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 417' ' ' THR . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 403' ' ' ASN . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 323' ' ' ILE . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.697 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 344' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.14 0.495 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.667 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 411' ' ' ILE . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.667 HG22 ' HA3' ' A' ' 400' ' ' GLY . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.697 ' CG ' HG12 ' A' ' 326' ' ' VAL . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.579 HG12 HG21 ' A' ' 426' ' ' ILE . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 419' ' ' LEU . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 414' ' ' VAL . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.509 HG12 ' CD1' ' A' ' 412' ' ' PHE . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' ASN . . . . . 0.48 ' CB ' HD11 ' A' ' 411' ' ' ILE . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 331' ' ' ALA . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.557 ' O ' HD13 ' A' ' 332' ' ' ILE . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 331' ' ' ALA . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 344' ' ' LEU . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 341' ' ' VAL . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 340' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.045 0.45 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 344' ' ' LEU . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' A' ' 332' ' ' ILE . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 327' ' ' ASN . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.64 ' CE1' HG21 ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.64 HG21 ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 414' ' ' VAL . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 418' ' ' CYS . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.475 ' N ' HG23 ' A' ' 417' ' ' THR . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.471 HG23 ' ND2' ' A' ' 422' ' ' ASN . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ASN . . . . . 0.471 ' ND2' HG23 ' A' ' 420' ' ' ILE . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.158 0.504 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASP . . . . . 0.823 ' HB3' HD13 ' A' ' 323' ' ' ILE . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 322' ' ' ASP . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.745 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 340' ' ' LEU . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 342' ' ' PHE . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.429 ' N ' HG23 ' A' ' 341' ' ' VAL . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.548 HD22 ' HZ3' ' A' ' 399' ' ' TRP . 3.0 tp . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 121.391 0.615 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.548 ' HZ3' HD22 ' A' ' 344' ' ' LEU . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 408' ' ' LYS . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.493 ' HB3' HG21 ' A' ' 404' ' ' THR . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.893 ' N ' HD13 ' A' ' 411' ' ' ILE . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.561 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 335' ' ' PHE . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 331' ' ' ALA . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 340' ' ' LEU . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.666 HD21 HD23 ' A' ' 344' ' ' LEU . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 342' ' ' PHE . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.458 ' N ' HG13 ' A' ' 341' ' ' VAL . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.666 HD23 HD21 ' A' ' 340' ' ' LEU . 6.4 mt . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.097 0.475 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.438 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.896 ' N ' HD13 ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.418 ' OD1' HD12 ' A' ' 344' ' ' LEU . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 424' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.705 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.419 0.628 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 323' ' ' ILE . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.711 HG12 ' CB ' ' A' ' 412' ' ' PHE . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 334' ' ' LEU . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 344' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.109 0.481 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.535 ' CH2' HD11 ' A' ' 411' ' ' ILE . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.801 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.801 ' N ' HD13 ' A' ' 411' ' ' ILE . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.272 0.558 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ASP . . . . . 0.64 ' OD2' HG22 ' A' ' 323' ' ' ILE . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.64 HG22 ' OD2' ' A' ' 322' ' ' ASP . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.663 HG12 ' CG ' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' ASN . . . . . 0.487 ' HB2' HG23 ' A' ' 411' ' ' ILE . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 409' ' ' CYS . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 342' ' ' PHE . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 341' ' ' VAL . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 344' ' ' LEU . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 343' ' ' GLU . 4.7 mp . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.49 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 411' ' ' ILE . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 422' ' ' ASN . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 403' ' ' ASN . . . . . 0.408 ' HB2' ' CA ' ' A' ' 422' ' ' ASN . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 408' ' ' LYS . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 404' ' ' THR . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 329' ' ' PHE . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.573 HD13 ' HA2' ' A' ' 400' ' ' GLY . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.663 ' CG ' HG12 ' A' ' 326' ' ' VAL . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' CYS . . . . . 0.64 ' SG ' HG22 ' A' ' 420' ' ' ILE . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.64 HG22 ' SG ' ' A' ' 418' ' ' CYS . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 401' ' ' ASN . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.758 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.156 0.503 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 323' ' ' ILE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 332' ' ' ILE . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 407' ' ' GLN . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.402 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 340' ' ' LEU . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.755 ' HA ' HD13 ' A' ' 426' ' ' ILE . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLN . . . . . 0.632 ' HG3' HG21 ' A' ' 332' ' ' ILE . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 414' ' ' VAL . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 413' ' ' ASN . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 419' ' ' LEU . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 420' ' ' ILE . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.755 HD13 ' HA ' ' A' ' 399' ' ' TRP . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.335 0.588 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 334' ' ' LEU . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.537 ' N ' HD12 ' A' ' 334' ' ' LEU . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.536 ' O ' HD22 ' A' ' 340' ' ' LEU . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 339' ' ' LYS . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 342' ' ' PHE . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 341' ' ' VAL . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.688 ' O ' HD23 ' A' ' 344' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.112 0.482 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.4 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 404' ' ' THR . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.719 ' HB2' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 414' ' ' VAL . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 416' ' ' PRO . . . . . 0.469 ' HD3' HG13 ' A' ' 414' ' ' VAL . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.775 HG12 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 334' ' ' LEU . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' CYS . . . . . 0.441 ' SG ' HD11 ' A' ' 411' ' ' ILE . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' ' 402' ' ' TYR . 46.7 t30 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.408 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HE1' HD22 ' A' ' 398' ' ' ASN . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.567 ' C ' HD12 ' A' ' 411' ' ' ILE . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.567 HD12 ' C ' ' A' ' 410' ' ' GLU . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CG ' HG12 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 426' ' ' ILE . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.351 0.596 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 323' ' ' ILE . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LEU . . . . . 0.475 HD21 ' HD2' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.536 ' N ' HD23 ' A' ' 340' ' ' LEU . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.432 ' C ' HD23 ' A' ' 344' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.109 0.48 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.551 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.715 ' H ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 414' ' ' VAL . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 413' ' ' ASN . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.66 HD13 ' H ' ' A' ' 419' ' ' LEU . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 420' ' ' ILE . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.08 0.467 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.725 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 411' ' ' ILE . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.72 HG23 ' H ' ' A' ' 343' ' ' GLU . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' GLU . . . . . 0.72 ' H ' HG23 ' A' ' 341' ' ' VAL . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.176 0.512 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 340' ' ' LEU . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.725 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' LYS . . . . . 0.475 ' N ' HG22 ' A' ' 414' ' ' VAL . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 417' ' ' THR . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 419' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 419' ' ' LEU . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 426' ' ' ILE . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 324' ' ' PRO . . . . . 0.647 ' O ' HD13 ' A' ' 323' ' ' ILE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 326' ' ' VAL . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 342' ' ' PHE . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 412' ' ' PHE . 1.7 mm? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.495 ' O ' HD11 ' A' ' 426' ' ' ILE . 7.9 m120 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.996 0.427 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 407' ' ' GLN . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 406' ' ' THR . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.425 ' C ' HD12 ' A' ' 411' ' ' ILE . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 411' ' ' ILE . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.577 ' HA ' HD11 ' A' ' 344' ' ' LEU . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 427' ' ' ALA . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.44 ' C ' HG23 ' A' ' 426' ' ' ILE . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 427' ' ' ALA . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ALA . . . . . 0.713 ' N ' HD12 ' A' ' 426' ' ' ILE . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.227 0.537 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 323' ' ' ILE . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.653 HG12 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.752 ' HB3' ' CG ' ' A' ' 407' ' ' GLN . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ASN . . . . . 0.913 ' ND2' HG11 ' A' ' 341' ' ' VAL . 6.0 t-20 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' LYS . . . . . 0.669 ' C ' HD13 ' A' ' 340' ' ' LEU . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.913 HG11 ' ND2' ' A' ' 338' ' ' ASN . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ASN . . . . . 0.413 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.132 0.491 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.442 ' CH2' ' CG1' ' A' ' 341' ' ' VAL . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.418 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLN . . . . . 0.752 ' CG ' ' HB3' ' A' ' 331' ' ' ALA . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.418 ' H ' HG21 ' A' ' 404' ' ' THR . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.653 ' CD2' HG12 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 417' ' ' THR . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 420' ' ' ILE . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.097 0.475 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' VAL . . . . . 0.583 ' O ' HG22 ' A' ' 341' ' ' VAL . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 411' ' ' ILE . 5.5 mt . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.059 0.457 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' THR . . . . . 0.644 HG21 ' H ' ' A' ' 408' ' ' LYS . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LYS . . . . . 0.644 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLU . . . . . 0.701 ' OE2' HG21 ' A' ' 326' ' ' VAL . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.793 ' CB ' HG12 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 412' ' ' PHE . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 420' ' ' ILE . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.136 0.493 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -146.2 78.89 1.53 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -135.75 173.96 21.56 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.0 m -131.41 -169.39 2.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.919 . . . . 0.0 110.024 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.23 124.6 28.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.709 . . . . 0.0 110.086 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -82.59 164.32 20.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -161.07 172.34 17.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.564 -0.71 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -147.78 47.4 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.578 -0.701 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -110.78 -159.65 0.69 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.571 -0.706 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -108.03 151.1 26.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.605 -0.684 . . . . 0.0 110.226 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.85 -142.69 4.49 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 74.2 m -105.15 -65.11 1.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.54 -0.976 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -72.0 -28.37 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.24 -47.23 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.697 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -141.62 -164.39 1.77 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.584 -0.697 . . . . 0.0 110.327 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CZ ' HG12 ' A' ' 323' ' ' ILE . 49.2 t80 -150.09 80.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.026 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.89 -159.16 8.66 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.18 -178.99 6.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.656 -0.908 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.638 ' CE3' HG22 ' A' ' 316' ' ' VAL . 1.3 p-90 -81.95 172.01 13.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.638 HG22 ' CE3' ' A' ' 315' ' ' TRP . 34.1 m -48.4 171.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.526 -0.734 . . . . 0.0 111.454 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -52.82 147.43 8.99 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.659 0.742 . . . . 0.0 111.304 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.91 -116.24 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.49 -30.53 6.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.593 -0.945 . . . . 0.0 110.216 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t -110.22 92.98 4.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.63 -0.669 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 323' ' ' ILE . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.468 ' HG3' HG21 ' A' ' 420' ' ' ILE . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.614 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.56 ' CD1' HD23 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 340' ' ' LEU . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 340' ' ' LEU . 2.0 mm? -98.4 -23.99 15.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 53.7 p -57.76 -28.91 64.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.46 -0.775 . . . . 0.0 110.418 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.24 84.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.0 t -98.2 10.63 40.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -59.26 -39.76 83.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.163 -0.961 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.17 80.77 63.27 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.56 -0.713 . . . . 0.0 110.366 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.24 -46.46 0.37 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.427 1.225 . . . . 0.0 110.315 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.18 -169.02 1.53 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.654 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -62.21 98.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.631 -0.668 . . . . 0.0 110.185 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.4 28.89 8.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.069 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -104.3 -27.93 11.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.8 65.16 0.89 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.368 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -109.85 18.26 20.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.72 -28.75 69.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.367 -0.833 . . . . 0.0 110.064 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 4.2 m -81.65 1.89 31.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.514 -0.741 . . . . 0.0 111.039 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.79 -16.31 32.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 363' ' ' ILE . 0.0 OUTLIER -82.36 -31.12 29.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.22 63.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.478 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -83.84 6.39 21.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.472 -0.768 . . . . 0.0 111.244 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 360' ' ' TYR . 7.5 tp -64.75 -28.8 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -20.71 50.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.608 -0.683 . . . . 0.0 110.582 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.26 19.33 12.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -0.851 . . . . 0.0 110.609 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.06 -30.13 76.88 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -103.66 22.49 14.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.597 -0.943 . . . . 0.0 110.567 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -54.29 -25.95 26.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 109.696 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -76.39 -139.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -147.63 8.89 0.9 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.884 -1.135 . . . . 0.0 111.703 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -59.16 -26.49 64.81 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.854 -1.154 . . . . 0.0 110.675 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.07 -25.95 64.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.797 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 12.9 t -101.08 -28.34 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.461 -0.774 . . . . 0.0 110.563 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 378' ' ' ALA . 4.8 mmt -87.56 9.74 20.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 111.127 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -41.19 -58.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.362 -0.837 . . . . 0.0 113.098 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.05 -27.11 0.86 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.46 -0.775 . . . . 0.0 111.984 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.2 47.62 0.83 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.44 -0.788 . . . . 0.0 110.126 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 374' ' ' MET . . . -83.69 102.35 12.18 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.894 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.12 88.09 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 3.4 mt -41.31 99.55 0.2 Allowed Pre-proline 0 N--CA 1.506 2.367 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.68 60.78 3.49 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.519 1.273 . . . . 0.0 109.944 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.51 HG23 ' NH1' ' A' ' 389' ' ' ARG . 43.0 m -78.37 58.4 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 110.501 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -160.74 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -65.21 -75.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.679 -0.895 . . . . 0.0 109.7 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -91.14 42.46 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.497 -0.752 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -68.1 -26.7 65.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.265 -0.897 . . . . 0.0 110.421 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.86 -6.33 48.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.483 -0.761 . . . . 0.0 110.612 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.66 -28.58 58.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.285 -0.885 . . . . 0.0 111.308 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ARG . . . . . 0.51 ' NH1' HG23 ' A' ' 382' ' ' THR . 9.0 ptt180 -72.97 62.79 0.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.328 -0.858 . . . . 0.0 110.812 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.55 70.34 10.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 109.75 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -66.14 -162.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.624 -0.673 . . . . 0.0 110.26 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.5 p -82.51 60.03 4.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.742 . . . . 0.0 109.878 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -50.29 -26.32 4.67 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.562 -0.711 . . . . 0.0 110.94 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.02 -30.92 78.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -114.92 52.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.93 . . . . 0.0 109.955 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -132.25 79.34 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.503 ' HB2' HG21 ' A' ' 428' ' ' THR . 13.4 m-85 -56.73 -21.91 31.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.623 -0.928 . . . . 0.0 110.808 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -90.82 130.27 36.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.337 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.41 ' CE2' ' O ' ' A' ' 397' ' ' TYR . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 404' ' ' THR . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.67 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.67 ' N ' HD13 ' A' ' 411' ' ' ILE . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 324' ' ' PRO . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -58.39 137.68 57.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.503 HG21 ' HB2' ' A' ' 397' ' ' TYR . 1.7 m -155.44 156.25 34.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.7 p -61.14 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.677 -0.639 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.49 66.22 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.62 -0.675 . . . . 0.0 110.455 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 431' ' ' LEU . 0.1 OUTLIER -154.49 -68.54 0.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.419 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 84.0 p -83.9 141.27 31.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.01 61.97 54.51 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 -169.41 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.403 1.212 . . . . 0.0 110.425 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.97 -28.53 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.65 -0.656 . . . . 0.0 110.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.445 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -85.7 89.06 7.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.613 -0.68 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -84.21 125.27 7.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 60.4 p -94.84 -35.59 12.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.576 -0.955 . . . . 0.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.9 -36.54 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.565 -0.71 . . . . 0.0 110.175 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.47 146.8 51.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -120.67 147.97 44.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.597 -0.689 . . . . 0.0 110.222 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -135.17 103.62 5.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.63 -0.669 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -135.42 52.28 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.554 -0.716 . . . . 0.0 110.1 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' HIS . . . . . 0.45 ' CD2' HG21 ' A' ' 414' ' ' VAL . 0.1 OUTLIER -78.16 157.41 29.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.625 -0.672 . . . . 0.0 110.035 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.6 ' O ' HG11 ' A' ' 414' ' ' VAL . . . -149.9 179.46 26.64 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.5 p -123.97 175.81 6.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.229 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -140.59 -69.58 0.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 110.285 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -148.41 -161.41 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -132.9 85.83 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.604 -0.685 . . . . 0.0 110.282 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.814 ' CE2' HG21 ' A' ' 323' ' ' ILE . 28.6 t80 -106.35 44.63 1.03 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.64 27.49 1.06 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 419' ' ' LEU . 14.8 tp -144.66 160.0 41.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 110.161 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -171.78 148.57 2.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 110.26 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.1 p -96.34 89.49 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.559 -0.713 . . . . 0.0 109.797 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -169.29 -63.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 110.915 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -106.54 -101.44 2.72 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.561 ' HA ' HD12 ' A' ' 419' ' ' LEU . 27.2 t-20 -152.28 -45.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.628 -0.925 . . . . 0.0 109.856 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 42.4 t -150.85 159.07 44.79 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 312' ' ' PHE . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 391' ' ' LYS . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 332' ' ' ILE . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.601 ' O ' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 339' ' ' LYS . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 341' ' ' VAL . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp -72.57 -22.5 60.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 11.3 t -57.07 -27.09 61.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.349 -0.845 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.41 0.4 49.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.728 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 52.4 p -94.74 10.68 34.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.125 -0.985 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -25.15 64.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.175 -0.953 . . . . 0.0 110.577 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -52.08 108.24 1.03 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.341 -0.849 . . . . 0.0 111.01 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.879 0 O-C-N 123.036 1.019 . . . . 0.0 110.736 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -60.68 -76.46 0.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.541 -0.724 . . . . 0.0 110.354 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.79 94.43 0.82 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.502 -0.749 . . . . 0.0 110.018 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 354' ' ' GLU . 27.8 p90 -93.24 -25.73 17.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.595 -0.69 . . . . 0.0 110.343 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.43 ' N ' ' CD1' ' A' ' 353' ' ' TYR . 9.0 tt0 -128.68 -79.35 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.457 ' HB3' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -175.52 -156.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -91.1 19.4 5.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 355' ' ' GLN . 3.4 mp -52.0 -21.08 2.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.161 -0.962 . . . . 0.0 111.68 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 56.1 m -49.04 -64.1 0.91 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.077 -1.015 . . . . 0.0 111.264 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.39 -15.59 13.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.591 -0.693 . . . . 0.0 111.67 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.99 2.27 43.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.186 -0.946 . . . . 0.0 112.287 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -30.93 21.95 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.894 -1.129 . . . . 0.0 111.265 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -61.98 -32.26 72.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.297 -0.877 . . . . 0.0 109.785 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.21 -19.53 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.748 -0.595 . . . . 0.0 110.255 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.413 ' HE2' HD11 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.49 -24.82 19.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.867 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.22 -28.72 63.14 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.45 85.14 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.58 96.28 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 0.0 110.307 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 35.46 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.67 -0.644 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -114.01 -63.32 1.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.309 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -120.31 119.99 34.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.569 -0.707 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.19 -28.34 13.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.685 . . . . 0.0 110.267 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.75 65.43 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 110.478 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -102.56 10.79 38.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.628 -0.67 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.3 ttt -105.5 -24.66 12.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.688 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.17 -60.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.787 . . . . 0.0 111.157 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.68 -24.57 5.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.402 -0.811 . . . . 0.0 111.259 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.7 p -58.58 -26.15 63.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -158.94 52.61 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.53 -0.731 . . . . 0.0 110.23 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 380' ' ' LEU . 0.5 OUTLIER -96.16 39.11 1.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.61 -0.681 . . . . 0.0 110.212 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 379' ' ' PHE . 10.1 mp -109.29 73.89 0.61 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 110.5 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.81 66.35 3.16 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.206 1.108 . . . . 0.0 110.298 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.9 p -108.67 -83.54 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 0.0 110.439 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 179.2 51.13 0.08 OUTLIER Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -90.11 10.54 23.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.509 -0.995 . . . . 0.0 111.092 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.58 -30.49 17.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.258 -0.901 . . . . 0.0 110.457 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.07 -18.92 25.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.629 -0.669 . . . . 0.0 110.976 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.83 -15.89 45.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.21 141.64 34.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 110.872 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 152.61 39.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.418 ' O ' ' CD1' ' A' ' 390' ' ' TYR . 50.2 p90 -68.29 128.84 38.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.727 . . . . 0.0 110.526 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LYS . . . . . 0.528 ' HB2' ' HB1' ' A' ' 331' ' ' ALA . 0.0 OUTLIER -147.37 -44.21 0.17 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.738 . . . . 0.0 110.404 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.3 p -83.52 57.35 4.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -66.99 -30.77 70.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.607 -0.683 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -124.8 54.88 0.73 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 155.96 32.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.469 -1.018 . . . . 0.0 110.218 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 397' ' ' TYR . . . -144.53 23.73 2.01 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 396' ' ' GLY . 38.3 m-85 -140.73 93.38 2.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -1.047 . . . . 0.0 109.523 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -107.76 111.25 23.33 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.562 -0.711 . . . . 0.0 110.97 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.723 ' HB3' HG23 ' A' ' 428' ' ' THR . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.911 ' HA3' HD13 ' A' ' 411' ' ' ILE . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 404' ' ' THR . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.911 HD13 ' HA3' ' A' ' 400' ' ' GLY . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.824 ' CD1' HG12 ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' -2' ' ' GLY . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.656 HG21 HG11 ' A' ' 326' ' ' VAL . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.501 ' N ' HG23 ' A' ' 417' ' ' THR . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 319' ' ' ASN . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 426' ' ' ILE . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.636 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -167.36 90.1 0.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.723 HG23 ' HB3' ' A' ' 399' ' ' TRP . 40.0 p -59.87 -77.37 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.347 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 49.8 m -160.39 115.76 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.73 41.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' 431' ' ' LEU . 2.2 mm? -77.91 111.85 14.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 110.076 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.4 t -116.96 107.04 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.257 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 10.5 p80 -154.07 70.15 6.31 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 -178.91 3.77 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.343 1.181 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 435' ' ' ILE . 51.0 mm -91.59 48.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.593 -0.692 . . . . 0.0 109.945 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.187 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.931 0.396 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.93 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -132.88 139.89 11.35 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.5 t -119.49 155.83 31.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.493 -1.004 . . . . 0.0 110.203 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -92.32 -173.86 3.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 110.251 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.75 152.65 29.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -129.6 -49.49 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 110.144 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.68 -27.37 66.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.204 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -74.71 -30.88 61.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.533 -0.729 . . . . 0.0 110.297 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -122.14 83.82 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -148.86 45.82 0.7 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 t -125.65 67.87 1.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.992 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.687 HD21 HG23 ' A' ' 417' ' ' THR . 25.7 p30 -71.47 161.43 31.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.633 -0.667 . . . . 0.0 110.337 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -169.72 38.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.602 -0.686 . . . . 0.0 110.138 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -146.45 28.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -118.89 -65.55 1.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.238 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.38 157.11 27.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 39.0 mt -143.54 117.51 9.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.452 -1.028 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 321' ' ' GLU . 1.5 p-90 -150.11 163.06 39.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.859 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.1 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.71 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -177.67 -44.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 109.602 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -171.61 -100.59 0.14 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -149.45 19.71 0.94 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.564 -0.962 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 418' ' ' CYS . 33.7 t -150.74 138.79 20.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLU . . . . . 0.632 ' O ' HD11 ' A' ' 420' ' ' ILE . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.644 HG12 ' CB ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 409' ' ' CYS . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 332' ' ' ILE . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 343' ' ' GLU . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 340' ' ' LEU . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.46 -24.5 13.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.9 t -57.41 -40.5 78.45 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.476 -0.765 . . . . 0.0 110.664 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.08 17.29 24.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.532 -0.73 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 40.1 t -98.31 -33.94 10.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 0.0 110.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.73 -40.22 14.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 110.441 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -151.51 147.07 19.58 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.222 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.07 155.25 52.55 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.322 1.17 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -108.4 -67.17 0.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.27 90.37 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 110.121 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -136.69 34.1 2.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 110.324 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.45 -76.86 0.34 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.615 -0.678 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -168.61 32.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.335 -0.853 . . . . 0.0 110.374 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -85.41 -24.83 27.34 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.419 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.66 -21.42 18.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.497 -0.752 . . . . 0.0 111.068 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 54.6 m -51.23 -49.44 61.08 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.189 -0.944 . . . . 0.0 111.307 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.7 -16.99 13.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 0.0 111.454 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.666 ' O ' HG23 ' A' ' 363' ' ' ILE . 32.2 m-85 -91.35 0.65 57.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.224 -0.922 . . . . 0.0 111.726 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -19.53 65.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.08 -1.013 . . . . 0.0 110.75 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -65.79 -12.93 58.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -0.832 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 360' ' ' TYR . 37.3 pt -55.76 -33.31 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.125 -0.984 . . . . 0.0 110.682 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.41 ' N ' HG13 ' A' ' 363' ' ' ILE . 1.6 ptmt -57.31 -25.35 59.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 110.673 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -84.68 -22.55 29.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.547 -0.721 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -135.96 51.35 0.82 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 367' ' ' PHE . 26.2 t80 -97.28 27.43 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.511 -0.993 . . . . 0.0 110.154 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -27.62 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -170.08 30.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -110.17 -30.41 7.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.455 -0.778 . . . . 0.0 109.981 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -62.41 -20.16 64.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.694 -0.628 . . . . 0.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.46 58.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.3 -0.875 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.6 m -105.28 -45.42 4.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 111.003 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.623 ' O ' ' HB3' ' A' ' 378' ' ' ALA . 4.7 ppp? -54.01 -25.54 21.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.436 -0.79 . . . . 0.0 111.276 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.94 -29.34 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.362 -0.836 . . . . 0.0 110.0 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -20.95 12.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.2 m -98.13 -27.96 13.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.353 -0.842 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 374' ' ' MET . . . -97.06 34.12 1.8 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.09 -57.0 2.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 110.056 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 28.2 mt -127.46 154.3 77.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.72 . . . . 0.0 110.208 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.31 -26.83 14.11 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.392 1.206 . . . . 0.0 110.493 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.7 m -127.12 75.56 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 110.05 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -118.57 40.85 2.16 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -59.95 -26.57 66.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.53 -0.982 . . . . 0.0 110.36 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -27.39 68.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -77.77 -22.2 50.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.569 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.69 -13.51 54.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -0.795 . . . . 0.0 110.842 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.109 -0.995 . . . . 0.0 110.609 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -68.83 -75.66 0.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.739 . . . . 0.0 110.117 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -81.56 151.16 27.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.336 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -152.53 0.5 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.563 -0.71 . . . . 0.0 110.249 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.0 p -83.55 57.13 3.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.483 ' CE1' ' CD1' ' A' ' 397' ' ' TYR . 59.9 t-80 -65.89 -43.53 88.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 110.428 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -62.48 -34.81 90.56 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 38.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.533 -0.98 . . . . 0.0 110.499 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 54.58 0.08 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.483 ' CD1' ' CE1' ' A' ' 393' ' ' HIS . 66.2 t80 -130.71 -38.45 1.3 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.596 -0.944 . . . . 0.0 110.877 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -96.93 107.71 20.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.468 -0.77 . . . . 0.0 110.813 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 331' ' ' ALA . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 411' ' ' ILE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.644 ' CB ' HG12 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.429 ' C ' HG23 ' A' ' 414' ' ' VAL . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 415' ' ' LYS . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 414' ' ' VAL . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.687 HG23 HD21 ' A' ' 309' ' ' ASN . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 420' ' ' ILE . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 321' ' ' GLU . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -160.87 102.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.3 p -94.62 136.18 35.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.705 . . . . 0.0 109.771 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 431' ' ' LEU . 2.2 m -59.53 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.668 . . . . 0.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -60.69 -26.07 66.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.636 -0.665 . . . . 0.0 110.426 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.653 HD22 ' N ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -153.99 174.99 13.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.522 -0.736 . . . . 0.0 110.623 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 432' ' ' SER . . . . . 0.653 ' N ' HD22 ' A' ' 431' ' ' LEU . 8.3 t -83.61 -74.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -161.83 163.02 19.94 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 -28.74 12.83 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.477 1.251 . . . . 0.0 110.404 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.42 40.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.667 . . . . 0.0 109.998 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.771 -179.899 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 10.0 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.048 0.451 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -165.05 -58.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.686 . . . . 0.0 110.269 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -137.63 76.16 0.37 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 p -114.37 168.41 9.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.523 -0.987 . . . . 0.0 110.214 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.28 34.62 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.547 -0.721 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -150.53 158.72 44.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.65 -0.656 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -6' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' -4' ' ' HIS . 0.0 OUTLIER -59.84 -174.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.647 -0.658 . . . . 0.0 110.864 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 81.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.618 -0.676 . . . . 0.0 111.012 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -4' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' -6' ' ' HIS . 25.4 t60 -115.16 169.92 8.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.388 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -146.0 138.41 25.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.636 -0.665 . . . . 0.0 110.138 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.38 -159.92 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 t -81.0 160.29 24.62 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.938 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.37 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 110.241 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -166.66 170.92 12.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -156.61 -51.77 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.63 -0.669 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 314' ' ' LEU . 2.7 t80 -134.47 117.03 15.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.146 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -91.56 94.81 1.98 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 322' ' ' ASP . 0.5 OUTLIER -150.35 135.22 17.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.953 . . . . 0.0 110.153 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.566 ' CD2' HD12 ' A' ' 419' ' ' LEU . 3.1 p-90 -108.73 170.44 8.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 0.0 109.648 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 316' ' ' VAL . 9.8 p -56.39 128.74 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.438 -0.788 . . . . 0.0 110.25 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.83 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 0.0 110.718 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.421 ' HA3' ' CH2' ' A' ' 315' ' ' TRP . . . -115.24 -29.41 2.54 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -149.45 -43.82 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.483 -1.01 . . . . 0.0 110.755 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t -97.53 159.5 14.88 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.779 ' HA ' HD21 ' A' ' 314' ' ' LEU . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.638 ' H ' HD11 ' A' ' 314' ' ' LEU . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 326' ' ' VAL . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ASN . . . . . 0.433 ' O ' HD23 ' A' ' 340' ' ' LEU . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 338' ' ' ASN . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 341' ' ' VAL . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 346' ' ' ALA . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.03 -46.89 4.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.6 t -68.21 -24.77 64.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.588 -0.695 . . . . 0.0 110.283 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 342' ' ' PHE . . . -89.78 14.64 11.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 0.0 111.035 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.4 m -95.0 -28.45 15.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.281 -0.887 . . . . 0.0 110.013 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.63 -26.5 14.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.613 -0.68 . . . . 0.0 110.186 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.33 92.67 7.12 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.05 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.86 -20.36 22.52 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.392 1.206 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -58.37 -59.39 5.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.317 -0.864 . . . . 0.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -60.06 -26.36 66.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.521 -0.737 . . . . 0.0 110.629 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.14 -28.84 68.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.441 -0.787 . . . . 0.0 110.477 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -101.21 55.3 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.73 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -144.65 15.81 1.61 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 110.977 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -110.6 -29.58 7.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.13 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 357' ' ' LEU . 4.5 mm? -81.81 -16.6 50.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 110.913 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 7.6 m -101.77 -23.6 14.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.821 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 -47.1 3.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.26 1.39 28.69 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.592 -0.692 . . . . 0.0 111.357 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.68 6.18 18.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.135 -0.978 . . . . 0.0 111.469 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 25.2 pt -89.92 -25.59 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.436 -0.79 . . . . 0.0 110.633 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -28.56 67.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.438 -0.789 . . . . 0.0 110.658 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.04 -23.36 55.12 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.743 . . . . 0.0 110.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -107.24 76.63 0.23 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.18 52.1 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.538 -0.977 . . . . 0.0 110.403 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -24.82 11.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.562 -0.711 . . . . 0.0 110.254 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -162.12 104.92 1.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 110.034 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 155.13 8.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.507 -0.746 . . . . 0.0 110.501 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.85 -23.18 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -51.44 -25.48 6.44 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.337 -0.852 . . . . 0.0 111.012 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.8 p -79.84 -23.64 41.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.597 -0.69 . . . . 0.0 110.481 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -29.49 17.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 110.561 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 46.9 mm -63.79 -42.71 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.493 -0.754 . . . . 0.0 110.167 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -26.19 61.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.63 -0.669 . . . . 0.0 110.517 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.0 t -90.9 -26.48 19.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -130.55 75.24 1.64 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.496 -0.752 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -117.92 30.69 7.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.405 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 5.9 mt -57.03 -56.15 36.49 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.493 -0.755 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 52.4 Cg_endo -75.41 60.4 5.73 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.2 1.105 . . . . 0.0 110.601 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.8 m -160.77 92.42 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -58.53 -20.44 45.79 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -64.01 -12.89 42.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.387 -1.066 . . . . 0.0 111.222 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -54.74 -30.27 55.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.05 -1.031 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -59.85 -25.6 65.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.589 -0.694 . . . . 0.0 110.504 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.16 -12.13 59.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.549 -0.719 . . . . 0.0 110.544 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.86 159.04 4.3 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.195 -0.94 . . . . 0.0 110.612 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 67.89 0.67 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.36 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.38 -74.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -112.66 169.82 8.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.648 -0.658 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 34.4 t -84.97 55.83 3.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.253 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -140.74 21.07 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.502 -0.749 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -163.65 28.15 0.23 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -77.3 132.79 38.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.356 -1.085 . . . . 0.0 109.871 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.4 60.95 0.14 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.487 ' H ' HG21 ' A' ' 428' ' ' THR . 4.9 m-85 -161.96 28.81 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.508 -0.995 . . . . 0.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -123.39 140.72 52.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.69 . . . . 0.0 109.835 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.533 ' HA ' HD13 ' A' ' 426' ' ' ILE . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' ' CD1' ' A' ' 411' ' ' ILE . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.621 HG23 ' O ' ' A' ' 404' ' ' THR . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.401 ' CD1' ' HA3' ' A' ' 400' ' ' GLY . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 419' ' ' LEU . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.566 HD12 ' CD2' ' A' ' 315' ' ' TRP . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 399' ' ' TRP . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -109.1 95.15 5.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 397' ' ' TYR . 79.5 p -59.39 -62.81 1.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.595 -0.691 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 88.6 m -160.37 110.69 1.82 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.748 . . . . 0.0 110.276 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.74 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 110.29 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.7 pp -148.27 151.42 35.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.365 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.88 70.17 0.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' HIS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 434' ' ' PRO . 2.5 t-80 -76.3 -58.29 1.24 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.237 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 433' ' ' HIS . 43.7 Cg_endo -69.12 130.84 20.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.043 1.022 . . . . 0.0 110.364 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.68 -59.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.66 . . . . 0.0 110.11 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.442 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.146 0.498 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -107.91 -43.21 4.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.538 -0.726 . . . . 0.0 110.235 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -159.69 112.75 0.54 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 15.1 m -108.57 -55.89 2.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.926 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -162.6 133.48 4.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.644 -0.66 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.57 36.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -149.45 105.11 3.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -142.04 171.22 14.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.215 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -155.64 -60.04 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -129.24 -171.01 2.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -96.54 39.99 2.68 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 p -153.0 139.03 18.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.642 -0.916 . . . . 0.0 109.962 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -107.19 117.18 33.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 0.0 110.443 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -111.56 134.99 52.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.682 -0.636 . . . . 0.0 109.904 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -159.02 -43.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.487 -0.758 . . . . 0.0 109.928 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HE1' HD11 ' A' ' 323' ' ' ILE . 7.5 t80 -136.41 154.7 50.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.643 -0.661 . . . . 0.0 110.394 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.431 ' N ' ' CD1' ' A' ' 312' ' ' PHE . . . -115.67 82.55 0.32 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 314' ' ' LEU . 0.5 OUTLIER -104.52 160.06 15.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.934 . . . . 0.0 110.358 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 320' ' ' CYS . 0.1 OUTLIER -51.92 170.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.411 -0.805 . . . . 0.0 110.443 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 317' ' ' ASP . 8.6 p -65.38 166.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.692 -0.63 . . . . 0.0 109.99 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 316' ' ' VAL . 13.7 t70 -63.58 97.83 0.16 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.682 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -101.15 -86.7 1.94 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -150.24 30.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.939 . . . . 0.0 110.116 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 76.0 m -140.49 169.89 16.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.7 . . . . 0.0 110.37 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 420' ' ' ILE . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 416' ' ' PRO . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 411' ' ' ILE . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.681 HD13 ' HB2' ' A' ' 409' ' ' CYS . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 335' ' ' PHE . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.424 ' CE2' HD22 ' A' ' 334' ' ' LEU . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 340' ' ' LEU . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 342' ' ' PHE . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt -66.37 -26.31 67.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.6 p -78.38 -36.22 46.21 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.557 -0.714 . . . . 0.0 110.405 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -91.87 -37.4 12.93 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.547 -0.72 . . . . 0.0 110.334 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 5.0 m -88.73 10.83 19.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.61 -0.681 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.49 -27.82 64.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.167 -0.958 . . . . 0.0 110.349 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -87.08 127.35 59.71 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.72 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.21 -54.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.198 1.104 . . . . 0.0 110.455 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.11 176.2 8.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.472 -0.768 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -146.23 160.42 42.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.662 . . . . 0.0 110.256 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.18 -27.2 63.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.0 110.293 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.17 29.47 7.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -166.21 42.61 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.23 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -109.8 -28.53 8.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 360' ' ' TYR . 9.0 tt -66.21 -25.22 66.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.752 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 358' ' ' THR . 52.2 m -104.52 6.19 34.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.418 -0.801 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.9 -28.56 13.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.139 -0.976 . . . . 0.0 111.599 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.728 ' O ' HG22 ' A' ' 363' ' ' ILE . 13.6 p90 -80.34 -22.6 41.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.235 -0.916 . . . . 0.0 110.98 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.38 -24.57 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 110.686 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.403 ' HA ' ' CG ' ' A' ' 365' ' ' GLU . 0.0 OUTLIER -100.22 -10.61 21.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.461 -0.775 . . . . 0.0 111.474 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 360' ' ' TYR . 9.1 tt -58.47 -24.21 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.12 -0.988 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -92.75 -30.43 15.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.428 -0.795 . . . . 0.0 110.373 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.403 ' CG ' ' HA ' ' A' ' 362' ' ' LYS . 6.7 pt-20 -110.25 20.74 17.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.536 -0.728 . . . . 0.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.27 65.18 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -98.01 20.83 11.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.525 -0.985 . . . . 0.0 110.993 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -59.55 -36.77 76.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -113.44 -110.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.633 -0.667 . . . . 0.0 109.896 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -171.17 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.612 -1.305 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -76.3 -32.96 59.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.623 -0.673 . . . . 0.0 110.291 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.22 -28.66 69.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.648 -0.657 . . . . 0.0 110.278 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.6 m -101.47 -19.95 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.607 -0.683 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -38.76 73.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.427 -0.795 . . . . 0.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.6 pt -130.61 -113.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.496 -0.752 . . . . 0.0 109.616 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 380' ' ' LEU . 39.9 tttt -133.82 60.86 1.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.558 -1.338 . . . . 0.0 109.94 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -25.18 8.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.536 -0.727 . . . . 0.0 110.546 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -59.12 -31.81 69.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.94 -53.29 8.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.569 -0.707 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 380' ' ' LEU . 6.9 mp -98.07 126.02 41.76 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.45 62.77 4.47 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.051 1.027 . . . . 0.0 110.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 382' ' ' THR . 7.6 t -169.11 71.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -0.769 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -91.35 -34.14 7.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.99 -27.97 68.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.592 -0.946 . . . . 0.0 110.306 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.95 -26.22 65.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -79.63 -25.86 41.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.528 -0.732 . . . . 0.0 110.464 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.36 -11.8 58.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 0.0 110.665 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.99 -64.56 0.84 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.0 110.789 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -55.07 -176.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.525 -0.734 . . . . 0.0 111.171 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -90.9 114.69 27.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.909 -0.495 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -41.42 1.68 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 12.5 t -66.9 -27.85 67.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.499 -0.751 . . . . 0.0 110.22 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -69.99 84.1 0.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.589 -0.694 . . . . 0.0 110.184 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 179.73 -47.79 0.08 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 133.44 55.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.973 . . . . 0.0 109.577 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -155.66 28.17 0.6 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -150.96 172.5 15.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.966 . . . . 0.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -85.25 142.39 29.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.662 HG21 ' CB ' ' A' ' 408' ' ' LYS . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 404' ' ' THR . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLN . . . . . 0.442 ' H ' HG23 ' A' ' 406' ' ' THR . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.662 ' CB ' HG21 ' A' ' 404' ' ' THR . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.681 ' HB2' HD13 ' A' ' 332' ' ' ILE . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.438 ' C ' HG23 ' A' ' 411' ' ' ILE . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 414' ' ' VAL . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' PRO . . . . . 0.41 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 320' ' ' CYS . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 419' ' ' LEU . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 323' ' ' ILE . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 410' ' ' GLU . 57.7 m-20 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -112.61 -27.95 8.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 58.1 p -60.71 -71.61 0.13 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.592 -0.693 . . . . 0.0 110.281 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.5 p -147.89 115.91 6.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.619 -0.675 . . . . 0.0 110.243 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -105.86 157.22 17.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.4 mm? -109.92 84.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 8.6 t -154.99 161.5 41.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.171 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -82.91 152.02 65.03 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.93 120.3 6.56 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.431 1.227 . . . . 0.0 110.37 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.725 ' O ' HD13 ' A' ' 435' ' ' ILE . 0.1 OUTLIER -84.55 -37.95 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.685 . . . . 0.0 109.868 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 20.2 mtt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.113 0.483 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 8.9 ptt85 -164.18 34.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -152.66 71.4 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 32.0 m -104.23 -35.41 8.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.524 -0.986 . . . . 0.0 110.169 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -138.29 35.04 2.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.498 -0.751 . . . . 0.0 110.331 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -106.19 -58.41 1.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.613 -0.68 . . . . 0.0 110.197 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -158.29 118.92 3.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 110.286 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -144.33 39.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -167.47 145.56 4.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.563 -0.71 . . . . 0.0 110.311 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -92.91 -42.22 9.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.688 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.3 -117.6 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.2 m -118.44 -158.62 0.72 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.633 -0.922 . . . . 0.0 110.187 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.21 146.44 34.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.712 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -154.84 49.59 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.09 55.97 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 3.9 t80 -112.44 71.94 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.489 -0.757 . . . . 0.0 110.311 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.21 143.53 10.81 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 322' ' ' ASP . 3.0 pp -145.99 159.76 42.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.621 -0.929 . . . . 0.0 110.063 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -70.82 135.78 48.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.0 110.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.1 p -118.99 88.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.815 0.817 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.27 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.57 -0.706 . . . . 0.0 109.962 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.62 -115.38 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 417' ' ' THR . 2.0 p-10 -123.81 21.66 9.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.58 -0.953 . . . . 0.0 110.824 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.453 ' SG ' HD13 ' A' ' 314' ' ' LEU . 47.2 t -89.2 128.06 35.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.189 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.532 ' O ' HD21 ' A' ' 314' ' ' LEU . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 332' ' ' ILE . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 332' ' ' ILE . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 334' ' ' LEU . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' CYS . . . . . 0.499 ' O ' HG21 ' A' ' 411' ' ' ILE . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.419 ' HB3' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.59 ' N ' HD22 ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 395' ' ' LYS . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 386' ' ' LYS . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.847 HD11 ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER -103.84 5.22 35.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 12.6 p -50.99 -25.62 4.94 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.985 -1.072 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.62 -12.42 59.96 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 426' ' ' ILE . 8.6 t -86.58 10.54 15.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.206 -0.934 . . . . 0.0 111.179 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 431' ' ' LEU . 3.2 p30 -58.16 -23.11 54.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.098 -1.001 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -56.21 109.87 1.95 Allowed Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.412 -0.805 . . . . 0.0 110.528 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.73 159.91 47.47 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.196 1.103 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.54 -74.38 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 110.314 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.48 -28.14 17.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.0 110.308 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -57.15 -26.14 60.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.567 -0.708 . . . . 0.0 110.553 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 358' ' ' THR . 4.1 mp0 -122.76 81.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 0.0 110.192 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.67 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.601 -0.687 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.07 -24.61 63.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.23 -37.02 76.51 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.457 -0.777 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.487 HG21 ' HG3' ' A' ' 354' ' ' GLU . 3.7 m -103.97 -26.73 12.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 110.261 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 362' ' ' LYS . 3.0 t0 -59.7 -28.09 67.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.776 . . . . 0.0 110.311 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 363' ' ' ILE . 7.5 m-85 -77.06 -4.67 45.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.722 . . . . 0.0 111.072 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -91.19 -27.57 18.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.155 -0.966 . . . . 0.0 110.175 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 359' ' ' ASP . 14.7 mtpp -64.71 -25.62 68.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.607 -0.683 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 360' ' ' TYR . 7.6 tp -57.89 -40.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 363' ' ' ILE . 3.0 ptmt -100.38 -18.77 16.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.681 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.8 20.51 17.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.02 -31.37 57.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -74.81 -14.41 60.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.53 -0.982 . . . . 0.0 111.105 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -69.58 -23.19 63.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.06 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.2 86.89 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -114.47 -30.34 6.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' ASN . . . . . 0.524 ' HB3' HD12 ' A' ' 375' ' ' ILE . 3.5 m-20 -69.96 -37.63 75.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.289 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.64 65.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.642 -0.661 . . . . 0.0 110.504 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 t -105.29 -14.77 15.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.067 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.06 -37.76 6.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 110.926 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 371' ' ' ASN . 84.9 mt -96.21 -59.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.44 -0.787 . . . . 0.0 110.542 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -59.52 -30.43 68.58 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.622 -0.674 . . . . 0.0 110.493 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -26.46 27.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.568 -0.708 . . . . 0.0 110.349 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.0 -64.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.536 -0.727 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -70.93 96.06 1.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.646 -0.659 . . . . 0.0 110.332 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 10.2 tp -75.64 -58.87 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.559 -0.713 . . . . 0.0 109.814 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.72 65.05 2.37 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.02 1.01 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 10.3 m -87.33 -29.55 21.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 110.253 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -168.69 87.26 0.09 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -58.89 -20.09 48.25 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.453 -1.028 . . . . 0.0 110.74 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -25.12 59.39 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.359 -0.838 . . . . 0.0 110.486 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 342' ' ' PHE . 39.0 mmtt -78.47 -0.94 31.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.38 -0.825 . . . . 0.0 111.185 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.51 -12.26 61.0 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.135 -0.978 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -55.0 -175.93 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.227 -0.92 . . . . 0.0 110.967 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 128.12 35.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.56 -0.713 . . . . 0.0 110.571 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -90.34 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 0.0 110.362 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -119.01 145.78 45.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.3 p -90.45 58.29 3.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -64.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 109.948 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -105.86 61.73 0.35 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -112.15 4.42 17.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.956 . . . . 0.0 110.527 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -96.51 51.62 1.56 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.72 ' HB2' HG23 ' A' ' 428' ' ' THR . 75.3 m-85 -139.58 -170.43 2.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 110.24 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -119.73 133.87 55.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.847 ' CZ3' HD11 ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.721 ' CA ' HG22 ' A' ' 411' ' ' ILE . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 422' ' ' ASN . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.592 HG23 ' O ' ' A' ' 406' ' ' THR . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.721 HG22 ' CA ' ' A' ' 400' ' ' GLY . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 418' ' ' CYS . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 417' ' ' THR . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 403' ' ' ASN . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 347' ' ' SER . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -170.4 43.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.72 HG23 ' HB2' ' A' ' 397' ' ' TYR . 27.1 m -72.68 -65.85 0.74 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.712 . . . . 0.0 110.303 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 428' ' ' THR . 2.0 p -157.56 136.75 11.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.701 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -77.86 -170.33 1.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.686 . . . . 0.0 110.111 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 348' ' ' ASP . 1.0 OUTLIER -104.37 105.28 15.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.133 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.52 -28.98 7.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.282 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -122.4 160.38 48.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.52 -171.03 0.66 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.468 1.247 . . . . 0.0 110.396 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.67 -29.32 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 109.976 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.212 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.096 0.474 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -85.7 156.88 20.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 0.0 110.202 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -142.15 -88.24 0.11 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 1.2 m -141.47 -50.95 0.42 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.942 . . . . 0.0 110.156 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.26 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -84.73 90.48 7.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.678 . . . . 0.0 110.305 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -118.45 -59.0 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.639 -0.663 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.11 -175.39 5.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -66.58 150.17 49.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -82.55 -28.65 30.86 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.311 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.45 110.35 3.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -91.92 -46.67 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.941 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.91 -21.8 31.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 417' ' ' THR . . . -55.97 107.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.342 -0.848 . . . . 0.0 110.599 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -104.72 -157.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.662 . . . . 0.0 110.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 322' ' ' ASP . 36.1 t80 -90.23 55.75 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.57 -0.706 . . . . 0.0 110.068 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -151.13 64.99 0.38 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 322' ' ' ASP . 0.4 OUTLIER -151.01 147.34 27.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.42 -1.047 . . . . 0.0 110.354 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.406 ' CG ' ' O ' ' A' ' 419' ' ' LEU . 0.2 OUTLIER -56.18 170.43 0.33 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 111.06 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.02 89.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.771 -0.581 . . . . 0.0 109.824 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.4 -62.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.511 -0.743 . . . . 0.0 110.486 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -63.17 -111.7 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -119.01 41.5 3.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.973 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.808 ' SG ' HD22 ' A' ' 314' ' ' LEU . 39.0 m -148.9 127.36 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.851 -0.531 . . . . 0.0 109.956 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.816 ' HB2' HD11 ' A' ' 314' ' ' LEU . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 323' ' ' ILE . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.697 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -59.14 -19.65 46.73 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.2 t -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.37 -0.831 . . . . 0.0 110.622 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.14 17.53 23.91 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.509 -0.744 . . . . 0.0 110.948 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.3 p -90.14 -36.18 14.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.238 -0.914 . . . . 0.0 110.459 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -43.97 5.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.504 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.74 160.49 66.2 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.537 -0.727 . . . . 0.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.55 144.82 40.94 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.46 1.242 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -120.23 160.68 22.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 110.556 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.52 -19.39 59.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.7 -0.625 . . . . 0.0 110.47 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -52.86 -24.12 8.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.58 49.66 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 110.195 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -81.49 106.33 13.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -109.65 -26.34 9.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.599 -0.688 . . . . 0.0 110.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.8 mp -57.83 -27.1 62.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.9 m -63.04 -25.81 68.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.617 -0.677 . . . . 0.0 110.36 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -28.69 66.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.486 -0.759 . . . . 0.0 110.429 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -66.11 -14.43 61.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -72.16 -13.96 61.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.235 -0.915 . . . . 0.0 110.664 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -77.63 1.08 20.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.0 111.743 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 68.4 mt -60.41 -28.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.986 -1.071 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -73.83 -23.3 59.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.0 110.59 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.2 20.82 16.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.4 -0.812 . . . . 0.0 110.64 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.1 38.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -98.59 20.54 12.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.551 -0.97 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -87.99 -26.15 22.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -86.9 61.59 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 110.656 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -72.55 162.34 29.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -80.64 -21.49 41.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.02 64.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 69.8 m -105.63 6.47 32.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.651 -0.656 . . . . 0.0 110.984 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.0 ttp -105.39 0.73 27.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.177 -0.952 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.49 -77.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.099 -1.0 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -54.16 -27.22 32.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.253 -0.905 . . . . 0.0 110.432 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 m -114.55 -124.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -165.21 109.83 0.89 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.602 -1.312 . . . . 0.0 110.27 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -92.74 -24.68 18.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 110.559 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.632 ' C ' HD22 ' A' ' 380' ' ' LEU . 0.0 OUTLIER -151.66 157.67 34.5 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 110.932 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.1 -47.49 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.263 1.138 . . . . 0.0 110.548 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.4 m -154.89 -43.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.72 -0.613 . . . . 0.0 110.539 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -154.72 67.25 0.31 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -82.97 -14.62 53.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.955 . . . . 0.0 110.639 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.89 -31.28 64.7 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -83.52 -24.69 31.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.2 -11.82 58.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.546 -0.721 . . . . 0.0 110.575 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -153.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.344 -0.847 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -50.65 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.226 -0.921 . . . . 0.0 111.38 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -72.96 148.88 43.84 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.736 -0.602 . . . . 0.0 110.366 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -55.46 164.11 1.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.715 . . . . 0.0 110.915 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.2 m -78.44 58.5 2.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.675 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 394' ' ' GLY . 32.7 p-80 -83.42 -39.65 20.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.632 -0.667 . . . . 0.0 110.027 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.434 ' N ' ' CD2' ' A' ' 393' ' ' HIS . . . -127.45 53.77 0.79 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 173.66 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.647 -0.914 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -99.07 30.83 9.07 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' A' ' 428' ' ' THR . 45.1 m-85 -122.84 73.92 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.615 -0.932 . . . . 0.0 109.948 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -79.81 156.82 27.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.667 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 411' ' ' ILE . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.667 HG22 ' HA3' ' A' ' 400' ' ' GLY . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.697 ' CG ' HG12 ' A' ' 326' ' ' VAL . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.579 HG12 HG21 ' A' ' 426' ' ' ILE . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.618 HG21 ' N ' ' A' ' 310' ' ' ALA . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 419' ' ' LEU . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 414' ' ' VAL . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -161.74 40.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 397' ' ' TYR . 5.9 p -76.44 -56.91 4.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.558 -0.714 . . . . 0.0 110.038 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.3 p -127.38 121.97 32.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 110.26 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -103.69 -46.92 4.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.05 146.61 53.85 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.185 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.2 t -152.9 -44.56 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.621 -0.675 . . . . 0.0 110.246 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -127.49 105.19 21.41 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.616 -0.678 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.83 172.15 15.93 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.352 1.185 . . . . 0.0 110.19 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.1 tt -100.87 46.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.46 -0.775 . . . . 0.0 110.128 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.883 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 15.4 mmm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.107 0.48 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -130.61 -54.93 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 110.315 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.68 -45.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 93.0 p -75.38 142.73 43.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.484 -1.01 . . . . 0.0 110.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.96 -173.24 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -128.16 45.93 2.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.238 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -152.15 47.75 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.211 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -88.63 -49.14 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -142.01 -66.71 0.4 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.638 -0.664 . . . . 0.0 110.162 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -161.21 -174.62 4.42 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.597 -0.689 . . . . 0.0 110.283 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -118.61 64.67 0.4 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.2 m -136.63 127.3 27.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.6 -0.941 . . . . 0.0 110.285 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -152.14 -179.38 7.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.659 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -104.42 118.24 36.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.559 -0.713 . . . . 0.0 110.151 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -168.73 -41.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.012 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -89.71 -154.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.613 -0.68 . . . . 0.0 109.604 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -115.2 56.98 0.49 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 320' ' ' CYS . 88.8 mt -111.39 137.78 48.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.563 -0.963 . . . . 0.0 110.256 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.821 ' CE3' HD21 ' A' ' 419' ' ' LEU . 0.2 OUTLIER -66.9 170.01 7.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.378 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 316' ' ' VAL . 28.3 m -126.54 89.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.613 -0.679 . . . . 0.0 110.234 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.72 -67.21 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -91.23 -104.31 1.34 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -151.05 95.1 2.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.756 -0.849 . . . . 0.0 110.167 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 314' ' ' LEU . 52.8 t -89.95 158.17 17.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.667 ' CD1' HD21 ' A' ' 314' ' ' LEU . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.509 HG12 ' CD1' ' A' ' 412' ' ' PHE . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.48 ' CB ' HD11 ' A' ' 411' ' ' ILE . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 331' ' ' ALA . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.557 ' O ' HD13 ' A' ' 332' ' ' ILE . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 331' ' ' ALA . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 344' ' ' LEU . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 340' ' ' LEU . 0.3 OUTLIER -103.34 -32.58 9.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.3 t -67.65 -35.45 78.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.551 -0.718 . . . . 0.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.75 17.53 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.643 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 61.6 p -65.82 -53.85 34.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.64 -39.41 6.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 110.377 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -168.73 149.03 4.12 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.622 -0.674 . . . . 0.0 110.187 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.18 -165.08 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.434 1.229 . . . . 0.0 110.402 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -77.75 -173.82 3.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.524 -0.735 . . . . 0.0 110.13 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 354' ' ' GLU . 0.4 OUTLIER -144.39 -75.2 0.24 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.568 -0.707 . . . . 0.0 110.478 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 352' ' ' GLN . 16.1 m-85 3.78 63.23 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 352' ' ' GLN . 51.6 mt-10 2.1 69.45 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.88 -38.37 3.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -110.24 -61.69 1.62 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.489 -0.757 . . . . 0.0 110.445 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 358' ' ' THR . 1.4 pp -51.13 -50.0 59.7 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.463 -0.773 . . . . 0.0 111.5 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.645 ' N ' HD12 ' A' ' 357' ' ' LEU . 89.0 m -59.37 -19.07 44.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.447 -0.783 . . . . 0.0 110.794 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.15 -16.63 46.63 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 111.272 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -56.41 -31.67 64.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.111 -0.993 . . . . 0.0 110.75 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.36 6.15 49.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.556 -0.715 . . . . 0.0 111.201 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -89.36 -29.09 19.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.96 . . . . 0.0 110.127 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 pt -58.55 -27.95 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.57 -0.706 . . . . 0.0 110.363 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -96.87 -20.38 18.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 367' ' ' PHE . 4.1 tp10 -68.54 -36.35 78.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.366 -0.834 . . . . 0.0 110.43 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 2.45 63.18 0.0 OUTLIER Glycine 1 N--CA 1.521 4.367 0 C-N-CA 124.398 0.999 . . . . 0.0 114.143 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.478 ' CE2' ' CD2' ' A' ' 379' ' ' PHE . 26.3 p90 -84.99 9.46 14.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.762 -0.846 . . . . 0.0 111.323 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -61.31 -35.09 76.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.74 28.32 5.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.734 -0.604 . . . . 0.0 110.209 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -115.04 144.86 42.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -100.07 -28.21 13.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.612 -0.68 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -50.82 -26.1 5.3 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.353 -0.842 . . . . 0.0 111.056 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' SER . . . . . 0.584 ' HA ' ' HB3' ' A' ' 378' ' ' ALA . 44.4 t -104.53 -23.54 13.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.614 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.54 9.63 15.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.245 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 73.3 mt -112.66 -70.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.072 -1.018 . . . . 0.0 110.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -79.56 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.518 -0.739 . . . . 0.0 110.862 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.2 t -178.67 44.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.037 -1.04 . . . . 0.0 110.592 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 373' ' ' SER . . . -61.16 -54.62 42.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.14 -0.975 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.478 ' CD2' ' CE2' ' A' ' 367' ' ' PHE . 0.8 OUTLIER -108.1 86.47 2.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 109.809 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 6.8 mp -50.5 107.1 0.73 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.544 -0.722 . . . . 0.0 111.23 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.88 56.35 5.59 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.179 1.094 . . . . 0.0 110.487 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.6 t -107.0 39.43 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.447 -0.783 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -132.35 31.47 2.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -84.87 -28.46 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.66 -0.906 . . . . 0.0 110.325 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -60.89 -32.9 72.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -59.77 -20.21 55.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.646 -0.659 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.97 -10.45 53.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.416 -0.803 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -49.74 153.5 1.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.133 -0.979 . . . . 0.0 111.384 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -78.21 -16.05 58.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.683 -0.635 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -49.86 106.03 0.1 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.271 -0.893 . . . . 0.0 111.076 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -21.54 34.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 t -83.41 56.42 3.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -113.9 -33.66 5.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 109.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.45 -29.96 17.62 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 86.04 4.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.979 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -89.77 -27.9 20.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.402 ' CG ' ' O ' ' A' ' 427' ' ' ALA . 48.8 m-85 -94.06 151.45 19.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.953 . . . . 0.0 110.419 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -100.97 156.72 17.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 110.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 344' ' ' LEU . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' A' ' 332' ' ' ILE . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 327' ' ' ASN . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.64 ' CE1' HG21 ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.64 HG21 ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 414' ' ' VAL . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 418' ' ' CYS . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.475 ' N ' HG23 ' A' ' 417' ' ' THR . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.821 HD21 ' CE3' ' A' ' 315' ' ' TRP . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.471 HG23 ' ND2' ' A' ' 422' ' ' ASN . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ASN . . . . . 0.471 ' ND2' HG23 ' A' ' 420' ' ' ILE . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -113.75 25.24 11.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 68.2 p -86.5 -53.32 5.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.47 -0.769 . . . . 0.0 110.164 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 429' ' ' THR . 6.1 t -168.15 89.62 0.27 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.468 -0.77 . . . . 0.0 110.219 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -171.25 -165.48 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.47 -0.769 . . . . 0.0 110.093 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.42 ' HA ' HD13 ' A' ' 431' ' ' LEU . 0.7 OUTLIER -98.23 125.9 43.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.008 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 49.8 m -118.65 164.49 15.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.726 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -102.79 102.67 28.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 110.16 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.9 -12.73 28.76 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.254 1.134 . . . . 0.0 111.247 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.55 -52.84 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.065 0.459 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -37.75 3.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.571 -0.706 . . . . 0.0 110.161 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -68.45 -36.48 84.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 22.6 t -116.01 -173.09 2.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.931 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -138.16 -168.25 2.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.558 -0.713 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -113.42 -170.97 1.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.287 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -60.01 131.53 51.14 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.581 -0.699 . . . . 0.0 110.389 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -62.82 179.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.566 -0.709 . . . . 0.0 110.194 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -90.25 162.62 15.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.56 -0.713 . . . . 0.0 110.152 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -107.38 -178.7 3.71 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.693 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -177.81 173.78 46.32 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.4 m -132.33 131.32 41.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.572 -0.958 . . . . 0.0 110.253 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ASN . . . . . 0.54 ' HA ' HG21 ' A' ' 417' ' ' THR . 8.5 p30 -112.91 -28.58 7.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.525 -0.735 . . . . 0.0 110.34 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.24 115.14 19.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.257 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -127.71 -172.4 2.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.639 -0.663 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.435 ' HA ' HD11 ' A' ' 323' ' ' ILE . 34.1 t80 -114.0 25.53 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.721 . . . . 0.0 110.463 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 314' ' ' LEU . . . -150.38 92.82 0.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.95 160.32 43.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.582 -0.952 . . . . 0.0 110.82 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.732 ' CH2' HD11 ' A' ' 419' ' ' LEU . 0.1 OUTLIER -88.6 170.07 11.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.515 -0.741 . . . . 0.0 110.36 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.03 94.0 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -168.79 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 110.284 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -90.58 -89.68 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -139.99 36.29 1.95 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.95 . . . . 0.0 110.294 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.1 112.15 13.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.538 -0.726 . . . . 0.0 110.095 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.823 ' HB3' HD13 ' A' ' 323' ' ' ILE . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 322' ' ' ASP . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' HIS . . . . . 0.424 ' CD2' ' HD3' ' A' ' 351' ' ' LYS . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.745 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.439 ' HA ' HD13 ' A' ' 340' ' ' LEU . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 342' ' ' PHE . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.429 ' N ' HG23 ' A' ' 341' ' ' VAL . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.548 HD22 ' HZ3' ' A' ' 399' ' ' TRP . 3.0 tp -90.75 5.14 49.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.4 m -52.14 -28.56 18.41 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.0 110.55 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.69 -27.79 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.719 -0.613 . . . . 0.0 109.767 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.2 t -87.71 10.3 18.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.577 -0.702 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.52 8.64 43.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 111.1 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -56.82 149.55 42.38 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.39 118.91 5.82 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.514 1.271 . . . . 0.0 110.578 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' LYS . . . . . 0.424 ' HD3' ' CD2' ' A' ' 325' ' ' HIS . 5.0 mtpt -124.67 -64.64 1.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.605 -0.685 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.61 91.79 2.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 353' ' ' TYR . 32.0 p90 -140.31 24.77 2.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.518 -0.739 . . . . 0.0 110.583 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -169.79 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.433 -0.792 . . . . 0.0 110.096 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -62.59 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.56 -0.712 . . . . 0.0 110.24 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -68.06 -39.83 82.92 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 357' ' ' LEU . 2.0 mm? -60.65 -27.69 68.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.505 -0.747 . . . . 0.0 110.188 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 20.2 m -99.32 -27.09 13.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.619 -0.676 . . . . 0.0 110.385 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 14.0 t70 -76.56 -25.11 53.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.573 -0.704 . . . . 0.0 110.373 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 363' ' ' ILE . 4.2 m-85 -81.49 -20.76 39.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.495 -0.753 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -101.87 6.58 41.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.339 -0.851 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 359' ' ' ASP . 0.0 OUTLIER -88.45 -24.43 23.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.116 -0.99 . . . . 0.0 111.735 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.567 HD13 ' N ' ' A' ' 363' ' ' ILE . 0.2 OUTLIER -50.83 -23.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.23 -0.918 . . . . 0.0 111.508 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -24.37 21.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.385 -0.822 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 20.29 9.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -91.49 -50.11 2.83 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -169.19 32.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.958 . . . . 0.0 110.23 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -86.26 -29.7 22.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.639 -0.663 . . . . 0.0 110.242 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.75 105.55 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -106.16 -29.52 9.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.603 -0.685 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -93.78 -39.24 10.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.559 -0.713 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.31 -26.04 66.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.9 p -83.9 -22.88 31.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 110.641 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.79 -21.13 15.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.346 -0.846 . . . . 0.0 111.026 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.27 -66.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.62 -41.84 82.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.698 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -76.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 110.277 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -150.88 -161.19 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -152.92 -45.33 0.1 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.45 85.68 7.42 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.57 -0.706 . . . . 0.0 110.798 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.67 71.33 1.99 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.276 1.145 . . . . 0.0 109.85 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.6 m -115.15 73.15 0.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -89.66 52.61 3.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -66.85 -11.31 55.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.685 -0.891 . . . . 0.0 110.397 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.03 -28.76 40.48 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.189 -0.945 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -66.44 -20.95 66.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.589 -0.694 . . . . 0.0 110.331 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.85 48.4 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.375 -0.828 . . . . 0.0 111.097 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.37 -165.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.15 -0.969 . . . . 0.0 110.76 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.5 mmt-85 -58.05 -25.74 61.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.558 -0.714 . . . . 0.0 110.531 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -52.1 -24.59 7.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 111.068 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -136.25 -43.54 0.63 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.2 t -83.93 57.63 4.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.548 -0.72 . . . . 0.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -91.41 45.69 1.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.607 -0.683 . . . . 0.0 110.493 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 108.32 17.68 10.47 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.7 149.76 50.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 -38.41 0.07 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.66 -36.38 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.499 -1.0 . . . . 0.0 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -47.58 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.435 -0.791 . . . . 0.0 111.797 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.548 ' HZ3' HD22 ' A' ' 344' ' ' LEU . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 408' ' ' LYS . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.493 ' HB3' HG21 ' A' ' 404' ' ' THR . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.893 ' N ' HD13 ' A' ' 411' ' ' ILE . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 309' ' ' ASN . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.732 HD11 ' CH2' ' A' ' 315' ' ' TRP . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.405 ' CD2' ' O ' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 4.0 p -60.04 -35.72 75.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.564 -0.71 . . . . 0.0 110.344 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 40.7 p -99.99 91.84 4.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -165.0 -42.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.546 -0.721 . . . . 0.0 110.352 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.452 HD23 ' C ' ' A' ' 431' ' ' LEU . 10.2 tt -81.36 -30.81 33.62 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.639 -0.663 . . . . 0.0 110.277 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.5 t -80.69 -28.65 36.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.55 -0.719 . . . . 0.0 110.29 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -155.95 162.49 27.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 110.277 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 143.4 37.49 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.447 1.235 . . . . 0.0 110.351 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.0 mt -70.64 -32.11 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.619 -0.675 . . . . 0.0 109.854 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.752 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -64.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.576 -0.702 . . . . 0.0 110.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.39 147.35 17.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 5.9 m -144.63 -63.07 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.966 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -83.05 139.03 33.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 110.171 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -116.05 -72.24 0.7 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -145.14 -44.61 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.562 -0.711 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -78.62 148.79 33.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.552 -0.717 . . . . 0.0 110.134 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -133.21 176.19 8.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.567 -0.708 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -126.44 163.68 22.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 110.168 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.22 -84.58 0.73 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.9 m -128.38 155.1 45.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.583 -0.951 . . . . 0.0 110.178 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -135.56 14.02 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -101.53 -179.54 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -152.04 29.1 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.649 -0.657 . . . . 0.0 110.216 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -144.84 -77.15 0.21 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.681 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.12 -69.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.585 HD21 ' SG ' ' A' ' 418' ' ' CYS . 2.9 tp -111.42 153.92 25.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.981 . . . . 0.0 110.267 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.29 168.26 19.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.688 -0.632 . . . . 0.0 110.346 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.2 p -130.86 88.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.73 0.776 . . . . 0.0 109.933 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -175.75 34.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.659 -0.65 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.07 -117.18 0.93 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.07 20.93 0.87 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.45 -1.029 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t -93.43 169.97 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.919 . . . . 0.0 110.109 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' CG ' HD13 ' A' ' 314' ' ' LEU . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 335' ' ' PHE . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.674 HD13 ' O ' ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 331' ' ' ALA . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 340' ' ' LEU . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.666 HD21 HD23 ' A' ' 344' ' ' LEU . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 342' ' ' PHE . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.458 ' N ' HG13 ' A' ' 341' ' ' VAL . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.666 HD23 HD21 ' A' ' 340' ' ' LEU . 6.4 mt -103.2 -3.15 26.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.06 -35.92 10.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.123 -0.986 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.46 18.02 22.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.728 -0.608 . . . . 0.0 110.66 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.79 10.53 11.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 111.421 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.52 -72.24 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.98 -1.075 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.93 54.63 0.25 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.468 -0.77 . . . . 0.0 110.61 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.85 111.23 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.296 1.156 . . . . 0.0 110.475 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -146.95 -74.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.662 -0.649 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -162.42 165.93 25.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 0.0 109.914 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -155.55 -44.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 31.9 5.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.675 . . . . 0.0 110.108 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.47 170.44 1.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.552 -0.718 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -82.44 -30.99 29.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 357' ' ' LEU . 2.1 mm? -61.13 -24.5 66.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.622 -0.674 . . . . 0.0 110.36 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 358' ' ' THR . 63.0 m -101.57 5.76 41.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.483 -0.761 . . . . 0.0 111.231 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.94 -21.52 21.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.689 ' O ' HG22 ' A' ' 363' ' ' ILE . 26.2 p90 -99.97 -24.33 14.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.206 -0.934 . . . . 0.0 111.036 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.46 -16.35 60.37 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.465 -0.772 . . . . 0.0 111.02 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.05 -27.22 52.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 360' ' ' TYR . 5.2 tp -100.12 -22.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.629 -0.67 . . . . 0.0 110.342 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -90.01 -27.7 19.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 110.224 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -93.02 20.29 6.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.565 -0.709 . . . . 0.0 110.805 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.55 -27.24 63.32 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -56.33 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.493 -1.004 . . . . 0.0 110.494 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -96.23 25.13 5.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -112.8 18.3 18.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.736 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -102.87 -33.22 9.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.039 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -100.07 -28.3 13.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.738 -0.601 . . . . 0.0 110.261 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.86 48.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.47 -0.769 . . . . 0.0 110.76 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.6 t -82.49 -23.52 34.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.598 -0.689 . . . . 0.0 110.347 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 14.1 mtt -79.91 -26.37 40.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.414 -0.803 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 45.7 mm -59.13 -50.19 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.806 . . . . 0.0 110.03 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.46 -24.08 64.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.711 -0.618 . . . . 0.0 110.398 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.47 23.44 11.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.473 -0.767 . . . . 0.0 110.352 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -85.02 131.32 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.488 -0.758 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -64.83 81.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.717 -0.614 . . . . 0.0 110.132 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.849 ' O ' ' HB2' ' A' ' 384' ' ' ALA . 7.4 mt -77.74 -57.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.69 . . . . 0.0 110.82 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 47.6 Cg_endo -73.28 -27.08 13.9 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.144 1.076 . . . . 0.0 110.711 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.9 p -94.86 -36.1 11.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.2 29.11 11.92 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 380' ' ' LEU . . . -90.51 -24.31 20.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.947 . . . . 0.0 110.64 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.08 -21.53 54.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 110.986 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -89.65 -25.6 21.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.307 -0.871 . . . . 0.0 110.639 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.28 55.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 110.817 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -52.09 -54.24 32.79 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.156 -0.965 . . . . 0.0 111.866 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -122.27 111.49 16.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.329 -0.857 . . . . 0.0 111.138 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -91.31 46.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.774 -0.579 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -92.07 -22.45 19.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.5 p -58.53 -19.19 35.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.949 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -94.47 29.91 2.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.0 14.61 2.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -67.65 165.61 16.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.209 -1.171 . . . . 0.0 110.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -156.62 -60.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.453 ' CD2' ' HA ' ' A' ' 428' ' ' THR . 0.2 OUTLIER -128.98 -155.32 0.69 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.576 -0.955 . . . . 0.0 110.076 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -135.84 119.39 17.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.502 -0.749 . . . . 0.0 110.332 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.438 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.896 ' N ' HD13 ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.418 ' OD1' HD12 ' A' ' 344' ' ' LEU . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.585 ' SG ' HD21 ' A' ' 314' ' ' LEU . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.705 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -169.24 71.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.453 ' HA ' ' CD2' ' A' ' 397' ' ' TYR . 82.6 p -59.87 -52.74 64.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.415 -0.803 . . . . 0.0 110.226 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 10.2 p -137.25 101.48 4.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.0 110.146 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.13 -72.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.58 -0.7 . . . . 0.0 110.291 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.1 mm? -117.41 134.6 54.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.646 -0.659 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -115.34 28.81 8.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 11.6 p80 -169.5 76.02 0.69 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.79 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 64.0 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.3 1.158 . . . . 0.0 110.465 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.7 tp -76.56 -25.48 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.073 179.875 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 17.5 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.084 0.469 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -92.44 -66.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.618 -0.676 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -146.73 134.57 5.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.9 t -128.96 132.19 47.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.663 -0.904 . . . . 0.0 110.279 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -148.99 47.22 1.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.566 -0.708 . . . . 0.0 110.223 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -86.5 -36.38 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -126.0 -165.28 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -71.8 127.85 33.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -86.52 136.06 33.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 110.256 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -87.95 52.98 2.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.18 109.47 0.43 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 94.9 p -102.41 33.17 3.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.593 -0.945 . . . . 0.0 110.16 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -121.32 -71.46 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.696 . . . . 0.0 110.197 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -168.02 -176.3 2.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.626 -0.671 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -172.39 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.512 -0.742 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 314' ' ' LEU . 21.7 t80 -134.58 170.47 15.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.772 -0.58 . . . . 0.0 109.46 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 420' ' ' ILE . . . -95.19 31.6 6.89 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -150.17 146.77 27.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -1.075 . . . . 0.0 110.17 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.612 ' CE2' HD21 ' A' ' 419' ' ' LEU . 12.9 p-90 -143.3 171.32 14.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.607 . . . . 0.0 109.669 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.405 ' O ' ' CD2' ' A' ' 315' ' ' TRP . 59.9 t -50.42 134.17 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.54 126.65 24.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.49 -43.56 0.02 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.28 -40.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -1.0 . . . . 0.0 110.901 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t -89.33 170.26 10.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.49 -0.757 . . . . 0.0 110.465 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.436 ' OD1' HD21 ' A' ' 314' ' ' LEU . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 323' ' ' ILE . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.711 HG12 ' CB ' ' A' ' 412' ' ' PHE . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 334' ' ' LEU . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 344' ' ' LEU . 3.3 mm? -103.19 4.62 37.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.4 t -53.64 -29.22 37.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.094 -1.004 . . . . 0.0 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.8 -31.48 72.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.655 . . . . 0.0 109.674 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -98.22 10.5 40.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.654 -0.654 . . . . 0.0 110.897 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.42 8.97 40.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.195 -0.941 . . . . 0.0 111.116 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -102.48 98.43 10.79 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.207 -0.933 . . . . 0.0 110.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.13 -19.1 26.6 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.4 1.21 . . . . 0.0 110.931 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -55.92 -69.73 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.323 -0.86 . . . . 0.0 110.735 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -57.75 103.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.597 -0.689 . . . . 0.0 110.433 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.44 -50.34 1.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.694 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -149.32 77.75 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.609 -0.682 . . . . 0.0 110.343 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -165.21 -42.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.411 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -99.99 18.56 18.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.37 -40.59 96.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.421 -0.799 . . . . 0.0 110.057 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.4 m -60.24 -24.81 65.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.638 -0.664 . . . . 0.0 110.431 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -92.75 -25.85 18.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -0.771 . . . . 0.0 110.462 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.1 -27.94 35.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.524 -0.735 . . . . 0.0 110.526 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.85 -20.52 61.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.512 -0.742 . . . . 0.0 110.647 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -97.73 10.59 39.67 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.382 -0.824 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.68 -26.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -60.42 -32.83 71.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.404 -0.81 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -109.97 20.11 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.667 -0.646 . . . . 0.0 110.571 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.67 80.1 0.3 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.21 76.46 8.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.555 -0.968 . . . . 0.0 110.144 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -125.79 34.72 4.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.508 -0.745 . . . . 0.0 110.402 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -137.86 29.76 2.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.616 -0.677 . . . . 0.0 110.135 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -88.87 -157.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.585 -0.697 . . . . 0.0 110.172 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -79.26 -35.4 41.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.66 69.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.627 -0.671 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.9 t -94.63 -28.84 15.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 378' ' ' ALA . 3.9 mtt -60.45 -27.32 67.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.563 -0.711 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.63 -28.65 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.96 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -81.07 -27.28 35.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 7.4 m -99.1 -41.77 7.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.566 -0.709 . . . . 0.0 110.323 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.637 ' HB1' HD21 ' A' ' 380' ' ' LEU . . . -97.07 108.13 20.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.719 -0.613 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -83.36 76.53 9.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.681 -0.637 . . . . 0.0 110.16 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.637 HD21 ' HB1' ' A' ' 378' ' ' ALA . 0.8 OUTLIER -165.87 92.28 0.84 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.11 64.1 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.331 1.174 . . . . 0.0 110.378 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 17.6 p -80.29 -31.95 38.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.526 -0.734 . . . . 0.0 110.22 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -139.7 51.89 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -79.74 -28.19 40.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.682 -0.893 . . . . 0.0 110.277 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.96 -25.83 68.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.61 -0.681 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -19.94 44.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.432 -0.792 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.59 -19.26 36.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.415 -0.803 . . . . 0.0 110.688 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -57.01 -20.86 26.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.258 -0.901 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -55.3 135.98 49.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.337 -0.852 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -77.3 172.87 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.588 -0.695 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -52.4 -47.42 66.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 0.0 111.328 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.2 p -63.0 -27.18 69.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.599 -0.688 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -97.51 29.92 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.494 -0.754 . . . . 0.0 110.334 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -114.55 -38.08 1.12 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 396' ' ' GLY . 11.0 mttp -94.89 -70.85 0.69 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.272 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 395' ' ' LYS . . . 3.01 65.76 0.0 OUTLIER Glycine 1 N--CA 1.519 4.194 0 C-N-CA 124.722 1.153 . . . . 0.0 113.976 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 395' ' ' LYS . 65.9 t80 -146.98 62.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.732 . . . . 0.0 110.049 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -95.86 133.38 40.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.647 -0.658 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.535 ' CH2' HD11 ' A' ' 411' ' ' ILE . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.801 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.801 ' N ' HD13 ' A' ' 411' ' ' ILE . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 315' ' ' TRP . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.499 HG23 ' HA2' ' A' ' 313' ' ' GLY . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -147.34 104.63 3.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.4 p -80.13 -66.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 59.2 m -157.82 90.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.52 -0.737 . . . . 0.0 110.185 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.11 -74.93 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.238 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 431' ' ' LEU . 3.4 pp -143.42 138.17 29.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 110.446 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.2 p -112.96 65.5 0.64 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.709 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' HIS . . . . . 0.435 ' HB3' ' HD3' ' A' ' 434' ' ' PRO . 2.4 t-80 -75.61 -57.63 1.56 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.486 -0.759 . . . . 0.0 109.97 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 433' ' ' HIS . 46.0 Cg_endo -70.43 -166.27 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 122.962 0.98 . . . . 0.0 110.418 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 436' ' ' GLU . 5.8 tp -162.51 -40.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 435' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.755 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.075 0.464 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -114.01 -26.06 8.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -143.34 155.27 25.96 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.9 p -147.46 -67.71 0.25 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.953 . . . . 0.0 110.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -134.43 165.93 24.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.697 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.95 -162.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.586 -0.696 . . . . 0.0 110.046 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.29 167.18 2.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.721 . . . . 0.0 110.243 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -91.37 155.51 18.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.0 110.212 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -91.94 165.51 13.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' HIS . . . . . 0.673 ' HB3' ' HB1' ' A' ' 346' ' ' ALA . 32.5 m170 -137.48 -177.59 4.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.373 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -165.05 -159.14 11.03 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.1 t -169.12 92.28 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.508 -0.995 . . . . 0.0 110.25 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.13 147.59 4.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -160.03 173.2 16.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.595 -0.69 . . . . 0.0 110.12 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.37 -161.63 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.543 -0.723 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.451 ' CE2' HD11 ' A' ' 323' ' ' ILE . 3.9 t80 -150.25 94.63 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.636 -0.665 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -106.26 133.6 11.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 314' ' ' LEU . 6.1 mt -118.84 -165.51 1.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.647 -0.913 . . . . 0.0 110.066 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 320' ' ' CYS . 0.3 OUTLIER -162.78 170.56 18.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 33.9 m -68.62 170.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.565 -0.709 . . . . 0.0 110.039 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -57.74 117.74 4.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.458 -0.776 . . . . 0.0 110.577 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -144.51 -124.7 1.78 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -127.18 24.84 6.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.0 110.515 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -91.56 170.84 9.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.425 -0.797 . . . . 0.0 110.006 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.64 ' OD2' HG22 ' A' ' 323' ' ' ILE . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.64 HG22 ' OD2' ' A' ' 322' ' ' ASP . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.663 HG12 ' CG ' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ASN . . . . . 0.487 ' HB2' HG23 ' A' ' 411' ' ' ILE . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 409' ' ' CYS . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 342' ' ' PHE . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 341' ' ' VAL . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 344' ' ' LEU . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 343' ' ' GLU . 4.7 mp -103.31 -42.66 5.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 61.4 m -89.89 -2.69 58.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.666 -0.646 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' -3' ' ' HIS . . . -86.53 9.15 19.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 39.8 t -60.8 -29.0 69.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.14 8.43 43.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.12 112.11 4.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 -169.01 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.178 1.094 . . . . 0.0 110.439 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.9 165.49 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 110.376 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -81.59 101.66 10.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.69 . . . . 0.0 110.019 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.92 -29.88 69.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.551 -0.718 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.18 -70.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.712 . . . . 0.0 110.204 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -168.33 -172.99 1.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -110.07 18.42 20.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.552 -0.718 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.84 -28.53 10.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' THR . . . . . 0.47 ' HA ' ' CE2' ' A' ' 360' ' ' TYR . 23.0 m -83.6 4.14 29.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 111.171 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.07 -17.73 28.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.198 -0.939 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.768 ' O ' HG23 ' A' ' 363' ' ' ILE . 23.6 p90 -55.37 -22.64 20.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.115 -0.991 . . . . 0.0 110.918 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.19 -17.72 54.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.379 -0.826 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -73.87 -4.23 33.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 111.547 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 360' ' ' TYR . 35.5 pt -56.66 -25.71 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.964 -1.085 . . . . 0.0 110.447 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -17.9 22.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 110.558 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.6 20.67 6.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.353 -0.842 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.2 -27.83 63.34 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.88 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -1.062 . . . . 0.0 110.484 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 pttt -115.63 42.39 2.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.688 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -106.2 -29.93 9.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.581 -0.699 . . . . 0.0 110.079 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -105.23 -28.75 10.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 110.15 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -86.63 -32.1 20.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.624 -0.672 . . . . 0.0 110.405 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.66 68.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 t -105.02 5.07 32.27 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.574 -0.704 . . . . 0.0 111.178 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 15.1 mtt -105.16 -26.33 12.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 110.398 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.5 mp -134.33 -60.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -0.763 . . . . 0.0 109.899 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -55.91 -26.09 45.97 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.783 -0.573 . . . . 0.0 110.684 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.93 78.08 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.8 -47.62 4.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.749 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 381' ' ' PRO . 75.1 t80 -103.72 91.24 3.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.679 -0.638 . . . . 0.0 109.633 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.738 ' N ' HD13 ' A' ' 380' ' ' LEU . 0.0 OUTLIER -128.08 52.31 8.5 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.661 -0.65 . . . . 0.0 111.144 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 47.8 Cg_endo -71.99 64.19 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.388 1.204 . . . . 0.0 110.331 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 382' ' ' THR . 7.0 t -165.44 71.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 110.131 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 386' ' ' LYS . . . -60.15 -27.77 65.59 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.28 8.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.58 -0.953 . . . . 0.0 110.565 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -90.64 44.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.475 -0.766 . . . . 0.0 110.677 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HE3' ' HA2' ' A' ' 383' ' ' GLY . 26.5 ttmt -90.42 -24.1 20.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.69 -18.88 34.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.471 -0.768 . . . . 0.0 110.649 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.64 -50.06 7.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 33.3 mtt85 -70.78 -23.02 62.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.682 -0.636 . . . . 0.0 110.524 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.61 154.85 1.77 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.376 -0.828 . . . . 0.0 110.955 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.44 175.19 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.599 -0.688 . . . . 0.0 110.214 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.4 m -89.98 52.26 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.55 -0.718 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -59.58 -21.14 59.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.616 -0.677 . . . . 0.0 110.663 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -78.53 -1.01 81.45 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -55.89 144.24 28.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.885 -1.362 . . . . 0.0 110.697 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.9 -62.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.431 ' N ' ' CD1' ' A' ' 397' ' ' TYR . 51.3 m-85 -137.1 -161.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.545 -0.973 . . . . 0.0 109.537 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -113.49 58.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.52 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.49 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 411' ' ' ILE . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 422' ' ' ASN . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' ASN . . . . . 0.408 ' HB2' ' CA ' ' A' ' 422' ' ' ASN . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 408' ' ' LYS . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 404' ' ' THR . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 329' ' ' PHE . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.573 HD13 ' HA2' ' A' ' 400' ' ' GLY . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.663 ' CG ' HG12 ' A' ' 326' ' ' VAL . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' CYS . . . . . 0.64 ' SG ' HG22 ' A' ' 420' ' ' ILE . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.423 ' HB2' ' CD1' ' A' ' 315' ' ' TRP . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.64 HG22 ' SG ' ' A' ' 418' ' ' CYS . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 401' ' ' ASN . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.758 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -164.83 133.62 3.47 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 429' ' ' THR . 75.3 m -59.07 -81.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.251 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 428' ' ' THR . 1.1 p -160.11 97.28 1.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.61 70.78 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.721 . . . . 0.0 110.079 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 431' ' ' LEU . 0.2 OUTLIER -157.47 123.88 4.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.649 -0.657 . . . . 0.0 110.105 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 14.5 t -127.35 -179.03 4.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.557 -0.714 . . . . 0.0 110.372 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -86.34 147.26 44.17 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.51 -0.744 . . . . 0.0 110.124 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.0 -46.39 0.31 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.409 1.215 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.29 -32.42 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.702 -0.624 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.289 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.082 0.467 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -127.3 155.91 42.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.246 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -111.57 42.77 1.87 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 63.9 m -85.35 153.13 22.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.689 -0.889 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -71.8 129.91 39.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.541 -0.725 . . . . 0.0 110.322 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -157.61 -73.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -168.94 140.46 2.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -171.85 1.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.545 -0.722 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -151.86 -57.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 110.217 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -132.36 173.53 11.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.16 68.16 0.19 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -123.33 -158.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.525 -0.985 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.55 -33.2 23.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.582 -0.699 . . . . 0.0 110.055 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -142.56 179.41 6.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.587 -0.696 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.76 -46.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.715 . . . . 0.0 109.454 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.491 ' CD2' HD21 ' A' ' 314' ' ' LEU . 0.3 OUTLIER -113.92 -147.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -134.11 36.05 2.15 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.491 HD21 ' CD2' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -142.1 -164.91 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.929 -0.747 . . . . 0.0 110.239 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.464 ' CD1' HD21 ' A' ' 419' ' ' LEU . 0.1 OUTLIER -51.64 146.05 8.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.258 -0.902 . . . . 0.0 111.339 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.51 92.03 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.882 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -169.35 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.438 ' HA3' ' CZ2' ' A' ' 315' ' ' TRP . . . -61.66 -108.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -149.39 17.41 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.972 . . . . 0.0 111.284 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.66 86.12 6.93 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.157 -0.964 . . . . 0.0 109.934 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 332' ' ' ILE . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 407' ' ' GLN . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.402 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 340' ' ' LEU . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.27 4.31 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.5 p -83.22 -31.57 26.97 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.241 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.38 -30.36 63.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.619 -0.675 . . . . 0.0 110.14 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.9 p -98.02 10.54 40.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.984 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.58 -26.3 13.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.171 -0.955 . . . . 0.0 110.425 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -110.82 76.22 1.17 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.432 -0.792 . . . . 0.0 110.241 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.18 -165.52 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -106.5 -71.3 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.619 -0.676 . . . . 0.0 110.234 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -106.35 169.55 8.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 0.0 110.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -75.63 -22.96 56.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.69 . . . . 0.0 110.565 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.59 27.14 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.407 -0.808 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -150.46 104.99 3.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.237 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -110.03 -25.86 10.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.55 -23.98 59.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.379 -0.825 . . . . 0.0 110.57 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 6.8 m -63.32 -15.64 57.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.399 -0.813 . . . . 0.0 110.962 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -54.39 -22.68 13.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.272 -0.892 . . . . 0.0 111.084 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -55.61 -22.63 23.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -10.89 57.22 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -74.18 -3.98 33.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.216 -0.928 . . . . 0.0 111.36 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 53.1 mt -58.88 -25.71 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.075 -1.016 . . . . 0.0 110.138 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -27.76 66.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.562 -0.711 . . . . 0.0 110.287 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -26.46 15.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.286 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -89.48 75.34 1.86 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.93 98.07 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.623 -0.928 . . . . 0.0 110.039 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.9 pttt -55.09 -22.36 16.11 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.466 -0.771 . . . . 0.0 111.094 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.58 -22.62 19.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.82 . . . . 0.0 111.068 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -104.75 -25.19 12.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.318 -0.864 . . . . 0.0 110.786 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -58.53 -27.85 64.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.436 -0.79 . . . . 0.0 110.629 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.63 93.39 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.509 -0.744 . . . . 0.0 110.494 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.3 t -105.18 13.82 30.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.652 -0.655 . . . . 0.0 111.041 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 6.6 tpt -105.15 -31.36 9.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.26 -0.9 . . . . 0.0 110.484 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.24 -52.0 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 110.208 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -66.61 -28.79 68.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.192 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 58.19 1.78 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.212 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.32 100.79 11.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.56 -0.713 . . . . 0.0 110.237 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -113.79 -27.16 7.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 381' ' ' PRO . 5.5 mt -58.56 -56.38 36.17 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 380' ' ' LEU . 46.8 Cg_endo -73.54 -29.54 10.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.311 1.163 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.96 83.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 109.929 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -115.91 -27.58 2.94 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.9 -18.74 24.85 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.984 . . . . 0.0 111.237 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.44 18.07 5.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.163 -0.96 . . . . 0.0 111.169 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -82.56 -24.39 34.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.27 -18.05 46.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.48 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.36 -166.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -100.98 -170.91 1.91 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.676 -0.64 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.11 162.61 9.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 110.144 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -158.61 0.88 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.66 -0.65 . . . . 0.0 110.087 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 66.5 m -90.17 53.03 2.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -59.93 -27.42 66.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.554 -0.716 . . . . 0.0 110.389 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -115.2 43.84 1.6 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.85 171.62 1.15 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.963 . . . . 0.0 110.336 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -163.24 38.11 0.33 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -83.52 -170.71 3.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.899 . . . . 0.0 110.237 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -105.84 152.42 23.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.624 -0.672 . . . . 0.0 110.081 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.755 ' HA ' HD13 ' A' ' 426' ' ' ILE . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLN . . . . . 0.632 ' HG3' HG21 ' A' ' 332' ' ' ILE . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 414' ' ' VAL . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 413' ' ' ASN . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 419' ' ' LEU . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 420' ' ' ILE . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.755 HD13 ' HA ' ' A' ' 399' ' ' TRP . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -165.12 66.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 12.6 p -99.9 -51.99 3.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.61 -0.681 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 14.1 p -134.25 109.85 9.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.737 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.59 157.97 25.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.622 -0.674 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.61 39.51 1.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 90.9 p -165.33 -170.98 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.737 . . . . 0.0 110.269 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -96.01 151.94 38.61 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 110.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 126.9 11.79 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.368 1.194 . . . . 0.0 110.368 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.499 HG23 ' O ' ' A' ' 435' ' ' ILE . 1.2 tp -151.11 61.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.113 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.085 0.469 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -168.53 48.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.98 119.35 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 m -141.08 37.58 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.974 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.2 84.99 2.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.189 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.75 67.13 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.623 -0.673 . . . . 0.0 110.37 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -76.6 -71.78 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -166.32 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.714 . . . . 0.0 110.185 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -83.82 165.3 18.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.609 -0.682 . . . . 0.0 110.212 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.45 -167.04 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.74 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -159.22 172.21 35.86 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 t -119.24 51.41 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.498 -1.001 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.05 -153.69 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 109.866 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.03 128.93 38.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.457 -0.777 . . . . 0.0 109.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -168.81 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 0.0 109.661 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 2.3 t80 -129.2 -146.13 0.31 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.784 -0.572 . . . . 0.0 109.655 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -146.05 28.51 1.7 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.51 -163.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.56 -0.965 . . . . 0.0 110.095 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.64 ' HD1' HD12 ' A' ' 419' ' ' LEU . 0.4 OUTLIER -165.9 160.12 16.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 110.005 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.4 p -104.46 87.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -178.65 -148.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -150.56 65.44 0.38 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.1 22.48 0.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.478 -1.013 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 85.3 m -135.9 170.43 16.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.722 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 334' ' ' LEU . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.537 ' N ' HD12 ' A' ' 334' ' ' LEU . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.536 ' O ' HD22 ' A' ' 340' ' ' LEU . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 339' ' ' LYS . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 342' ' ' PHE . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 341' ' ' VAL . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 344' ' ' LEU . 1.0 OUTLIER -80.54 2.54 25.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.5 p -60.06 -34.38 73.34 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.033 -1.042 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -89.72 -28.59 19.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.541 -0.725 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 27.5 m -89.39 10.54 22.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.506 -0.747 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -58.65 -33.39 70.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.128 -0.983 . . . . 0.0 110.428 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.36 135.94 13.51 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.39 179.19 6.11 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.237 1.125 . . . . 0.0 110.471 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -108.11 158.08 17.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.551 -0.718 . . . . 0.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -140.8 139.28 34.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.596 -0.69 . . . . 0.0 110.241 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -62.69 -44.45 96.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.679 . . . . 0.0 109.984 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -170.59 65.68 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.41 -73.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.534 -0.728 . . . . 0.0 110.054 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -99.35 18.29 18.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -88.75 -40.04 13.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.932 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -27.92 22.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.707 . . . . 0.0 110.353 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.39 -30.42 68.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.545 -0.722 . . . . 0.0 110.327 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -84.62 -15.71 44.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.11 -30.43 13.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -65.07 -16.77 63.83 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.533 -0.73 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.28 -30.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.247 -0.908 . . . . 0.0 110.732 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -100.02 -14.71 18.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.57 -0.706 . . . . 0.0 110.949 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.81 -23.22 28.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.184 -0.948 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.95 65.27 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -56.77 100.91 0.05 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -1.03 . . . . 0.0 110.57 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -48.89 -28.05 3.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.604 -0.685 . . . . 0.0 110.575 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.38 53.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -45.79 121.49 3.18 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.759 -0.588 . . . . 0.0 111.787 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -99.66 -9.04 23.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.741 -0.599 . . . . 0.0 110.755 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.99 51.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.99 . . . . 0.0 110.461 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 67.5 m -59.88 -32.81 71.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.558 -0.714 . . . . 0.0 110.065 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 5.1 mtt -98.36 -32.32 11.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 84.1 mt -72.43 -28.19 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.637 -0.665 . . . . 0.0 110.029 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -56.34 -27.64 56.51 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.517 -0.74 . . . . 0.0 110.473 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.9 m -85.14 -30.48 23.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.67 . . . . 0.0 109.972 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -121.35 90.74 3.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.66 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.28 -25.86 62.29 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 99.3 mt -124.35 95.74 42.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.514 -0.741 . . . . 0.0 110.241 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.6 -48.79 0.29 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.345 1.182 . . . . 0.0 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.6 m -159.55 -63.89 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.737 -0.602 . . . . 0.0 110.404 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -145.85 74.42 0.3 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -89.97 14.68 11.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.947 . . . . 0.0 110.681 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -90.18 -29.74 18.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.875 . . . . 0.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -80.36 -23.61 40.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.681 -0.637 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.69 44.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.35 -0.844 . . . . 0.0 110.397 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.78 -168.84 0.5 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.448 -0.783 . . . . 0.0 110.267 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -126.03 23.92 7.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.69 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -55.54 -23.4 26.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.324 -0.86 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.22 172.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.341 -0.85 . . . . 0.0 110.6 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 t -86.78 55.8 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.623 -0.673 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -104.45 76.85 1.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 127.76 -29.39 4.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.49 114.12 2.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.352 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -168.8 -53.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -67.42 -177.09 0.66 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.968 . . . . 0.0 110.402 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -119.27 139.59 51.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.4 ' CE3' ' O ' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 404' ' ' THR . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.719 ' HB2' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 414' ' ' VAL . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 416' ' ' PRO . . . . . 0.469 ' HD3' HG13 ' A' ' 414' ' ' VAL . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.64 HD12 ' HD1' ' A' ' 315' ' ' TRP . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -167.22 109.71 0.67 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -37.87 88.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.597 -0.689 . . . . 0.0 110.086 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 429' ' ' THR . 7.5 t -143.66 110.99 5.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -118.71 -158.84 0.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.575 -0.703 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.8 mm? -96.27 63.99 2.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.3 m -150.14 102.6 3.11 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -129.31 67.04 78.13 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.725 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 -27.95 14.24 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.341 1.179 . . . . 0.0 110.507 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -62.27 -43.57 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.645 -0.659 . . . . 0.0 109.951 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.137 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.091 0.472 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -106.52 80.7 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.576 -0.703 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -128.56 118.25 2.72 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 17.5 t -86.04 -43.72 12.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.935 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.2 29.36 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.521 -0.737 . . . . 0.0 110.273 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -116.8 158.64 23.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -109.48 43.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.592 -0.692 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -102.69 131.08 49.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.526 -0.734 . . . . 0.0 110.246 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -137.25 168.82 18.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -135.58 58.83 1.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.687 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.51 148.11 43.19 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -124.71 178.74 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -160.03 136.52 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.61 -0.681 . . . . 0.0 110.288 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -146.21 61.34 1.24 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.563 -0.711 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.22 173.98 6.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.525 -0.734 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -144.77 64.66 1.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.327 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -110.9 90.43 0.57 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' ASP . 0.6 OUTLIER -107.81 -165.57 1.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.954 . . . . 0.0 110.567 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' A' ' 419' ' ' LEU . 68.2 t-105 -143.89 134.12 24.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.68 . . . . 0.0 109.467 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.6 HG23 HD12 ' A' ' 314' ' ' LEU . 57.9 t -142.23 89.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.566 -0.709 . . . . 0.0 109.877 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.58 -43.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -85.92 -90.96 0.89 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -149.94 26.74 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.572 -0.958 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m -89.34 170.71 10.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 110.671 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.702 ' O ' HD13 ' A' ' 314' ' ' LEU . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.775 HG12 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.443 ' HA ' HD22 ' A' ' 334' ' ' LEU . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' CYS . . . . . 0.441 ' SG ' HD11 ' A' ' 411' ' ' ILE . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.35 -27.6 64.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.8 t -80.49 -25.94 38.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.752 . . . . 0.0 110.489 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.84 68.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.457 -0.777 . . . . 0.0 110.364 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 m -95.23 10.51 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.624 -0.673 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.98 -33.74 15.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.09 73.95 13.48 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.501 -0.749 . . . . 0.0 110.382 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.69 -29.54 15.74 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.355 1.187 . . . . 0.0 110.204 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -95.62 -169.8 2.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -81.03 73.16 8.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.552 -0.718 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.81 28.0 7.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.085 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -139.04 27.03 2.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.677 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.23 152.77 45.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.751 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' HIS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 360' ' ' TYR . 34.7 m-70 -107.45 18.66 21.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.6 -0.688 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.79 -27.46 66.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.315 -0.866 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.9 m -77.53 -28.02 51.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.526 -0.734 . . . . 0.0 110.331 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 -27.13 16.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.557 ' O ' HG22 ' A' ' 363' ' ' ILE . 3.5 m-85 -80.47 1.32 29.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.538 -0.726 . . . . 0.0 111.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -56.51 -26.79 55.55 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.977 -1.077 . . . . 0.0 110.538 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -87.0 10.23 17.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.583 -0.698 . . . . 0.0 111.251 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 366' ' ' GLY . 6.0 tp -66.9 -21.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.189 -0.944 . . . . 0.0 110.775 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -54.99 -38.45 67.85 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 110.811 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.97 -25.81 18.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.702 -0.624 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.58 ' O ' HD12 ' A' ' 363' ' ' ILE . . . -116.38 71.12 0.27 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -90.24 15.65 10.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.59 -0.947 . . . . 0.0 111.11 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -115.2 32.2 6.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -114.56 -40.21 3.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.596 -0.69 . . . . 0.0 110.164 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 360' ' ' TYR . 26.0 mttt -69.33 -35.09 75.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.555 -0.716 . . . . 0.0 110.03 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.57 -28.74 69.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 110.187 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.69 73.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.115 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 41.1 t -104.98 -15.84 15.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.672 -0.642 . . . . 0.0 110.837 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.613 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 11.3 mtt -85.62 9.61 15.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.75 -30.85 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.096 -1.003 . . . . 0.0 109.757 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -65.05 -28.98 69.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.71 -0.619 . . . . 0.0 110.233 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 380' ' ' LEU . 5.8 t -134.75 33.42 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.265 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -93.6 44.39 1.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -155.75 27.77 0.38 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.621 -0.674 . . . . 0.0 110.223 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 377' ' ' SER . 0.5 OUTLIER -163.18 56.64 0.59 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.259 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.41 63.85 3.63 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.4 1.21 . . . . 0.0 110.529 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.5 m -127.66 -41.96 1.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.518 -0.739 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -126.29 52.44 0.81 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 387' ' ' ALA . . . -57.55 -21.15 36.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.642 -0.916 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -59.39 -60.5 3.75 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -86.23 -26.61 24.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.654 . . . . 0.0 110.264 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 384' ' ' ALA . . . -65.09 -13.85 59.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.71 . . . . 0.0 110.584 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.63 166.3 3.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.212 -0.93 . . . . 0.0 110.286 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 -176.95 4.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.671 -0.643 . . . . 0.0 110.285 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.5 113.01 1.13 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 0.0 110.749 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.47 -162.37 0.4 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.16 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 m -83.37 58.37 4.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.589 -0.695 . . . . 0.0 110.064 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.69 76.28 0.19 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.71 -0.619 . . . . 0.0 110.155 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 170.72 -45.41 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 73.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.707 -0.878 . . . . 0.0 110.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -127.9 -55.6 0.12 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -141.75 -174.01 3.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.976 . . . . 0.0 110.081 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.49 HD22 ' HE1' ' A' ' 402' ' ' TYR . 46.7 t30 -90.63 149.58 22.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.583 -0.698 . . . . 0.0 110.088 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.408 ' CE3' ' O ' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.49 ' HE1' HD22 ' A' ' 398' ' ' ASN . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.567 ' C ' HD12 ' A' ' 411' ' ' ILE . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.567 HD12 ' C ' ' A' ' 410' ' ' GLU . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CG ' HG12 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' A' ' 315' ' ' TRP . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 426' ' ' ILE . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -131.07 135.2 47.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.8 m -60.92 -48.34 82.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 0.0 110.16 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 9.1 m -154.03 98.28 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.528 -0.733 . . . . 0.0 110.226 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.69 153.83 9.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.55 -0.719 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 431' ' ' LEU . 4.5 mm? -91.16 123.59 34.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.56 -0.713 . . . . 0.0 110.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 43.1 t -116.06 108.46 16.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -144.54 53.64 2.27 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 134.49 21.88 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.314 1.165 . . . . 0.0 110.468 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 435' ' ' ILE . 5.5 tt -123.42 58.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.594 -0.691 . . . . 0.0 110.129 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.154 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.055 0.455 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -94.34 107.88 19.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 110.162 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.77 124.9 1.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.8 m -85.15 -37.42 20.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.947 . . . . 0.0 110.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -167.56 168.63 12.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.697 . . . . 0.0 110.249 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -148.39 60.46 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.676 . . . . 0.0 110.248 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.87 91.82 6.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.473 -0.767 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -118.56 -60.09 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.615 -0.678 . . . . 0.0 110.104 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -102.27 164.98 11.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.677 -0.639 . . . . 0.0 110.18 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -91.66 143.38 26.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.557 -0.714 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -103.99 51.54 0.81 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.2 p -166.76 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.913 . . . . 0.0 110.14 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.23 -29.14 69.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.61 113.78 2.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.581 -0.7 . . . . 0.0 110.122 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -107.75 -26.65 10.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.685 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -104.71 -79.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.485 -0.759 . . . . 0.0 110.231 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLY . . . . . 0.525 ' C ' HD13 ' A' ' 314' ' ' LEU . . . -150.34 -64.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.4 167.78 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.931 . . . . 0.0 110.764 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.838 ' NE1' HD11 ' A' ' 419' ' ' LEU . 0.2 OUTLIER -76.04 170.11 16.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 110.112 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.66 87.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.522 -0.736 . . . . 0.0 109.574 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -178.16 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 109.987 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.81 -117.85 0.71 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -145.3 40.08 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.506 -0.996 . . . . 0.0 110.761 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t -89.53 158.06 17.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 323' ' ' ILE . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 314' ' ' LEU . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LEU . . . . . 0.475 HD21 ' HD2' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.536 ' N ' HD23 ' A' ' 340' ' ' LEU . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.432 ' C ' HD23 ' A' ' 344' ' ' LEU . 10.1 tt -101.9 -28.29 12.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.1 m -86.53 -28.25 23.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.53 -0.731 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.54 82.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 110.286 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 p -93.74 10.53 32.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.499 -0.751 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.96 -27.92 16.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.47 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -153.55 89.62 3.51 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.572 -0.705 . . . . 0.0 110.48 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.14 -20.24 21.81 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.458 1.241 . . . . 0.0 110.701 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -53.13 -54.81 30.28 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.334 -0.854 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -48.73 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.661 -0.649 . . . . 0.0 111.507 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -103.27 -31.83 9.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.695 -0.628 . . . . 0.0 109.596 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -121.63 65.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.706 -0.621 . . . . 0.0 109.727 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 97.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.509 -0.744 . . . . 0.0 111.308 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -110.11 -29.19 8.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.767 . . . . 0.0 109.999 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 357' ' ' LEU . 6.7 mp -78.3 -15.63 58.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.636 -0.665 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 29.0 m -51.52 -24.27 5.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.162 -0.961 . . . . 0.0 111.203 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.01 -18.07 62.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.733 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -98.05 1.75 48.06 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 111.589 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -10.85 55.14 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.087 -1.008 . . . . 0.0 111.112 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -50.93 -24.26 3.49 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.027 -1.046 . . . . 0.0 111.271 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 364' ' ' LYS . 2.7 pp -56.43 -38.15 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.284 -0.885 . . . . 0.0 110.664 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 363' ' ' ILE . 0.4 OUTLIER -100.64 -22.89 14.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.546 -0.721 . . . . 0.0 109.788 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 367' ' ' PHE . 0.6 OUTLIER -96.19 23.07 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 110.411 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.68 80.43 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 365' ' ' GLU . 1.6 m-85 -77.2 106.7 9.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.68 -0.894 . . . . 0.0 108.929 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -39.69 -31.49 0.11 Allowed 'General case' 0 N--CA 1.511 2.588 0 CA-C-O 121.281 0.562 . . . . 0.0 111.929 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -98.42 43.77 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 109.448 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -79.34 -55.35 5.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.654 -0.654 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.81 7.09 13.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 111.69 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.65 -42.99 12.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.163 -0.961 . . . . 0.0 110.295 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.5 m -106.15 -19.8 13.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 111.459 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.723 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 17.5 mmt -78.89 0.51 27.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.229 -0.919 . . . . 0.0 111.554 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.32 -29.45 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 109.662 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -101.49 -23.81 14.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.722 -0.611 . . . . 0.0 110.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 t -115.53 26.04 10.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.453 -0.78 . . . . 0.0 110.716 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -71.2 65.49 0.4 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.493 -0.755 . . . . 0.0 110.26 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.608 ' C ' HD13 ' A' ' 380' ' ' LEU . 10.2 m-85 -161.27 91.24 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.504 -0.747 . . . . 0.0 110.076 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.745 ' N ' HD13 ' A' ' 380' ' ' LEU . 0.0 OUTLIER -153.15 51.92 0.78 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.633 -0.667 . . . . 0.0 110.98 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 46.5 Cg_endo -73.73 -29.31 10.71 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.29 1.153 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.7 m -92.91 -24.78 18.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 385' ' ' PHE . . . -136.33 59.35 0.64 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -56.86 -24.0 48.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.562 -0.964 . . . . 0.0 110.495 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 386' ' ' LYS . 25.5 p90 -69.32 -25.96 64.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' LYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 385' ' ' PHE . 11.7 tttp -87.52 5.38 39.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.709 . . . . 0.0 111.258 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' A' ' 380' ' ' LEU . . . -60.37 -26.94 67.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.189 -0.945 . . . . 0.0 110.241 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.64 144.43 43.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.353 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -76.97 -64.6 1.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.589 -0.695 . . . . 0.0 110.009 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -87.5 -168.98 2.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 110.113 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -45.55 2.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 109.885 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.5 m -90.13 50.73 1.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.57 -0.706 . . . . 0.0 110.284 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -118.65 79.3 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 110.192 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 129.32 -39.59 1.82 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -75.78 67.42 2.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.551 -0.97 . . . . 0.0 110.096 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -131.57 40.95 1.57 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 428' ' ' THR . 34.9 m-85 -149.89 -171.68 3.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.513 -0.992 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.82 139.82 30.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.637 -0.664 . . . . 0.0 110.129 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.551 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.715 ' H ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 414' ' ' VAL . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 413' ' ' ASN . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.838 HD11 ' NE1' ' A' ' 315' ' ' TRP . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 420' ' ' ILE . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -151.72 42.16 0.7 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 397' ' ' TYR . 5.7 m -61.67 -28.06 69.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.519 -0.738 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 6.1 m -135.25 136.44 41.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.56 -0.712 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -62.87 -28.31 69.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.553 -0.717 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 9.0 tt -73.36 134.32 44.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.479 -0.763 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 60.4 m -117.61 -74.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -145.63 59.87 6.15 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.73 -28.35 13.95 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.338 1.178 . . . . 0.0 110.267 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.9 81.74 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.641 -0.662 . . . . 0.0 109.914 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.186 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.098 0.475 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.64 169.86 18.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.282 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -71.54 161.73 54.23 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.21 176.18 12.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.923 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -130.15 71.39 1.45 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.549 -0.72 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -7' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' -5' ' ' HIS . 3.0 p80 -119.11 -167.68 1.44 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.519 -0.738 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -63.84 -73.36 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -5' ' ' HIS . . . . . 0.494 ' O ' ' CE1' ' A' ' -7' ' ' HIS . 23.1 p80 -143.39 -172.9 3.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.26 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -62.6 122.54 16.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.645 -0.659 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -130.14 -44.5 1.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.142 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.8 42.04 2.07 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 m -114.11 -64.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.693 -0.886 . . . . 0.0 110.151 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -88.34 -29.78 20.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -120.84 -167.51 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -148.41 29.1 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 323' ' ' ILE . 1.9 t80 -113.52 86.21 2.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -125.87 126.34 5.81 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 322' ' ' ASP . 0.5 OUTLIER -129.76 161.34 30.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.534 -0.98 . . . . 0.0 110.438 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.435 ' CH2' ' HB3' ' A' ' 320' ' ' CYS . 0.0 OUTLIER -57.56 168.85 0.75 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 317' ' ' ASP . 59.1 t -65.04 163.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.598 -0.689 . . . . 0.0 109.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 316' ' ' VAL . 5.8 t0 -61.43 91.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.589 -0.694 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -96.38 -93.33 1.82 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -123.19 25.51 8.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.962 . . . . 0.0 110.429 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' CYS . . . . . 0.435 ' HB3' ' CH2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -150.06 154.61 38.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.515 -0.741 . . . . 0.0 110.112 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.607 ' HA ' HD13 ' A' ' 314' ' ' LEU . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 312' ' ' PHE . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.725 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 411' ' ' ILE . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.72 HG23 ' H ' ' A' ' 343' ' ' GLU . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' GLU . . . . . 0.72 ' H ' HG23 ' A' ' 341' ' ' VAL . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? -92.12 6.75 45.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.9 t -97.8 -35.31 10.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.44 67.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 31.4 m -63.31 -28.41 69.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.506 -0.746 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.25 -65.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -158.37 155.48 25.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 110.298 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.97 122.64 7.82 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.396 1.208 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -121.98 -65.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.58 -0.7 . . . . 0.0 110.155 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -84.96 113.18 21.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.67 -48.19 3.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 0.0 110.305 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.74 65.99 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.601 -0.687 . . . . 0.0 110.507 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.78 -160.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.0 110.038 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -90.54 18.35 6.39 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.32 -0.862 . . . . 0.0 111.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.483 HD13 ' O ' ' A' ' 357' ' ' LEU . 0.2 OUTLIER -98.73 -26.7 14.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.328 -0.857 . . . . 0.0 110.198 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 60.3 m -89.46 -24.33 21.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.756 . . . . 0.0 110.584 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -75.11 -28.73 60.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.424 -0.798 . . . . 0.0 110.483 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -74.66 -39.62 61.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.578 -0.702 . . . . 0.0 110.239 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.65 6.64 23.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.46 -27.26 46.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 110.663 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 364' ' ' LYS . 31.0 pt -100.14 -28.26 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.409 ' N ' HG13 ' A' ' 363' ' ' ILE . 8.6 ptmt -100.63 -26.53 13.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 110.307 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 367' ' ' PHE . 5.4 tt0 -111.76 -4.29 14.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.553 -0.717 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 4.89 56.8 0.0 OUTLIER Glycine 1 N--CA 1.523 4.471 0 C-N-CA 124.422 1.01 . . . . 0.0 114.403 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 367' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 365' ' ' GLU . 43.7 p90 -61.53 102.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.965 0.888 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -23.39 12.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -106.26 40.9 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -104.65 -76.6 0.6 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -85.37 -39.04 18.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.583 -0.698 . . . . 0.0 110.154 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.49 -21.94 60.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.713 -0.617 . . . . 0.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 18.2 t -76.83 -52.06 10.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.495 -0.753 . . . . 0.0 109.989 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.512 ' O ' HG23 ' A' ' 375' ' ' ILE . 0.4 OUTLIER -66.77 -67.85 0.42 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.615 -0.678 . . . . 0.0 109.731 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 374' ' ' MET . 4.5 pt -152.06 -110.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.715 . . . . 0.0 109.529 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -115.17 -33.88 5.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.674 -1.266 . . . . 0.0 109.951 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.39 107.29 3.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.594 . . . . 0.0 109.717 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -60.1 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.655 -0.653 . . . . 0.0 110.758 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 379' ' ' PHE . 60.0 t80 -138.77 94.26 2.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 380' ' ' LEU . 7.6 mp -103.22 96.87 8.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.723 . . . . 0.0 110.682 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.44 -26.8 16.6 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.381 1.201 . . . . 0.0 110.194 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 382' ' ' THR . 6.3 t -128.67 77.34 1.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.732 . . . . 0.0 109.809 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -93.56 48.34 2.33 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.57 40.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.951 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -55.47 -26.68 43.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.298 -0.876 . . . . 0.0 110.55 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -65.74 -13.95 60.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.576 -0.703 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.95 -20.9 18.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.934 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -23.75 8.88 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.304 -0.872 . . . . 0.0 111.041 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.85 153.48 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.488 -0.757 . . . . 0.0 110.331 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.34 -74.93 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.406 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -114.52 159.65 20.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.575 -0.703 . . . . 0.0 110.324 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.1 m -90.21 49.88 1.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.597 -0.689 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 6.7 t-80 -86.96 80.33 8.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.489 -0.757 . . . . 0.0 110.316 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 81.12 45.97 7.27 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 15.69 2.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.589 -0.948 . . . . 0.0 110.9 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -137.9 69.67 0.49 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 397' ' ' TYR . 6.7 p90 -170.54 100.79 0.25 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -1.024 . . . . 0.0 110.15 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -169.65 -40.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.507 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 340' ' ' LEU . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.725 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' LYS . . . . . 0.475 ' N ' HG22 ' A' ' 414' ' ' VAL . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 417' ' ' THR . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 419' ' ' LEU . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 426' ' ' ILE . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -156.81 77.5 0.9 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -34.9 75.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.437 -0.789 . . . . 0.0 110.024 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 21.5 p -146.59 93.91 2.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.695 . . . . 0.0 110.242 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.38 -165.17 1.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.38 98.77 0.07 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.606 -0.684 . . . . 0.0 110.264 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 15.4 p -150.28 128.76 12.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 110.298 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -150.71 67.06 7.8 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.596 -0.69 . . . . 0.0 110.215 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.29 -28.88 11.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.381 1.201 . . . . 0.0 110.508 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -104.42 74.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.514 -0.741 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.769 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.063 0.459 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -88.87 -64.81 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.589 -0.695 . . . . 0.0 110.112 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -75.36 103.41 1.6 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.37 -177.82 3.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.58 -0.953 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.48 -169.53 2.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 110.211 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 91.04 2.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.763 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -88.5 95.54 10.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.614 -0.679 . . . . 0.0 110.231 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -120.26 72.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.595 -0.691 . . . . 0.0 110.239 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -114.46 -61.32 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.18 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -148.47 34.15 0.79 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.3 165.71 19.55 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.7 m -83.95 -57.67 3.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.556 -0.967 . . . . 0.0 110.129 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -86.21 136.36 33.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.525 -0.735 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.99 -73.25 0.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.501 -0.749 . . . . 0.0 110.196 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -151.36 166.63 30.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.54 -0.725 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.401 ' CE2' HD22 ' A' ' 314' ' ' LEU . 3.9 t80 -106.1 114.78 29.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.807 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -124.48 125.17 5.67 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -150.05 157.91 43.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.654 -0.909 . . . . 0.0 110.248 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.469 ' CE2' HD12 ' A' ' 419' ' ' LEU . 6.5 t-105 -74.92 103.14 5.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 316' ' ' VAL . 33.8 m -86.01 117.5 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.693 -0.629 . . . . 0.0 110.714 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -168.13 -74.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 179.58 38.64 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -149.85 -35.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.628 -0.925 . . . . 0.0 111.502 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m -88.67 169.86 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 324' ' ' PRO . . . . . 0.647 ' O ' HD13 ' A' ' 323' ' ' ILE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 326' ' ' VAL . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 342' ' ' PHE . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 412' ' ' PHE . 1.7 mm? -103.16 4.33 36.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.5 t -52.83 -26.87 15.9 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.094 -1.004 . . . . 0.0 110.737 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.51 -22.37 64.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.56 -0.712 . . . . 0.0 110.232 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' SER . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 412' ' ' PHE . 60.7 p -86.35 10.06 16.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 111.199 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -87.45 9.32 21.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 111.041 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -50.73 167.26 0.27 Allowed Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.063 -1.023 . . . . 0.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.74 -167.18 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.425 1.224 . . . . 0.0 110.316 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -92.54 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.673 -0.642 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.38 -26.58 67.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.77 -24.57 51.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.492 -0.755 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.2 69.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.489 -0.757 . . . . 0.0 110.248 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.28 49.05 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.43 -0.794 . . . . 0.0 110.286 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -108.88 18.93 20.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.819 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.63 -38.73 82.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 15.2 m -62.54 -28.44 69.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.504 -0.747 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -97.58 -18.1 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.597 -0.689 . . . . 0.0 110.702 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.448 ' HA ' HD12 ' A' ' 363' ' ' ILE . 0.0 OUTLIER -86.41 1.03 52.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -57.28 -23.84 50.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -89.07 -19.52 25.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.393 -0.817 . . . . 0.0 110.727 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 360' ' ' TYR . 81.9 mt -75.66 -22.15 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.33 -0.856 . . . . 0.0 110.599 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.08 65.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -20.77 21.69 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.562 -0.711 . . . . 0.0 110.747 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.93 85.53 0.89 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.8 -5.6 41.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.946 . . . . 0.0 111.458 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -26.39 68.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -147.51 92.67 2.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.745 . . . . 0.0 110.237 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.94 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.205 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -100.21 -4.24 29.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.15 73.35 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.4 t -105.22 12.97 31.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 111.12 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.5 ttt -105.21 -29.81 10.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.557 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.79 -54.32 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 110.319 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -57.33 -25.9 60.1 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.607 -0.683 . . . . 0.0 110.692 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.2 m -84.34 -25.93 28.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 110.319 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.73 97.73 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.418 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.58 -77.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.715 -0.616 . . . . 0.0 109.705 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.459 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 13.9 mt -107.55 -65.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 111.161 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 55.4 Cg_endo -73.81 76.6 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.619 0.799 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 382' ' ' THR . 8.4 t -80.88 57.26 2.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.487 -0.758 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -148.0 74.17 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 387' ' ' ALA . . . -56.73 -21.36 27.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.557 -0.967 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.22 -69.9 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.402 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -78.74 -22.24 46.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 384' ' ' ALA . . . -61.95 -16.3 50.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 110.664 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -73.76 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.189 -0.945 . . . . 0.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 65.88 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.606 -0.684 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 390' ' ' TYR . 26.4 p90 -81.78 145.01 30.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.5 -0.75 . . . . 0.0 110.268 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.09 -167.08 1.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.417 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.91 52.92 2.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.13 -22.43 13.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.619 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -59.52 -50.17 70.66 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -60.54 134.85 57.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.535 -0.979 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -165.7 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.48 177.85 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.96 . . . . 0.0 110.184 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.495 ' O ' HD11 ' A' ' 426' ' ' ILE . 7.9 m120 -74.62 130.0 38.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 109.987 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.801 ' HB3' HG21 ' A' ' 428' ' ' THR . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 407' ' ' GLN . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 406' ' ' THR . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.425 ' C ' HD12 ' A' ' 411' ' ' ILE . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.483 HD12 ' N ' ' A' ' 411' ' ' ILE . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.577 ' HA ' HD11 ' A' ' 344' ' ' LEU . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 427' ' ' ALA . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' LEU . . . . . 0.469 HD12 ' CE2' ' A' ' 315' ' ' TRP . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.44 ' C ' HG23 ' A' ' 426' ' ' ILE . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 427' ' ' ALA . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ALA . . . . . 0.713 ' N ' HD12 ' A' ' 426' ' ' ILE . . . -127.98 100.49 5.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.801 HG21 ' HB3' ' A' ' 399' ' ' TRP . 9.9 p -60.73 -38.08 83.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 429' ' ' THR . 8.0 t -144.66 116.66 8.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.598 -0.689 . . . . 0.0 110.245 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -57.89 165.46 1.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 6.8 mt -88.65 -165.67 1.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.184 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 33.9 t -81.15 -155.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.597 -0.689 . . . . 0.0 110.174 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.5 156.57 22.21 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.437 -0.789 . . . . 0.0 110.411 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.44 -29.91 10.63 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.377 1.199 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 81.0 mt -72.97 79.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.055 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.302 -179.91 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.7 ptp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.079 0.466 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 40.3 mtm-85 -123.01 -177.4 3.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.592 -0.692 . . . . 0.0 110.155 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -151.18 125.48 1.9 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 6.9 m -110.21 -29.95 7.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.587 -0.949 . . . . 0.0 110.183 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -8' ' ' HIS . . . . . 0.459 ' N ' ' CD2' ' A' ' -8' ' ' HIS . 0.4 OUTLIER -62.0 -164.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.583 -0.698 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -57.91 -56.36 23.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.558 -0.714 . . . . 0.0 110.693 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.31 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.515 -0.74 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -79.13 -50.51 10.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.0 110.302 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -119.72 -169.13 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.537 -0.727 . . . . 0.0 110.285 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -125.13 46.97 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.41 158.94 27.9 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 43.9 t -88.82 171.96 9.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.84 115.93 27.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . . . -170.15 164.58 9.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.62 -0.675 . . . . 0.0 109.959 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 0.75 71.34 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.193 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 323' ' ' ILE . 8.5 t80 -146.83 -61.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.668 -0.645 . . . . 0.0 109.379 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.72 23.56 1.04 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.8 mt -123.48 157.82 32.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -1.09 . . . . 0.0 110.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.414 ' CZ2' ' HA3' ' A' ' 318' ' ' GLY . 7.3 p-90 -165.3 173.7 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.659 -0.65 . . . . 0.0 109.654 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 317' ' ' ASP . 90.8 t -45.75 167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.692 -0.63 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 316' ' ' VAL . 8.5 t70 -43.78 112.14 0.36 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.526 -0.734 . . . . 0.0 112.147 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.414 ' HA3' ' CZ2' ' A' ' 315' ' ' TRP . . . -128.62 -115.39 1.85 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -150.22 30.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.966 . . . . 0.0 110.454 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.19 137.88 34.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.516 -0.74 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 312' ' ' PHE . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.653 HG12 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.752 ' HB3' ' CG ' ' A' ' 407' ' ' GLN . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ASN . . . . . 0.913 ' ND2' HG11 ' A' ' 341' ' ' VAL . 6.0 t-20 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' LYS . . . . . 0.669 ' C ' HD13 ' A' ' 340' ' ' LEU . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' LEU . . . . . 0.704 ' N ' HD13 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.913 HG11 ' ND2' ' A' ' 338' ' ' ASN . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt -81.32 4.87 19.1 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.5 p -89.83 -43.32 10.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.34 -26.1 16.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.356 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.1 t -78.97 -19.56 51.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.841 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.05 -31.62 65.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.288 -0.882 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.57 132.63 78.02 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.108 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.18 157.59 46.04 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.18 1.095 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -103.33 -58.55 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.582 -0.699 . . . . 0.0 110.121 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.05 105.81 8.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 110.25 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -150.62 28.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 110.354 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.73 -29.48 6.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.549 -0.72 . . . . 0.0 110.344 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -87.56 -24.73 23.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -92.12 18.34 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.416 -0.802 . . . . 0.0 110.913 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tp -76.4 -19.87 57.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.285 -0.884 . . . . 0.0 110.666 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.96 -26.04 14.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -0.82 . . . . 0.0 110.646 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.69 -19.0 46.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.08 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 363' ' ' ILE . 8.1 p90 -56.24 -24.59 43.36 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.61 -53.79 42.0 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.438 -0.788 . . . . 0.0 111.064 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -59.26 -15.48 15.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.706 -0.621 . . . . 0.0 111.968 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 360' ' ' TYR . 47.0 mm -57.21 -37.64 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -29.72 70.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.443 -0.785 . . . . 0.0 110.095 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -97.8 21.02 11.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.672 -0.642 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -56.01 -26.69 49.35 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.35 53.17 2.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.989 . . . . 0.0 110.381 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 369' ' ' ASN . 4.7 pttm -103.19 56.96 0.75 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 368' ' ' LYS . 5.8 t30 2.09 68.31 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -139.69 -50.87 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -58.42 -27.9 64.75 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.888 -0.507 . . . . 0.0 110.601 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.45 67.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.577 -0.702 . . . . 0.0 110.459 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.4 t -105.19 14.48 29.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -26.85 12.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 71.0 mt -102.79 -63.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.115 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.27 58.84 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.64 -0.662 . . . . 0.0 110.424 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.9 t -169.97 -40.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.24 -59.58 2.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.642 . . . . 0.0 110.305 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -124.98 71.13 1.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.601 -0.687 . . . . 0.0 110.222 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 8.5 mt -58.83 110.86 2.96 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 110.089 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.22 -55.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.215 1.113 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 382' ' ' THR . 6.6 t -170.64 78.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -60.81 -30.51 73.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -61.64 -24.06 66.46 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.569 -0.959 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -90.82 22.92 3.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.391 -0.818 . . . . 0.0 111.105 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -84.02 5.08 27.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.29 -0.881 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.132 -0.98 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -55.36 -24.1 27.67 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.378 -0.826 . . . . 0.0 110.946 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -56.66 -24.21 47.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 110.772 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.2 -75.28 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -0.787 . . . . 0.0 110.538 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -129.46 -39.95 1.46 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 110.711 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.5 m -84.83 53.79 2.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.418 -0.801 . . . . 0.0 110.72 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.01 61.63 5.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.32 39.36 0.8 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -58.49 -25.21 62.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.637 -0.92 . . . . 0.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -97.49 27.14 20.03 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 396' ' ' GLY . 64.1 m-85 -153.77 27.76 0.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.467 -1.019 . . . . 0.0 110.302 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASN . . . . . 0.413 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 -87.98 76.2 8.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.496 ' HB3' HG23 ' A' ' 428' ' ' THR . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.418 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLN . . . . . 0.752 ' CG ' ' HB3' ' A' ' 331' ' ' ALA . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.418 ' H ' HG21 ' A' ' 404' ' ' THR . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.653 ' CD2' HG12 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 417' ' ' THR . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 420' ' ' ILE . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.75 69.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 399' ' ' TRP . 3.9 p -75.74 124.83 27.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 110.074 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.9 p -63.58 89.68 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.07 151.05 47.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.708 . . . . 0.0 110.164 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.28 -45.87 11.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.571 -0.706 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 77.5 p -168.26 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.715 . . . . 0.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -105.95 126.49 30.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.583 -0.698 . . . . 0.0 110.206 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' PRO . . . . . 0.494 ' N ' HD12 ' A' ' 435' ' ' ILE . 51.9 Cg_endo -76.94 59.43 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.127 1.067 . . . . 0.0 110.651 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 434' ' ' PRO . 4.6 mp -140.51 -44.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 109.936 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.515 -179.96 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.253 0.549 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -117.41 38.08 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -125.95 61.69 0.62 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 18.4 p -124.8 151.82 44.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.982 . . . . 0.0 110.265 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -164.22 -178.33 5.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.589 -0.694 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.18 123.26 42.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -88.19 135.82 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 110.143 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -116.53 144.74 43.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.501 -0.749 . . . . 0.0 110.252 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -130.37 46.85 2.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.172 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -146.78 155.14 42.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -166.97 -68.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.8 m -105.09 156.91 17.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.601 -0.941 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.78 -51.78 5.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.147 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.15 140.26 51.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -156.14 128.42 7.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 0.0 110.254 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -94.32 44.46 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -126.63 -173.88 13.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.577 ' O ' HD12 ' A' ' 314' ' ' LEU . 2.0 pp -150.15 117.59 6.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.646 -0.914 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' TRP . . . . . 0.413 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 1.0 OUTLIER -55.86 125.44 21.37 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 110.731 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.49 90.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -149.75 -62.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.72 . . . . 0.0 110.324 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -77.36 -112.11 0.16 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.36 27.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.905 . . . . 0.0 110.179 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t -96.93 95.6 7.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.689 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.408 HD11 HD23 ' A' ' 314' ' ' LEU . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 411' ' ' ILE . 5.5 mt -77.83 -29.63 50.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -25.59 65.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.589 -0.694 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.76 -32.28 23.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.47 -0.769 . . . . 0.0 110.256 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.4 t -72.52 -21.5 61.18 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.6 -0.688 . . . . 0.0 110.585 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.28 -20.63 29.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 110.955 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -51.74 149.5 8.44 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.93 -166.98 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.414 1.218 . . . . 0.0 110.573 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -98.53 -168.68 1.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 110.237 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -77.99 117.94 19.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -155.47 30.09 0.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.529 -0.732 . . . . 0.0 110.117 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -133.05 -64.44 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -145.07 -169.52 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -109.69 -30.78 7.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.656 -0.653 . . . . 0.0 110.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.474 HD13 ' HA ' ' A' ' 357' ' ' LEU . 2.8 mm? -91.37 -29.44 17.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.516 -0.74 . . . . 0.0 110.321 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.7 m -58.36 -26.18 62.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.78 -20.45 42.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 110.66 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.57 -25.93 18.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.683 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -90.73 -20.29 22.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.45 -0.781 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -63.08 -18.05 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -0.848 . . . . 0.0 110.791 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.11 -26.92 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.314 -0.866 . . . . 0.0 109.917 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -91.56 -30.86 16.15 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.08 20.53 18.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.531 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -78.92 83.46 1.27 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -80.11 80.95 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.552 -0.969 . . . . 0.0 110.071 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -156.46 28.85 0.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 110.435 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -87.09 -39.44 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -168.87 -67.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.561 -0.712 . . . . 0.0 110.321 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -53.91 -23.84 14.12 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.698 -0.626 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.78 -34.84 73.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.477 -0.764 . . . . 0.0 110.302 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 73.2 m -104.93 13.09 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.782 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.613 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 12.7 mmt -104.48 -12.44 16.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.297 -0.877 . . . . 0.0 110.817 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.18 -31.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.278 -0.889 . . . . 0.0 109.931 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -94.71 -32.62 13.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 56.9 p -114.36 33.8 5.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.772 -0.58 . . . . 0.0 109.968 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -57.63 113.22 1.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.715 -0.616 . . . . 0.0 110.727 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' PHE . . . . . 0.626 ' CE2' ' HB1' ' A' ' 384' ' ' ALA . 3.1 t80 -84.31 86.05 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.584 -0.698 . . . . 0.0 109.802 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 384' ' ' ALA . 9.4 mt -53.57 124.15 40.27 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.22 -26.89 17.25 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.127 1.067 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 36.8 p -61.03 -29.16 69.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.5 42.64 1.06 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 380' ' ' LEU . . . -85.46 -28.22 25.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.62 -39.97 90.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.521 -0.737 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -90.29 -20.88 22.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.705 -0.622 . . . . 0.0 110.727 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.71 -19.24 38.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.77 142.75 52.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.424 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -124.09 -157.46 0.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.666 -0.646 . . . . 0.0 110.312 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.47 179.33 6.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.509 -0.744 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -107.28 -38.02 6.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.612 -0.68 . . . . 0.0 110.339 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 59.7 p -85.63 -28.11 24.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.235 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -85.13 82.01 8.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.586 -0.696 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 110.58 34.67 2.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.72 126.72 28.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.545 -0.973 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.79 56.29 0.14 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.1 32.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.94 . . . . 0.0 110.189 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -135.67 129.93 33.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 110.067 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' THR . . . . . 0.644 HG21 ' H ' ' A' ' 408' ' ' LYS . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LYS . . . . . 0.644 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLU . . . . . 0.701 ' OE2' HG21 ' A' ' 326' ' ' VAL . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.793 ' CB ' HG12 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 412' ' ' PHE . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 420' ' ' ILE . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -129.31 58.1 1.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.5 p -124.89 -46.34 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.553 -0.717 . . . . 0.0 110.129 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 429' ' ' THR . 6.4 t -151.67 104.22 3.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.58 -0.7 . . . . 0.0 110.183 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.02 151.83 20.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 431' ' ' LEU . 0.6 OUTLIER -116.59 -20.15 9.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.566 -0.709 . . . . 0.0 110.776 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -26.83 13.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' HIS . . . . . 0.402 ' N ' ' HD2' ' A' ' 434' ' ' PRO . 1.8 m-70 -70.36 -56.74 6.41 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.445 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 433' ' ' HIS . 46.3 Cg_endo -72.82 171.85 16.54 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.155 1.082 . . . . 0.0 110.363 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 16.7 tt -60.56 -27.74 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 110.306 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.275 -179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.035 0.445 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 323' ' ' ILE . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.468 ' HG3' HG21 ' A' ' 420' ' ' ILE . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.614 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.56 ' CD1' HD23 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 340' ' ' LEU . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 340' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.054 0.454 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 404' ' ' THR . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.67 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.67 ' N ' HD13 ' A' ' 411' ' ' ILE . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.739 HD13 ' N ' ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 324' ' ' PRO . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.517 ' HB ' ' HD3' ' A' ' 324' ' ' PRO . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 332' ' ' ILE . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.601 ' O ' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 339' ' ' LYS . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 341' ' ' VAL . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.295 0.569 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.911 ' HA3' HD13 ' A' ' 411' ' ' ILE . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 404' ' ' THR . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.911 HD13 ' HA3' ' A' ' 400' ' ' GLY . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.824 ' CD1' HG12 ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.656 HG21 HG11 ' A' ' 326' ' ' VAL . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.501 ' N ' HG23 ' A' ' 417' ' ' THR . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 419' ' ' LEU . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 426' ' ' ILE . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.636 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 418' ' ' CYS . 33.7 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . 0.632 ' O ' HD11 ' A' ' 420' ' ' ILE . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.644 HG12 ' CB ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 409' ' ' CYS . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 332' ' ' ILE . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 343' ' ' GLU . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 340' ' ' LEU . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp . . . . . 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 N--CA 1.496 1.833 0 CA-C-O 121.097 0.475 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 331' ' ' ALA . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 411' ' ' ILE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.644 ' CB ' HG12 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.429 ' C ' HG23 ' A' ' 414' ' ' VAL . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 415' ' ' LYS . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 414' ' ' VAL . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 417' ' ' THR . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 420' ' ' ILE . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 321' ' ' GLU . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.6 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 326' ' ' VAL . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . 0.433 ' O ' HD23 ' A' ' 340' ' ' LEU . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 338' ' ' ASN . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 341' ' ' VAL . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.011 0.434 . . . . 0.0 109.835 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.533 ' HA ' HD13 ' A' ' 426' ' ' ILE . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' ' CD1' ' A' ' 411' ' ' ILE . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 404' ' ' THR . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.401 ' CD1' ' HA3' ' A' ' 400' ' ' GLY . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 419' ' ' LEU . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 418' ' ' CYS . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 399' ' ' TRP . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 417' ' ' THR . 76.0 m . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.217 0.532 . . . . 0.0 110.37 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 420' ' ' ILE . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 416' ' ' PRO . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 411' ' ' ILE . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.681 HD13 ' HB2' ' A' ' 409' ' ' CYS . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 335' ' ' PHE . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.424 ' CE2' HD22 ' A' ' 334' ' ' LEU . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 340' ' ' LEU . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 m120 . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.181 0.515 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.662 HG21 ' CB ' ' A' ' 408' ' ' LYS . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 404' ' ' THR . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . 0.442 ' H ' HG23 ' A' ' 406' ' ' THR . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.662 ' CB ' HG21 ' A' ' 404' ' ' THR . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.681 ' HB2' HD13 ' A' ' 332' ' ' ILE . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.438 ' C ' HG23 ' A' ' 411' ' ' ILE . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 414' ' ' VAL . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . 0.41 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 320' ' ' CYS . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 419' ' ' LEU . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 323' ' ' ILE . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.164 0.507 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 332' ' ' ILE . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 332' ' ' ILE . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 334' ' ' LEU . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . 0.499 ' O ' HG21 ' A' ' 411' ' ' ILE . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.419 ' HB3' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 344' ' ' LEU . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.847 HD11 ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.106 0.479 . . . . 0.0 110.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.847 ' CZ3' HD11 ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.721 ' CA ' HG22 ' A' ' 411' ' ' ILE . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 422' ' ' ASN . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 406' ' ' THR . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.721 HG22 ' CA ' ' A' ' 400' ' ' GLY . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 418' ' ' CYS . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 417' ' ' THR . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 403' ' ' ASN . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 323' ' ' ILE . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.697 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.503 HD23 ' H ' ' A' ' 344' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.14 0.495 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.667 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 411' ' ' ILE . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.667 HG22 ' HA3' ' A' ' 400' ' ' GLY . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.697 ' CG ' HG12 ' A' ' 326' ' ' VAL . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.579 HG12 HG21 ' A' ' 426' ' ' ILE . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.43 ' N ' HD23 ' A' ' 419' ' ' LEU . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 414' ' ' VAL . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.509 HG12 ' CD1' ' A' ' 412' ' ' PHE . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . 0.48 ' CB ' HD11 ' A' ' 411' ' ' ILE . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 331' ' ' ALA . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.557 ' O ' HD13 ' A' ' 332' ' ' ILE . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 331' ' ' ALA . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 344' ' ' LEU . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 340' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.045 0.45 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 344' ' ' LEU . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' A' ' 332' ' ' ILE . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 327' ' ' ASN . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.64 ' CE1' HG21 ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.64 HG21 ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 414' ' ' VAL . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 418' ' ' CYS . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.475 ' N ' HG23 ' A' ' 417' ' ' THR . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.623 HD12 ' O ' ' A' ' 419' ' ' LEU . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.471 HG23 ' ND2' ' A' ' 422' ' ' ASN . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . 0.471 ' ND2' HG23 ' A' ' 420' ' ' ILE . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.158 0.504 . . . . 0.0 110.095 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . 0.823 ' HB3' HD13 ' A' ' 323' ' ' ILE . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 322' ' ' ASP . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.745 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 340' ' ' LEU . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 342' ' ' PHE . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.429 ' N ' HG23 ' A' ' 341' ' ' VAL . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.548 HD22 ' HZ3' ' A' ' 399' ' ' TRP . 3.0 tp . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 . . . . . 0 N--CA 1.505 2.299 0 CA-C-O 121.391 0.615 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.548 ' HZ3' HD22 ' A' ' 344' ' ' LEU . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 408' ' ' LYS . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.493 ' HB3' HG21 ' A' ' 404' ' ' THR . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.893 ' N ' HD13 ' A' ' 411' ' ' ILE . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.277 0.561 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 335' ' ' PHE . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.674 ' O ' HD13 ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 331' ' ' ALA . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 340' ' ' LEU . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.666 HD21 HD23 ' A' ' 344' ' ' LEU . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 342' ' ' PHE . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.458 ' N ' HG13 ' A' ' 341' ' ' VAL . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.666 HD23 HD21 ' A' ' 340' ' ' LEU . 6.4 mt . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 121.097 0.475 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.438 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.896 ' N ' HD13 ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.418 ' OD1' HD12 ' A' ' 344' ' ' LEU . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.622 HD12 ' O ' ' A' ' 419' ' ' LEU . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.705 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.419 0.628 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 323' ' ' ILE . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.711 HG12 ' CB ' ' A' ' 412' ' ' PHE . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 334' ' ' LEU . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 344' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.109 0.481 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.535 ' CH2' HD11 ' A' ' 411' ' ' ILE . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.801 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.801 ' N ' HD13 ' A' ' 411' ' ' ILE . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 426' ' ' ILE . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.272 0.558 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . 0.64 ' OD2' HG22 ' A' ' 323' ' ' ILE . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.64 HG22 ' OD2' ' A' ' 322' ' ' ASP . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.663 HG12 ' CG ' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . 0.487 ' HB2' HG23 ' A' ' 411' ' ' ILE . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 409' ' ' CYS . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 342' ' ' PHE . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 341' ' ' VAL . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 344' ' ' LEU . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 343' ' ' GLU . 4.7 mp . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.49 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 411' ' ' ILE . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 422' ' ' ASN . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . 0.408 ' HB2' ' CA ' ' A' ' 422' ' ' ASN . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 408' ' ' LYS . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 404' ' ' THR . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 329' ' ' PHE . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.573 HD13 ' HA2' ' A' ' 400' ' ' GLY . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.663 ' CG ' HG12 ' A' ' 326' ' ' VAL . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . 0.64 ' SG ' HG22 ' A' ' 420' ' ' ILE . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.64 HG22 ' SG ' ' A' ' 418' ' ' CYS . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 401' ' ' ASN . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.758 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.156 0.503 . . . . 0.0 109.934 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 323' ' ' ILE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 332' ' ' ILE . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 407' ' ' GLN . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.402 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 340' ' ' LEU . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.755 ' HA ' HD13 ' A' ' 426' ' ' ILE . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . 0.632 ' HG3' HG21 ' A' ' 332' ' ' ILE . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 414' ' ' VAL . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 413' ' ' ASN . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.749 HD12 ' O ' ' A' ' 419' ' ' LEU . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 420' ' ' ILE . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.755 HD13 ' HA ' ' A' ' 399' ' ' TRP . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 121.335 0.588 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 334' ' ' LEU . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.537 ' N ' HD12 ' A' ' 334' ' ' LEU . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.536 ' O ' HD22 ' A' ' 340' ' ' LEU . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 339' ' ' LYS . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 342' ' ' PHE . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 341' ' ' VAL . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.688 ' O ' HD23 ' A' ' 344' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.112 0.482 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.4 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 404' ' ' THR . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.719 ' HB2' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 414' ' ' VAL . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . 0.469 ' HD3' HG13 ' A' ' 414' ' ' VAL . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.464 0.649 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.775 HG12 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 334' ' ' LEU . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . 0.441 ' SG ' HD11 ' A' ' 411' ' ' ILE . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp . . . . . 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.12 0.486 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.408 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.567 ' C ' HD12 ' A' ' 411' ' ' ILE . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.567 HD12 ' C ' ' A' ' 410' ' ' GLU . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CG ' HG12 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 426' ' ' ILE . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.351 0.596 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 323' ' ' ILE . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . 0.475 HD21 ' HD2' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.536 ' N ' HD23 ' A' ' 340' ' ' LEU . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 344' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 121.109 0.48 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.551 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 414' ' ' VAL . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 413' ' ' ASN . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.66 HD13 ' H ' ' A' ' 419' ' ' LEU . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 420' ' ' ILE . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.08 0.467 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.725 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 411' ' ' ILE . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.72 HG23 ' H ' ' A' ' 343' ' ' GLU . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . 0.72 ' H ' HG23 ' A' ' 341' ' ' VAL . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.176 0.512 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 340' ' ' LEU . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.725 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . 0.475 ' N ' HG22 ' A' ' 414' ' ' VAL . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 417' ' ' THR . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 419' ' ' LEU . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 426' ' ' ILE . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . 0.647 ' O ' HD13 ' A' ' 323' ' ' ILE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 326' ' ' VAL . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 342' ' ' PHE . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 412' ' ' PHE . 1.7 mm? . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.495 ' O ' HD11 ' A' ' 426' ' ' ILE . 7.9 m120 . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.996 0.427 . . . . 0.0 109.987 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 407' ' ' GLN . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 406' ' ' THR . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.425 ' C ' HD12 ' A' ' 411' ' ' ILE . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 411' ' ' ILE . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.577 ' HA ' HD11 ' A' ' 344' ' ' LEU . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 427' ' ' ALA . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.44 ' C ' HG23 ' A' ' 426' ' ' ILE . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 427' ' ' ALA . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . 0.713 ' N ' HD12 ' A' ' 426' ' ' ILE . . . . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 121.227 0.537 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 323' ' ' ILE . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.653 HG12 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.752 ' HB3' ' CG ' ' A' ' 407' ' ' GLN . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . 0.766 ' OD1' HG11 ' A' ' 341' ' ' VAL . 16.8 t30 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . 0.669 ' C ' HD13 ' A' ' 340' ' ' LEU . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.766 HG11 ' OD1' ' A' ' 338' ' ' ASN . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . 0.413 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.132 0.491 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.442 ' CH2' ' CG1' ' A' ' 341' ' ' VAL . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.418 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . 0.752 ' CG ' ' HB3' ' A' ' 331' ' ' ALA . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.418 ' H ' HG21 ' A' ' 404' ' ' THR . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.653 ' CD2' HG12 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 417' ' ' THR . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 420' ' ' ILE . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.097 0.475 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 411' ' ' ILE . 5.5 mt . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.059 0.457 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' THR . . . . . 0.644 HG21 ' H ' ' A' ' 408' ' ' LYS . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LYS . . . . . 0.644 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . 0.701 ' OE2' HG21 ' A' ' 326' ' ' VAL . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.793 ' CB ' HG12 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 412' ' ' PHE . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 420' ' ' ILE . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.136 0.493 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 5.3 ttt85 -146.2 78.89 1.53 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.516 -0.74 . . . . 0.0 110.155 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -135.75 173.96 21.56 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.0 m -131.41 -169.39 2.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.637 -0.919 . . . . 0.0 110.024 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.23 124.6 28.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.709 . . . . 0.0 110.086 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -82.59 164.32 20.89 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.538 -0.726 . . . . 0.0 110.367 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -161.07 172.34 17.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.564 -0.71 . . . . 0.0 110.234 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -147.78 47.4 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.578 -0.701 . . . . 0.0 110.321 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -110.78 -159.65 0.69 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.571 -0.706 . . . . 0.0 110.138 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -108.03 151.1 26.29 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.605 -0.684 . . . . 0.0 110.226 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.85 -142.69 4.49 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 74.2 m -105.15 -65.11 1.07 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.54 -0.976 . . . . 0.0 110.247 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -72.0 -28.37 63.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.582 -0.699 . . . . 0.0 110.302 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.24 -47.23 24.67 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.697 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.5 ttmt -141.62 -164.39 1.77 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.584 -0.697 . . . . 0.0 110.327 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.449 ' CZ ' HG12 ' A' ' 323' ' ' ILE . 49.2 t80 -150.09 80.19 1.36 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.599 -0.688 . . . . 0.0 110.026 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.89 -159.16 8.66 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.18 -178.99 6.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.656 -0.908 . . . . 0.0 110.272 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.638 ' CE3' HG22 ' A' ' 316' ' ' VAL . 1.3 p-90 -81.95 172.01 13.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.638 HG22 ' CE3' ' A' ' 315' ' ' TRP . 34.1 m -48.4 171.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 O-C-N 121.526 -0.734 . . . . 0.0 111.454 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -52.82 147.43 8.99 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.659 0.742 . . . . 0.0 111.304 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.91 -116.24 0.45 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.447 HD21 HD12 ' A' ' 419' ' ' LEU . 9.3 p30 -113.49 -30.53 6.83 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.593 -0.945 . . . . 0.0 110.216 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 53.9 t -110.22 92.98 4.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.63 -0.669 . . . . 0.0 110.181 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -92.61 88.86 6.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.533 -0.729 . . . . 0.0 109.696 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -174.09 -154.98 0.06 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.553 -0.717 . . . . 0.0 109.747 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 323' ' ' ILE . 7.0 tp -159.77 110.38 1.46 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.379 -0.826 . . . . 0.0 110.161 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.468 ' HG3' HG21 ' A' ' 420' ' ' ILE . 45.1 Cg_endo -71.93 175.36 9.85 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.112 1.059 . . . . 0.0 110.383 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 325' ' ' HIS . 8.8 p80 -141.35 89.92 2.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.559 -0.713 . . . . 0.0 110.582 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' CG ' ' A' ' 412' ' ' PHE . 35.4 m -97.23 160.43 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.508 -0.745 . . . . 0.0 109.969 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -89.38 122.09 32.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.577 -0.702 . . . . 0.0 110.41 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -76.87 159.96 29.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.631 -0.668 . . . . 0.0 110.084 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -147.05 120.42 4.95 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.52 -0.737 . . . . 0.0 110.467 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.02 65.64 5.11 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.24 1.126 . . . . 0.0 109.851 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.614 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -53.18 -25.32 13.29 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.477 -0.764 . . . . 0.0 110.969 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.3 tp -61.77 -27.05 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.548 -0.72 . . . . 0.0 110.182 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -85.93 -45.85 11.12 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.514 -0.741 . . . . 0.0 110.382 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 335' ' ' PHE . 19.5 mt -95.29 -76.86 0.48 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.516 -0.74 . . . . 0.0 110.41 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 334' ' ' LEU . 1.5 m-85 -163.71 -75.28 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.514 -0.741 . . . . 0.0 110.201 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.614 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 20.2 mt-10 -149.17 -168.99 3.26 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.518 -0.739 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.96 56.51 4.01 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.628 -0.67 . . . . 0.0 110.132 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -102.08 -39.67 7.18 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.544 -0.723 . . . . 0.0 110.379 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -85.5 112.28 20.77 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.523 -0.736 . . . . 0.0 110.319 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.56 ' CD1' HD23 ' A' ' 344' ' ' LEU . 0.4 OUTLIER -169.51 91.29 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.546 -0.721 . . . . 0.0 110.176 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.401 HG13 ' C ' ' A' ' 340' ' ' LEU . 34.5 m -146.09 42.71 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.524 -0.735 . . . . 0.0 110.294 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -35.66 11.06 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.738 . . . . 0.0 110.276 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -149.53 28.28 0.8 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.51 -0.744 . . . . 0.0 110.354 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 340' ' ' LEU . 2.0 mm? -98.4 -23.99 15.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.511 -0.743 . . . . 0.0 110.342 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 53.7 p -57.76 -28.91 64.37 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.46 -0.775 . . . . 0.0 110.418 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.24 84.74 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.6 -0.687 . . . . 0.0 110.038 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 23.0 t -98.2 10.63 40.12 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 110.97 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -59.26 -39.76 83.86 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.163 -0.961 . . . . 0.0 110.475 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -132.17 80.77 63.27 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.56 -0.713 . . . . 0.0 110.366 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.24 -46.46 0.37 Allowed 'Trans proline' 0 C--N 1.316 -1.15 0 O-C-N 123.427 1.225 . . . . 0.0 110.315 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.18 -169.02 1.53 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.653 -0.654 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -62.21 98.28 0.1 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.631 -0.668 . . . . 0.0 110.185 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.4 28.89 8.19 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.576 -0.703 . . . . 0.0 110.069 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -104.3 -27.93 11.7 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.625 -0.672 . . . . 0.0 110.196 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.8 65.16 0.89 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.368 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 28.5 p80 -109.85 18.26 20.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.493 -0.754 . . . . 0.0 110.919 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.72 -28.75 69.64 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.367 -0.833 . . . . 0.0 110.064 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 4.2 m -81.65 1.89 31.98 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.514 -0.741 . . . . 0.0 111.039 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -88.79 -16.31 32.43 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.069 -1.019 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 363' ' ' ILE . 0.0 OUTLIER -82.36 -31.12 29.93 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -24.22 63.07 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.444 -0.785 . . . . 0.0 110.478 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -83.84 6.39 21.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.472 -0.768 . . . . 0.0 111.244 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 360' ' ' TYR . 7.5 tp -64.75 -28.8 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.032 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.5 -20.71 50.22 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.608 -0.683 . . . . 0.0 110.582 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -96.26 19.33 12.06 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.339 -0.851 . . . . 0.0 110.609 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.06 -30.13 76.88 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -103.66 22.49 14.29 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.597 -0.943 . . . . 0.0 110.567 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -54.29 -25.95 26.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.343 -0.848 . . . . 0.0 109.696 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -76.39 -139.93 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -147.63 8.89 0.9 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.884 -1.135 . . . . 0.0 111.703 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -59.16 -26.49 64.81 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.854 -1.154 . . . . 0.0 110.675 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.07 -25.95 64.2 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.424 -0.797 . . . . 0.0 110.76 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 12.9 t -101.08 -28.34 12.76 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.461 -0.774 . . . . 0.0 110.563 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.402 ' O ' ' N ' ' A' ' 378' ' ' ALA . 4.8 mmt -87.56 9.74 20.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.523 -0.735 . . . . 0.0 111.127 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -41.19 -58.97 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.612 0 O-C-N 121.362 -0.837 . . . . 0.0 113.098 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.05 -27.11 0.86 Allowed 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.46 -0.775 . . . . 0.0 111.984 -179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.2 47.62 0.83 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.44 -0.788 . . . . 0.0 110.126 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 374' ' ' MET . . . -83.69 102.35 12.18 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.894 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.12 88.09 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 3.4 mt -41.31 99.55 0.2 Allowed Pre-proline 0 N--CA 1.506 2.367 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.68 60.78 3.49 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.519 1.273 . . . . 0.0 109.944 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.51 HG23 ' NH1' ' A' ' 389' ' ' ARG . 43.0 m -78.37 58.4 2.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.532 -0.73 . . . . 0.0 110.501 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -160.74 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -65.21 -75.99 0.08 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.679 -0.895 . . . . 0.0 109.7 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -91.14 42.46 1.1 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.497 -0.752 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -68.1 -26.7 65.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.265 -0.897 . . . . 0.0 110.421 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -74.86 -6.33 48.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.483 -0.761 . . . . 0.0 110.612 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.66 -28.58 58.79 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.285 -0.885 . . . . 0.0 111.308 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . 0.51 ' NH1' HG23 ' A' ' 382' ' ' THR . 9.0 ptt180 -72.97 62.79 0.63 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.328 -0.858 . . . . 0.0 110.812 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -86.55 70.34 10.43 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.0 109.75 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -66.14 -162.69 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.624 -0.673 . . . . 0.0 110.26 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.5 p -82.51 60.03 4.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.514 -0.742 . . . . 0.0 109.878 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -50.29 -26.32 4.67 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.562 -0.711 . . . . 0.0 110.94 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.02 -30.92 78.96 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -114.92 52.95 0.83 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.619 -0.93 . . . . 0.0 109.955 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -132.25 79.34 0.35 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.503 ' HB2' HG21 ' A' ' 428' ' ' THR . 13.4 m-85 -56.73 -21.91 31.57 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.623 -0.928 . . . . 0.0 110.808 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 m-20 -90.82 130.27 36.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.25 -0.906 . . . . 0.0 110.337 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.41 ' CE2' ' O ' ' A' ' 397' ' ' TYR . 0.2 OUTLIER -135.59 60.2 1.7 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -142.79 167.83 26.15 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.863 -1.16 . . . . 0.0 110.558 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -117.08 158.23 24.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.926 -0.749 . . . . 0.0 109.621 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 45.8 m-85 -117.53 132.81 56.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.49 -0.756 . . . . 0.0 110.63 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -110.78 126.36 54.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.819 -0.551 . . . . 0.0 109.835 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.604 ' O ' HG23 ' A' ' 404' ' ' THR . 6.8 t -95.04 84.03 4.04 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.432 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -122.34 -66.01 1.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.563 -0.71 . . . . 0.0 109.221 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 98.3 m -121.41 -73.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.753 -0.592 . . . . 0.0 109.478 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -174.7 72.18 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.388 -0.82 . . . . 0.0 109.892 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.0 ttpm? -150.07 162.87 39.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.368 -0.833 . . . . 0.0 110.687 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.3 t -128.87 156.14 44.12 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.656 -0.653 . . . . 0.0 110.127 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -126.57 140.09 52.7 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.51 -0.744 . . . . 0.0 110.279 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.67 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -152.86 127.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.431 -0.793 . . . . 0.0 110.489 179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.67 ' N ' HD13 ' A' ' 411' ' ' ILE . 10.7 t80 -170.72 -62.85 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.598 -0.689 . . . . 0.0 110.031 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -170.07 -167.42 0.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.485 -0.759 . . . . 0.0 110.265 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.51 144.75 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.572 -0.705 . . . . 0.0 109.871 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -78.82 148.28 72.18 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.457 -0.777 . . . . 0.0 110.408 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.88 -56.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.08 0 O-C-N 123.3 1.158 . . . . 0.0 110.317 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 59.6 m -160.39 72.0 0.46 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.623 -0.673 . . . . 0.0 109.96 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 70.8 m -137.68 -169.2 2.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.524 -0.735 . . . . 0.0 110.292 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.739 ' N ' HD13 ' A' ' 419' ' ' LEU . 0.0 OUTLIER -137.62 57.89 1.72 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.662 -0.649 . . . . 0.0 111.723 -179.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 324' ' ' PRO . 10.9 tp -131.88 30.2 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.398 -0.814 . . . . 0.0 109.413 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -132.18 172.39 12.46 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.655 -0.653 . . . . 0.0 110.044 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.82 -82.87 0.09 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.558 -0.714 . . . . 0.0 110.449 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 402' ' ' TYR . 29.9 t -87.37 161.97 17.6 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.162 -0.961 . . . . 0.0 109.994 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 5.6 p -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.497 -0.752 . . . . 0.0 110.612 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -98.68 106.3 18.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.619 -0.676 . . . . 0.0 109.994 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.93 -30.43 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.58 -0.7 . . . . 0.0 110.08 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -58.39 137.68 57.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.449 -0.782 . . . . 0.0 110.565 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.503 HG21 ' HB2' ' A' ' 397' ' ' TYR . 1.7 m -155.44 156.25 34.98 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.7 p -61.14 89.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.677 -0.639 . . . . 0.0 110.006 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -58.89 -28.49 66.22 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.62 -0.675 . . . . 0.0 110.455 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 431' ' ' LEU . 0.1 OUTLIER -154.49 -68.54 0.13 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.645 -0.659 . . . . 0.0 110.419 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 84.0 p -83.9 141.27 31.41 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.499 -0.751 . . . . 0.0 110.305 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -134.01 61.97 54.51 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.48 -0.763 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 -169.41 0.46 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 O-C-N 123.403 1.212 . . . . 0.0 110.425 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 50.7 mm -76.97 -28.53 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.65 -0.656 . . . . 0.0 110.122 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 . . . . . 0 N--CA 1.498 1.971 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.445 -179.813 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.118 0.485 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -85.7 89.06 7.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.613 -0.68 . . . . 0.0 110.171 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -84.21 125.27 7.03 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 60.4 p -94.84 -35.59 12.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.576 -0.955 . . . . 0.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -100.9 -36.54 9.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.565 -0.71 . . . . 0.0 110.175 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.47 146.8 51.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -120.67 147.97 44.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.597 -0.689 . . . . 0.0 110.222 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -135.17 103.62 5.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.63 -0.669 . . . . 0.0 110.299 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.42 52.28 2.03 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.554 -0.716 . . . . 0.0 110.1 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . 0.45 ' CD2' HG21 ' A' ' 414' ' ' VAL . 0.1 OUTLIER -78.16 157.41 29.41 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.625 -0.672 . . . . 0.0 110.035 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . 0.6 ' O ' HG11 ' A' ' 414' ' ' VAL . . . -149.9 179.46 26.64 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 60.5 p -123.97 175.81 6.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.553 -0.969 . . . . 0.0 110.229 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -140.59 -69.58 0.39 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.54 -0.725 . . . . 0.0 110.285 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -148.41 -161.41 1.34 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.647 -0.658 . . . . 0.0 110.209 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -132.9 85.83 2.26 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.604 -0.685 . . . . 0.0 110.282 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.814 ' CE2' HG21 ' A' ' 323' ' ' ILE . 28.6 t80 -106.35 44.63 1.03 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.524 -0.735 . . . . 0.0 110.038 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.64 27.49 1.06 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 419' ' ' LEU . 14.8 tp -144.66 160.0 41.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.274 -1.133 . . . . 0.0 110.161 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -171.78 148.57 2.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.65 -0.656 . . . . 0.0 110.26 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.1 p -96.34 89.49 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.559 -0.713 . . . . 0.0 109.797 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -169.29 -63.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.478 -0.764 . . . . 0.0 110.915 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -106.54 -101.44 2.72 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.561 ' HA ' HD12 ' A' ' 419' ' ' LEU . 27.2 t-20 -152.28 -45.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.628 -0.925 . . . . 0.0 109.856 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 42.4 t -150.85 159.07 44.79 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.582 0.706 . . . . 0.0 110.759 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -110.69 170.54 8.02 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -110.89 35.68 3.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.438 -0.789 . . . . 0.0 110.752 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.814 HG21 ' CE2' ' A' ' 312' ' ' PHE . 5.7 mt -90.61 -46.49 0.38 Allowed Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.365 -0.835 . . . . 0.0 110.837 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.517 ' HD3' ' HB ' ' A' ' 323' ' ' ILE . 49.2 Cg_endo -96.58 -177.13 0.34 Allowed 'Trans proline' 0 C--N 1.323 -0.809 0 C-N-CA 120.718 0.945 . . . . 0.0 111.017 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -145.45 133.37 21.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.682 -0.636 . . . . 0.0 109.45 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.824 HG12 ' CD1' ' A' ' 412' ' ' PHE . 17.4 m -126.14 160.51 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.337 -0.852 . . . . 0.0 110.691 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -98.06 132.96 43.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.689 -0.632 . . . . 0.0 110.006 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -86.94 126.47 34.73 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.711 -0.618 . . . . 0.0 110.019 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -107.16 102.09 41.58 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.666 -0.646 . . . . 0.0 110.265 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.39 -67.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.319 -0.98 0 O-C-N 123.332 1.175 . . . . 0.0 110.601 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' A' ' 391' ' ' LYS . . . -172.06 33.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.304 -0.873 . . . . 0.0 110.129 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 332' ' ' ILE . 1.1 tp -109.52 59.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.587 -0.695 . . . . 0.0 110.153 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.19 171.97 12.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.876 -0.515 . . . . 0.0 110.163 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 5.1 mp -83.53 -29.18 28.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -149.29 -50.4 0.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.502 -0.749 . . . . 0.0 110.238 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.13 -163.93 1.85 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.515 -0.741 . . . . 0.0 109.954 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 85.0 m -84.44 56.05 3.64 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.47 -0.769 . . . . 0.0 110.237 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -141.41 39.18 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.57 -0.706 . . . . 0.0 110.243 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.601 ' O ' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -125.2 38.35 4.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.573 -0.705 . . . . 0.0 110.023 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.601 HD22 ' O ' ' A' ' 339' ' ' LYS . 2.4 mm? -124.33 80.86 1.87 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.582 -0.699 . . . . 0.0 110.217 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 341' ' ' VAL . 57.9 t -103.3 53.54 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.568 -0.707 . . . . 0.0 109.984 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -144.08 29.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.506 -0.746 . . . . 0.0 110.185 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -160.55 -42.98 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.506 -0.746 . . . . 0.0 110.198 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 2.2 mp -72.57 -22.5 60.99 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.545 -0.722 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 11.3 t -57.07 -27.09 61.41 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.349 -0.845 . . . . 0.0 110.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.41 0.4 49.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.728 . . . . 0.0 111.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 52.4 p -94.74 10.68 34.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.125 -0.985 . . . . 0.0 111.063 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.43 -25.15 64.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.175 -0.953 . . . . 0.0 110.577 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -52.08 108.24 1.03 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.341 -0.849 . . . . 0.0 111.01 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.74 -53.77 0.06 OUTLIER 'Trans proline' 0 C--N 1.321 -0.879 0 O-C-N 123.036 1.019 . . . . 0.0 110.736 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -60.68 -76.46 0.05 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.541 -0.724 . . . . 0.0 110.354 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.79 94.43 0.82 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.502 -0.749 . . . . 0.0 110.018 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.43 ' CD1' ' N ' ' A' ' 354' ' ' GLU . 27.8 p90 -93.24 -25.73 17.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.595 -0.69 . . . . 0.0 110.343 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.43 ' N ' ' CD1' ' A' ' 353' ' ' TYR . 9.0 tt0 -128.68 -79.35 0.57 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.468 -0.77 . . . . 0.0 110.069 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.457 ' HB3' HD12 ' A' ' 357' ' ' LEU . 0.6 OUTLIER -175.52 -156.66 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.244 -0.91 . . . . 0.0 109.764 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -91.1 19.4 5.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.451 -0.781 . . . . 0.0 110.802 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 355' ' ' GLN . 3.4 mp -52.0 -21.08 2.78 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.161 -0.962 . . . . 0.0 111.68 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 56.1 m -49.04 -64.1 0.91 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.077 -1.015 . . . . 0.0 111.264 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -111.39 -15.59 13.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.591 -0.693 . . . . 0.0 111.67 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -99.99 2.27 43.32 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.186 -0.946 . . . . 0.0 112.287 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -30.93 21.95 Favored 'General case' 0 N--CA 1.509 2.485 0 O-C-N 120.894 -1.129 . . . . 0.0 111.265 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -61.98 -32.26 72.7 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.297 -0.877 . . . . 0.0 109.785 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -100.21 -19.53 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.748 -0.595 . . . . 0.0 110.255 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.413 ' HE2' HD11 ' A' ' 357' ' ' LEU . 0.0 OUTLIER -91.49 -24.82 19.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.316 -0.865 . . . . 0.0 109.867 -179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.22 -28.72 63.14 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -64.45 85.14 0.07 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -59.58 96.28 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.513 -0.992 . . . . 0.0 110.307 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.94 35.46 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.67 -0.644 . . . . 0.0 110.22 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -114.01 -63.32 1.47 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.588 -0.695 . . . . 0.0 110.309 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -120.31 119.99 34.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.569 -0.707 . . . . 0.0 110.384 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -100.19 -28.34 13.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.685 . . . . 0.0 110.267 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.85 -27.75 65.43 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.55 -0.719 . . . . 0.0 110.478 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 19.7 m -102.56 10.79 38.59 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.628 -0.67 . . . . 0.0 111.112 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.3 ttt -105.5 -24.66 12.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.245 -0.909 . . . . 0.0 110.688 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.17 -60.4 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.44 -0.787 . . . . 0.0 111.157 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -51.68 -24.57 5.84 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.402 -0.811 . . . . 0.0 111.259 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.7 p -58.58 -26.15 63.31 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.439 -0.788 . . . . 0.0 110.464 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -158.94 52.61 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.53 -0.731 . . . . 0.0 110.23 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 380' ' ' LEU . 0.5 OUTLIER -96.16 39.11 1.16 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.61 -0.681 . . . . 0.0 110.212 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 379' ' ' PHE . 10.1 mp -109.29 73.89 0.61 Allowed Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.567 -0.708 . . . . 0.0 110.5 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -71.81 66.35 3.16 Favored 'Trans proline' 0 C--N 1.316 -1.141 0 O-C-N 123.206 1.108 . . . . 0.0 110.298 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 1.9 p -108.67 -83.54 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.508 -0.745 . . . . 0.0 110.439 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . 179.2 51.13 0.08 OUTLIER Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -90.11 10.54 23.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.509 -0.995 . . . . 0.0 111.092 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.58 -30.49 17.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.258 -0.901 . . . . 0.0 110.457 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -90.07 -18.92 25.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.629 -0.669 . . . . 0.0 110.976 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -61.83 -15.89 45.69 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.298 -0.876 . . . . 0.0 110.906 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.21 141.64 34.45 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.137 -0.977 . . . . 0.0 110.872 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.2 152.61 39.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.635 -0.666 . . . . 0.0 110.231 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.418 ' CD1' ' O ' ' A' ' 390' ' ' TYR . 50.2 p90 -68.29 128.84 38.04 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.727 . . . . 0.0 110.526 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . 0.528 ' HB2' ' HB1' ' A' ' 331' ' ' ALA . 0.0 OUTLIER -147.37 -44.21 0.17 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.52 -0.738 . . . . 0.0 110.404 -179.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 53.3 p -83.52 57.35 4.0 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.513 -0.742 . . . . 0.0 110.313 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -66.99 -30.77 70.98 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.607 -0.683 . . . . 0.0 110.134 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -124.8 54.88 0.73 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 155.96 32.97 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.469 -1.018 . . . . 0.0 110.218 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.403 ' O ' ' CD1' ' A' ' 397' ' ' TYR . . . -144.53 23.73 2.01 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.403 ' CD1' ' O ' ' A' ' 396' ' ' GLY . 38.3 m-85 -140.73 93.38 2.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.42 -1.047 . . . . 0.0 109.523 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -107.76 111.25 23.33 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.562 -0.711 . . . . 0.0 110.97 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.723 ' HB3' HG23 ' A' ' 428' ' ' THR . 14.9 p-90 -142.54 32.26 1.47 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.574 -0.704 . . . . 0.0 109.652 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.911 ' HA3' HD13 ' A' ' 411' ' ' ILE . . . -155.64 -137.31 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -128.3 124.11 35.71 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.464 -1.021 . . . . 0.0 110.357 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 16.0 m-85 -120.8 130.43 53.98 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.66 134.49 34.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.572 -0.705 . . . . 0.0 109.114 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 404' ' ' THR . 7.8 t -89.7 82.66 6.27 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.036 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -123.56 -66.75 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 21.0 p -122.33 -70.8 0.76 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 20.7 tp60 -175.55 42.77 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.714 -0.616 . . . . 0.0 109.482 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp -93.38 166.88 12.07 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.537 -0.727 . . . . 0.0 110.802 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 44.8 t -148.59 137.9 21.86 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.579 -0.7 . . . . 0.0 109.768 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -134.45 133.65 40.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.285 -0.884 . . . . 0.0 110.565 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.911 HD13 ' HA3' ' A' ' 400' ' ' GLY . 6.3 tp -169.09 156.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.938 0.875 . . . . 0.0 111.542 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.824 ' CD1' HG12 ' A' ' 326' ' ' VAL . 2.9 p90 -171.48 -145.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -57.08 150.33 17.43 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.989 -1.069 . . . . 0.0 109.869 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.6 HG11 ' O ' ' A' ' -2' ' ' GLY . 52.9 t -57.81 92.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 121.333 -0.854 . . . . 0.0 110.52 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.428 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 0.1 OUTLIER -177.16 156.37 1.24 Allowed Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.826 . . . . 0.0 109.978 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.5 -173.02 1.26 Allowed 'Trans proline' 0 C--N 1.315 -1.226 0 O-C-N 123.22 1.116 . . . . 0.0 109.922 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.656 HG21 HG11 ' A' ' 326' ' ' VAL . 6.8 t -169.41 -42.59 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.293 -0.88 . . . . 0.0 110.708 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.501 ' N ' HG23 ' A' ' 417' ' ' THR . 75.4 m -128.0 -167.65 1.79 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 319' ' ' ASN . 10.4 mt -76.73 67.65 2.85 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.1 pt -78.99 65.96 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.374 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -109.05 89.97 3.15 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.532 -0.73 . . . . 0.0 109.838 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -161.09 -85.61 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.652 . . . . 0.0 109.6 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.7 m -118.55 62.35 0.78 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 109.774 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 6.5 t -85.97 132.15 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.275 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.636 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 8.1 t80 -169.3 162.88 10.65 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.619 -0.676 . . . . 0.0 109.905 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 426' ' ' ILE . 74.9 mt -136.26 64.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.516 -0.74 . . . . 0.0 110.032 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.636 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -167.36 90.1 0.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.5 -0.75 . . . . 0.0 110.023 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.723 HG23 ' HB3' ' A' ' 399' ' ' TRP . 40.0 p -59.87 -77.37 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.347 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 49.8 m -160.39 115.76 2.29 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.417 -0.802 . . . . 0.0 110.203 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -72.8 151.73 41.91 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.568 -0.707 . . . . 0.0 110.126 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.2 mm? -77.91 111.85 14.19 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.595 -0.691 . . . . 0.0 110.076 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.4 t -116.96 107.04 14.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.553 -0.717 . . . . 0.0 110.257 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 10.5 p80 -154.07 70.15 6.31 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.571 -0.705 . . . . 0.0 110.236 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.83 -178.91 3.77 Favored 'Trans proline' 0 C--N 1.317 -1.084 0 O-C-N 123.343 1.181 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.575 HG22 ' O ' ' A' ' 435' ' ' ILE . 51.0 mm -91.59 48.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.593 -0.692 . . . . 0.0 109.945 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.187 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 120.931 0.396 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.93 -62.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.334 -0.854 . . . . 0.0 110.247 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -132.88 139.89 11.35 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.5 t -119.49 155.83 31.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.493 -1.004 . . . . 0.0 110.203 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -92.32 -173.86 3.54 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.507 -0.746 . . . . 0.0 110.251 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.75 152.65 29.72 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -129.6 -49.49 1.16 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 110.144 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -67.68 -27.37 66.79 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.204 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -74.71 -30.88 61.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.533 -0.729 . . . . 0.0 110.297 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -122.14 83.82 2.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.557 -0.714 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -148.86 45.82 0.7 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.4 t -125.65 67.87 1.16 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.514 -0.992 . . . . 0.0 110.124 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.687 HD21 HG23 ' A' ' 417' ' ' THR . 25.7 p30 -71.47 161.43 31.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.633 -0.667 . . . . 0.0 110.337 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -169.72 38.29 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.602 -0.686 . . . . 0.0 110.138 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -146.45 28.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.38 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -118.89 -65.55 1.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.238 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.38 157.11 27.05 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 39.0 mt -143.54 117.51 9.41 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.452 -1.028 . . . . 0.0 110.801 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 321' ' ' GLU . 1.5 p-90 -150.11 163.06 39.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.555 -0.716 . . . . 0.0 109.859 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.1 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.71 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -177.67 -44.98 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.534 -0.729 . . . . 0.0 109.602 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -171.61 -100.59 0.14 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -149.45 19.71 0.94 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.564 -0.962 . . . . 0.0 110.814 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 418' ' ' CYS . 33.7 t -150.74 138.79 20.09 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . 0.632 ' O ' HD11 ' A' ' 420' ' ' ILE . 2.2 pt-20 -130.44 170.37 14.29 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.309 -0.869 . . . . 0.0 110.959 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -66.35 128.77 37.47 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.611 -0.681 . . . . 0.0 110.213 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' A' ' 324' ' ' PRO . 23.0 mt -142.07 -67.56 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 110.585 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' A' ' 323' ' ' ILE . 48.9 Cg_endo -71.68 -165.59 0.21 Allowed 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 122.592 0.785 . . . . 0.0 110.631 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . 0.403 ' O ' ' CG ' ' A' ' 325' ' ' HIS . 19.5 p80 -135.03 111.77 10.04 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.625 -0.672 . . . . 0.0 110.272 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.644 HG12 ' CB ' ' A' ' 412' ' ' PHE . 33.9 m -80.3 160.19 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.49 -0.757 . . . . 0.0 110.208 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -90.68 125.23 35.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.528 -0.733 . . . . 0.0 110.38 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -74.89 158.25 33.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.477 -0.764 . . . . 0.0 110.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.53 131.69 8.15 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.586 -0.696 . . . . 0.0 110.292 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.75 65.93 6.68 Favored 'Trans proline' 0 C--N 1.322 -0.853 0 O-C-N 123.266 1.14 . . . . 0.0 109.931 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.578 ' HB2' ' HB2' ' A' ' 409' ' ' CYS . . . -48.47 -79.49 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.623 -0.673 . . . . 0.0 111.543 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 332' ' ' ILE . 2.0 tt -80.54 64.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.333 -0.854 . . . . 0.0 110.192 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -155.56 -54.37 0.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.905 -0.497 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.4 mt -143.53 -50.35 0.32 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 0.0 110.552 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -123.83 158.68 31.27 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.541 -0.724 . . . . 0.0 110.472 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -87.23 -169.41 2.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.608 -0.683 . . . . 0.0 109.746 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 60.3 m -96.06 26.75 3.98 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.439 -0.788 . . . . 0.0 110.113 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -131.35 44.22 2.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 109.992 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -158.66 90.72 1.02 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.522 -0.736 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.581 HD12 ' CG ' ' A' ' 343' ' ' GLU . 3.2 mm? -89.11 -166.39 1.58 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.533 -0.729 . . . . 0.0 109.89 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 52.4 t -129.79 -56.97 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.43 -0.794 . . . . 0.0 110.174 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.8 48.64 0.16 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.307 -0.871 . . . . 0.0 110.801 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.581 ' CG ' HD12 ' A' ' 340' ' ' LEU . 11.7 pt-20 -137.92 -41.44 0.53 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.482 -0.761 . . . . 0.0 110.67 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.46 -24.5 13.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.415 -0.803 . . . . 0.0 110.573 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.9 t -57.41 -40.5 78.45 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.476 -0.765 . . . . 0.0 110.664 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.08 17.29 24.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.532 -0.73 . . . . 0.0 110.862 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 40.1 t -98.31 -33.94 10.88 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 0.0 110.323 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -87.73 -40.22 14.29 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.579 -0.701 . . . . 0.0 110.441 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -151.51 147.07 19.58 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.487 -0.758 . . . . 0.0 110.222 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.07 155.25 52.55 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.322 1.17 . . . . 0.0 110.334 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -108.4 -67.17 0.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.27 90.37 7.89 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.479 -0.763 . . . . 0.0 110.121 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -136.69 34.1 2.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.593 -0.692 . . . . 0.0 110.324 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -139.45 -76.86 0.34 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.615 -0.678 . . . . 0.0 110.202 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -168.61 32.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.335 -0.853 . . . . 0.0 110.374 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -85.41 -24.83 27.34 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.565 -0.709 . . . . 0.0 110.419 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.66 -21.42 18.02 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.497 -0.752 . . . . 0.0 111.068 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 54.6 m -51.23 -49.44 61.08 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.189 -0.944 . . . . 0.0 111.307 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -110.7 -16.99 13.48 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.642 -0.661 . . . . 0.0 111.454 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.666 ' O ' HG23 ' A' ' 363' ' ' ILE . 32.2 m-85 -91.35 0.65 57.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.224 -0.922 . . . . 0.0 111.726 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.02 -19.53 65.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.08 -1.013 . . . . 0.0 110.75 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -65.79 -12.93 58.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.369 -0.832 . . . . 0.0 111.15 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.666 HG23 ' O ' ' A' ' 360' ' ' TYR . 37.3 pt -55.76 -33.31 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.125 -0.984 . . . . 0.0 110.682 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.41 ' N ' HG13 ' A' ' 363' ' ' ILE . 1.6 ptmt -57.31 -25.35 59.17 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.618 -0.676 . . . . 0.0 110.673 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -84.68 -22.55 29.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.547 -0.721 . . . . 0.0 110.613 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -135.96 51.35 0.82 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 367' ' ' PHE . 26.2 t80 -97.28 27.43 4.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.511 -0.993 . . . . 0.0 110.154 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.69 -27.62 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.529 -0.732 . . . . 0.0 109.893 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -170.08 30.77 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.484 -0.76 . . . . 0.0 110.623 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -110.17 -30.41 7.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.455 -0.778 . . . . 0.0 109.981 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -62.41 -20.16 64.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.694 -0.628 . . . . 0.0 110.648 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -72.35 -9.46 58.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.3 -0.875 . . . . 0.0 111.337 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.6 m -105.28 -45.42 4.49 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 111.003 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.623 ' O ' ' HB3' ' A' ' 378' ' ' ALA . 4.7 ppp? -54.01 -25.54 21.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.436 -0.79 . . . . 0.0 111.276 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 95.0 mt -60.94 -29.34 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.362 -0.836 . . . . 0.0 110.0 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -20.95 12.86 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.685 -0.635 . . . . 0.0 110.869 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 5.2 m -98.13 -27.96 13.95 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.353 -0.842 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 374' ' ' MET . . . -97.06 34.12 1.8 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.563 -0.711 . . . . 0.0 110.248 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -104.09 -57.0 2.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 110.056 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 28.2 mt -127.46 154.3 77.36 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.72 . . . . 0.0 110.208 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.31 -26.83 14.11 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.392 1.206 . . . . 0.0 110.493 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.7 m -127.12 75.56 1.59 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.586 -0.696 . . . . 0.0 110.05 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -118.57 40.85 2.16 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -59.95 -26.57 66.08 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.53 -0.982 . . . . 0.0 110.36 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.39 -27.39 68.49 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.593 -0.692 . . . . 0.0 110.194 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.7 ttmm -77.77 -22.2 50.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.559 -0.713 . . . . 0.0 110.569 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -64.69 -13.51 54.59 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.428 -0.795 . . . . 0.0 110.842 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.76 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.109 -0.995 . . . . 0.0 110.609 -179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -68.83 -75.66 0.1 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.517 -0.739 . . . . 0.0 110.117 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -81.56 151.16 27.84 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.534 -0.729 . . . . 0.0 110.336 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.35 -152.53 0.5 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.563 -0.71 . . . . 0.0 110.249 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.0 p -83.55 57.13 3.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.374 -0.829 . . . . 0.0 110.152 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.483 ' CE1' ' CD1' ' A' ' 397' ' ' TYR . 59.9 t-80 -65.89 -43.53 88.01 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.576 -0.703 . . . . 0.0 110.428 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -62.48 -34.81 90.56 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.57 38.77 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.533 -0.98 . . . . 0.0 110.499 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 54.58 0.08 OUTLIER Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.483 ' CD1' ' CE1' ' A' ' 393' ' ' HIS . 66.2 t80 -130.71 -38.45 1.3 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.596 -0.944 . . . . 0.0 110.877 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -96.93 107.71 20.28 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.468 -0.77 . . . . 0.0 110.813 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.448 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 5.8 p-90 -164.18 29.22 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.532 -0.73 . . . . 0.0 110.344 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -156.25 -129.13 1.15 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -130.69 129.9 43.17 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.486 -1.008 . . . . 0.0 110.4 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 50.0 m-85 -125.4 120.86 32.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 0.0 110.092 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -111.75 115.53 29.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.619 -0.675 . . . . 0.0 109.871 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 80.6 m -89.78 85.13 6.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 0.0 110.243 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.27 -65.53 1.13 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 5.8 p -120.66 -72.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.784 -0.572 . . . . 0.0 109.706 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -173.0 67.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.537 -0.727 . . . . 0.0 110.08 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -150.57 155.49 39.54 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 0.0 111.156 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 331' ' ' ALA . 51.3 t -125.79 153.61 43.79 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -137.13 148.26 46.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.299 -0.875 . . . . 0.0 110.775 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 411' ' ' ILE . 5.0 mp -131.92 124.94 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.532 -0.73 . . . . 0.0 110.107 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.644 ' CB ' HG12 ' A' ' 326' ' ' VAL . 1.8 t80 -169.91 -160.86 0.25 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.585 -0.697 . . . . 0.0 110.008 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.429 ' C ' HG23 ' A' ' 414' ' ' VAL . 4.2 p30 -134.26 98.24 4.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.474 -0.766 . . . . 0.0 110.285 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 415' ' ' LYS . 58.6 t -147.23 166.52 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.526 -0.734 . . . . 0.0 110.014 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 414' ' ' VAL . 10.7 mttt -80.38 156.41 73.67 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.639 -0.663 . . . . 0.0 110.188 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.13 -43.06 2.55 Favored 'Trans proline' 0 C--N 1.317 -1.114 0 O-C-N 123.42 1.221 . . . . 0.0 110.463 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.687 HG23 HD21 ' A' ' 309' ' ' ASN . 7.2 t -72.23 64.48 0.56 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.55 -0.719 . . . . 0.0 110.07 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.547 ' SG ' HD12 ' A' ' 420' ' ' ILE . 6.8 t -151.69 163.67 38.61 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.533 -0.729 . . . . 0.0 109.478 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.463 HD22 ' N ' ' A' ' 419' ' ' LEU . 4.6 mm? -95.31 27.4 3.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.61 -0.681 . . . . 0.0 110.543 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.632 HD11 ' O ' ' A' ' 321' ' ' GLU . 95.7 mt -112.95 -28.09 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 0.0 110.113 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -134.59 156.22 49.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.54 -0.725 . . . . 0.0 110.249 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 20.8 t30 -107.23 -63.63 1.27 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.594 -0.691 . . . . 0.0 110.291 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.8 m -97.97 105.35 17.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 17.9 t -102.35 133.92 46.49 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.642 -0.661 . . . . 0.0 110.09 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -162.61 115.9 1.69 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -122.89 62.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.616 -0.678 . . . . 0.0 109.916 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -160.87 102.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.58 -0.7 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.3 p -94.62 136.18 35.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.571 -0.705 . . . . 0.0 109.771 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 431' ' ' LEU . 2.2 m -59.53 89.8 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.632 -0.668 . . . . 0.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -60.69 -26.07 66.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.636 -0.665 . . . . 0.0 110.426 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.653 HD22 ' N ' ' A' ' 432' ' ' SER . 0.0 OUTLIER -153.99 174.99 13.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.522 -0.736 . . . . 0.0 110.623 -179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . 0.653 ' N ' HD22 ' A' ' 431' ' ' LEU . 8.3 t -83.61 -74.68 0.36 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.511 -0.743 . . . . 0.0 110.592 -179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -161.83 163.02 19.94 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.95 -28.74 12.83 Favored 'Trans proline' 0 C--N 1.317 -1.122 0 O-C-N 123.477 1.251 . . . . 0.0 110.404 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 6.9 tt -137.42 40.88 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.632 -0.667 . . . . 0.0 109.998 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.771 -179.899 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 10.0 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.048 0.451 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.4 ttt-85 -165.05 -58.42 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.603 -0.686 . . . . 0.0 110.269 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -137.63 76.16 0.37 Allowed Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 p -114.37 168.41 9.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.523 -0.987 . . . . 0.0 110.214 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -113.28 34.62 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.547 -0.721 . . . . 0.0 110.209 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 7.3 m80 -150.53 158.72 44.47 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.65 -0.656 . . . . 0.0 110.11 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' -4' ' ' HIS . 0.0 OUTLIER -59.84 -174.31 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.647 -0.658 . . . . 0.0 110.864 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 81.97 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.618 -0.676 . . . . 0.0 111.012 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . 0.419 ' HB2' ' CE1' ' A' ' -6' ' ' HIS . 25.4 t60 -115.16 169.92 8.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.388 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 42.4 t60 -146.0 138.41 25.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.636 -0.665 . . . . 0.0 110.138 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -62.38 -159.92 0.16 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.7 t -81.0 160.29 24.62 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.605 -0.938 . . . . 0.0 110.187 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -84.37 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.539 -0.725 . . . . 0.0 110.241 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -166.66 170.92 12.12 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.532 -0.73 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -156.61 -51.77 0.08 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.63 -0.669 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.722 ' CE2' HD12 ' A' ' 314' ' ' LEU . 2.7 t80 -134.47 117.03 15.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.53 -0.731 . . . . 0.0 110.146 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -91.56 94.81 1.98 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.779 HD21 ' HA ' ' A' ' 322' ' ' ASP . 0.5 OUTLIER -150.35 135.22 17.61 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.58 -0.953 . . . . 0.0 110.153 179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.566 ' CD2' HD12 ' A' ' 419' ' ' LEU . 3.1 p-90 -108.73 170.44 8.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.562 -0.711 . . . . 0.0 109.648 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 316' ' ' VAL . 9.8 p -56.39 128.74 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.438 -0.788 . . . . 0.0 110.25 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.83 97.92 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.465 -0.772 . . . . 0.0 110.718 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.421 ' HA3' ' CH2' ' A' ' 315' ' ' TRP . . . -115.24 -29.41 2.54 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -149.45 -43.82 0.14 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.483 -1.01 . . . . 0.0 110.755 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 43.2 t -97.53 159.5 14.88 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.6 0.714 . . . . 0.0 110.55 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -73.23 172.14 11.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.869 -0.519 . . . . 0.0 109.859 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.779 ' HA ' HD21 ' A' ' 314' ' ' LEU . 0.9 OUTLIER -57.39 -163.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.673 -0.642 . . . . 0.0 110.636 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.638 ' H ' HD11 ' A' ' 314' ' ' LEU . 5.5 tp -46.53 109.76 1.09 Allowed Pre-proline 0 N--CA 1.505 2.296 0 O-C-N 121.334 -0.854 . . . . 0.0 111.561 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.34 -164.55 0.18 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 123.075 1.039 . . . . 0.0 110.043 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -108.27 89.65 3.06 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.532 -0.73 . . . . 0.0 110.569 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 326' ' ' VAL . 34.5 m -89.95 160.95 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 109.498 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -88.31 103.86 16.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.551 -0.718 . . . . 0.0 110.222 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -77.97 160.06 28.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.756 -0.59 . . . . 0.0 110.52 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 337' ' ' CYS . 1.1 t80 -109.73 101.81 47.93 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.674 -0.641 . . . . 0.0 109.89 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.98 68.33 3.17 Favored 'Trans proline' 0 C--N 1.319 -1.02 0 O-C-N 123.361 1.19 . . . . 0.0 110.202 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -57.35 91.33 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.604 -0.685 . . . . 0.0 110.595 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 6.7 tp -110.64 -26.12 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.586 -0.696 . . . . 0.0 110.032 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -154.56 27.68 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 110.074 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 18.5 mt -106.08 -163.86 0.96 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.693 . . . . 0.0 110.108 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -96.65 -63.67 1.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.547 -0.72 . . . . 0.0 110.385 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.14 -178.31 5.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.478 -0.764 . . . . 0.0 110.38 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 329' ' ' PHE . 93.6 m -93.66 -41.12 9.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.571 -0.706 . . . . 0.0 110.431 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . 0.433 ' O ' HD23 ' A' ' 340' ' ' LEU . 9.1 p-10 -57.83 -24.77 58.97 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.509 -0.744 . . . . 0.0 110.514 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 41.9 tttm -93.63 118.0 30.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.571 -0.706 . . . . 0.0 110.562 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.433 HD23 ' O ' ' A' ' 338' ' ' ASN . 0.5 OUTLIER -159.21 150.58 20.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.546 -0.721 . . . . 0.0 110.048 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 341' ' ' VAL . 10.6 p -163.56 29.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.492 -0.755 . . . . 0.0 110.187 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.463 ' HA ' ' HB2' ' A' ' 346' ' ' ALA . 51.2 p90 -141.11 29.27 1.84 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.252 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.37 -56.93 1.02 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.534 -0.729 . . . . 0.0 110.047 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.03 -46.89 4.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.614 -0.679 . . . . 0.0 110.015 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.6 t -68.21 -24.77 64.97 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.588 -0.695 . . . . 0.0 110.283 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 342' ' ' PHE . . . -89.78 14.64 11.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.403 -0.811 . . . . 0.0 111.035 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 58.4 m -95.0 -28.45 15.13 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.281 -0.887 . . . . 0.0 110.013 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -98.63 -26.5 14.36 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.613 -0.68 . . . . 0.0 110.186 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -106.33 92.67 7.12 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.71 . . . . 0.0 110.05 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.86 -20.36 22.52 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.392 1.206 . . . . 0.0 111.095 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -58.37 -59.39 5.41 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.317 -0.864 . . . . 0.0 110.639 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -60.06 -26.36 66.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.521 -0.737 . . . . 0.0 110.629 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -60.14 -28.84 68.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.441 -0.787 . . . . 0.0 110.477 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -101.21 55.3 0.84 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.531 -0.73 . . . . 0.0 110.332 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -144.65 15.81 1.61 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.556 -0.715 . . . . 0.0 110.977 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -110.6 -29.58 7.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.181 -0.949 . . . . 0.0 110.13 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.431 ' HA ' HD13 ' A' ' 357' ' ' LEU . 4.5 mm? -81.81 -16.6 50.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.563 -0.711 . . . . 0.0 110.913 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 7.6 m -101.77 -23.6 14.18 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.321 -0.862 . . . . 0.0 110.821 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.26 -47.1 3.34 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.287 -0.883 . . . . 0.0 110.916 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -80.26 1.39 28.69 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.592 -0.692 . . . . 0.0 111.357 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -82.68 6.18 18.77 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.135 -0.978 . . . . 0.0 111.469 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -99.94 -23.79 14.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.18 -0.95 . . . . 0.0 110.596 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 25.2 pt -89.92 -25.59 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.436 -0.79 . . . . 0.0 110.633 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -28.56 67.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.438 -0.789 . . . . 0.0 110.658 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -76.04 -23.36 55.12 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.743 . . . . 0.0 110.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -107.24 76.63 0.23 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -88.18 52.1 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.538 -0.977 . . . . 0.0 110.403 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 -24.82 11.11 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.562 -0.711 . . . . 0.0 110.254 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -162.12 104.92 1.15 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 110.034 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 155.13 8.11 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.507 -0.746 . . . . 0.0 110.501 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.438 ' ND2' HD11 ' A' ' 375' ' ' ILE . 15.8 t30 -94.85 -23.18 17.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.641 -0.662 . . . . 0.0 110.65 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -51.44 -25.48 6.44 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.337 -0.852 . . . . 0.0 111.012 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 5.8 p -79.84 -23.64 41.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.597 -0.69 . . . . 0.0 110.481 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -91.15 -29.49 17.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.46 -0.775 . . . . 0.0 110.561 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.438 HD11 ' ND2' ' A' ' 371' ' ' ASN . 46.9 mm -63.79 -42.71 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.493 -0.754 . . . . 0.0 110.167 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.63 -26.19 61.23 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.63 -0.669 . . . . 0.0 110.517 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.0 t -90.9 -26.48 19.3 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.572 -0.705 . . . . 0.0 110.387 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -130.55 75.24 1.64 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.496 -0.752 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -117.92 30.69 7.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.405 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 5.9 mt -57.03 -56.15 36.49 Favored Pre-proline 0 N--CA 1.498 1.963 0 O-C-N 121.493 -0.755 . . . . 0.0 110.609 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.405 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 52.4 Cg_endo -75.41 60.4 5.73 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.2 1.105 . . . . 0.0 110.601 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 37.8 m -160.77 92.42 0.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.339 -0.851 . . . . 0.0 110.199 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -58.53 -20.44 45.79 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -64.01 -12.89 42.4 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.387 -1.066 . . . . 0.0 111.222 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -54.74 -30.27 55.88 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.05 -1.031 . . . . 0.0 110.793 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -59.85 -25.6 65.16 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.589 -0.694 . . . . 0.0 110.504 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.16 -12.13 59.18 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.549 -0.719 . . . . 0.0 110.544 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -56.86 159.04 4.3 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.195 -0.94 . . . . 0.0 110.612 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.81 67.89 0.67 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.548 -0.72 . . . . 0.0 110.36 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -64.38 -74.13 0.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.524 -0.735 . . . . 0.0 110.154 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -112.66 169.82 8.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.648 -0.658 . . . . 0.0 110.254 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 34.4 t -84.97 55.83 3.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.567 -0.708 . . . . 0.0 110.253 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -140.74 21.07 2.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.502 -0.749 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -163.65 28.15 0.23 Allowed Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -77.3 132.79 38.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.356 -1.085 . . . . 0.0 109.871 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.4 60.95 0.14 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.487 ' H ' HG21 ' A' ' 428' ' ' THR . 4.9 m-85 -161.96 28.81 0.12 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.508 -0.995 . . . . 0.0 110.358 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.39 140.72 52.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.597 -0.69 . . . . 0.0 109.835 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.533 ' HA ' HD13 ' A' ' 426' ' ' ILE . 19.5 p-90 -157.65 24.86 0.28 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.546 -0.721 . . . . 0.0 110.861 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' ' CD1' ' A' ' 411' ' ' ILE . . . -137.38 -160.27 8.52 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -132.23 167.13 20.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.578 -0.954 . . . . 0.0 110.329 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -134.9 142.12 46.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 110.366 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -119.86 123.51 43.79 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.621 ' O ' HG23 ' A' ' 404' ' ' THR . 7.5 t -89.8 85.65 6.46 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.509 -0.744 . . . . 0.0 110.726 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -121.0 -65.78 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.75 . . . . 0.0 109.511 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 97.0 m -121.15 -70.04 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.668 -0.645 . . . . 0.0 109.675 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -174.0 57.72 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.511 -0.743 . . . . 0.0 109.8 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -146.4 159.64 43.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.441 -0.787 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 91.0 m -121.46 168.5 11.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.659 -0.651 . . . . 0.0 110.039 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -124.52 133.62 53.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.467 -0.77 . . . . 0.0 110.191 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.401 ' CD1' ' HA3' ' A' ' 400' ' ' GLY . 0.4 OUTLIER -155.23 148.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.388 -0.82 . . . . 0.0 110.149 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 412' ' ' PHE . 31.9 p90 -165.61 -169.46 1.57 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -60.05 168.98 1.67 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.531 -0.731 . . . . 0.0 110.321 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 59.5 t -57.5 150.96 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.468 -0.77 . . . . 0.0 110.248 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -55.56 109.52 1.67 Allowed Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.592 -0.692 . . . . 0.0 110.542 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -79.83 -76.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.298 1.157 . . . . 0.0 110.712 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 3.4 p -145.69 42.04 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.358 -0.839 . . . . 0.0 110.023 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.439 ' O ' HD23 ' A' ' 419' ' ' LEU . 86.0 m -132.12 175.4 9.28 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.575 -0.703 . . . . 0.0 110.049 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.566 HD12 ' CD2' ' A' ' 315' ' ' TRP . 48.2 mt -136.81 130.21 31.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.529 -0.732 . . . . 0.0 110.337 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 21.0 pt -131.2 121.31 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.59 -0.694 . . . . 0.0 110.078 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.43 99.29 9.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.413 -0.804 . . . . 0.0 110.428 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -156.37 -171.68 3.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.581 -0.7 . . . . 0.0 109.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 16.1 m -77.2 66.88 3.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.454 -0.779 . . . . 0.0 109.829 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 60.4 p -70.82 160.84 32.01 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.641 -0.662 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.01 40.74 0.49 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 109.955 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 399' ' ' TRP . 46.3 mm -61.23 -30.9 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.683 -0.636 . . . . 0.0 109.857 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -109.1 95.15 5.44 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.579 -0.701 . . . . 0.0 110.187 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.487 HG21 ' H ' ' A' ' 397' ' ' TYR . 79.5 p -59.39 -62.81 1.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.595 -0.691 . . . . 0.0 110.229 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 88.6 m -160.37 110.69 1.82 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.503 -0.748 . . . . 0.0 110.276 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.74 -81.1 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 110.29 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.7 pp -148.27 151.42 35.39 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.386 -0.821 . . . . 0.0 110.365 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -166.88 70.17 0.11 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.553 -0.717 . . . . 0.0 110.264 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.421 ' HB3' ' HD3' ' A' ' 434' ' ' PRO . 5.0 t60 -76.3 -58.29 1.24 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.237 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 433' ' ' HIS . 43.7 Cg_endo -69.12 130.84 20.89 Favored 'Trans proline' 0 N--CA 1.487 1.137 0 O-C-N 123.043 1.022 . . . . 0.0 110.364 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 79.2 mt -109.68 -59.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.645 -0.66 . . . . 0.0 110.11 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.442 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 11.9 mtt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.146 0.498 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.3 mtt180 -107.91 -43.21 4.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.538 -0.726 . . . . 0.0 110.235 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -159.69 112.75 0.54 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 15.1 m -108.57 -55.89 2.33 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.625 -0.926 . . . . 0.0 110.188 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -162.6 133.48 4.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.644 -0.66 . . . . 0.0 110.227 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -146.57 36.41 0.97 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.549 -0.719 . . . . 0.0 110.225 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -149.45 105.11 3.43 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.59 -0.694 . . . . 0.0 110.198 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -142.04 171.22 14.36 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.586 -0.696 . . . . 0.0 110.215 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -155.64 -60.04 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.554 -0.716 . . . . 0.0 110.276 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -129.24 -171.01 2.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.577 -0.702 . . . . 0.0 110.165 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -96.54 39.99 2.68 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 p -153.0 139.03 18.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.642 -0.916 . . . . 0.0 109.962 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -107.19 117.18 33.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 0.0 110.443 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -111.56 134.99 52.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.682 -0.636 . . . . 0.0 109.904 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -159.02 -43.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.487 -0.758 . . . . 0.0 109.928 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HE1' HD11 ' A' ' 323' ' ' ILE . 7.5 t80 -136.41 154.7 50.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.643 -0.661 . . . . 0.0 110.394 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.431 ' N ' ' CD1' ' A' ' 312' ' ' PHE . . . -115.67 82.55 0.32 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 314' ' ' LEU . 0.5 OUTLIER -104.52 160.06 15.24 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.612 -0.934 . . . . 0.0 110.358 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.43 ' CZ2' ' HB2' ' A' ' 320' ' ' CYS . 0.1 OUTLIER -51.92 170.44 0.06 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.411 -0.805 . . . . 0.0 110.443 179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.467 HG22 ' N ' ' A' ' 317' ' ' ASP . 8.6 p -65.38 166.4 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.692 -0.63 . . . . 0.0 109.99 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.467 ' N ' HG22 ' A' ' 316' ' ' VAL . 13.7 t70 -63.58 97.83 0.16 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.609 -0.682 . . . . 0.0 110.267 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -101.15 -86.7 1.94 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -150.24 30.35 0.7 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.603 -0.939 . . . . 0.0 110.116 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.43 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 76.0 m -140.49 169.89 16.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.581 -0.7 . . . . 0.0 110.37 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -90.35 170.59 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.87 127.59 16.59 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.315 -0.865 . . . . 0.0 110.759 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 420' ' ' ILE . 11.6 pt -64.72 162.21 38.3 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.748 -0.595 . . . . 0.0 110.58 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.41 ' HD3' ' HB3' ' A' ' 416' ' ' PRO . 41.9 Cg_endo -67.7 -163.37 0.08 OUTLIER 'Trans proline' 0 N--CA 1.486 1.062 0 O-C-N 123.482 1.254 . . . . 0.0 110.207 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -99.9 123.3 44.0 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.623 -0.673 . . . . 0.0 111.142 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 32.7 m -130.13 160.65 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.649 -0.657 . . . . 0.0 109.431 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.483 ' HB3' HD11 ' A' ' 411' ' ' ILE . 2.7 m120 -89.25 135.35 33.62 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.524 -0.735 . . . . 0.0 109.948 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -117.8 135.39 54.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.666 -0.646 . . . . 0.0 110.322 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.76 97.82 49.72 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.723 -0.611 . . . . 0.0 109.875 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.77 -45.51 0.51 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 O-C-N 123.266 1.14 . . . . 0.0 110.564 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -85.55 117.17 24.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.535 -0.728 . . . . 0.0 110.298 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.681 HD13 ' HB2' ' A' ' 409' ' ' CYS . 3.6 tt -143.4 28.25 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.582 -0.699 . . . . 0.0 110.11 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.66 -40.0 10.98 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.504 -0.748 . . . . 0.0 110.436 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 335' ' ' PHE . 1.5 tt -98.03 -35.11 10.54 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.578 -0.701 . . . . 0.0 110.199 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.424 ' CE2' HD22 ' A' ' 334' ' ' LEU . 95.8 m-85 -108.66 -172.11 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.532 -0.73 . . . . 0.0 110.13 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -132.92 156.25 47.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.723 . . . . 0.0 110.366 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.2 m -68.87 -28.05 66.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -95.23 44.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.531 -0.731 . . . . 0.0 110.256 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 1.9 ttmm -135.38 61.82 1.65 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.599 -0.688 . . . . 0.0 110.326 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 340' ' ' LEU . 0.7 OUTLIER -145.37 151.44 38.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.529 -0.732 . . . . 0.0 110.36 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 32.2 m -95.75 -149.11 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.605 -0.684 . . . . 0.0 109.688 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.405 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 82.5 t80 -68.74 74.06 0.27 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.241 -0.912 . . . . 0.0 109.934 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -123.44 -38.71 2.52 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.579 -0.701 . . . . 0.0 110.312 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 5.4 tt -66.37 -26.31 67.2 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.486 -0.759 . . . . 0.0 110.372 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.6 p -78.38 -36.22 46.21 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.557 -0.714 . . . . 0.0 110.405 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -91.87 -37.4 12.93 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.547 -0.72 . . . . 0.0 110.334 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 5.0 m -88.73 10.83 19.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.61 -0.681 . . . . 0.0 111.045 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.49 -27.82 64.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.167 -0.958 . . . . 0.0 110.349 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -87.08 127.35 59.71 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.72 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.21 -54.45 0.1 OUTLIER 'Trans proline' 0 C--N 1.32 -0.965 0 O-C-N 123.198 1.104 . . . . 0.0 110.455 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.11 176.2 8.46 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.472 -0.768 . . . . 0.0 110.373 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -146.23 160.42 42.0 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.64 -0.662 . . . . 0.0 110.256 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -71.18 -27.2 63.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.561 -0.712 . . . . 0.0 110.293 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -113.17 29.47 7.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.569 -0.707 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -166.21 42.61 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.23 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 31.5 p80 -109.8 -28.53 8.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.623 -0.673 . . . . 0.0 110.306 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.415 ' O ' ' CE2' ' A' ' 360' ' ' TYR . 9.0 tt -66.21 -25.22 66.82 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.496 -0.752 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 358' ' ' THR . 52.2 m -104.52 6.19 34.54 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.418 -0.801 . . . . 0.0 111.106 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -98.9 -28.56 13.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.139 -0.976 . . . . 0.0 111.599 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.728 ' O ' HG22 ' A' ' 363' ' ' ILE . 13.6 p90 -80.34 -22.6 41.26 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.235 -0.916 . . . . 0.0 110.98 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.38 -24.57 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.352 -0.842 . . . . 0.0 110.686 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.403 ' HA ' ' CG ' ' A' ' 365' ' ' GLU . 0.0 OUTLIER -100.22 -10.61 21.19 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.461 -0.775 . . . . 0.0 111.474 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 360' ' ' TYR . 9.1 tt -58.47 -24.21 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.12 -0.988 . . . . 0.0 110.76 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.3 mtpp -92.75 -30.43 15.51 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.428 -0.795 . . . . 0.0 110.373 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.403 ' CG ' ' HA ' ' A' ' 362' ' ' LYS . 6.7 pt-20 -110.25 20.74 17.51 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.536 -0.728 . . . . 0.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.27 65.18 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -98.01 20.83 11.59 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.525 -0.985 . . . . 0.0 110.993 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.5 mmmt -59.55 -36.77 76.8 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.294 -0.879 . . . . 0.0 110.186 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -113.44 -110.76 0.35 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.633 -0.667 . . . . 0.0 109.896 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -171.17 -75.81 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.612 -1.305 . . . . 0.0 110.015 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -76.3 -32.96 59.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.623 -0.673 . . . . 0.0 110.291 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.22 -28.66 69.32 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.648 -0.657 . . . . 0.0 110.278 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 75.6 m -101.47 -19.95 15.33 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.607 -0.683 . . . . 0.0 110.76 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -38.76 73.77 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.427 -0.795 . . . . 0.0 110.627 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 3.6 pt -130.61 -113.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.496 -0.752 . . . . 0.0 109.616 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 380' ' ' LEU . 39.9 tttt -133.82 60.86 1.69 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.558 -1.338 . . . . 0.0 109.94 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.7 m -115.15 -25.18 8.19 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.536 -0.727 . . . . 0.0 110.546 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -59.12 -31.81 69.28 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.332 -0.855 . . . . 0.0 110.406 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -76.94 -53.29 8.04 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.569 -0.707 . . . . 0.0 110.081 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 380' ' ' LEU . 6.9 mp -98.07 126.02 41.76 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 110.001 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.45 62.77 4.47 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.051 1.027 . . . . 0.0 110.502 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 382' ' ' THR . 7.6 t -169.11 71.69 0.08 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.469 -0.769 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -91.35 -34.14 7.66 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.99 -27.97 68.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.592 -0.946 . . . . 0.0 110.306 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -59.95 -26.22 65.81 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.542 -0.724 . . . . 0.0 110.458 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -79.63 -25.86 41.28 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.528 -0.732 . . . . 0.0 110.464 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.36 -11.8 58.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.449 -0.782 . . . . 0.0 110.665 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -56.99 -64.56 0.84 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.246 -0.909 . . . . 0.0 110.789 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 25.0 mmt-85 -55.07 -176.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.525 -0.734 . . . . 0.0 111.171 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -90.9 114.69 27.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.909 -0.495 . . . . 0.0 110.236 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.65 -41.42 1.68 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.507 -0.746 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 12.5 t -66.9 -27.85 67.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.499 -0.751 . . . . 0.0 110.22 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 5.5 m170 -69.99 84.1 0.5 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.589 -0.694 . . . . 0.0 110.184 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 179.73 -47.79 0.08 OUTLIER Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 133.44 55.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.546 -0.973 . . . . 0.0 109.577 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -155.66 28.17 0.6 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -150.96 172.5 15.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.558 -0.966 . . . . 0.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -85.25 142.39 29.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.643 -0.661 . . . . 0.0 110.279 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -157.3 50.97 0.46 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.547 -0.721 . . . . 0.0 110.171 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.506 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -129.56 176.61 18.49 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.467 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 23.1 p30 -112.68 141.08 46.89 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.999 . . . . 0.0 110.4 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 51.2 m-85 -133.41 117.68 17.52 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.538 -0.726 . . . . 0.0 110.721 -178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -153.25 89.51 1.36 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.327 -0.858 . . . . 0.0 109.81 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.662 HG21 ' CB ' ' A' ' 408' ' ' LYS . 2.9 m -152.01 152.47 32.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.357 -0.84 . . . . 0.0 111.17 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -92.31 -16.58 25.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.81 -0.556 . . . . 0.0 109.92 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.471 ' H ' HG22 ' A' ' 404' ' ' THR . 0.0 OUTLIER -116.83 -88.74 0.59 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.426 -0.796 . . . . 0.0 109.945 179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . 0.442 ' H ' HG23 ' A' ' 406' ' ' THR . 1.3 tp-100 -154.75 80.31 1.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.968 -1.083 . . . . 0.0 111.085 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.662 ' CB ' HG21 ' A' ' 404' ' ' THR . 6.5 tptt -137.06 154.45 50.34 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.835 . . . . 0.0 109.611 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.681 ' HB2' HD13 ' A' ' 332' ' ' ILE . 52.5 t -152.84 150.53 29.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.512 -0.743 . . . . 0.0 110.406 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.438 ' C ' HG23 ' A' ' 411' ' ' ILE . 76.6 mt-10 -147.88 168.51 22.04 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.65 -0.656 . . . . 0.0 109.256 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.663 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -153.55 141.82 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.405 -0.81 . . . . 0.0 110.952 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.467 ' CE2' ' ND2' ' A' ' 401' ' ' ASN . 13.0 p90 -173.16 -170.77 0.66 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.623 -0.673 . . . . 0.0 109.953 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -116.44 -76.11 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.451 -0.781 . . . . 0.0 110.862 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.421 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -81.14 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.428 -0.795 . . . . 0.0 110.643 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 414' ' ' VAL . 15.2 ptpt -126.2 156.35 72.38 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.543 -0.723 . . . . 0.0 110.211 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . 0.41 ' HB3' ' HD3' ' A' ' 324' ' ' PRO . 49.2 Cg_endo -74.6 -95.97 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.051 0 O-C-N 123.42 1.221 . . . . 0.0 110.648 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 320' ' ' CYS . 4.9 t -177.89 34.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.798 -1.189 . . . . 0.0 110.306 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.89 -169.59 3.31 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.388 -0.82 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 419' ' ' LEU . 0.9 OUTLIER -80.01 89.69 5.36 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.301 -179.21 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.87 HG21 HG21 ' A' ' 323' ' ' ILE . 10.9 tp -160.36 28.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.494 -0.754 . . . . 0.0 109.755 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -131.75 172.61 12.08 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.565 -0.709 . . . . 0.0 110.065 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -126.86 -159.45 0.93 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.505 -0.747 . . . . 0.0 110.31 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.7 m -83.72 79.24 9.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.504 -0.747 . . . . 0.0 110.266 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 77.3 p -55.81 159.42 3.13 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.517 -0.74 . . . . 0.0 110.911 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -159.01 45.04 0.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.769 -0.582 . . . . 0.0 109.819 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 10.2 mt -59.64 105.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.512 -0.742 . . . . 0.0 110.117 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -112.61 -27.95 8.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.587 -0.696 . . . . 0.0 110.26 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 58.1 p -60.71 -71.61 0.13 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.592 -0.693 . . . . 0.0 110.281 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.5 p -147.89 115.91 6.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.619 -0.675 . . . . 0.0 110.243 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -105.86 157.22 17.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.581 -0.699 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.4 mm? -109.92 84.07 1.86 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.569 -0.707 . . . . 0.0 110.236 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 8.6 t -154.99 161.5 41.35 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.522 -0.736 . . . . 0.0 110.171 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -82.91 152.02 65.03 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.709 . . . . 0.0 110.319 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.93 120.3 6.56 Favored 'Trans proline' 0 C--N 1.317 -1.096 0 O-C-N 123.431 1.227 . . . . 0.0 110.37 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.725 ' O ' HD13 ' A' ' 435' ' ' ILE . 0.1 OUTLIER -84.55 -37.95 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.605 -0.685 . . . . 0.0 109.868 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 117.999 -1.0 . . . . 0.0 110.336 -179.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 20.2 mtt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.113 0.483 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 8.9 ptt85 -164.18 34.25 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.539 -0.726 . . . . 0.0 110.253 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -152.66 71.4 0.29 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 32.0 m -104.23 -35.41 8.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.524 -0.986 . . . . 0.0 110.169 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -138.29 35.04 2.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.498 -0.751 . . . . 0.0 110.331 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 24.2 t60 -106.19 -58.41 1.92 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.613 -0.68 . . . . 0.0 110.197 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -158.29 118.92 3.36 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.57 -0.706 . . . . 0.0 110.286 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -144.33 39.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -167.47 145.56 4.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.563 -0.71 . . . . 0.0 110.311 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -92.91 -42.22 9.61 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.598 -0.688 . . . . 0.0 110.254 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.3 -117.6 0.41 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.2 m -118.44 -158.62 0.72 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.633 -0.922 . . . . 0.0 110.187 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -78.21 146.44 34.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.562 -0.712 . . . . 0.0 110.207 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -154.84 49.59 0.58 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.55 -0.719 . . . . 0.0 110.142 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.09 55.97 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.088 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 3.9 t80 -112.44 71.94 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.489 -0.757 . . . . 0.0 110.311 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.21 143.53 10.81 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.532 HD21 ' O ' ' A' ' 322' ' ' ASP . 3.0 pp -145.99 159.76 42.8 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.621 -0.929 . . . . 0.0 110.063 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 1.2 p-90 -70.82 135.78 48.33 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.537 -0.727 . . . . 0.0 110.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.1 p -118.99 88.63 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.815 0.817 . . . . 0.0 110.055 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.27 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.57 -0.706 . . . . 0.0 109.962 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.62 -115.38 0.48 Allowed Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -123.81 21.66 9.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.58 -0.953 . . . . 0.0 110.824 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.453 ' SG ' HD13 ' A' ' 314' ' ' LEU . 47.2 t -89.2 128.06 35.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 110.189 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -69.44 171.18 9.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.72 -0.612 . . . . 0.0 110.282 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.532 ' O ' HD21 ' A' ' 314' ' ' LEU . 7.0 t70 -50.23 -25.65 3.89 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.498 -0.751 . . . . 0.0 111.152 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.2 tp -167.94 125.62 0.93 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.481 -0.762 . . . . 0.0 109.992 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.66 179.36 4.25 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 O-C-N 123.159 1.084 . . . . 0.0 110.354 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -124.05 89.7 3.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.551 -0.718 . . . . 0.0 110.597 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 412' ' ' PHE . 35.5 m -113.9 161.81 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.62 -0.675 . . . . 0.0 109.569 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -87.51 100.09 12.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.394 -0.816 . . . . 0.0 109.94 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -76.24 160.0 30.09 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.648 -0.657 . . . . 0.0 110.66 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.68 103.27 4.24 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.711 -0.618 . . . . 0.0 109.458 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.91 -51.73 0.14 Allowed 'Trans proline' 0 C--N 1.318 -1.073 0 O-C-N 123.258 1.136 . . . . 0.0 110.652 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.415 ' C ' HG23 ' A' ' 332' ' ' ILE . . . -73.42 151.34 41.18 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.46 -0.775 . . . . 0.0 110.281 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.474 ' O ' HD12 ' A' ' 332' ' ' ILE . 2.2 pp -146.34 25.06 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.569 -0.707 . . . . 0.0 110.476 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.9 -65.53 0.99 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.487 -0.758 . . . . 0.0 110.064 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.418 ' HA ' HD22 ' A' ' 334' ' ' LEU . 0.1 OUTLIER -90.15 -43.46 10.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.56 -0.713 . . . . 0.0 109.814 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -98.65 141.77 31.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.591 -0.693 . . . . 0.0 109.872 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -127.01 -170.81 2.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.503 -0.748 . . . . 0.0 110.554 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . 0.499 ' O ' HG21 ' A' ' 411' ' ' ILE . 4.4 m -72.05 -9.16 58.01 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.586 -0.696 . . . . 0.0 110.825 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -108.17 78.92 1.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.293 -0.879 . . . . 0.0 109.882 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.419 ' HB3' HD22 ' A' ' 340' ' ' LEU . 0.0 OUTLIER -130.15 -43.26 1.19 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.521 -0.737 . . . . 0.0 110.154 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.59 HD22 ' N ' ' A' ' 340' ' ' LEU . 3.8 mm? -74.96 144.14 43.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.532 -0.73 . . . . 0.0 109.313 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 395' ' ' LYS . 61.2 t -142.43 -41.23 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.273 -0.892 . . . . 0.0 111.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 386' ' ' LYS . 1.3 t80 -51.91 -46.4 64.61 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.314 -0.866 . . . . 0.0 111.41 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -93.8 21.69 6.29 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.482 -0.761 . . . . 0.0 110.736 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.847 HD11 ' CZ3' ' A' ' 399' ' ' TRP . 1.0 OUTLIER -103.84 5.22 35.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.419 -0.801 . . . . 0.0 111.262 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 12.6 p -50.99 -25.62 4.94 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.985 -1.072 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -77.62 -12.42 59.96 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.514 -0.741 . . . . 0.0 110.891 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.77 ' OG ' HG23 ' A' ' 426' ' ' ILE . 8.6 t -86.58 10.54 15.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.206 -0.934 . . . . 0.0 111.179 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.41 ' HB3' HD23 ' A' ' 431' ' ' LEU . 3.2 p30 -58.16 -23.11 54.12 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.098 -1.001 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -56.21 109.87 1.95 Allowed Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 121.412 -0.805 . . . . 0.0 110.528 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.73 159.91 47.47 Favored 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.196 1.103 . . . . 0.0 110.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.54 -74.38 0.61 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.547 -0.721 . . . . 0.0 110.314 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -92.48 -28.14 17.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.0 110.308 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -57.15 -26.14 60.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.567 -0.708 . . . . 0.0 110.553 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.487 ' HG3' HG21 ' A' ' 358' ' ' THR . 4.1 mp0 -122.76 81.8 1.91 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.534 -0.729 . . . . 0.0 110.192 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -60.67 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.601 -0.687 . . . . 0.0 110.254 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -59.07 -24.61 63.06 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.432 -0.793 . . . . 0.0 110.638 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -59.23 -37.02 76.51 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.457 -0.777 . . . . 0.0 110.279 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.487 HG21 ' HG3' ' A' ' 354' ' ' GLU . 3.7 m -103.97 -26.73 12.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.507 -0.746 . . . . 0.0 110.261 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 362' ' ' LYS . 3.0 t0 -59.7 -28.09 67.0 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.459 -0.776 . . . . 0.0 110.311 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.586 ' O ' HG22 ' A' ' 363' ' ' ILE . 7.5 m-85 -77.06 -4.67 45.51 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.545 -0.722 . . . . 0.0 111.072 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -91.19 -27.57 18.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.155 -0.966 . . . . 0.0 110.175 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 359' ' ' ASP . 14.7 mtpp -64.71 -25.62 68.02 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.607 -0.683 . . . . 0.0 110.594 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.586 HG22 ' O ' ' A' ' 360' ' ' TYR . 7.6 tp -57.89 -40.28 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.438 -0.789 . . . . 0.0 110.607 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.467 ' N ' HG23 ' A' ' 363' ' ' ILE . 3.0 ptmt -100.38 -18.77 16.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.641 -0.662 . . . . 0.0 110.681 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -102.8 20.51 17.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.366 -0.834 . . . . 0.0 110.625 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.02 -31.37 57.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -74.81 -14.41 60.69 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.53 -0.982 . . . . 0.0 111.105 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -69.58 -23.19 63.5 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.06 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -143.2 86.89 1.93 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 110.184 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -114.47 -30.34 6.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.612 -0.68 . . . . 0.0 110.35 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . 0.524 ' HB3' HD12 ' A' ' 375' ' ' ILE . 3.5 m-20 -69.96 -37.63 75.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.579 -0.701 . . . . 0.0 110.289 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.32 -25.64 65.94 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.642 -0.661 . . . . 0.0 110.504 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 1.4 t -105.29 -14.77 15.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.492 -0.755 . . . . 0.0 111.067 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -105.06 -37.76 6.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.266 -0.896 . . . . 0.0 110.926 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 371' ' ' ASN . 84.9 mt -96.21 -59.54 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.44 -0.787 . . . . 0.0 110.542 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -59.52 -30.43 68.58 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.622 -0.674 . . . . 0.0 110.493 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -26.46 27.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.568 -0.708 . . . . 0.0 110.349 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.0 -64.6 1.13 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.536 -0.727 . . . . 0.0 110.395 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -70.93 96.06 1.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.646 -0.659 . . . . 0.0 110.332 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 10.2 tp -75.64 -58.87 1.32 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.559 -0.713 . . . . 0.0 109.814 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.72 65.05 2.37 Favored 'Trans proline' 0 N--CA 1.486 1.08 0 O-C-N 123.02 1.01 . . . . 0.0 110.486 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 10.3 m -87.33 -29.55 21.49 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 110.253 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -168.69 87.26 0.09 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -58.89 -20.09 48.25 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.453 -1.028 . . . . 0.0 110.74 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.52 -25.12 59.39 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.359 -0.838 . . . . 0.0 110.486 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 342' ' ' PHE . 39.0 mmtt -78.47 -0.94 31.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.38 -0.825 . . . . 0.0 111.185 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.51 -12.26 61.0 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.135 -0.978 . . . . 0.0 111.015 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -55.0 -175.93 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.227 -0.92 . . . . 0.0 110.967 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.76 128.12 35.38 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.56 -0.713 . . . . 0.0 110.571 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -90.34 -173.1 3.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.556 -0.715 . . . . 0.0 110.362 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -119.01 145.78 45.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.588 -0.695 . . . . 0.0 110.243 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 5.3 p -90.45 58.29 3.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 110.479 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.43 -64.93 0.96 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.465 -0.772 . . . . 0.0 109.948 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -105.86 61.73 0.35 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.54 ' HB2' HG21 ' A' ' 341' ' ' VAL . 0.0 OUTLIER -112.15 4.42 17.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.575 -0.956 . . . . 0.0 110.527 -179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -96.51 51.62 1.56 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.72 ' HB2' HG23 ' A' ' 428' ' ' THR . 75.3 m-85 -139.58 -170.43 2.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.5 -1.0 . . . . 0.0 110.24 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -119.73 133.87 55.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.488 -0.758 . . . . 0.0 110.313 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.847 ' CZ3' HD11 ' A' ' 344' ' ' LEU . 65.1 p-90 -170.91 30.65 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.587 -0.696 . . . . 0.0 110.481 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.721 ' CA ' HG22 ' A' ' 411' ' ' ILE . . . -112.92 -175.94 19.5 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 120.01 -1.09 . . . . 0.0 110.417 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -111.77 129.18 56.21 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.735 -0.862 . . . . 0.0 110.089 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 408' ' ' LYS . 7.1 m-85 -126.94 97.46 4.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.539 -0.725 . . . . 0.0 110.489 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.4 ' HB2' ' CB ' ' A' ' 422' ' ' ASN . 3.1 t30 -151.65 89.13 1.46 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.565 -0.709 . . . . 0.0 110.036 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 8.9 m -151.96 167.1 29.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.583 -0.698 . . . . 0.0 110.393 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -75.71 -35.07 60.37 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.592 ' O ' HG23 ' A' ' 406' ' ' THR . 5.1 t -114.51 86.41 2.43 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 406' ' ' THR . 51.7 tt0 2.06 80.13 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 402' ' ' TYR . 22.7 ttpt -101.61 169.2 8.99 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.347 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 5.9 t -129.14 125.05 36.25 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.642 -0.661 . . . . 0.0 109.314 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.58 135.94 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.492 -0.755 . . . . 0.0 110.359 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.721 HG22 ' CA ' ' A' ' 400' ' ' GLY . 2.5 pp -143.84 161.63 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.472 -0.768 . . . . 0.0 110.627 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 326' ' ' VAL . 33.7 t80 -168.16 -87.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -174.49 -165.57 0.22 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.092 -1.005 . . . . 0.0 109.96 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.83 148.44 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.561 -0.712 . . . . 0.0 109.751 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.64 109.96 2.05 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 121.503 -0.748 . . . . 0.0 110.684 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -79.63 -51.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.964 0 O-C-N 123.042 1.022 . . . . 0.0 110.212 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.467 HG23 ' N ' ' A' ' 418' ' ' CYS . 8.8 t -131.93 -40.61 1.05 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.722 -0.611 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.467 ' N ' HG23 ' A' ' 417' ' ' THR . 1.8 t -100.22 -179.99 4.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.0 109.643 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.508 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.2 pp -150.33 135.61 17.95 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.478 -0.764 . . . . 0.0 110.637 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.7 tt -126.99 132.26 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.635 -0.665 . . . . 0.0 109.776 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -86.39 95.99 9.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.504 -0.748 . . . . 0.0 110.559 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . 0.4 ' CB ' ' HB2' ' A' ' 403' ' ' ASN . 60.1 m-20 -132.5 169.44 16.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.544 -0.722 . . . . 0.0 110.045 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 73.0 m -63.0 87.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.408 -0.807 . . . . 0.0 109.791 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.6 p -87.96 146.44 25.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.606 -0.684 . . . . 0.0 110.616 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.75 39.75 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.658 -0.651 . . . . 0.0 109.757 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.77 HG23 ' OG ' ' A' ' 347' ' ' SER . 7.7 mt -56.7 108.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 110.554 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -170.4 43.27 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.588 -0.695 . . . . 0.0 110.098 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.72 HG23 ' HB2' ' A' ' 397' ' ' TYR . 27.1 m -72.68 -65.85 0.74 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.712 . . . . 0.0 110.303 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.603 HG23 ' O ' ' A' ' 428' ' ' THR . 2.0 p -157.56 136.75 11.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.579 -0.701 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -77.86 -170.33 1.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.602 -0.686 . . . . 0.0 110.111 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 348' ' ' ASP . 1.0 OUTLIER -104.37 105.28 15.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.133 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -113.52 -28.98 7.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.609 -0.682 . . . . 0.0 110.282 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 22.3 m-70 -122.4 160.38 48.42 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.62 -0.675 . . . . 0.0 110.236 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.52 -171.03 0.66 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.468 1.247 . . . . 0.0 110.396 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -82.67 -29.32 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 0.0 109.976 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.047 -0.977 . . . . 0.0 110.212 179.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.096 0.474 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 15.3 mtt85 -85.7 156.88 20.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 0.0 110.202 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -142.15 -88.24 0.11 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 1.2 m -141.47 -50.95 0.42 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.942 . . . . 0.0 110.156 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -168.26 45.76 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.552 -0.717 . . . . 0.0 110.236 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -84.73 90.48 7.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.678 . . . . 0.0 110.305 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -118.45 -59.0 1.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.639 -0.663 . . . . 0.0 110.264 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 27.9 p80 -151.11 -175.39 5.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.56 -0.712 . . . . 0.0 110.307 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . 0.402 ' O ' ' CD2' ' A' ' -4' ' ' HIS . 4.9 p-80 -66.58 150.17 49.39 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.573 -0.704 . . . . 0.0 110.352 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -82.55 -28.65 30.86 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.622 -0.674 . . . . 0.0 110.311 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -63.45 110.35 3.33 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 6.9 t -91.92 -46.67 7.71 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.601 -0.941 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -83.91 -21.8 31.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.588 -0.695 . . . . 0.0 110.514 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.618 ' N ' HG21 ' A' ' 417' ' ' THR . . . -55.97 107.42 0.35 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.342 -0.848 . . . . 0.0 110.599 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -104.72 -157.45 0.61 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.64 -0.662 . . . . 0.0 110.165 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.426 ' HA ' ' HB3' ' A' ' 322' ' ' ASP . 36.1 t80 -90.23 55.75 3.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.57 -0.706 . . . . 0.0 110.068 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -151.13 64.99 0.38 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.816 HD11 ' HB2' ' A' ' 322' ' ' ASP . 0.4 OUTLIER -151.01 147.34 27.01 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.42 -1.047 . . . . 0.0 110.354 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.406 ' CG ' ' O ' ' A' ' 419' ' ' LEU . 0.2 OUTLIER -56.18 170.43 0.33 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.45 -0.781 . . . . 0.0 111.06 -179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 63.8 t -115.02 89.69 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.771 -0.581 . . . . 0.0 109.824 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -169.4 -62.69 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.511 -0.743 . . . . 0.0 110.486 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -63.17 -111.7 0.01 OUTLIER Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -119.01 41.5 3.04 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.547 -0.973 . . . . 0.0 109.687 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.808 ' SG ' HD22 ' A' ' 314' ' ' LEU . 39.0 m -148.9 127.36 12.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.851 -0.531 . . . . 0.0 109.956 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -131.04 89.12 2.69 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.381 -0.824 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.816 ' HB2' HD11 ' A' ' 314' ' ' LEU . 6.8 m-20 -172.84 132.78 0.55 Allowed 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 323' ' ' ILE . 21.9 mm -144.01 121.06 6.57 Favored Pre-proline 0 N--CA 1.504 2.237 0 O-C-N 120.973 -1.08 . . . . 0.0 111.213 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -87.11 -165.01 0.22 Allowed 'Trans proline' 0 N--CA 1.482 0.818 0 O-C-N 123.344 1.181 . . . . 0.0 109.878 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -97.75 89.59 4.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.588 -0.695 . . . . 0.0 109.726 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.697 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -79.84 160.62 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.496 -0.752 . . . . 0.0 110.433 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -89.58 128.89 36.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.871 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -106.82 146.98 30.27 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.534 -0.729 . . . . 0.0 110.741 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -123.83 91.8 49.25 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.662 -0.649 . . . . 0.0 109.975 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -88.16 15.35 2.12 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 O-C-N 123.372 1.196 . . . . 0.0 111.28 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -59.54 175.16 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.136 -0.978 . . . . 0.0 110.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 27.4 pt -106.98 27.91 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.648 -0.657 . . . . 0.0 110.27 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.01 115.03 28.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.566 -0.709 . . . . 0.0 110.183 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 2.5 mt -96.88 79.62 2.94 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.537 -0.727 . . . . 0.0 110.28 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.0 -64.53 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.612 -0.68 . . . . 0.0 109.976 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.71 111.55 3.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.632 -0.667 . . . . 0.0 109.786 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.74 -25.34 64.77 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.708 . . . . 0.0 110.558 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -92.41 47.86 1.35 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.522 -0.736 . . . . 0.0 110.475 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.94 39.69 1.21 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.516 -0.74 . . . . 0.0 109.89 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 6.5 mt -107.26 154.74 20.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.569 -0.707 . . . . 0.0 110.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 35.4 m -111.11 27.8 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.586 -0.696 . . . . 0.0 110.272 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -169.61 34.57 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.58 -0.7 . . . . 0.0 109.765 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -59.55 -176.83 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.582 -0.699 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 344' ' ' LEU . 0.6 OUTLIER -59.14 -19.65 46.73 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.578 -0.701 . . . . 0.0 110.884 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.2 t -64.59 -46.63 81.86 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.37 -0.831 . . . . 0.0 110.622 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.14 17.53 23.91 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.509 -0.744 . . . . 0.0 110.948 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 53.3 p -90.14 -36.18 14.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.238 -0.914 . . . . 0.0 110.459 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -43.97 5.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.504 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -130.74 160.49 66.2 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.537 -0.727 . . . . 0.0 110.416 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.55 144.82 40.94 Favored 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.46 1.242 . . . . 0.0 110.144 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 15.3 mmtt -120.23 160.68 22.47 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 110.556 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -75.52 -19.39 59.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.7 -0.625 . . . . 0.0 110.47 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -52.86 -24.12 8.44 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.282 -0.886 . . . . 0.0 110.906 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -89.58 49.66 1.78 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.516 -0.74 . . . . 0.0 110.195 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -81.49 106.33 13.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -109.65 -26.34 9.94 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.599 -0.688 . . . . 0.0 110.466 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.459 ' N ' HD12 ' A' ' 357' ' ' LEU . 8.8 mp -57.83 -27.1 62.87 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.423 -0.798 . . . . 0.0 110.465 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 11.9 m -63.04 -25.81 68.55 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.617 -0.677 . . . . 0.0 110.36 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.02 -28.69 66.65 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.486 -0.759 . . . . 0.0 110.429 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -66.11 -14.43 61.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.638 -0.664 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -72.16 -13.96 61.69 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.235 -0.915 . . . . 0.0 110.664 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -77.63 1.08 20.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.348 -0.845 . . . . 0.0 111.743 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 68.4 mt -60.41 -28.11 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.986 -1.071 . . . . 0.0 110.117 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -73.83 -23.3 59.62 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.527 -0.733 . . . . 0.0 110.59 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -103.2 20.82 16.97 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.4 -0.812 . . . . 0.0 110.64 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -82.17 -29.1 38.47 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -98.59 20.54 12.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.551 -0.97 . . . . 0.0 111.053 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 2.9 mmmm -87.99 -26.15 22.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 41.5 p-10 -86.9 61.59 6.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.594 -0.691 . . . . 0.0 110.656 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -72.55 162.34 29.6 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.091 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -80.64 -21.49 41.41 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.641 -0.662 . . . . 0.0 110.554 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.02 64.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 69.8 m -105.63 6.47 32.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.651 -0.656 . . . . 0.0 110.984 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 10.0 ttp -105.39 0.73 27.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.177 -0.952 . . . . 0.0 111.419 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -138.49 -77.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 O-C-N 121.099 -1.0 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 12.0 mmmt -54.16 -27.22 32.3 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.253 -0.905 . . . . 0.0 110.432 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.6 m -114.55 -124.24 0.29 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.606 -0.684 . . . . 0.0 109.51 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -165.21 109.83 0.89 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.602 -1.312 . . . . 0.0 110.27 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -92.74 -24.68 18.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.621 -0.674 . . . . 0.0 110.559 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.632 ' C ' HD22 ' A' ' 380' ' ' LEU . 0.0 OUTLIER -151.66 157.67 34.5 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.531 -0.731 . . . . 0.0 110.932 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.1 -47.49 0.19 Allowed 'Trans proline' 0 C--N 1.319 -1.019 0 O-C-N 123.263 1.138 . . . . 0.0 110.548 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 11.4 m -154.89 -43.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.72 -0.613 . . . . 0.0 110.539 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -154.72 67.25 0.31 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -82.97 -14.62 53.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.576 -0.955 . . . . 0.0 110.639 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -56.89 -31.28 64.7 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.256 -0.902 . . . . 0.0 110.368 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -83.52 -24.69 31.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.666 -0.646 . . . . 0.0 110.245 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.2 -11.82 58.41 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.546 -0.721 . . . . 0.0 110.575 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.49 -153.44 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.344 -0.847 . . . . 0.0 110.276 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -50.65 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.226 -0.921 . . . . 0.0 111.38 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -72.96 148.88 43.84 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.736 -0.602 . . . . 0.0 110.366 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -55.46 164.11 1.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.557 -0.715 . . . . 0.0 110.915 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 46.2 m -78.44 58.5 2.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.465 -0.772 . . . . 0.0 110.675 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.434 ' CD2' ' N ' ' A' ' 394' ' ' GLY . 32.7 p-80 -83.42 -39.65 20.33 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.632 -0.667 . . . . 0.0 110.027 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.434 ' N ' ' CD2' ' A' ' 393' ' ' HIS . . . -127.45 53.77 0.79 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.7 173.66 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.647 -0.914 . . . . 0.0 110.828 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -99.07 30.83 9.07 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.46 ' HB3' HG22 ' A' ' 428' ' ' THR . 45.1 m-85 -122.84 73.92 1.17 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.615 -0.932 . . . . 0.0 109.948 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -79.81 156.82 27.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.569 -0.707 . . . . 0.0 110.269 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.406 ' CD1' ' N ' ' A' ' 399' ' ' TRP . 31.4 p-90 -168.25 42.13 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.66 -0.65 . . . . 0.0 110.074 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.667 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -127.1 -166.16 12.08 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -130.38 143.03 50.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.636 -0.92 . . . . 0.0 110.143 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 59.2 m-85 -129.89 112.55 13.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.512 -0.743 . . . . 0.0 110.49 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -106.31 121.24 43.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.572 -0.705 . . . . 0.0 109.63 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 35.8 p -89.79 84.87 6.29 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.588 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -121.81 -66.27 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.465 0.65 . . . . 0.0 109.296 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 56.8 p -121.51 -74.19 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.364 0.602 . . . . 0.0 109.595 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -173.33 69.33 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.543 -0.723 . . . . 0.0 109.654 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -150.3 150.69 31.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.412 -0.805 . . . . 0.0 110.82 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 42.0 t -130.52 157.15 43.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.767 -0.583 . . . . 0.0 109.47 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.403 ' C ' HG23 ' A' ' 411' ' ' ILE . 6.1 pt-20 -150.81 156.33 41.04 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.386 -0.821 . . . . 0.0 111.22 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.667 HG22 ' HA3' ' A' ' 400' ' ' GLY . 2.5 pp -146.9 161.36 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.754 -0.591 . . . . 0.0 110.036 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.697 ' CG ' HG12 ' A' ' 326' ' ' VAL . 38.2 t80 -165.49 -68.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.396 -0.815 . . . . 0.0 110.66 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -168.17 -157.29 0.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.419 -0.8 . . . . 0.0 110.373 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.579 HG12 HG21 ' A' ' 426' ' ' ILE . 34.4 m -90.69 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.692 . . . . 0.0 110.448 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -133.57 87.85 35.75 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.534 -0.729 . . . . 0.0 110.209 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -80.64 -38.35 0.29 Allowed 'Trans proline' 0 C--N 1.318 -1.079 0 O-C-N 123.313 1.165 . . . . 0.0 111.27 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.618 HG21 ' N ' ' A' ' 310' ' ' ALA . 11.1 p -79.02 -81.47 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.31 -0.869 . . . . 0.0 110.987 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.5 m -103.19 -169.94 1.72 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.919 . . . . 0.0 109.991 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.43 HD23 ' N ' ' A' ' 419' ' ' LEU . 0.6 OUTLIER -127.79 153.89 46.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.698 . . . . 0.0 110.296 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 79.4 mt -110.72 -30.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.516 -0.74 . . . . 0.0 110.024 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -131.24 173.53 10.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.59 -0.693 . . . . 0.0 110.555 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.72 -69.31 0.27 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.632 . . . . 0.0 110.394 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.7 m -88.06 144.25 26.62 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.555 -0.716 . . . . 0.0 110.374 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 49.0 m -138.28 64.41 1.5 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.678 -0.639 . . . . 0.0 109.986 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -65.15 98.15 0.29 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.593 -0.692 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.579 HG21 HG12 ' A' ' 414' ' ' VAL . 77.8 mt -127.1 121.09 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.626 -0.671 . . . . 0.0 110.138 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -161.74 40.48 0.14 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.644 -0.66 . . . . 0.0 110.205 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 397' ' ' TYR . 5.9 p -76.44 -56.91 4.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.558 -0.714 . . . . 0.0 110.038 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 43.3 p -127.38 121.97 32.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.59 -0.694 . . . . 0.0 110.26 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -103.69 -46.92 4.39 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.594 -0.691 . . . . 0.0 110.139 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 3.2 pp -64.05 146.61 53.85 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.185 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 10.2 t -152.9 -44.56 0.1 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.621 -0.675 . . . . 0.0 110.246 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -127.49 105.19 21.41 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.616 -0.678 . . . . 0.0 109.454 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.83 172.15 15.93 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.352 1.185 . . . . 0.0 110.19 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.1 tt -100.87 46.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.46 -0.775 . . . . 0.0 110.128 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 . . . . . 0 N--CA 1.501 2.087 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.883 -179.998 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 15.4 mmm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.107 0.48 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -130.61 -54.93 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.473 -0.767 . . . . 0.0 110.315 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.68 -45.48 0.02 OUTLIER Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 93.0 p -75.38 142.73 43.05 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.484 -1.01 . . . . 0.0 110.126 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -92.96 -173.24 3.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 110.25 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.7 t60 -128.16 45.93 2.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.238 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -152.15 47.75 0.77 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.211 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -88.63 -49.14 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.615 -0.678 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -142.01 -66.71 0.4 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.638 -0.664 . . . . 0.0 110.162 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -161.21 -174.62 4.42 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.597 -0.689 . . . . 0.0 110.283 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -118.61 64.67 0.4 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.2 m -136.63 127.3 27.11 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.6 -0.941 . . . . 0.0 110.285 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -152.14 -179.38 7.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.659 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -104.42 118.24 36.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.559 -0.713 . . . . 0.0 110.151 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -168.73 -41.34 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.591 -0.693 . . . . 0.0 110.012 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -89.71 -154.2 0.31 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.613 -0.68 . . . . 0.0 109.604 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -115.2 56.98 0.49 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.668 HD22 ' SG ' ' A' ' 320' ' ' CYS . 88.8 mt -111.39 137.78 48.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.563 -0.963 . . . . 0.0 110.256 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.821 ' CE3' HD21 ' A' ' 419' ' ' LEU . 0.2 OUTLIER -66.9 170.01 7.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.537 -0.727 . . . . 0.0 110.378 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 316' ' ' VAL . 28.3 m -126.54 89.63 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.613 -0.679 . . . . 0.0 110.234 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -145.72 -67.21 0.3 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.342 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -91.23 -104.31 1.34 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -151.05 95.1 2.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.756 -0.849 . . . . 0.0 110.167 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.668 ' SG ' HD22 ' A' ' 314' ' ' LEU . 52.8 t -89.95 158.17 17.51 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.662 0.744 . . . . 0.0 110.413 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -130.35 170.64 13.89 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -56.31 117.27 3.64 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.373 -0.83 . . . . 0.0 110.649 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.667 ' CD1' HD21 ' A' ' 314' ' ' LEU . 87.6 mt -69.17 120.49 76.99 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.483 -0.76 . . . . 0.0 109.827 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -72.37 -86.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.959 0 O-C-N 123.175 1.092 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 13.8 t60 -145.74 123.11 11.64 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.983 -1.073 . . . . 0.0 110.504 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.509 HG12 ' CD1' ' A' ' 412' ' ' PHE . 34.6 m -79.85 160.06 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.497 -0.752 . . . . 0.0 109.85 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.48 ' CB ' HD11 ' A' ' 411' ' ' ILE . 6.5 m-20 -89.66 131.04 35.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.518 -0.739 . . . . 0.0 110.299 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -98.05 140.51 32.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.695 . . . . 0.0 110.557 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 331' ' ' ALA . 0.7 OUTLIER -116.12 92.66 36.28 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 110.228 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.95 63.95 6.81 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.377 1.198 . . . . 0.0 110.479 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.557 ' O ' HD13 ' A' ' 332' ' ' ILE . . . -150.65 119.74 6.73 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.437 -0.789 . . . . 0.0 110.415 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.557 HD13 ' O ' ' A' ' 331' ' ' ALA . 49.3 mm -134.96 62.29 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.58 -0.7 . . . . 0.0 109.927 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -105.87 -63.25 1.27 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.605 -0.685 . . . . 0.0 110.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -154.05 -64.65 0.14 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.591 -0.693 . . . . 0.0 110.032 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 335' ' ' PHE . 49.7 p90 -51.62 135.07 29.22 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.56 -0.713 . . . . 0.0 110.912 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -62.54 -174.96 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.562 -0.711 . . . . 0.0 110.419 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 80.5 m -95.13 26.25 3.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.46 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -128.15 27.9 5.58 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.437 -0.789 . . . . 0.0 110.249 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -103.68 43.52 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.526 -0.734 . . . . 0.0 110.436 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.773 HD22 HD13 ' A' ' 344' ' ' LEU . 1.9 mp -88.08 138.39 31.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.604 -0.685 . . . . 0.0 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.7 p -139.47 50.75 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.587 -0.695 . . . . 0.0 109.978 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -128.61 -63.23 0.99 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.581 -0.699 . . . . 0.0 110.212 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -135.79 10.91 3.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.509 -0.745 . . . . 0.0 110.968 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.773 HD13 HD22 ' A' ' 340' ' ' LEU . 0.3 OUTLIER -103.34 -32.58 9.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.277 -0.889 . . . . 0.0 110.108 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.3 t -67.65 -35.45 78.91 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.551 -0.718 . . . . 0.0 110.221 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.75 17.53 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.592 -0.693 . . . . 0.0 110.643 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 61.6 p -65.82 -53.85 34.57 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.303 -0.873 . . . . 0.0 110.161 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -104.64 -39.41 6.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.635 -0.665 . . . . 0.0 110.377 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -168.73 149.03 4.12 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.622 -0.674 . . . . 0.0 110.187 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.18 -165.08 0.24 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.434 1.229 . . . . 0.0 110.402 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -77.75 -173.82 3.2 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.524 -0.735 . . . . 0.0 110.13 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.455 ' O ' ' N ' ' A' ' 354' ' ' GLU . 0.4 OUTLIER -144.39 -75.2 0.24 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.568 -0.707 . . . . 0.0 110.478 -179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.437 ' C ' ' O ' ' A' ' 352' ' ' GLN . 16.1 m-85 3.78 63.23 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 352' ' ' GLN . 51.6 mt-10 2.1 69.45 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.034 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -114.88 -38.37 3.94 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.578 -0.701 . . . . 0.0 110.384 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -110.24 -61.69 1.62 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.489 -0.757 . . . . 0.0 110.445 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 358' ' ' THR . 1.4 pp -51.13 -50.0 59.7 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.463 -0.773 . . . . 0.0 111.5 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.645 ' N ' HD12 ' A' ' 357' ' ' LEU . 89.0 m -59.37 -19.07 44.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.447 -0.783 . . . . 0.0 110.794 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -61.15 -16.63 46.63 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.249 -0.907 . . . . 0.0 111.272 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -56.41 -31.67 64.1 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.111 -0.993 . . . . 0.0 110.75 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.36 6.15 49.76 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.556 -0.715 . . . . 0.0 111.201 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 49.2 mttt -89.36 -29.09 19.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.165 -0.96 . . . . 0.0 110.127 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 45.0 pt -58.55 -27.95 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.57 -0.706 . . . . 0.0 110.363 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -96.87 -20.38 18.19 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.625 -0.672 . . . . 0.0 110.549 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.457 ' O ' ' N ' ' A' ' 367' ' ' PHE . 4.1 tp10 -68.54 -36.35 78.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.366 -0.834 . . . . 0.0 110.43 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 2.45 63.18 0.0 OUTLIER Glycine 1 N--CA 1.521 4.367 0 C-N-CA 124.398 0.999 . . . . 0.0 114.143 -179.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 379' ' ' PHE . 26.3 p90 -84.99 9.46 14.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.762 -0.846 . . . . 0.0 111.323 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -61.31 -35.09 76.43 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.09 -1.006 . . . . 0.0 109.869 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -101.74 28.32 5.73 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.734 -0.604 . . . . 0.0 110.209 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 4.6 mtpp -115.04 144.86 42.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.562 -0.711 . . . . 0.0 110.235 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -100.07 -28.21 13.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.612 -0.68 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -50.82 -26.1 5.3 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.353 -0.842 . . . . 0.0 111.056 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . 0.584 ' HA ' ' HB3' ' A' ' 378' ' ' ALA . 44.4 t -104.53 -23.54 13.12 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.53 -0.731 . . . . 0.0 110.614 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -85.54 9.63 15.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.245 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 73.3 mt -112.66 -70.1 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.072 -1.018 . . . . 0.0 110.367 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.64 -79.56 0.35 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.518 -0.739 . . . . 0.0 110.862 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.2 t -178.67 44.78 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.037 -1.04 . . . . 0.0 110.592 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.584 ' HB3' ' HA ' ' A' ' 373' ' ' SER . . . -61.16 -54.62 42.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.14 -0.975 . . . . 0.0 109.986 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.478 ' CE2' ' CE2' ' A' ' 367' ' ' PHE . 0.8 OUTLIER -108.1 86.47 2.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 0.0 109.809 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 6.8 mp -50.5 107.1 0.73 Allowed Pre-proline 0 N--CA 1.502 2.146 0 O-C-N 121.544 -0.722 . . . . 0.0 111.23 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -82.88 56.35 5.59 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 O-C-N 123.179 1.094 . . . . 0.0 110.487 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.6 t -107.0 39.43 1.87 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.447 -0.783 . . . . 0.0 110.408 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -132.35 31.47 2.99 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -84.87 -28.46 26.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.66 -0.906 . . . . 0.0 110.325 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -60.89 -32.9 72.34 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.625 -0.672 . . . . 0.0 110.138 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -59.77 -20.21 55.21 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.646 -0.659 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -67.97 -10.45 53.6 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.416 -0.803 . . . . 0.0 111.038 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -49.74 153.5 1.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.133 -0.979 . . . . 0.0 111.384 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 77.3 mmt-85 -78.21 -16.05 58.23 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.683 -0.635 . . . . 0.0 110.673 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -49.86 106.03 0.1 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.271 -0.893 . . . . 0.0 111.076 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -21.54 34.68 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.668 -0.645 . . . . 0.0 110.666 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 33.3 t -83.41 56.42 3.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.385 -0.822 . . . . 0.0 110.311 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -113.9 -33.66 5.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 109.923 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -88.45 -29.96 17.62 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.66 86.04 4.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.979 . . . . 0.0 110.079 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -89.77 -27.9 20.4 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.402 ' CG ' ' O ' ' A' ' 427' ' ' ALA . 48.8 m-85 -94.06 151.45 19.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.953 . . . . 0.0 110.419 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 29.6 m-20 -100.97 156.72 17.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.622 -0.674 . . . . 0.0 110.08 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.528 ' CH2' HD22 ' A' ' 344' ' ' LEU . 58.8 p-90 -151.89 37.93 0.58 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.609 -0.682 . . . . 0.0 110.128 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -126.01 150.69 17.64 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -108.61 154.01 22.58 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.425 -1.044 . . . . 0.0 110.52 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -129.29 147.61 51.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.679 . . . . 0.0 110.253 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.32 118.45 26.78 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 62.0 p -89.89 84.51 6.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 110.985 -178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -122.41 -67.09 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 94.1 m -122.34 -68.03 0.92 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.49 0.662 . . . . 0.0 109.249 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -176.58 72.88 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -149.95 149.45 30.42 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.39 -0.818 . . . . 0.0 111.0 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.426 ' HB2' HD11 ' A' ' 332' ' ' ILE . 42.7 t -119.37 161.87 19.76 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -148.02 161.27 41.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.395 -0.816 . . . . 0.0 110.751 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 327' ' ' ASN . 2.1 pp -144.17 172.96 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.603 -0.685 . . . . 0.0 110.213 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.64 ' CE1' HG21 ' A' ' 414' ' ' VAL . 83.9 t80 -168.22 84.99 0.19 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.523 -0.735 . . . . 0.0 109.373 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -94.23 29.68 2.12 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.572 -0.705 . . . . 0.0 111.1 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.64 HG21 ' CE1' ' A' ' 412' ' ' PHE . 61.3 t -61.96 169.83 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.394 -0.816 . . . . 0.0 109.39 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.481 ' N ' HG12 ' A' ' 414' ' ' VAL . 25.7 mttt -49.15 149.36 3.59 Favored Pre-proline 0 N--CA 1.505 2.277 0 O-C-N 121.3 -0.875 . . . . 0.0 111.094 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.74 116.66 4.79 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 O-C-N 123.449 1.236 . . . . 0.0 110.451 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 418' ' ' CYS . 7.4 t -168.6 -40.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.626 -0.671 . . . . 0.0 110.382 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.475 ' N ' HG23 ' A' ' 417' ' ' THR . 38.6 t -137.65 161.64 35.94 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.473 -0.767 . . . . 0.0 110.492 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.821 HD21 ' CE3' ' A' ' 315' ' ' TRP . 3.1 pp -138.73 124.51 19.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.745 -0.597 . . . . 0.0 109.959 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.471 HG23 ' ND2' ' A' ' 422' ' ' ASN . 9.9 tt -79.78 165.26 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.456 -0.778 . . . . 0.0 110.456 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -85.33 91.79 8.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.539 -0.726 . . . . 0.0 110.281 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . 0.471 ' ND2' HG23 ' A' ' 420' ' ' ILE . 42.6 p30 -142.52 170.37 15.82 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.553 -0.717 . . . . 0.0 109.738 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.1 m -82.36 80.95 8.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.486 -0.759 . . . . 0.0 109.829 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 40.5 p -126.74 -164.01 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.614 -0.679 . . . . 0.0 110.582 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -168.08 56.16 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.712 -0.617 . . . . 0.0 109.744 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 57.3 mt -61.15 92.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.635 -0.666 . . . . 0.0 110.117 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.402 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -113.75 25.24 11.38 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.697 -0.627 . . . . 0.0 110.282 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 68.2 p -86.5 -53.32 5.05 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.47 -0.769 . . . . 0.0 110.164 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.603 ' O ' HG23 ' A' ' 429' ' ' THR . 6.1 t -168.15 89.62 0.27 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.468 -0.77 . . . . 0.0 110.219 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -171.25 -165.48 0.41 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.47 -0.769 . . . . 0.0 110.093 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 431' ' ' LEU . 0.7 OUTLIER -98.23 125.9 43.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.649 -0.657 . . . . 0.0 110.008 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 49.8 m -118.65 164.49 15.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.539 -0.726 . . . . 0.0 110.299 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -102.79 102.67 28.32 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.614 -0.679 . . . . 0.0 110.16 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.9 -12.73 28.76 Favored 'Trans proline' 0 N--CA 1.486 1.061 0 O-C-N 123.254 1.134 . . . . 0.0 111.247 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 9.3 mt -58.55 -52.84 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.218 -0.926 . . . . 0.0 110.301 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.465 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.065 0.459 . . . . 0.0 110.236 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.33 -37.75 3.7 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.571 -0.706 . . . . 0.0 110.161 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -68.45 -36.48 84.0 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 22.6 t -116.01 -173.09 2.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.618 -0.931 . . . . 0.0 110.21 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 14.3 m-70 -138.16 -168.25 2.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.558 -0.713 . . . . 0.0 110.159 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -113.42 -170.97 1.79 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.287 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -60.01 131.53 51.14 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.581 -0.699 . . . . 0.0 110.389 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -62.82 179.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.566 -0.709 . . . . 0.0 110.194 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -90.25 162.62 15.13 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.56 -0.713 . . . . 0.0 110.152 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -107.38 -178.7 3.71 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.59 -0.693 . . . . 0.0 110.239 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -177.81 173.78 46.32 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 38.4 m -132.33 131.32 41.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.572 -0.958 . . . . 0.0 110.253 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . 0.54 ' HA ' HG21 ' A' ' 417' ' ' THR . 8.5 p30 -112.91 -28.58 7.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.525 -0.735 . . . . 0.0 110.34 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.24 115.14 19.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.576 -0.703 . . . . 0.0 110.257 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -127.71 -172.4 2.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.639 -0.663 . . . . 0.0 110.194 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.435 ' HA ' HD11 ' A' ' 323' ' ' ILE . 34.1 t80 -114.0 25.53 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.547 -0.721 . . . . 0.0 110.463 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.541 ' C ' HD13 ' A' ' 314' ' ' LEU . . . -150.38 92.82 0.14 Allowed Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.743 ' N ' HD13 ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.95 160.32 43.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.582 -0.952 . . . . 0.0 110.82 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.732 ' CH2' HD11 ' A' ' 419' ' ' LEU . 0.1 OUTLIER -88.6 170.07 11.16 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.515 -0.741 . . . . 0.0 110.36 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 67.5 t -122.03 94.0 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.537 -0.727 . . . . 0.0 110.071 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -168.79 -41.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.718 . . . . 0.0 110.284 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -90.58 -89.68 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -139.99 36.29 1.95 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.95 . . . . 0.0 110.294 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.1 112.15 13.69 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.538 -0.726 . . . . 0.0 110.095 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -130.12 108.28 9.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.537 -0.727 . . . . 0.0 110.313 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.823 ' HB3' HD13 ' A' ' 323' ' ' ILE . 0.3 OUTLIER -158.7 -83.9 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.581 -0.7 . . . . 0.0 109.995 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.823 HD13 ' HB3' ' A' ' 322' ' ' ASP . 0.1 OUTLIER -151.6 86.21 4.71 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.098 -1.002 . . . . 0.0 110.68 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.08 107.94 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.165 1.087 . . . . 0.0 110.378 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . 0.424 ' CD2' ' HD3' ' A' ' 351' ' ' LYS . 0.7 OUTLIER -145.4 107.48 4.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.5 -0.75 . . . . 0.0 110.46 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.745 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.3 m -127.64 160.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.484 -0.76 . . . . 0.0 110.405 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -90.92 132.39 35.97 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.703 . . . . 0.0 110.181 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -90.91 160.13 15.84 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.61 -0.681 . . . . 0.0 110.289 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.13 106.55 6.17 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 110.148 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.19 68.18 2.56 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 O-C-N 123.22 1.116 . . . . 0.0 110.037 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -64.13 82.74 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.647 -0.658 . . . . 0.0 110.653 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 89.0 mt -96.5 -31.31 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.56 -0.713 . . . . 0.0 109.527 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -88.5 -146.97 0.15 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.626 -0.671 . . . . 0.0 109.712 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 39.8 mt -54.63 146.58 16.28 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.999 -1.063 . . . . 0.0 110.598 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.43 116.33 11.64 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.553 -0.717 . . . . 0.0 110.329 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -169.42 58.73 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.66 -0.65 . . . . 0.0 110.259 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 75.8 m -60.94 -29.44 69.63 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.454 -0.779 . . . . 0.0 110.159 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -60.46 -25.03 65.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.533 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 11.0 tttt -79.13 124.49 28.36 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.356 -0.84 . . . . 0.0 110.134 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 340' ' ' LEU . 1.6 mm? -114.78 146.69 40.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.542 -0.724 . . . . 0.0 110.195 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 342' ' ' PHE . 33.6 m -58.5 -37.7 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.607 -0.683 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.429 ' N ' HG23 ' A' ' 341' ' ' VAL . 1.7 m-85 -149.06 -64.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.465 -0.772 . . . . 0.0 110.223 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -167.52 -167.17 0.85 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.639 -0.663 . . . . 0.0 110.342 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.548 HD22 ' HZ3' ' A' ' 399' ' ' TRP . 3.0 tp -90.75 5.14 49.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.514 -0.742 . . . . 0.0 110.88 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.4 m -52.14 -28.56 18.41 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.105 -0.997 . . . . 0.0 110.55 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.69 -27.79 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.719 -0.613 . . . . 0.0 109.767 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 6.2 t -87.71 10.3 18.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.577 -0.702 . . . . 0.0 110.943 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -96.52 8.64 43.62 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.238 -0.914 . . . . 0.0 111.1 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -56.82 149.55 42.38 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.39 118.91 5.82 Favored 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.514 1.271 . . . . 0.0 110.578 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . 0.424 ' HD3' ' CD2' ' A' ' 325' ' ' HIS . 5.0 mtpt -124.67 -64.64 1.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.605 -0.685 . . . . 0.0 110.087 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -144.61 91.79 2.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.099 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 353' ' ' TYR . 32.0 p90 -140.31 24.77 2.29 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.518 -0.739 . . . . 0.0 110.583 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -169.79 33.05 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.433 -0.792 . . . . 0.0 110.096 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -62.59 -166.94 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.56 -0.712 . . . . 0.0 110.24 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -68.06 -39.83 82.92 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.537 -0.727 . . . . 0.0 110.344 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 357' ' ' LEU . 2.0 mm? -60.65 -27.69 68.0 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.505 -0.747 . . . . 0.0 110.188 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 20.2 m -99.32 -27.09 13.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.619 -0.676 . . . . 0.0 110.385 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.405 ' HA ' ' HG2' ' A' ' 362' ' ' LYS . 14.0 t70 -76.56 -25.11 53.7 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.573 -0.704 . . . . 0.0 110.373 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.53 ' O ' HD12 ' A' ' 363' ' ' ILE . 4.2 m-85 -81.49 -20.76 39.49 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.495 -0.753 . . . . 0.0 110.61 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -101.87 6.58 41.54 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.339 -0.851 . . . . 0.0 111.315 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 359' ' ' ASP . 0.0 OUTLIER -88.45 -24.43 23.01 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.116 -0.99 . . . . 0.0 111.735 -178.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.567 ' N ' HD13 ' A' ' 363' ' ' ILE . 0.2 OUTLIER -50.83 -23.87 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.352 0 O-C-N 121.23 -0.918 . . . . 0.0 111.508 -179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.47 -24.37 21.86 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.385 -0.822 . . . . 0.0 110.673 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 20.29 9.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.473 -0.767 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -91.49 -50.11 2.83 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -169.19 32.31 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.571 -0.958 . . . . 0.0 110.23 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -86.26 -29.7 22.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.639 -0.663 . . . . 0.0 110.242 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -152.75 105.55 2.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.643 -0.661 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -106.16 -29.52 9.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.603 -0.685 . . . . 0.0 110.245 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -93.78 -39.24 10.85 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.559 -0.713 . . . . 0.0 110.208 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.31 -26.04 66.24 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.698 -0.626 . . . . 0.0 110.4 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 4.9 p -83.9 -22.88 31.44 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.534 -0.729 . . . . 0.0 110.641 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -99.79 -21.13 15.89 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.346 -0.846 . . . . 0.0 111.026 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 83.3 mt -116.27 -66.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.289 -0.882 . . . . 0.0 110.705 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.1 tmtt? -57.62 -41.84 82.1 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.575 -0.703 . . . . 0.0 110.698 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.41 -76.3 0.05 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 110.277 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -150.88 -161.19 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.617 -0.677 . . . . 0.0 110.201 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -152.92 -45.33 0.1 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.609 -0.682 . . . . 0.0 109.719 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.45 85.68 7.42 Favored Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.57 -0.706 . . . . 0.0 110.798 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.67 71.33 1.99 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.276 1.145 . . . . 0.0 109.85 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.6 m -115.15 73.15 0.82 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.668 -0.645 . . . . 0.0 110.178 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -89.66 52.61 3.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -66.85 -11.31 55.21 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.685 -0.891 . . . . 0.0 110.397 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -54.03 -28.76 40.48 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.189 -0.945 . . . . 0.0 110.407 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -66.44 -20.95 66.19 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.589 -0.694 . . . . 0.0 110.331 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -65.66 -11.85 48.4 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.375 -0.828 . . . . 0.0 111.097 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -58.37 -165.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.15 -0.969 . . . . 0.0 110.76 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 9.5 mmt-85 -58.05 -25.74 61.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.558 -0.714 . . . . 0.0 110.531 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -52.1 -24.59 7.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.499 -0.751 . . . . 0.0 111.068 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -136.25 -43.54 0.63 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 110.287 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 8.2 t -83.93 57.63 4.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.548 -0.72 . . . . 0.0 110.153 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -91.41 45.69 1.25 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.607 -0.683 . . . . 0.0 110.493 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 108.32 17.68 10.47 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 3.4 ptmt -66.7 149.76 50.06 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.274 -1.133 . . . . 0.0 110.204 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.86 -38.41 0.07 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -170.66 -36.38 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.499 -1.0 . . . . 0.0 110.87 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -47.58 94.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.435 -0.791 . . . . 0.0 111.797 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.548 ' HZ3' HD22 ' A' ' 344' ' ' LEU . 1.3 m95 -124.6 71.48 1.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.536 -0.727 . . . . 0.0 109.798 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -162.08 151.71 21.83 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.1 142.78 13.47 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.469 -1.018 . . . . 0.0 109.766 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -100.15 110.87 23.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.321 -0.862 . . . . 0.0 110.537 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -144.06 90.77 2.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.682 -0.636 . . . . 0.0 110.033 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 408' ' ' LYS . 5.2 m -149.72 159.68 44.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.618 -0.677 . . . . 0.0 110.208 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -82.05 -25.57 34.48 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.595 -0.691 . . . . 0.0 110.434 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 7.4 p -106.45 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.51 -0.744 . . . . 0.0 110.442 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -170.28 80.21 0.1 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.271 -0.893 . . . . 0.0 110.291 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.493 ' HB3' HG21 ' A' ' 404' ' ' THR . 17.5 tttt -146.04 160.4 41.94 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.547 -0.721 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 43.9 t -111.61 160.77 16.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.548 -0.72 . . . . 0.0 110.022 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -147.03 166.94 25.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.566 -0.709 . . . . 0.0 110.345 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.893 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -140.46 144.47 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.528 -0.732 . . . . 0.0 109.833 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.893 ' N ' HD13 ' A' ' 411' ' ' ILE . 11.0 t80 -170.73 173.1 5.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.531 -0.731 . . . . 0.0 110.057 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -60.24 165.99 3.19 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 110.283 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.37 158.04 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.607 -0.683 . . . . 0.0 110.325 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -60.98 111.83 4.78 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.606 -0.684 . . . . 0.0 110.303 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -75.2 -81.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.963 0 O-C-N 123.191 1.101 . . . . 0.0 110.787 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 309' ' ' ASN . 5.3 p -133.69 26.86 4.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.246 -0.909 . . . . 0.0 110.234 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.12 154.03 22.98 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.727 . . . . 0.0 109.928 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.732 HD11 ' CH2' ' A' ' 315' ' ' TRP . 1.6 pp -79.68 120.19 23.64 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.615 -0.678 . . . . 0.0 110.266 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 20.9 mt -115.76 -37.29 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.61 -0.681 . . . . 0.0 109.947 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -116.05 171.83 7.54 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.598 -0.689 . . . . 0.0 110.314 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -111.47 -59.52 1.97 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.669 -0.644 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -111.98 93.16 4.32 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.552 -0.717 . . . . 0.0 109.797 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 21.3 p -82.42 154.48 25.15 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.617 -0.677 . . . . 0.0 110.321 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.405 ' O ' ' CD2' ' A' ' 425' ' ' TYR . 60.9 t80 -96.6 32.95 1.92 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.664 -0.647 . . . . 0.0 110.301 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 90.6 mt -63.85 85.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.542 -0.724 . . . . 0.0 109.919 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.84 80.51 0.23 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.631 -0.668 . . . . 0.0 110.058 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 4.0 p -60.04 -35.72 75.74 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.564 -0.71 . . . . 0.0 110.344 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 40.7 p -99.99 91.84 4.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.498 -0.751 . . . . 0.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -165.0 -42.22 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.546 -0.721 . . . . 0.0 110.352 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.452 ' C ' HD23 ' A' ' 431' ' ' LEU . 10.2 tt -81.36 -30.81 33.62 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.639 -0.663 . . . . 0.0 110.277 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 47.5 t -80.69 -28.65 36.66 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.55 -0.719 . . . . 0.0 110.29 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -155.95 162.49 27.3 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.593 -0.692 . . . . 0.0 110.277 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.71 143.4 37.49 Favored 'Trans proline' 0 C--N 1.317 -1.085 0 O-C-N 123.447 1.235 . . . . 0.0 110.351 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.0 mt -70.64 -32.11 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.619 -0.675 . . . . 0.0 109.854 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.502 2.146 0 CA-C-O 117.92 -1.038 . . . . 0.0 110.752 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.116 0.484 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.86 -64.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.576 -0.702 . . . . 0.0 110.008 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.39 147.35 17.84 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 5.9 m -144.63 -63.07 0.36 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.557 -0.966 . . . . 0.0 110.231 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -83.05 139.03 33.49 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.59 -0.694 . . . . 0.0 110.171 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -116.05 -72.24 0.7 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.279 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -145.14 -44.61 0.22 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.562 -0.711 . . . . 0.0 110.2 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -78.62 148.79 33.11 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.552 -0.717 . . . . 0.0 110.134 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 48.4 p-80 -133.21 176.19 8.72 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.567 -0.708 . . . . 0.0 110.306 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -126.44 163.68 22.79 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.629 -0.669 . . . . 0.0 110.168 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -81.22 -84.58 0.73 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 3.9 m -128.38 155.1 45.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.583 -0.951 . . . . 0.0 110.178 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -135.56 14.02 3.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.596 -0.69 . . . . 0.0 110.995 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -101.53 -179.54 4.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.308 -0.87 . . . . 0.0 110.166 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -152.04 29.1 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.649 -0.657 . . . . 0.0 110.216 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -144.84 -77.15 0.21 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.61 -0.681 . . . . 0.0 109.974 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.12 -69.12 0.01 OUTLIER Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.585 HD21 ' SG ' ' A' ' 418' ' ' CYS . 2.9 tp -111.42 153.92 25.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.981 . . . . 0.0 110.267 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -73.29 168.26 19.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.688 -0.632 . . . . 0.0 110.346 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.2 p -130.86 88.55 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.73 0.776 . . . . 0.0 109.933 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -175.75 34.86 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.659 -0.65 . . . . 0.0 109.982 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.07 -117.18 0.93 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -150.07 20.93 0.87 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.45 -1.029 . . . . 0.0 110.936 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 4.0 t -93.43 169.97 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.23 -0.919 . . . . 0.0 110.109 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -71.71 170.11 14.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.686 -0.634 . . . . 0.0 110.124 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -70.21 -33.43 71.68 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.61 -0.681 . . . . 0.0 110.268 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.626 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.4 tp -144.97 96.83 4.95 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.561 -0.712 . . . . 0.0 110.166 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.554 ' CG ' HD13 ' A' ' 314' ' ' LEU . 46.5 Cg_endo -72.06 -165.51 0.21 Allowed 'Trans proline' 0 C--N 1.318 -1.072 0 O-C-N 123.182 1.096 . . . . 0.0 110.519 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -118.92 127.82 53.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.622 -0.674 . . . . 0.0 110.485 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 35.3 m -110.07 161.13 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.025 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -88.9 122.9 32.74 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.505 -0.747 . . . . 0.0 110.22 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.03 160.18 28.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.64 -0.663 . . . . 0.0 110.305 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -134.81 103.58 10.93 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.652 -0.655 . . . . 0.0 110.006 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.97 64.32 4.1 Favored 'Trans proline' 0 N--CA 1.486 1.054 0 O-C-N 123.236 1.124 . . . . 0.0 110.216 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 335' ' ' PHE . . . -140.93 134.97 30.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.539 -0.725 . . . . 0.0 110.085 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.674 ' O ' HD13 ' A' ' 332' ' ' ILE . 0.1 OUTLIER -166.68 -41.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.587 -0.696 . . . . 0.0 109.841 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.3 -66.97 0.42 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.489 -0.757 . . . . 0.0 110.492 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 12.6 mt -124.42 34.95 4.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.59 -0.694 . . . . 0.0 110.415 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.508 ' HB3' ' HB1' ' A' ' 331' ' ' ALA . 21.5 m-85 -155.2 174.57 15.02 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.566 -0.709 . . . . 0.0 110.293 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -152.55 -178.11 6.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.558 -0.714 . . . . 0.0 110.159 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 1.5 m -88.71 52.08 2.33 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.65 -0.656 . . . . 0.0 110.153 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -119.69 19.93 12.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.533 -0.729 . . . . 0.0 110.703 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.442 ' HB3' HD12 ' A' ' 340' ' ' LEU . 10.2 tttt -64.13 -27.71 69.27 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.054 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.666 HD21 HD23 ' A' ' 344' ' ' LEU . 7.8 mp -92.57 -169.85 2.32 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.481 -0.762 . . . . 0.0 110.366 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 342' ' ' PHE . 9.0 p -133.94 -40.52 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.509 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.458 ' N ' HG13 ' A' ' 341' ' ' VAL . 8.1 t80 -161.8 -45.95 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.419 -0.801 . . . . 0.0 110.057 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -125.49 -178.55 4.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.636 -0.665 . . . . 0.0 109.92 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.666 HD23 HD21 ' A' ' 340' ' ' LEU . 6.4 mt -103.2 -3.15 26.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.424 -0.797 . . . . 0.0 111.616 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.06 -35.92 10.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.123 -0.986 . . . . 0.0 110.203 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -105.46 18.02 22.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.728 -0.608 . . . . 0.0 110.66 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.79 10.53 11.24 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 0.0 111.421 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.52 -72.24 0.06 Allowed 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.98 -1.075 . . . . 0.0 110.678 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.93 54.63 0.25 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.468 -0.77 . . . . 0.0 110.61 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -76.85 111.23 3.2 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.296 1.156 . . . . 0.0 110.475 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.1 mmmt -146.95 -74.99 0.2 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.662 -0.649 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -162.42 165.93 25.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.547 -0.721 . . . . 0.0 109.914 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -155.55 -44.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.524 -0.735 . . . . 0.0 110.087 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.8 31.9 5.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.619 -0.675 . . . . 0.0 110.108 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -61.47 170.44 1.84 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.552 -0.718 . . . . 0.0 110.226 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -82.44 -30.99 29.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 357' ' ' LEU . 2.1 mm? -61.13 -24.5 66.31 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.622 -0.674 . . . . 0.0 110.36 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 358' ' ' THR . 63.0 m -101.57 5.76 41.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.483 -0.761 . . . . 0.0 111.231 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -90.94 -21.52 21.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.167 -0.958 . . . . 0.0 111.449 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.689 ' O ' HG22 ' A' ' 363' ' ' ILE . 26.2 p90 -99.97 -24.33 14.66 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.206 -0.934 . . . . 0.0 111.036 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -63.46 -16.35 60.37 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.465 -0.772 . . . . 0.0 111.02 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.05 -27.22 52.43 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.212 -0.93 . . . . 0.0 110.55 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 360' ' ' TYR . 5.2 tp -100.12 -22.29 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.629 -0.67 . . . . 0.0 110.342 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -90.01 -27.7 19.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.361 -0.837 . . . . 0.0 110.224 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -93.02 20.29 6.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.565 -0.709 . . . . 0.0 110.805 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.55 -27.24 63.32 Favored Glycine 0 N--CA 1.495 2.619 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -56.33 96.58 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.493 -1.004 . . . . 0.0 110.494 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -96.23 25.13 5.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.62 -0.675 . . . . 0.0 110.473 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -112.8 18.3 18.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.523 -0.736 . . . . 0.0 110.611 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -102.87 -33.22 9.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.039 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -100.07 -28.3 13.12 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.738 -0.601 . . . . 0.0 110.261 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -54.55 -28.86 48.72 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.47 -0.769 . . . . 0.0 110.76 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 16.6 t -82.49 -23.52 34.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.598 -0.689 . . . . 0.0 110.347 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 14.1 mtt -79.91 -26.37 40.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.414 -0.803 . . . . 0.0 110.391 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 45.7 mm -59.13 -50.19 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.411 -0.806 . . . . 0.0 110.03 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -60.46 -24.08 64.97 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.711 -0.618 . . . . 0.0 110.398 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.47 23.44 11.77 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.473 -0.767 . . . . 0.0 110.352 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -85.02 131.32 34.48 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.488 -0.758 . . . . 0.0 110.244 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -64.83 81.79 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.717 -0.614 . . . . 0.0 110.132 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.849 ' O ' ' HB2' ' A' ' 384' ' ' ALA . 7.4 mt -77.74 -57.09 1.04 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.595 -0.69 . . . . 0.0 110.82 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 47.6 Cg_endo -73.28 -27.08 13.9 Favored 'Trans proline' 0 N--CA 1.485 1.021 0 O-C-N 123.144 1.076 . . . . 0.0 110.711 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.9 p -94.86 -36.1 11.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.477 -0.764 . . . . 0.0 110.495 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -98.2 29.11 11.92 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.849 ' HB2' ' O ' ' A' ' 380' ' ' LEU . . . -90.51 -24.31 20.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.591 -0.947 . . . . 0.0 110.64 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -77.08 -21.53 54.22 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.422 -0.799 . . . . 0.0 110.986 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -89.65 -25.6 21.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.307 -0.871 . . . . 0.0 110.639 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -68.78 -10.28 55.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.518 -0.739 . . . . 0.0 110.817 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -52.09 -54.24 32.79 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.156 -0.965 . . . . 0.0 111.866 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -122.27 111.49 16.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.329 -0.857 . . . . 0.0 111.138 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -91.31 46.67 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.774 -0.579 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -92.07 -22.45 19.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.551 -0.718 . . . . 0.0 110.83 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 79.5 p -58.53 -19.19 35.56 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.949 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -94.47 29.91 2.13 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.269 -0.894 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -142.0 14.61 2.6 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -67.65 165.61 16.75 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.209 -1.171 . . . . 0.0 110.313 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -156.62 -60.69 0.01 OUTLIER Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.453 ' CD2' ' HA ' ' A' ' 428' ' ' THR . 0.2 OUTLIER -128.98 -155.32 0.69 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.576 -0.955 . . . . 0.0 110.076 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -135.84 119.39 17.0 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.502 -0.749 . . . . 0.0 110.332 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -142.53 40.07 1.56 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.592 -0.693 . . . . 0.0 110.179 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -105.93 -151.32 19.46 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.438 ' HA ' ' CB ' ' A' ' 424' ' ' SER . 73.2 m-20 -132.93 145.64 51.09 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.66 -0.906 . . . . 0.0 110.147 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 423' ' ' SER . 13.0 m-85 -129.68 144.84 51.47 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 0.0 110.038 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -124.83 134.62 52.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 21.4 m -89.75 83.96 6.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.893 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -66.85 0.99 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 59.1 p -122.3 -75.58 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -174.76 61.26 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.572 -0.705 . . . . 0.0 109.469 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -140.41 167.24 22.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.52 -0.738 . . . . 0.0 110.784 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.7 t -121.62 161.96 21.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 109.754 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -143.03 156.02 44.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.405 -0.809 . . . . 0.0 110.174 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.896 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -170.51 144.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.357 -0.84 . . . . 0.0 109.817 179.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.896 ' N ' HD13 ' A' ' 411' ' ' ILE . 38.3 t80 -150.1 170.52 18.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.64 -0.663 . . . . 0.0 110.065 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.418 ' OD1' HD12 ' A' ' 344' ' ' LEU . 2.1 t30 -60.42 131.38 50.59 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.557 -0.714 . . . . 0.0 110.265 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.94 93.16 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.541 -0.724 . . . . 0.0 109.965 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -100.58 156.37 35.29 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.586 -0.696 . . . . 0.0 110.205 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.8 -43.73 1.67 Allowed 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.369 1.194 . . . . 0.0 110.481 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.6 t -64.44 -27.9 69.31 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.522 -0.736 . . . . 0.0 110.18 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.585 ' SG ' HD21 ' A' ' 314' ' ' LEU . 3.3 t -143.44 125.21 15.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.586 -0.696 . . . . 0.0 109.766 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 419' ' ' LEU . 3.5 pp -147.72 132.82 18.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.521 -0.737 . . . . 0.0 110.918 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 14.6 tt -122.14 142.51 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 109.461 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.6 m-80 -147.59 95.62 2.55 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.0 110.807 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -80.26 -86.63 0.08 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.592 -0.692 . . . . 0.0 109.537 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 402' ' ' TYR . 0.3 OUTLIER -137.73 115.41 11.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.048 -1.033 . . . . 0.0 108.98 179.421 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . 0.438 ' CB ' ' HA ' ' A' ' 401' ' ' ASN . 0.2 OUTLIER -175.31 -158.73 0.07 Allowed 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.079 -1.013 . . . . 0.0 111.609 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.705 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 68.4 t80 -151.15 92.85 1.85 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 80.6 mt -84.43 87.39 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.518 -0.739 . . . . 0.0 110.05 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.705 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -169.24 71.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.603 -0.686 . . . . 0.0 110.379 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.453 ' HA ' ' CD2' ' A' ' 397' ' ' TYR . 82.6 p -59.87 -52.74 64.16 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.415 -0.803 . . . . 0.0 110.226 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 10.2 p -137.25 101.48 4.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.0 110.146 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.13 -72.6 0.1 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.58 -0.7 . . . . 0.0 110.291 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.1 mm? -117.41 134.6 54.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.646 -0.659 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 2.9 t -115.34 28.81 8.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.538 -0.726 . . . . 0.0 110.189 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.418 ' O ' ' CG ' ' A' ' 433' ' ' HIS . 11.6 p80 -169.5 76.02 0.69 Allowed Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.437 -0.79 . . . . 0.0 110.298 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 64.0 3.6 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 123.3 1.158 . . . . 0.0 110.465 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.7 tp -76.56 -25.48 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.737 . . . . 0.0 110.424 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.073 179.875 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 17.5 ttp . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.084 0.469 . . . . 0.0 110.139 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -92.44 -66.7 0.9 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.618 -0.676 . . . . 0.0 110.172 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -146.73 134.57 5.34 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 9.9 t -128.96 132.19 47.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.663 -0.904 . . . . 0.0 110.279 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 4.7 t-160 -148.99 47.22 1.0 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.566 -0.708 . . . . 0.0 110.223 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -86.5 -36.38 19.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.604 -0.685 . . . . 0.0 110.3 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -126.0 -165.28 1.41 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.566 -0.709 . . . . 0.0 110.255 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 6.8 m170 -71.8 127.85 33.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.524 -0.735 . . . . 0.0 110.148 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 17.5 t60 -86.52 136.06 33.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.462 -0.774 . . . . 0.0 110.256 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -87.95 52.98 2.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.619 -0.676 . . . . 0.0 110.169 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.18 109.47 0.43 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 94.9 p -102.41 33.17 3.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.593 -0.945 . . . . 0.0 110.16 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -121.32 -71.46 0.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.587 -0.696 . . . . 0.0 110.197 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -168.02 -176.3 2.95 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.626 -0.671 . . . . 0.0 110.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -172.39 -40.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.512 -0.742 . . . . 0.0 109.415 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.448 ' CE2' ' HB2' ' A' ' 314' ' ' LEU . 21.7 t80 -134.58 170.47 15.74 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.772 -0.58 . . . . 0.0 109.46 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.499 ' HA2' HG23 ' A' ' 420' ' ' ILE . . . -95.19 31.6 6.89 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -150.17 146.77 27.06 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.373 -1.075 . . . . 0.0 110.17 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.612 ' CE2' HD21 ' A' ' 419' ' ' LEU . 12.9 p-90 -143.3 171.32 14.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.73 -0.607 . . . . 0.0 109.669 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.405 ' O ' ' CD2' ' A' ' 315' ' ' TRP . 59.9 t -50.42 134.17 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 O-C-N 121.428 -0.795 . . . . 0.0 110.738 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.54 126.65 24.49 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.531 -0.731 . . . . 0.0 110.99 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -156.49 -43.56 0.02 OUTLIER Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.28 -40.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.501 -1.0 . . . . 0.0 110.901 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 1.1 t -89.33 170.26 10.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.49 -0.757 . . . . 0.0 110.465 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -102.04 170.78 7.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.826 -0.546 . . . . 0.0 109.981 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.436 ' OD1' HD21 ' A' ' 314' ' ' LEU . 0.5 OUTLIER -52.24 172.61 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.485 -0.759 . . . . 0.0 110.95 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 323' ' ' ILE . 9.9 tt -57.5 110.31 2.39 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.63 -0.669 . . . . 0.0 110.511 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -74.84 -165.5 0.28 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 O-C-N 123.052 1.027 . . . . 0.0 110.179 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -99.32 95.31 6.97 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.598 -0.688 . . . . 0.0 110.097 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.711 HG12 ' CB ' ' A' ' 412' ' ' PHE . 34.5 m -113.69 159.81 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.566 -0.709 . . . . 0.0 110.314 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -92.28 131.95 37.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.571 -0.706 . . . . 0.0 110.066 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -108.36 134.45 51.15 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.544 -0.723 . . . . 0.0 110.333 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -108.57 90.68 7.56 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.0 110.068 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.91 -34.5 6.52 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 O-C-N 123.476 1.251 . . . . 0.0 110.604 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -90.79 168.01 12.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.484 -0.76 . . . . 0.0 110.381 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -167.51 40.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.481 0.658 . . . . 0.0 109.845 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -59.22 -66.29 0.53 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.704 -0.622 . . . . 0.0 110.401 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 334' ' ' LEU . 1.0 OUTLIER -133.75 44.54 2.75 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 44.6 p90 -168.35 139.73 2.74 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.625 -0.672 . . . . 0.0 110.388 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -94.86 -155.67 0.47 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.61 -0.681 . . . . 0.0 109.522 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -82.82 57.4 3.81 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.246 -0.909 . . . . 0.0 109.883 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -157.87 33.12 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.521 -0.737 . . . . 0.0 109.959 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -87.38 -22.79 24.83 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.687 -0.633 . . . . 0.0 110.681 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 26.1 mt -57.51 172.77 0.32 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.427 -0.796 . . . . 0.0 110.501 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.75 -81.77 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -160.61 25.66 0.15 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.332 -0.855 . . . . 0.0 110.617 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -171.96 -169.71 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 344' ' ' LEU . 3.3 mm? -103.19 4.62 37.03 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.702 -0.624 . . . . 0.0 110.947 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.4 t -53.64 -29.22 37.21 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.094 -1.004 . . . . 0.0 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.8 -31.48 72.73 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.655 . . . . 0.0 109.674 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.3 t -98.22 10.5 40.44 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.654 -0.654 . . . . 0.0 110.897 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.42 8.97 40.19 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.195 -0.941 . . . . 0.0 111.116 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -102.48 98.43 10.79 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.207 -0.933 . . . . 0.0 110.475 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.13 -19.1 26.6 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 O-C-N 123.4 1.21 . . . . 0.0 110.931 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 10.8 mtpp -55.92 -69.73 0.13 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.323 -0.86 . . . . 0.0 110.735 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -57.75 103.1 0.12 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.597 -0.689 . . . . 0.0 110.433 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -126.44 -50.34 1.52 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.589 -0.694 . . . . 0.0 110.198 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -149.32 77.75 1.36 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.609 -0.682 . . . . 0.0 110.343 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -165.21 -42.23 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.514 -0.741 . . . . 0.0 110.411 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -99.99 18.56 18.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.494 -0.754 . . . . 0.0 110.816 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.1 tp -64.37 -40.59 96.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.421 -0.799 . . . . 0.0 110.057 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 5.4 m -60.24 -24.81 65.17 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.638 -0.664 . . . . 0.0 110.431 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -92.75 -25.85 18.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.467 -0.771 . . . . 0.0 110.462 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -81.1 -27.94 35.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.524 -0.735 . . . . 0.0 110.526 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.85 -20.52 61.91 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.512 -0.742 . . . . 0.0 110.647 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -97.73 10.59 39.67 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.382 -0.824 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.6 mm -97.68 -26.28 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.202 -0.936 . . . . 0.0 110.252 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -60.42 -32.83 71.72 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.404 -0.81 . . . . 0.0 110.244 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -109.97 20.11 18.31 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.667 -0.646 . . . . 0.0 110.571 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -116.67 80.1 0.3 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -81.21 76.46 8.16 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.555 -0.968 . . . . 0.0 110.144 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -125.79 34.72 4.84 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.508 -0.745 . . . . 0.0 110.402 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -137.86 29.76 2.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.616 -0.677 . . . . 0.0 110.135 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -88.87 -157.5 0.44 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.585 -0.697 . . . . 0.0 110.172 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -79.26 -35.4 41.51 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.584 -0.698 . . . . 0.0 110.214 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.85 -28.66 69.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.627 -0.671 . . . . 0.0 110.285 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.9 t -94.63 -28.84 15.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.595 -0.69 . . . . 0.0 110.253 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.465 ' O ' ' HB3' ' A' ' 378' ' ' ALA . 3.9 mtt -60.45 -27.32 67.43 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.563 -0.711 . . . . 0.0 110.28 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 82.7 mt -71.63 -28.65 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.467 -0.771 . . . . 0.0 109.96 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -81.07 -27.28 35.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.608 -0.682 . . . . 0.0 110.38 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 7.4 m -99.1 -41.77 7.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.566 -0.709 . . . . 0.0 110.323 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.637 ' HB1' HD21 ' A' ' 380' ' ' LEU . . . -97.07 108.13 20.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.719 -0.613 . . . . 0.0 110.301 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -83.36 76.53 9.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.681 -0.637 . . . . 0.0 110.16 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.637 HD21 ' HB1' ' A' ' 378' ' ' ALA . 0.8 OUTLIER -165.87 92.28 0.84 Allowed Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.545 -0.722 . . . . 0.0 110.335 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -72.11 64.1 3.41 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.331 1.174 . . . . 0.0 110.378 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 17.6 p -80.29 -31.95 38.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.526 -0.734 . . . . 0.0 110.22 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -139.7 51.89 0.73 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -79.74 -28.19 40.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.682 -0.893 . . . . 0.0 110.277 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -63.96 -25.83 68.31 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.61 -0.681 . . . . 0.0 110.435 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -19.94 44.66 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.432 -0.792 . . . . 0.0 110.704 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.59 -19.26 36.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.415 -0.803 . . . . 0.0 110.688 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -57.01 -20.86 26.54 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.258 -0.901 . . . . 0.0 110.924 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 52.0 mtp180 -55.3 135.98 49.45 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.337 -0.852 . . . . 0.0 110.605 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -77.3 172.87 12.61 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.588 -0.695 . . . . 0.0 110.311 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -52.4 -47.42 66.28 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.606 -0.684 . . . . 0.0 111.328 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 31.2 p -63.0 -27.18 69.24 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.599 -0.688 . . . . 0.0 110.283 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -97.51 29.92 3.09 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.494 -0.754 . . . . 0.0 110.334 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -114.55 -38.08 1.12 Allowed Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 396' ' ' GLY . 11.0 mttp -94.89 -70.85 0.69 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.669 -0.901 . . . . 0.0 110.272 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 395' ' ' LYS . . . 3.01 65.76 0.0 OUTLIER Glycine 1 N--CA 1.519 4.194 0 C-N-CA 124.722 1.153 . . . . 0.0 113.976 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 395' ' ' LYS . 65.9 t80 -146.98 62.11 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.956 -0.732 . . . . 0.0 110.049 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -95.86 133.38 40.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.647 -0.658 . . . . 0.0 110.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.535 ' CH2' HD11 ' A' ' 411' ' ' ILE . 27.9 p-90 -159.18 32.06 0.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.573 -0.704 . . . . 0.0 110.326 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -119.25 -139.3 5.96 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -144.81 162.0 37.87 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.657 -0.908 . . . . 0.0 110.094 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 409' ' ' CYS . 47.8 m-85 -129.15 122.99 30.98 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.592 -0.693 . . . . 0.0 110.301 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -93.58 128.22 39.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.508 -0.745 . . . . 0.0 109.665 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 17.4 p -89.78 84.94 6.3 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.728 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -121.86 -65.56 1.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 16.6 p -121.07 -68.88 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.429 0.633 . . . . 0.0 109.356 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -173.08 57.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.561 -0.712 . . . . 0.0 109.729 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -149.25 -179.99 7.47 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.409 -0.807 . . . . 0.0 110.992 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 402' ' ' TYR . 26.6 p -151.6 171.95 16.81 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.735 -0.603 . . . . 0.0 109.928 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.75 160.04 37.96 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 110.451 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.801 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -146.33 141.46 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.573 -0.704 . . . . 0.0 109.703 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.801 ' N ' HD13 ' A' ' 411' ' ' ILE . 51.0 p90 -169.43 -164.41 0.45 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.622 -0.674 . . . . 0.0 110.173 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -60.63 -167.37 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.557 -0.714 . . . . 0.0 110.188 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.67 147.58 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.295 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -128.98 148.52 69.31 Favored Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.611 -0.68 . . . . 0.0 109.965 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -75.64 -80.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.092 0 O-C-N 123.36 1.19 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 4.5 m -114.12 114.19 25.73 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.26 -0.9 . . . . 0.0 110.21 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 18.4 t -155.71 163.0 40.45 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.547 -0.721 . . . . 0.0 110.178 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.612 HD21 ' CE2' ' A' ' 315' ' ' TRP . 0.5 OUTLIER -135.46 67.08 1.49 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.499 HG23 ' HA2' ' A' ' 313' ' ' GLY . 86.2 mt -122.09 -39.75 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.522 -0.736 . . . . 0.0 110.143 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -97.25 161.82 13.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.304 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 29.9 t-20 -88.88 -63.59 1.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.63 -0.669 . . . . 0.0 110.191 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 5.0 p -115.8 127.92 55.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.531 -0.73 . . . . 0.0 110.088 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.0 p -119.7 92.51 3.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.48 104.52 15.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.284 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.485 ' O ' HG22 ' A' ' 426' ' ' ILE . 85.0 mt -108.23 64.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.594 -0.691 . . . . 0.0 109.937 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -147.34 104.63 3.66 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.506 -0.746 . . . . 0.0 110.179 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.4 p -80.13 -66.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.694 . . . . 0.0 110.22 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 59.2 m -157.82 90.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.52 -0.737 . . . . 0.0 110.185 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -155.11 -74.93 0.11 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.513 -0.742 . . . . 0.0 110.238 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.455 ' O ' HD12 ' A' ' 431' ' ' LEU . 3.4 pp -143.42 138.17 29.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.613 -0.68 . . . . 0.0 110.446 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 6.2 p -112.96 65.5 0.64 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.565 -0.709 . . . . 0.0 110.152 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.435 ' HB3' ' HD3' ' A' ' 434' ' ' PRO . 4.5 t60 -75.61 -57.63 1.56 Allowed Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.486 -0.759 . . . . 0.0 109.97 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 433' ' ' HIS . 46.0 Cg_endo -70.43 -166.27 0.2 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 O-C-N 122.962 0.98 . . . . 0.0 110.418 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 436' ' ' GLU . 5.8 tp -162.51 -40.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.545 -0.722 . . . . 0.0 110.438 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.468 ' N ' HG23 ' A' ' 435' ' ' ILE . 0.7 OUTLIER . . . . . 0 N--CA 1.502 2.13 0 CA-C-O 118.062 -0.971 . . . . 0.0 110.755 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.075 0.464 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 44.0 ptt85 -114.01 -26.06 8.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.649 -0.657 . . . . 0.0 110.449 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -143.34 155.27 25.96 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 54.9 p -147.46 -67.71 0.25 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.953 . . . . 0.0 110.279 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -134.43 165.93 24.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.586 -0.697 . . . . 0.0 110.207 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.95 -162.96 0.06 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.586 -0.696 . . . . 0.0 110.046 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -60.29 167.18 2.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.546 -0.721 . . . . 0.0 110.243 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' -5' ' ' HIS . 16.5 m-70 -91.37 155.51 18.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.0 110.212 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -91.94 165.51 13.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.51 -0.744 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . 0.673 ' HB3' ' HB1' ' A' ' 346' ' ' ALA . 32.5 m170 -137.48 -177.59 4.85 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.603 -0.686 . . . . 0.0 110.373 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -165.05 -159.14 11.03 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.1 t -169.12 92.28 0.26 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.508 -0.995 . . . . 0.0 110.25 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.13 147.59 4.68 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.513 -0.742 . . . . 0.0 110.318 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -160.03 173.2 16.2 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.595 -0.69 . . . . 0.0 110.12 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.37 -161.63 1.31 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.543 -0.723 . . . . 0.0 110.261 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.451 ' CE2' HD11 ' A' ' 323' ' ' ILE . 3.9 t80 -150.25 94.63 2.16 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.636 -0.665 . . . . 0.0 110.259 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -106.26 133.6 11.7 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 314' ' ' LEU . 6.1 mt -118.84 -165.51 1.14 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.647 -0.913 . . . . 0.0 110.066 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 320' ' ' CYS . 0.3 OUTLIER -162.78 170.56 18.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.49 -0.756 . . . . 0.0 110.066 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 33.9 m -68.62 170.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.565 -0.709 . . . . 0.0 110.039 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -57.74 117.74 4.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.458 -0.776 . . . . 0.0 110.577 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -144.51 -124.7 1.78 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -127.18 24.84 6.28 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.568 -0.96 . . . . 0.0 110.515 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.442 ' HB3' ' CZ2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -91.56 170.84 9.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.425 -0.797 . . . . 0.0 110.006 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.35 170.95 9.37 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.69 -0.631 . . . . 0.0 109.913 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.64 ' OD2' HG22 ' A' ' 323' ' ' ILE . 10.1 p-10 -50.66 -25.74 4.6 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.394 -0.816 . . . . 0.0 110.946 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.64 HG22 ' OD2' ' A' ' 322' ' ' ASP . 6.2 tp -167.32 116.35 0.69 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.562 -0.711 . . . . 0.0 110.142 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.14 171.69 15.45 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 O-C-N 123.022 1.011 . . . . 0.0 109.991 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -145.1 91.5 2.15 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.435 -0.791 . . . . 0.0 110.817 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.663 HG12 ' CG ' ' A' ' 412' ' ' PHE . 12.4 m -129.48 161.08 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.542 -0.724 . . . . 0.0 109.076 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . 0.487 ' HB2' HG23 ' A' ' 411' ' ' ILE . 13.0 m120 -88.64 110.2 20.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.385 -0.822 . . . . 0.0 110.394 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -89.97 135.5 33.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.635 . . . . 0.0 110.06 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.4 ' HB3' ' HB3' ' A' ' 409' ' ' CYS . 0.1 OUTLIER -129.07 94.09 34.84 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.596 -0.69 . . . . 0.0 109.982 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.53 -41.99 1.01 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.427 1.225 . . . . 0.0 110.416 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -70.95 105.14 3.18 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.612 -0.68 . . . . 0.0 110.114 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 7.0 tt -144.75 26.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.644 -0.66 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.66 -49.48 11.18 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.41 -0.806 . . . . 0.0 110.456 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 335' ' ' PHE . 2.3 mm? -96.04 -30.25 13.68 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.594 -0.691 . . . . 0.0 110.324 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.437 ' CD1' ' HB3' ' A' ' 334' ' ' LEU . 91.6 m-85 -125.5 178.64 5.53 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.54 -0.725 . . . . 0.0 110.145 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -130.82 149.76 52.31 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.575 -0.703 . . . . 0.0 110.161 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 26.5 p -61.51 -18.01 57.21 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.513 -0.742 . . . . 0.0 110.762 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -56.89 -25.91 57.95 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.365 -0.834 . . . . 0.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -60.99 -30.96 70.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.545 -0.722 . . . . 0.0 110.247 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.6 tp -103.0 97.45 7.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.611 -0.681 . . . . 0.0 110.178 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 342' ' ' PHE . 8.5 p -106.57 -25.27 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 110.296 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.493 ' CD2' HG13 ' A' ' 341' ' ' VAL . 27.2 m-85 -112.87 61.45 0.64 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.571 -0.706 . . . . 0.0 110.078 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.513 ' HG2' HD12 ' A' ' 344' ' ' LEU . 6.0 pm0 -102.91 7.36 39.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.56 -0.713 . . . . 0.0 111.097 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.513 HD12 ' HG2' ' A' ' 343' ' ' GLU . 4.7 mp -103.31 -42.66 5.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.21 -0.931 . . . . 0.0 109.827 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 61.4 m -89.89 -2.69 58.24 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.666 -0.646 . . . . 0.0 110.899 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' -3' ' ' HIS . . . -86.53 9.15 19.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.206 -0.934 . . . . 0.0 111.042 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 39.8 t -60.8 -29.0 69.19 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.213 -0.929 . . . . 0.0 110.111 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -95.14 8.43 43.02 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.61 -0.681 . . . . 0.0 110.999 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.12 112.11 4.95 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.134 -0.979 . . . . 0.0 110.186 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 -169.01 0.36 Allowed 'Trans proline' 0 N--CA 1.486 1.031 0 O-C-N 123.178 1.094 . . . . 0.0 110.439 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 32.6 mttt -84.9 165.49 17.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.569 -0.707 . . . . 0.0 110.376 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -81.59 101.66 10.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.595 -0.69 . . . . 0.0 110.019 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -66.92 -29.88 69.87 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.551 -0.718 . . . . 0.0 110.243 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.18 -70.89 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.562 -0.712 . . . . 0.0 110.204 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -168.33 -172.99 1.86 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.578 -0.701 . . . . 0.0 110.205 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -110.07 18.42 20.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.552 -0.718 . . . . 0.0 110.846 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.84 -28.53 10.06 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.325 -0.859 . . . . 0.0 110.066 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . 0.47 ' HA ' ' CE2' ' A' ' 360' ' ' TYR . 23.0 m -83.6 4.14 29.64 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.552 -0.718 . . . . 0.0 111.171 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.07 -17.73 28.62 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.198 -0.939 . . . . 0.0 111.351 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.768 ' O ' HG23 ' A' ' 363' ' ' ILE . 23.6 p90 -55.37 -22.64 20.45 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.115 -0.991 . . . . 0.0 110.918 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -61.19 -17.72 54.51 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.379 -0.826 . . . . 0.0 110.836 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.3 mtpt -73.87 -4.23 33.67 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.257 -0.902 . . . . 0.0 111.547 -179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.768 HG23 ' O ' ' A' ' 360' ' ' TYR . 35.5 pt -56.66 -25.71 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.964 -1.085 . . . . 0.0 110.447 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.76 -17.9 22.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.491 -0.756 . . . . 0.0 110.558 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -92.6 20.67 6.11 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.353 -0.842 . . . . 0.0 110.864 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -59.2 -27.83 63.34 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -57.88 91.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.394 -1.062 . . . . 0.0 110.484 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 11.8 pttt -115.63 42.39 2.3 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.598 -0.688 . . . . 0.0 110.259 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -106.2 -29.93 9.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.581 -0.699 . . . . 0.0 110.079 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -105.23 -28.75 10.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.697 -0.627 . . . . 0.0 110.15 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -86.63 -32.1 20.76 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.624 -0.672 . . . . 0.0 110.405 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.66 68.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.587 -0.696 . . . . 0.0 110.367 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 8.5 t -105.02 5.07 32.27 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.574 -0.704 . . . . 0.0 111.178 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 15.1 mtt -105.16 -26.33 12.12 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.154 -0.966 . . . . 0.0 110.398 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 375' ' ' ILE . 4.5 mp -134.33 -60.87 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.479 -0.763 . . . . 0.0 109.899 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -55.91 -26.09 45.97 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.783 -0.573 . . . . 0.0 110.684 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.93 78.08 0.9 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.583 -0.698 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.8 -47.62 4.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.502 -0.749 . . . . 0.0 110.081 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 381' ' ' PRO . 75.1 t80 -103.72 91.24 3.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.679 -0.638 . . . . 0.0 109.633 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.738 HD13 ' N ' ' A' ' 380' ' ' LEU . 0.0 OUTLIER -128.08 52.31 8.5 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.661 -0.65 . . . . 0.0 111.144 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 47.8 Cg_endo -71.99 64.19 3.31 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 O-C-N 123.388 1.204 . . . . 0.0 110.331 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 382' ' ' THR . 7.0 t -165.44 71.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.549 -0.719 . . . . 0.0 110.131 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.4 ' HA2' ' HE3' ' A' ' 386' ' ' LYS . . . -60.15 -27.77 65.59 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.41 -58.28 8.96 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.58 -0.953 . . . . 0.0 110.565 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -90.64 44.53 1.2 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.475 -0.766 . . . . 0.0 110.677 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.4 ' HE3' ' HA2' ' A' ' 383' ' ' GLY . 26.5 ttmt -90.42 -24.1 20.85 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.444 -0.785 . . . . 0.0 110.616 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.69 -18.88 34.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.471 -0.768 . . . . 0.0 110.649 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -86.64 -50.06 7.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.323 -0.86 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 33.3 mtt85 -70.78 -23.02 62.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.682 -0.636 . . . . 0.0 110.524 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -51.61 154.85 1.77 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.376 -0.828 . . . . 0.0 110.955 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.44 175.19 0.62 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.599 -0.688 . . . . 0.0 110.214 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.4 m -89.98 52.26 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.55 -0.718 . . . . 0.0 110.3 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -59.58 -21.14 59.9 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.616 -0.677 . . . . 0.0 110.663 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -78.53 -1.01 81.45 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -55.89 144.24 28.84 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.885 -1.362 . . . . 0.0 110.697 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . 179.9 -62.76 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.431 ' CD1' ' N ' ' A' ' 397' ' ' TYR . 51.3 m-85 -137.1 -161.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.545 -0.973 . . . . 0.0 109.537 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -113.49 58.11 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.52 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.49 ' CD1' HD11 ' A' ' 411' ' ' ILE . 0.4 OUTLIER -67.14 73.96 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.467 0.651 . . . . 0.0 111.21 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.573 ' HA2' HD13 ' A' ' 411' ' ' ILE . . . -100.67 -166.16 28.34 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . 0.429 ' CB ' ' HB2' ' A' ' 422' ' ' ASN . 32.3 m-20 -145.02 149.75 35.67 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.293 -1.122 . . . . 0.0 110.205 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 22.3 m-85 -137.72 108.71 6.73 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.303 -0.873 . . . . 0.0 110.638 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . 0.408 ' HB2' ' CA ' ' A' ' 422' ' ' ASN . 1.3 t-20 -152.4 89.97 1.46 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.055 -1.028 . . . . 0.0 110.12 178.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.575 HG21 ' HB2' ' A' ' 408' ' ' LYS . 1.0 OUTLIER -151.11 167.21 28.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.0 110.258 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -65.39 -27.2 68.38 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.588 -0.695 . . . . 0.0 110.267 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 75.1 m -110.37 -85.25 0.55 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.51 -0.744 . . . . 0.0 110.258 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -172.83 80.58 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.575 ' HB2' HG21 ' A' ' 404' ' ' THR . 50.4 mttt -107.37 168.09 9.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.486 -0.759 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 329' ' ' PHE . 51.9 t -138.62 118.68 13.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.507 -0.746 . . . . 0.0 110.661 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -109.39 127.89 54.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.675 -0.641 . . . . 0.0 109.59 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.573 HD13 ' HA2' ' A' ' 400' ' ' GLY . 4.4 tp -138.01 141.09 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.366 -0.834 . . . . 0.0 110.934 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.663 ' CG ' HG12 ' A' ' 326' ' ' VAL . 25.5 p90 -169.3 -41.26 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.788 -0.57 . . . . 0.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 399' ' ' TRP . 6.8 t30 -177.09 -174.34 0.51 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.369 -0.832 . . . . 0.0 109.555 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 8.1 p -59.93 154.23 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.475 -0.765 . . . . 0.0 109.948 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -56.86 110.09 2.17 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.514 -0.741 . . . . 0.0 110.892 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -81.96 -165.26 0.32 Allowed 'Trans proline' 0 C--N 1.321 -0.881 0 O-C-N 122.906 0.95 . . . . 0.0 110.169 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 18.5 p -100.03 61.22 1.09 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.534 -0.729 . . . . 0.0 109.966 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . 0.64 ' SG ' HG22 ' A' ' 420' ' ' ILE . 52.8 t -119.26 161.48 20.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.548 -0.72 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.423 ' HB2' ' CD1' ' A' ' 315' ' ' TRP . 4.1 mm? -86.11 53.37 2.77 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.64 -0.663 . . . . 0.0 110.357 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.64 HG22 ' SG ' ' A' ' 418' ' ' CYS . 0.6 OUTLIER -160.15 35.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.76 . . . . 0.0 109.678 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -79.83 120.48 24.14 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.755 -0.591 . . . . 0.0 110.435 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . 0.429 ' HB2' ' CB ' ' A' ' 401' ' ' ASN . 1.6 m-80 -93.81 -168.47 1.89 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.686 -0.634 . . . . 0.0 109.828 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 52.8 p -69.92 94.4 0.84 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.186 -0.946 . . . . 0.0 110.805 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 m -54.96 143.97 24.64 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.168 -0.958 . . . . 0.0 111.058 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.758 ' CE2' ' HB3' ' A' ' 427' ' ' ALA . 62.1 t80 -149.79 90.89 1.74 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.629 -0.669 . . . . 0.0 109.971 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 75.7 mt -87.26 101.61 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.568 -0.707 . . . . 0.0 110.322 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.758 ' HB3' ' CE2' ' A' ' 425' ' ' TYR . . . -164.83 133.62 3.47 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 429' ' ' THR . 75.3 m -59.07 -81.98 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.379 -0.826 . . . . 0.0 110.251 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 428' ' ' THR . 1.1 p -160.11 97.28 1.25 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.304 -0.873 . . . . 0.0 110.179 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.61 70.78 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.721 . . . . 0.0 110.079 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 431' ' ' LEU . 0.2 OUTLIER -157.47 123.88 4.89 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.649 -0.657 . . . . 0.0 110.105 179.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 14.5 t -127.35 -179.03 4.68 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.557 -0.714 . . . . 0.0 110.372 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -86.34 147.26 44.17 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.51 -0.744 . . . . 0.0 110.124 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.0 -46.39 0.31 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.409 1.215 . . . . 0.0 110.583 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 80.9 mt -76.29 -32.42 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.702 -0.624 . . . . 0.0 109.979 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.289 -179.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.082 0.467 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -127.3 155.91 42.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.492 -0.755 . . . . 0.0 110.246 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -111.57 42.77 1.87 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 63.9 m -85.35 153.13 22.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.689 -0.889 . . . . 0.0 110.287 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -71.8 129.91 39.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.541 -0.725 . . . . 0.0 110.322 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -157.61 -73.3 0.09 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.521 -0.737 . . . . 0.0 110.366 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 27.2 p-80 -168.94 140.46 2.52 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.51 -0.744 . . . . 0.0 110.305 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.61 -171.85 1.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.545 -0.722 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -151.86 -57.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.51 -0.744 . . . . 0.0 110.217 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -132.36 173.53 11.19 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -167.16 68.16 0.19 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -123.33 -158.8 0.81 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.525 -0.985 . . . . 0.0 110.163 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -84.55 -33.2 23.5 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.582 -0.699 . . . . 0.0 110.055 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -142.56 179.41 6.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.587 -0.696 . . . . 0.0 110.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -139.76 -46.87 0.45 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.557 -0.715 . . . . 0.0 109.454 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.491 ' CD2' HD21 ' A' ' 314' ' ' LEU . 0.3 OUTLIER -113.92 -147.49 0.42 Allowed 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -134.11 36.05 2.15 Favored Glycine 0 N--CA 1.484 1.843 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.491 HD21 ' CD2' ' A' ' 312' ' ' PHE . 0.4 OUTLIER -142.1 -164.91 1.9 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.929 -0.747 . . . . 0.0 110.239 -178.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.464 ' CD1' HD21 ' A' ' 419' ' ' LEU . 0.1 OUTLIER -51.64 146.05 8.27 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.258 -0.902 . . . . 0.0 111.339 -179.198 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.51 92.03 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.497 -0.752 . . . . 0.0 109.882 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -169.35 -39.81 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.639 -0.663 . . . . 0.0 110.47 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.438 ' HA3' ' CZ2' ' A' ' 315' ' ' TRP . . . -61.66 -108.17 0.01 OUTLIER Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -149.39 17.41 0.93 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.547 -0.972 . . . . 0.0 111.284 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.66 86.12 6.93 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.157 -0.964 . . . . 0.0 109.934 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -134.02 89.26 2.55 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.628 -0.67 . . . . 0.0 110.505 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -173.73 -63.26 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.156 -0.965 . . . . 0.0 110.638 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.46 ' CD1' ' CG ' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -44.7 142.39 2.54 Favored Pre-proline 0 N--CA 1.51 2.553 0 O-C-N 121.741 -0.599 . . . . 0.0 112.336 -179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -85.41 -82.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.897 0 O-C-N 122.851 0.921 . . . . 0.0 110.301 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.9 m80 -145.84 107.82 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 0.0 110.118 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.7 m -79.82 158.79 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.493 -0.754 . . . . 0.0 110.23 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -89.75 126.82 35.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.553 -0.717 . . . . 0.0 110.283 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -106.48 121.37 44.15 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.611 -0.68 . . . . 0.0 110.219 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.402 ' CE1' ' HG2' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -108.46 123.04 38.52 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.586 -0.696 . . . . 0.0 109.907 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 332' ' ' ILE . 49.8 Cg_endo -75.69 -3.87 14.46 Favored 'Trans proline' 0 N--CA 1.484 0.941 0 O-C-N 123.172 1.091 . . . . 0.0 111.287 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.01 143.31 43.69 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.148 -0.97 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.632 HG21 ' HG3' ' A' ' 407' ' ' GLN . 45.1 pt -141.04 31.68 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.696 . . . . 0.0 110.459 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -161.42 -72.6 0.06 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.493 -0.755 . . . . 0.0 110.33 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.31 165.96 19.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.567 -0.708 . . . . 0.0 110.276 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.03 92.24 8.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.601 -0.687 . . . . 0.0 110.343 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.402 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 5.1 tt0 -114.58 -25.21 8.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.609 -0.682 . . . . 0.0 110.534 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 81.8 m -58.8 -27.44 65.04 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.416 -0.802 . . . . 0.0 110.519 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -95.81 25.59 4.57 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.534 -0.729 . . . . 0.0 110.51 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -121.87 95.8 4.81 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.509 -0.744 . . . . 0.0 110.245 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 340' ' ' LEU . 2.3 mm? -98.87 161.02 13.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.602 -0.686 . . . . 0.0 110.238 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 58.5 t -61.96 -48.98 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.554 -0.716 . . . . 0.0 109.977 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -160.64 -43.32 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.585 -0.697 . . . . 0.0 109.994 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -163.9 145.16 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.626 -0.671 . . . . 0.0 109.954 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.27 4.31 24.17 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.522 -0.736 . . . . 0.0 111.04 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 59.5 p -83.22 -31.57 26.97 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.173 -0.954 . . . . 0.0 110.241 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -73.38 -30.36 63.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.619 -0.675 . . . . 0.0 110.14 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 8.9 p -98.02 10.54 40.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.587 -0.696 . . . . 0.0 110.984 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.58 -26.3 13.58 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.171 -0.955 . . . . 0.0 110.425 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -110.82 76.22 1.17 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.432 -0.792 . . . . 0.0 110.241 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.18 -165.52 0.24 Allowed 'Trans proline' 0 C--N 1.317 -1.094 0 O-C-N 123.274 1.144 . . . . 0.0 110.395 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -106.5 -71.3 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.619 -0.676 . . . . 0.0 110.234 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -106.35 169.55 8.45 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.631 -0.668 . . . . 0.0 110.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -75.63 -22.96 56.35 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.595 -0.69 . . . . 0.0 110.565 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -113.59 27.14 9.8 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.407 -0.808 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -150.46 104.99 3.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.237 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -110.03 -25.86 10.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.548 -0.72 . . . . 0.0 110.383 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.55 -23.98 59.66 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.379 -0.825 . . . . 0.0 110.57 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 6.8 m -63.32 -15.64 57.93 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.399 -0.813 . . . . 0.0 110.962 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -54.39 -22.68 13.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.272 -0.892 . . . . 0.0 111.084 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -55.61 -22.63 23.34 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.341 -0.849 . . . . 0.0 110.858 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -10.89 57.22 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.337 -0.852 . . . . 0.0 111.171 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -74.18 -3.98 33.04 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.216 -0.928 . . . . 0.0 111.36 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 53.1 mt -58.88 -25.71 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.075 -1.016 . . . . 0.0 110.138 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.59 -27.76 66.56 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.562 -0.711 . . . . 0.0 110.287 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.26 -26.46 15.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.555 -0.716 . . . . 0.0 110.286 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -89.48 75.34 1.86 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -61.93 98.07 0.09 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.623 -0.928 . . . . 0.0 110.039 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 20.9 pttt -55.09 -22.36 16.11 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.466 -0.771 . . . . 0.0 111.094 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -92.58 -22.62 19.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.387 -0.82 . . . . 0.0 111.068 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -104.75 -25.19 12.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.318 -0.864 . . . . 0.0 110.786 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 36.0 p-10 -58.53 -27.85 64.91 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.436 -0.79 . . . . 0.0 110.629 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.63 93.39 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.509 -0.744 . . . . 0.0 110.494 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.3 t -105.18 13.82 30.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.652 -0.655 . . . . 0.0 111.041 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 6.6 tpt -105.15 -31.36 9.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.26 -0.9 . . . . 0.0 110.484 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.24 -52.0 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 110.208 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -66.61 -28.79 68.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.66 -0.65 . . . . 0.0 110.192 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.49 58.19 1.78 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.592 -0.693 . . . . 0.0 110.212 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -84.32 100.79 11.48 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.56 -0.713 . . . . 0.0 110.237 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -113.79 -27.16 7.89 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.655 -0.653 . . . . 0.0 110.388 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 381' ' ' PRO . 5.5 mt -58.56 -56.38 36.17 Favored Pre-proline 0 N--CA 1.497 1.901 0 O-C-N 121.525 -0.735 . . . . 0.0 110.567 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 380' ' ' LEU . 46.8 Cg_endo -73.54 -29.54 10.82 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.311 1.163 . . . . 0.0 110.285 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.96 83.47 1.89 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.65 -0.656 . . . . 0.0 109.929 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -115.91 -27.58 2.94 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -57.9 -18.74 24.85 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.527 -0.984 . . . . 0.0 111.237 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.44 18.07 5.64 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.163 -0.96 . . . . 0.0 111.169 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -82.56 -24.39 34.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.263 -0.898 . . . . 0.0 110.548 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.27 -18.05 46.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.447 -0.783 . . . . 0.0 110.48 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -74.36 -166.5 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.321 -0.862 . . . . 0.0 110.335 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -100.98 -170.91 1.91 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.676 -0.64 . . . . 0.0 110.211 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.11 162.61 9.21 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 110.144 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.43 -158.61 0.88 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.66 -0.65 . . . . 0.0 110.087 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 66.5 m -90.17 53.03 2.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.511 -0.743 . . . . 0.0 110.184 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -59.93 -27.42 66.75 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.554 -0.716 . . . . 0.0 110.389 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -115.2 43.84 1.6 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.85 171.62 1.15 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.563 -0.963 . . . . 0.0 110.336 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -163.24 38.11 0.33 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -83.52 -170.71 3.19 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.672 -0.899 . . . . 0.0 110.237 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -105.84 152.42 23.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.624 -0.672 . . . . 0.0 110.081 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.755 ' HA ' HD13 ' A' ' 426' ' ' ILE . 24.7 p-90 -160.38 48.83 0.26 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.55 -0.719 . . . . 0.0 110.325 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -157.9 -164.84 14.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -99.92 110.6 22.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.647 -0.914 . . . . 0.0 110.318 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -107.98 111.41 23.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.492 -0.755 . . . . 0.0 110.142 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -123.34 111.02 15.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.446 -0.784 . . . . 0.0 109.885 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 38.2 p -91.35 85.76 5.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.493 -0.754 . . . . 0.0 110.607 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -121.01 -65.31 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.656 -0.652 . . . . 0.0 109.397 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 87.8 m -120.73 -68.0 0.94 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.751 -0.593 . . . . 0.0 109.661 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . 0.632 ' HG3' HG21 ' A' ' 332' ' ' ILE . 8.4 tt0 -174.26 68.8 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.587 -0.696 . . . . 0.0 109.963 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -150.07 127.58 11.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.354 -0.841 . . . . 0.0 110.461 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 46.5 t -124.3 114.85 20.12 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.607 -0.683 . . . . 0.0 110.039 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -98.46 140.96 31.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.495 -0.753 . . . . 0.0 110.398 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.4 mp -139.38 118.84 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.579 -0.701 . . . . 0.0 110.044 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -157.32 -85.2 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.71 . . . . 0.0 110.087 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.458 ' C ' HG13 ' A' ' 414' ' ' VAL . 15.4 t-20 -173.85 -63.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.106 -0.996 . . . . 0.0 110.241 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.458 HG13 ' C ' ' A' ' 413' ' ' ASN . 35.5 m -150.42 173.12 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.506 -0.746 . . . . 0.0 110.119 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.71 134.33 7.79 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.549 -0.719 . . . . 0.0 110.284 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.21 -164.85 0.23 Allowed 'Trans proline' 0 N--CA 1.486 1.083 0 O-C-N 123.185 1.097 . . . . 0.0 110.416 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 77.7 p -55.45 116.4 2.84 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.418 -0.802 . . . . 0.0 110.418 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 5.1 t -159.72 169.71 23.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.657 . . . . 0.0 110.112 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.749 ' O ' HD12 ' A' ' 419' ' ' LEU . 2.8 pp -93.94 36.84 1.1 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.426 -0.796 . . . . 0.0 111.137 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 420' ' ' ILE . 4.2 mp -137.07 60.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.313 -0.867 . . . . 0.0 109.71 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -79.96 117.58 20.93 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.574 -0.704 . . . . 0.0 110.207 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -124.03 -179.93 4.6 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.594 -0.692 . . . . 0.0 110.199 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 4.1 m -76.12 87.85 3.01 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.646 -0.659 . . . . 0.0 110.063 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.92 80.53 8.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.544 -0.722 . . . . 0.0 110.254 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -93.65 87.7 5.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.549 -0.72 . . . . 0.0 110.239 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.755 HD13 ' HA ' ' A' ' 399' ' ' TRP . 49.5 mm -90.63 110.17 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.569 -0.707 . . . . 0.0 110.0 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -165.12 66.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 0.0 110.259 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 12.6 p -99.9 -51.99 3.56 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.61 -0.681 . . . . 0.0 110.177 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 14.1 p -134.25 109.85 9.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.52 -0.737 . . . . 0.0 110.223 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.59 157.97 25.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.622 -0.674 . . . . 0.0 110.185 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 90.5 mt -106.61 39.51 1.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.567 -0.708 . . . . 0.0 110.208 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 90.9 p -165.33 -170.98 2.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.52 -0.737 . . . . 0.0 110.269 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -96.01 151.94 38.61 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.501 -0.749 . . . . 0.0 110.128 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 126.9 11.79 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.368 1.194 . . . . 0.0 110.368 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.499 ' O ' HG23 ' A' ' 435' ' ' ILE . 1.2 tp -151.11 61.61 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.645 -0.659 . . . . 0.0 110.15 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.113 -179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.6 ttm . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.085 0.469 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.6 ptt85 -168.53 48.48 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.626 -0.671 . . . . 0.0 110.32 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -153.98 119.35 0.93 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.0 m -141.08 37.58 1.75 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.974 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -113.2 84.99 2.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.608 -0.683 . . . . 0.0 110.189 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . 0.405 ' O ' ' CD2' ' A' ' -7' ' ' HIS . 0.6 OUTLIER -164.75 67.13 0.14 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.623 -0.673 . . . . 0.0 110.37 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -76.6 -71.78 0.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -166.32 -56.05 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.714 . . . . 0.0 110.185 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -83.82 165.3 18.9 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.609 -0.682 . . . . 0.0 110.212 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -164.45 -167.04 1.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.517 -0.74 . . . . 0.0 110.248 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -159.22 172.21 35.86 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 44.7 t -119.24 51.41 1.14 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.498 -1.001 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -168.05 -153.69 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.705 . . . . 0.0 109.866 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -63.03 128.93 38.12 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.457 -0.777 . . . . 0.0 109.962 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 5.6 pttt -168.81 33.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.683 -0.635 . . . . 0.0 109.661 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.436 ' CZ ' ' CD1' ' A' ' 323' ' ' ILE . 2.3 t80 -129.2 -146.13 0.31 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.784 -0.572 . . . . 0.0 109.655 -179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -146.05 28.51 1.7 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 3.8 tp -91.51 -163.96 1.11 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.56 -0.965 . . . . 0.0 110.095 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.64 ' HD1' HD12 ' A' ' 419' ' ' LEU . 0.4 OUTLIER -165.9 160.12 16.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.479 -0.763 . . . . 0.0 110.005 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.613 ' O ' HG13 ' A' ' 316' ' ' VAL . 7.4 p -104.46 87.65 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -178.65 -148.83 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -150.56 65.44 0.38 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.1 22.48 0.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.478 -1.013 . . . . 0.0 110.918 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.452 ' HB2' ' CZ2' ' A' ' 315' ' ' TRP . 85.3 m -135.9 170.43 16.0 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.265 -0.897 . . . . 0.0 110.722 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 171.19 15.33 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.85 -0.531 . . . . 0.0 110.129 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -63.63 -150.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.671 -0.643 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 323' ' ' ILE . 6.8 tp -48.44 104.3 0.41 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.183 -0.948 . . . . 0.0 111.061 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.12 163.01 7.19 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 O-C-N 123.16 1.084 . . . . 0.0 110.75 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -145.32 89.92 1.98 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.652 -0.655 . . . . 0.0 109.929 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.719 HG12 ' HB2' ' A' ' 412' ' ' PHE . 34.0 m -105.64 155.13 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.507 -0.746 . . . . 0.0 110.412 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -102.03 131.11 48.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.638 -0.663 . . . . 0.0 110.085 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -93.53 136.0 34.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.616 -0.678 . . . . 0.0 110.32 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -107.83 100.86 37.73 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.635 -0.666 . . . . 0.0 110.067 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.12 68.54 2.48 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.352 1.185 . . . . 0.0 110.393 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -58.5 90.69 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.516 -0.74 . . . . 0.0 110.269 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.11 -24.15 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.634 -0.666 . . . . 0.0 110.584 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -154.92 77.82 1.03 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.252 -0.905 . . . . 0.0 110.889 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.564 ' C ' HD12 ' A' ' 334' ' ' LEU . 4.4 pp -172.73 -166.78 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.484 -0.76 . . . . 0.0 110.126 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.537 ' N ' HD12 ' A' ' 334' ' ' LEU . 34.8 t80 -79.67 -65.36 1.01 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.54 -0.725 . . . . 0.0 110.48 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -157.16 -166.74 2.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.468 -0.77 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 71.6 m -97.1 32.88 2.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.544 -0.722 . . . . 0.0 110.258 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.72 -28.64 21.64 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.601 -0.687 . . . . 0.0 110.241 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.536 ' O ' HD22 ' A' ' 340' ' ' LEU . 10.5 mttp -80.87 174.86 11.2 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.508 -0.745 . . . . 0.0 110.163 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 339' ' ' LYS . 1.4 mm? -124.67 133.69 53.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.629 -0.669 . . . . 0.0 110.245 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.465 HG22 ' N ' ' A' ' 342' ' ' PHE . 8.6 p -93.21 167.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.574 -0.704 . . . . 0.0 110.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.465 ' N ' HG22 ' A' ' 341' ' ' VAL . 2.0 t80 -71.54 65.53 0.46 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.53 -0.731 . . . . 0.0 110.076 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.43 -43.48 0.19 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.555 -0.716 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.688 ' O ' HD23 ' A' ' 344' ' ' LEU . 1.0 OUTLIER -80.54 2.54 25.02 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.599 -0.688 . . . . 0.0 111.405 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 4.5 p -60.06 -34.38 73.34 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.033 -1.042 . . . . 0.0 110.221 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -89.72 -28.59 19.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.541 -0.725 . . . . 0.0 110.093 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 27.5 m -89.39 10.54 22.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.506 -0.747 . . . . 0.0 110.932 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -58.65 -33.39 70.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.128 -0.983 . . . . 0.0 110.428 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -143.36 135.94 13.51 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.578 -0.701 . . . . 0.0 110.108 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.39 179.19 6.11 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.237 1.125 . . . . 0.0 110.471 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -108.11 158.08 17.72 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.551 -0.718 . . . . 0.0 110.107 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -140.8 139.28 34.52 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.596 -0.69 . . . . 0.0 110.241 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -62.69 -44.45 96.22 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.614 -0.679 . . . . 0.0 109.984 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -170.59 65.68 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.654 -0.654 . . . . 0.0 110.287 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -142.41 -73.82 0.3 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.534 -0.728 . . . . 0.0 110.054 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -99.35 18.29 18.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.522 -0.736 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 2.7 tp -88.75 -40.04 13.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.346 -0.846 . . . . 0.0 109.932 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -27.92 22.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.568 -0.707 . . . . 0.0 110.353 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.39 -30.42 68.42 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.545 -0.722 . . . . 0.0 110.327 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -84.62 -15.71 44.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.555 -0.716 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.11 -30.43 13.54 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.214 -0.929 . . . . 0.0 110.242 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -65.07 -16.77 63.83 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.533 -0.73 . . . . 0.0 110.815 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.28 -30.01 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.247 -0.908 . . . . 0.0 110.732 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -100.02 -14.71 18.53 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.57 -0.706 . . . . 0.0 110.949 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -55.81 -23.22 28.97 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.184 -0.948 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.95 65.27 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -56.77 100.91 0.05 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.449 -1.03 . . . . 0.0 110.57 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -48.89 -28.05 3.51 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.604 -0.685 . . . . 0.0 110.575 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -95.38 53.04 1.45 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -45.79 121.49 3.18 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.759 -0.588 . . . . 0.0 111.787 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -99.66 -9.04 23.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.741 -0.599 . . . . 0.0 110.755 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -56.09 -26.99 51.92 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.115 -0.99 . . . . 0.0 110.461 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 67.5 m -59.88 -32.81 71.06 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.558 -0.714 . . . . 0.0 110.065 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 5.1 mtt -98.36 -32.32 11.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.572 -0.705 . . . . 0.0 110.06 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 84.1 mt -72.43 -28.19 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.637 -0.665 . . . . 0.0 110.029 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -56.34 -27.64 56.51 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.517 -0.74 . . . . 0.0 110.473 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 19.9 m -85.14 -30.48 23.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.629 -0.67 . . . . 0.0 109.972 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -121.35 90.74 3.37 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.643 -0.66 . . . . 0.0 110.033 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -58.28 -25.86 62.29 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.551 -0.718 . . . . 0.0 110.578 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 99.3 mt -124.35 95.74 42.83 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.514 -0.741 . . . . 0.0 110.241 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.6 -48.79 0.29 Allowed 'Trans proline' 0 C--N 1.317 -1.104 0 O-C-N 123.345 1.182 . . . . 0.0 110.542 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 33.6 m -159.55 -63.89 0.07 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.737 -0.602 . . . . 0.0 110.404 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -145.85 74.42 0.3 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -89.97 14.68 11.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.589 -0.947 . . . . 0.0 110.681 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -90.18 -29.74 18.05 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.299 -0.875 . . . . 0.0 110.132 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -80.36 -23.61 40.39 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.681 -0.637 . . . . 0.0 110.633 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -59.67 -18.69 44.13 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.35 -0.844 . . . . 0.0 110.397 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.78 -168.84 0.5 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.448 -0.783 . . . . 0.0 110.267 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -126.03 23.92 7.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.597 -0.69 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -55.54 -23.4 26.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.324 -0.86 . . . . 0.0 110.848 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.22 172.11 0.34 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.341 -0.85 . . . . 0.0 110.6 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 9.9 t -86.78 55.8 3.73 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.623 -0.673 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -104.45 76.85 1.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 0.0 110.203 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 127.76 -29.39 4.21 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.49 114.12 2.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.549 -0.971 . . . . 0.0 110.352 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -168.8 -53.12 0.03 OUTLIER Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -67.42 -177.09 0.66 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.555 -0.968 . . . . 0.0 110.402 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -119.27 139.59 51.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.587 -0.696 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.4 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 40.2 p-90 -145.56 54.94 1.19 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.516 -0.74 . . . . 0.0 110.331 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -146.21 -169.98 14.51 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -101.86 160.63 14.31 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.745 -0.856 . . . . 0.0 110.016 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -136.37 120.29 17.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 109.757 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -107.13 126.78 52.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.395 -0.815 . . . . 0.0 109.972 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 404' ' ' THR . 7.4 t -89.73 85.4 6.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -120.98 -65.18 1.17 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.742 . . . . 0.0 109.431 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 95.4 m -120.62 -70.31 0.79 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.746 -0.596 . . . . 0.0 109.592 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -174.46 66.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 110.107 179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -150.02 175.66 11.5 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.322 -0.861 . . . . 0.0 111.111 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 82.7 m -133.67 -179.64 5.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.757 -0.59 . . . . 0.0 109.833 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -139.31 144.63 38.38 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.588 -0.695 . . . . 0.0 110.186 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . . . . . . . . . 4.3 mp -140.1 134.77 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.632 -0.667 . . . . 0.0 109.891 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.719 ' HB2' HG12 ' A' ' 326' ' ' VAL . 31.2 t80 -168.66 -71.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.452 -0.78 . . . . 0.0 110.388 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.419 ' ND2' ' CE2' ' A' ' 412' ' ' PHE . 52.1 p30 -168.51 -149.51 0.09 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.357 -0.84 . . . . 0.0 110.094 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.6 p -51.9 167.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.165 -0.96 . . . . 0.0 110.777 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.47 ' N ' HG22 ' A' ' 414' ' ' VAL . 0.0 OUTLIER -108.13 81.7 1.34 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.587 -0.695 . . . . 0.0 110.653 -179.693 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . 0.469 ' HD3' HG13 ' A' ' 414' ' ' VAL . 45.7 Cg_endo -72.27 147.67 47.99 Favored 'Trans proline' 0 C--N 1.316 -1.146 0 O-C-N 123.224 1.118 . . . . 0.0 110.103 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 6.3 m -59.2 95.51 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.571 -0.705 . . . . 0.0 110.249 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -129.64 160.97 31.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.657 -0.652 . . . . 0.0 110.172 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.64 HD12 ' HD1' ' A' ' 315' ' ' TRP . 72.9 mt -80.29 0.75 31.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.515 -0.74 . . . . 0.0 111.088 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 17.5 mt -107.26 -27.34 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.117 -0.99 . . . . 0.0 109.78 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -79.91 139.83 36.94 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.565 -0.709 . . . . 0.0 110.136 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -64.22 1.34 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.691 -0.631 . . . . 0.0 110.241 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.67 160.84 27.62 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.555 -0.716 . . . . 0.0 110.021 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 73.0 p -169.39 139.78 2.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.56 -0.712 . . . . 0.0 110.236 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -169.48 155.64 6.28 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.554 -0.716 . . . . 0.0 110.359 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 4.3 mp -139.07 105.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.683 -0.636 . . . . 0.0 109.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -167.22 109.71 0.67 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.626 -0.672 . . . . 0.0 110.084 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.06 -37.87 88.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.597 -0.689 . . . . 0.0 110.086 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.58 ' O ' HG23 ' A' ' 429' ' ' THR . 7.5 t -143.66 110.99 5.81 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.598 -0.689 . . . . 0.0 110.363 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -118.71 -158.84 0.74 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.575 -0.703 . . . . 0.0 110.06 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 431' ' ' LEU . 2.8 mm? -96.27 63.99 2.24 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.582 -0.699 . . . . 0.0 110.072 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 22.3 m -150.14 102.6 3.11 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.546 -0.721 . . . . 0.0 110.136 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -129.31 67.04 78.13 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.725 . . . . 0.0 110.257 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.78 -27.95 14.24 Favored 'Trans proline' 0 C--N 1.317 -1.124 0 O-C-N 123.341 1.179 . . . . 0.0 110.507 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -62.27 -43.57 98.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.645 -0.659 . . . . 0.0 109.951 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.137 179.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 28.3 ttp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.091 0.472 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -106.52 80.7 1.5 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.576 -0.703 . . . . 0.0 110.179 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -128.56 118.25 2.72 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 17.5 t -86.04 -43.72 12.89 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.611 -0.935 . . . . 0.0 110.232 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -107.2 29.36 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.521 -0.737 . . . . 0.0 110.273 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -116.8 158.64 23.58 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.521 -0.737 . . . . 0.0 110.206 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -109.48 43.62 1.28 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.592 -0.692 . . . . 0.0 110.317 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -102.69 131.08 49.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.526 -0.734 . . . . 0.0 110.246 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -137.25 168.82 18.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.285 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 10.6 p80 -135.58 58.83 1.74 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.687 . . . . 0.0 110.435 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -71.51 148.11 43.19 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -124.71 178.74 5.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.531 -0.982 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -160.03 136.52 8.96 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.61 -0.681 . . . . 0.0 110.288 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -146.21 61.34 1.24 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.563 -0.711 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -110.22 173.98 6.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.525 -0.734 . . . . 0.0 110.104 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -144.77 64.66 1.28 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.567 -0.708 . . . . 0.0 110.327 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -110.9 90.43 0.57 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 322' ' ' ASP . 0.6 OUTLIER -107.81 -165.57 1.06 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.954 . . . . 0.0 110.567 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.446 ' CZ2' HD23 ' A' ' 419' ' ' LEU . 68.2 t-105 -143.89 134.12 24.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.613 -0.68 . . . . 0.0 109.467 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.6 HG23 HD12 ' A' ' 314' ' ' LEU . 57.9 t -142.23 89.79 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.566 -0.709 . . . . 0.0 109.877 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.58 -43.13 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 110.073 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -85.92 -90.96 0.89 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -149.94 26.74 0.8 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.572 -0.958 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 61.5 m -89.34 170.71 10.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 110.671 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 170.58 9.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.879 -0.513 . . . . 0.0 110.346 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.702 ' O ' HD13 ' A' ' 314' ' ' LEU . 7.0 t70 -58.13 -42.01 84.91 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.558 -0.714 . . . . 0.0 110.557 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.62 ' O ' HG23 ' A' ' 323' ' ' ILE . 5.6 tp -156.78 106.79 1.96 Allowed Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.547 -0.72 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.46 -165.21 0.23 Allowed 'Trans proline' 0 N--CA 1.485 0.993 0 O-C-N 122.99 0.995 . . . . 0.0 110.254 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.66 96.32 4.74 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.514 -0.742 . . . . 0.0 110.393 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.775 HG12 ' CG ' ' A' ' 412' ' ' PHE . 35.7 m -135.14 159.7 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.573 -0.704 . . . . 0.0 110.195 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -89.96 125.83 35.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.579 -0.701 . . . . 0.0 110.023 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.6 135.99 48.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.559 -0.713 . . . . 0.0 110.311 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.15 89.49 10.02 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.555 -0.716 . . . . 0.0 109.828 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -78.57 -49.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 123.504 1.265 . . . . 0.0 110.656 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -76.6 -171.57 1.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.56 -0.712 . . . . 0.0 110.549 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 13.2 pt -129.06 99.6 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.652 -0.655 . . . . 0.0 110.355 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -60.54 -60.75 3.3 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 0.0 110.219 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 334' ' ' LEU . 0.2 OUTLIER -123.78 -65.31 1.08 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.582 -0.698 . . . . 0.0 110.225 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 43.5 t80 -102.26 -63.58 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.267 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -167.17 -62.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.547 -0.72 . . . . 0.0 110.431 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . 0.441 ' SG ' HD11 ' A' ' 411' ' ' ILE . 44.0 t -151.98 87.6 1.35 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.455 -0.778 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -158.18 -40.81 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.499 -0.751 . . . . 0.0 110.608 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.73 87.94 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.454 -0.779 . . . . 0.0 110.131 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 13.5 mt -143.82 37.5 1.31 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.57 -0.706 . . . . 0.0 110.251 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 57.6 t -88.97 82.85 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.567 -0.708 . . . . 0.0 109.953 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -130.07 -53.66 1.12 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.56 -0.712 . . . . 0.0 110.329 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -166.81 -41.22 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.552 -0.717 . . . . 0.0 110.437 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 18.2 tp -58.35 -27.6 64.33 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.5 -0.75 . . . . 0.0 110.535 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 1.8 t -80.49 -25.94 38.5 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.752 . . . . 0.0 110.489 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.72 -29.84 68.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.457 -0.777 . . . . 0.0 110.364 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 13.0 m -95.23 10.51 35.77 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.624 -0.673 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.98 -33.74 15.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.161 -0.962 . . . . 0.0 110.255 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.09 73.95 13.48 Favored Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.501 -0.749 . . . . 0.0 110.382 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.69 -29.54 15.74 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.355 1.187 . . . . 0.0 110.204 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.0 mtpp -95.62 -169.8 2.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.592 -0.693 . . . . 0.0 110.079 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -81.03 73.16 8.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.552 -0.718 . . . . 0.0 110.258 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -122.81 28.0 7.48 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.522 -0.736 . . . . 0.0 110.085 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -139.04 27.03 2.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.616 -0.677 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -67.23 152.77 45.14 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.498 -0.751 . . . . 0.0 110.224 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . 0.447 ' HB3' ' CD2' ' A' ' 360' ' ' TYR . 34.7 m-70 -107.45 18.66 21.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.6 -0.688 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.1 mp -59.79 -27.46 66.58 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.315 -0.866 . . . . 0.0 110.23 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 13.9 m -77.53 -28.02 51.84 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.526 -0.734 . . . . 0.0 110.331 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.42 -27.13 16.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.546 -0.721 . . . . 0.0 110.349 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.557 ' O ' HG22 ' A' ' 363' ' ' ILE . 3.5 m-85 -80.47 1.32 29.77 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.538 -0.726 . . . . 0.0 111.148 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -56.51 -26.79 55.55 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.977 -1.077 . . . . 0.0 110.538 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -87.0 10.23 17.06 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.583 -0.698 . . . . 0.0 111.251 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 366' ' ' GLY . 6.0 tp -66.9 -21.11 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.189 -0.944 . . . . 0.0 110.775 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -54.99 -38.45 67.85 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.379 -0.825 . . . . 0.0 110.811 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -91.97 -25.81 18.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.702 -0.624 . . . . 0.0 110.194 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.58 ' O ' HD12 ' A' ' 363' ' ' ILE . . . -116.38 71.12 0.27 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -90.24 15.65 10.03 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.59 -0.947 . . . . 0.0 111.11 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 13.7 pttp -115.2 32.2 6.2 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.27 -0.894 . . . . 0.0 110.132 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -114.56 -40.21 3.64 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.596 -0.69 . . . . 0.0 110.164 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.445 ' HE2' ' CE1' ' A' ' 360' ' ' TYR . 26.0 mttt -69.33 -35.09 75.57 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.555 -0.716 . . . . 0.0 110.03 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -65.57 -28.74 69.37 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.694 -0.629 . . . . 0.0 110.187 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -61.82 -32.69 73.02 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.593 -0.692 . . . . 0.0 110.115 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 41.1 t -104.98 -15.84 15.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.672 -0.642 . . . . 0.0 110.837 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.613 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 11.3 mtt -85.62 9.61 15.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 111.317 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.75 -30.85 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.096 -1.003 . . . . 0.0 109.757 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -65.05 -28.98 69.85 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.71 -0.619 . . . . 0.0 110.233 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 380' ' ' LEU . 5.8 t -134.75 33.42 3.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.612 -0.68 . . . . 0.0 110.265 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -93.6 44.39 1.13 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.515 -0.741 . . . . 0.0 110.22 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -155.75 27.77 0.38 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.621 -0.674 . . . . 0.0 110.223 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' A' ' 377' ' ' SER . 0.5 OUTLIER -163.18 56.64 0.59 Allowed Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.259 179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.41 63.85 3.63 Favored 'Trans proline' 0 N--CA 1.487 1.099 0 O-C-N 123.4 1.21 . . . . 0.0 110.529 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 6.5 m -127.66 -41.96 1.65 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.518 -0.739 . . . . 0.0 110.237 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -126.29 52.44 0.81 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 387' ' ' ALA . . . -57.55 -21.15 36.73 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.642 -0.916 . . . . 0.0 110.779 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -59.39 -60.5 3.75 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -86.23 -26.61 24.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.653 -0.654 . . . . 0.0 110.264 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 384' ' ' ALA . . . -65.09 -13.85 59.04 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.563 -0.71 . . . . 0.0 110.584 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.63 166.3 3.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.212 -0.93 . . . . 0.0 110.286 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.46 -176.95 4.32 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.671 -0.643 . . . . 0.0 110.285 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -54.5 113.01 1.13 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.446 -0.783 . . . . 0.0 110.749 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -79.47 -162.37 0.4 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.16 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 7.5 m -83.37 58.37 4.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.589 -0.695 . . . . 0.0 110.064 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -67.69 76.28 0.19 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.71 -0.619 . . . . 0.0 110.155 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 170.72 -45.41 0.2 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.48 73.25 0.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.707 -0.878 . . . . 0.0 110.353 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -127.9 -55.6 0.12 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -141.75 -174.01 3.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.976 . . . . 0.0 110.081 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -90.63 149.58 22.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.583 -0.698 . . . . 0.0 110.088 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.408 ' O ' ' CE3' ' A' ' 399' ' ' TRP . 47.2 p-90 -148.62 49.97 1.01 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.552 -0.717 . . . . 0.0 110.399 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -155.74 168.42 33.33 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -105.82 159.09 16.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.554 -0.968 . . . . 0.0 110.049 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 52.1 m-85 -120.5 120.98 37.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 110.022 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -92.16 112.2 24.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.573 -0.704 . . . . 0.0 109.488 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 56.6 m -89.74 84.58 6.29 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.54 -0.725 . . . . 0.0 110.65 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -121.95 -66.03 1.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 76.8 p -121.35 -67.54 0.96 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.352 0.596 . . . . 0.0 109.432 179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -173.36 69.76 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.829 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -150.08 -179.96 7.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.274 -0.891 . . . . 0.0 111.171 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 48.0 t -146.98 161.33 41.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.769 -0.582 . . . . 0.0 109.82 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.567 ' C ' HD12 ' A' ' 411' ' ' ILE . 8.0 mt-10 -136.83 143.86 43.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.484 -0.76 . . . . 0.0 110.409 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.567 HD12 ' C ' ' A' ' 410' ' ' GLU . 5.3 mp -141.42 147.15 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.465 -0.772 . . . . 0.0 110.238 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.775 ' CG ' HG12 ' A' ' 326' ' ' VAL . 34.8 t80 -169.33 -64.9 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.573 -0.705 . . . . 0.0 109.995 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -169.22 -173.85 1.85 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.535 -0.728 . . . . 0.0 110.1 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.54 171.21 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.53 -0.731 . . . . 0.0 110.111 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -54.72 108.69 1.22 Allowed Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.574 -0.704 . . . . 0.0 110.665 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -83.53 -168.4 0.56 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 O-C-N 123.235 1.124 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 11.2 m -94.4 50.07 1.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.585 -0.697 . . . . 0.0 109.705 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 12.6 t -146.59 127.06 14.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 110.136 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.446 HD23 ' CZ2' ' A' ' 315' ' ' TRP . 39.2 tp -80.02 99.21 7.55 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.806 -0.559 . . . . 0.0 109.59 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 7.0 tt -159.21 27.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.43 -0.794 . . . . 0.0 110.379 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -142.89 170.07 16.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.556 -0.715 . . . . 0.0 110.378 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -118.09 -64.98 1.22 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.5 -0.75 . . . . 0.0 110.179 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 8.1 t -101.67 148.02 25.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.487 -0.758 . . . . 0.0 110.202 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 30.5 p -162.12 120.42 2.24 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 110.33 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.445 ' CE1' ' CE1' ' A' ' 402' ' ' TYR . 45.2 p90 -158.62 176.16 12.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.571 -0.706 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 426' ' ' ILE . 90.0 mt -130.41 70.14 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.556 -0.715 . . . . 0.0 109.955 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -131.07 135.2 47.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.567 -0.708 . . . . 0.0 110.172 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 3.8 m -60.92 -48.34 82.25 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.524 -0.735 . . . . 0.0 110.16 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 9.1 m -154.03 98.28 2.15 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.528 -0.733 . . . . 0.0 110.226 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -166.69 153.83 9.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.55 -0.719 . . . . 0.0 110.277 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 431' ' ' LEU . 4.5 mm? -91.16 123.59 34.73 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.56 -0.713 . . . . 0.0 110.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 43.1 t -116.06 108.46 16.23 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.51 -0.744 . . . . 0.0 110.274 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -144.54 53.64 2.27 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.588 -0.695 . . . . 0.0 110.144 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.84 134.49 21.88 Favored 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.314 1.165 . . . . 0.0 110.468 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 435' ' ' ILE . 5.5 tt -123.42 58.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.594 -0.691 . . . . 0.0 110.129 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.154 179.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.6 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.055 0.455 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 20.7 ttt-85 -94.34 107.88 19.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.6 -0.688 . . . . 0.0 110.162 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -148.77 124.9 1.92 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 16.8 m -85.15 -37.42 20.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.947 . . . . 0.0 110.137 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -167.56 168.63 12.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.584 -0.697 . . . . 0.0 110.249 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . 0.427 ' CD2' ' N ' ' A' ' -7' ' ' HIS . 4.6 p80 -148.39 60.46 1.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.619 -0.676 . . . . 0.0 110.248 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -94.87 91.82 6.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.473 -0.767 . . . . 0.0 110.164 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -118.56 -60.09 1.81 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.615 -0.678 . . . . 0.0 110.104 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.2 t-80 -102.27 164.98 11.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.677 -0.639 . . . . 0.0 110.18 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -91.66 143.38 26.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.557 -0.714 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -103.99 51.54 0.81 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.2 p -166.76 -41.71 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.648 -0.913 . . . . 0.0 110.14 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.23 -29.14 69.65 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.58 -0.7 . . . . 0.0 110.153 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -61.61 113.78 2.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.581 -0.7 . . . . 0.0 110.122 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 8.1 mtpt -107.75 -26.65 10.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.605 -0.685 . . . . 0.0 110.348 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -104.71 -79.84 0.55 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.485 -0.759 . . . . 0.0 110.231 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . 0.525 ' C ' HD13 ' A' ' 314' ' ' LEU . . . -150.34 -64.76 0.01 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.74 ' N ' HD13 ' A' ' 314' ' ' LEU . 0.0 OUTLIER -150.4 167.78 26.08 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.617 -0.931 . . . . 0.0 110.764 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.838 ' NE1' HD11 ' A' ' 419' ' ' LEU . 0.2 OUTLIER -76.04 170.11 16.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 0.0 110.112 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.66 87.63 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.522 -0.736 . . . . 0.0 109.574 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -178.16 35.27 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.589 -0.694 . . . . 0.0 109.987 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -152.81 -117.85 0.71 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -145.3 40.08 1.21 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.506 -0.996 . . . . 0.0 110.761 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 51.9 t -89.53 158.06 17.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.502 -0.749 . . . . 0.0 109.773 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -70.13 170.54 11.32 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.762 -0.587 . . . . 0.0 110.226 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -53.77 -52.94 58.62 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.542 -0.724 . . . . 0.0 110.886 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 323' ' ' ILE . 2.5 tt -165.59 104.73 0.74 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.495 -0.753 . . . . 0.0 110.573 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.453 ' HD2' HD12 ' A' ' 314' ' ' LEU . 48.8 Cg_endo -74.17 104.95 1.94 Allowed 'Trans proline' 0 N--CA 1.485 1.026 0 O-C-N 123.096 1.05 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -85.18 96.41 9.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.622 -0.674 . . . . 0.0 110.107 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.435 ' HA ' ' CD1' ' A' ' 412' ' ' PHE . 35.2 m -79.9 159.23 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.603 -0.685 . . . . 0.0 110.397 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -89.83 127.46 35.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.565 -0.709 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -93.92 159.17 15.3 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.603 -0.685 . . . . 0.0 110.394 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -156.17 98.22 2.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.651 -0.655 . . . . 0.0 110.021 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.49 67.96 2.82 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 123.341 1.179 . . . . 0.0 110.232 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -65.02 89.89 0.08 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.582 -0.699 . . . . 0.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.6 pt -111.28 -25.29 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.532 -0.73 . . . . 0.0 110.38 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.08 -26.83 11.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.423 -0.798 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . 0.475 HD21 ' HD2' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -87.04 -157.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.522 -0.736 . . . . 0.0 110.3 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -95.81 -56.77 2.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -159.47 -157.28 0.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.541 -0.724 . . . . 0.0 110.185 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 4.1 m -84.22 56.5 3.79 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.537 -0.727 . . . . 0.0 110.253 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -122.71 22.23 9.84 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.492 -0.755 . . . . 0.0 110.826 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.536 ' N ' HD23 ' A' ' 340' ' ' LEU . 16.6 tttt -146.18 76.85 1.47 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.419 -0.801 . . . . 0.0 110.475 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.536 HD23 ' N ' ' A' ' 339' ' ' LYS . 0.8 OUTLIER -169.92 54.64 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.495 -0.753 . . . . 0.0 110.296 179.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . . . . . . . . . 59.1 t -115.47 100.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.472 -0.767 . . . . 0.0 110.041 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -168.07 -48.36 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.62 -0.675 . . . . 0.0 110.187 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -132.72 32.96 3.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.49 -0.756 . . . . 0.0 110.275 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.432 HD23 ' C ' ' A' ' 344' ' ' LEU . 10.1 tt -101.9 -28.29 12.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.616 -0.677 . . . . 0.0 110.376 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 6.1 m -86.53 -28.25 23.49 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.53 -0.731 . . . . 0.0 110.341 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.52 -37.54 82.91 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.521 -0.737 . . . . 0.0 110.286 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 14.2 p -93.74 10.53 32.58 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.499 -0.751 . . . . 0.0 111.02 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.96 -27.92 16.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.47 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 -153.55 89.62 3.51 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.572 -0.705 . . . . 0.0 110.48 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.14 -20.24 21.81 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 O-C-N 123.458 1.241 . . . . 0.0 110.701 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -53.13 -54.81 30.28 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.334 -0.854 . . . . 0.0 111.02 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -48.73 95.0 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.661 -0.649 . . . . 0.0 111.507 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -103.27 -31.83 9.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.695 -0.628 . . . . 0.0 109.596 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -121.63 65.53 0.9 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.706 -0.621 . . . . 0.0 109.727 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.9 97.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.509 -0.744 . . . . 0.0 111.308 -179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -110.11 -29.19 8.31 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.474 -0.767 . . . . 0.0 109.999 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.535 ' N ' HD12 ' A' ' 357' ' ' LEU . 6.7 mp -78.3 -15.63 58.55 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.636 -0.665 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 29.0 m -51.52 -24.27 5.01 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.162 -0.961 . . . . 0.0 111.203 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.01 -18.07 62.61 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.418 -0.801 . . . . 0.0 110.733 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -98.05 1.75 48.06 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 111.589 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.37 -10.85 55.14 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.087 -1.008 . . . . 0.0 111.112 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -50.93 -24.26 3.49 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.027 -1.046 . . . . 0.0 111.271 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 364' ' ' LYS . 2.7 pp -56.43 -38.15 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.284 -0.885 . . . . 0.0 110.664 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.662 ' N ' HD12 ' A' ' 363' ' ' ILE . 0.4 OUTLIER -100.64 -22.89 14.79 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.546 -0.721 . . . . 0.0 109.788 178.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 367' ' ' PHE . 0.6 OUTLIER -96.19 23.07 6.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.549 -0.72 . . . . 0.0 110.411 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -60.68 80.43 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.432 ' N ' ' O ' ' A' ' 365' ' ' GLU . 1.6 m-85 -77.2 106.7 9.09 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.68 -0.894 . . . . 0.0 108.929 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -39.69 -31.49 0.11 Allowed 'General case' 0 N--CA 1.511 2.588 0 CA-C-O 121.281 0.562 . . . . 0.0 111.929 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -98.42 43.77 1.05 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.648 -0.658 . . . . 0.0 109.448 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.0 ttmm -79.34 -55.35 5.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.654 -0.654 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -81.81 7.09 13.62 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.53 -0.731 . . . . 0.0 111.69 -179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -87.65 -42.99 12.28 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.163 -0.961 . . . . 0.0 110.295 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 15.5 m -106.15 -19.8 13.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.609 -0.682 . . . . 0.0 111.459 -179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.723 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 17.5 mmt -78.89 0.51 27.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.229 -0.919 . . . . 0.0 111.554 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.32 -29.45 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.112 -0.992 . . . . 0.0 109.662 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -101.49 -23.81 14.26 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.722 -0.611 . . . . 0.0 110.427 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 27.6 t -115.53 26.04 10.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.453 -0.78 . . . . 0.0 110.716 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -71.2 65.49 0.4 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.493 -0.755 . . . . 0.0 110.26 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.608 ' C ' HD13 ' A' ' 380' ' ' LEU . 10.2 m-85 -161.27 91.24 0.85 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.504 -0.747 . . . . 0.0 110.076 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.745 HD13 ' N ' ' A' ' 380' ' ' LEU . 0.0 OUTLIER -153.15 51.92 0.78 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.633 -0.667 . . . . 0.0 110.98 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 380' ' ' LEU . 46.5 Cg_endo -73.73 -29.31 10.71 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 O-C-N 123.29 1.153 . . . . 0.0 110.29 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 26.7 m -92.91 -24.78 18.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.607 -0.683 . . . . 0.0 110.449 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . 0.436 ' HA2' ' CE2' ' A' ' 385' ' ' PHE . . . -136.33 59.35 0.64 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -56.86 -24.0 48.43 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.562 -0.964 . . . . 0.0 110.495 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 386' ' ' LYS . 25.5 p90 -69.32 -25.96 64.48 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.367 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 385' ' ' PHE . 11.7 tttp -87.52 5.38 39.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.566 -0.709 . . . . 0.0 111.258 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.567 ' HB2' ' HG ' ' A' ' 380' ' ' LEU . . . -60.37 -26.94 67.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.189 -0.945 . . . . 0.0 110.241 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.64 144.43 43.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 110.353 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -76.97 -64.6 1.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.589 -0.695 . . . . 0.0 110.009 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -87.5 -168.98 2.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.785 -0.572 . . . . 0.0 110.113 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.42 -45.55 2.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.54 -0.725 . . . . 0.0 109.885 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 58.5 m -90.13 50.73 1.91 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.57 -0.706 . . . . 0.0 110.284 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -118.65 79.3 1.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.577 -0.702 . . . . 0.0 110.192 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 129.32 -39.59 1.82 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -75.78 67.42 2.2 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.551 -0.97 . . . . 0.0 110.096 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -131.57 40.95 1.57 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.803 ' HB2' HG23 ' A' ' 428' ' ' THR . 34.9 m-85 -149.89 -171.68 3.96 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.513 -0.992 . . . . 0.0 110.27 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.82 139.82 30.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.637 -0.664 . . . . 0.0 110.129 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 18.1 p-90 -149.95 28.27 0.76 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.676 -0.64 . . . . 0.0 110.29 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -136.2 -133.1 3.17 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -150.48 160.81 43.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.545 -0.974 . . . . 0.0 110.394 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.452 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 62.6 m-85 -123.9 126.77 46.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.476 -0.765 . . . . 0.0 110.446 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -148.65 90.74 1.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.551 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.1 t -150.52 167.35 27.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.554 -0.716 . . . . 0.0 111.5 -178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -108.23 -24.2 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.831 -0.543 . . . . 0.0 109.613 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 34.8 m -119.22 -65.42 1.17 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.397 -0.814 . . . . 0.0 110.515 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -169.14 80.83 0.13 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.373 -0.83 . . . . 0.0 110.787 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.551 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -141.32 134.2 28.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.537 -0.727 . . . . 0.0 110.125 179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 52.5 t -116.5 154.19 30.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.539 -0.725 . . . . 0.0 109.993 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -149.21 162.89 39.11 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.397 -0.814 . . . . 0.0 110.364 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.715 HD13 ' H ' ' A' ' 411' ' ' ILE . 0.2 OUTLIER -147.91 148.0 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.566 -0.708 . . . . 0.0 110.37 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 326' ' ' VAL . 5.0 t80 -169.61 110.31 0.44 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.636 -0.665 . . . . 0.0 110.238 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.427 ' C ' HG13 ' A' ' 414' ' ' VAL . 19.1 m-80 -100.13 98.73 9.41 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.605 -0.684 . . . . 0.0 110.345 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.427 HG13 ' C ' ' A' ' 413' ' ' ASN . 34.4 m -147.43 171.62 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.602 -0.686 . . . . 0.0 110.297 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.83 120.73 56.08 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.583 -0.698 . . . . 0.0 110.03 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.52 87.98 0.91 Allowed 'Trans proline' 0 N--CA 1.485 1.012 0 O-C-N 123.046 1.024 . . . . 0.0 110.707 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 44.7 p -122.41 43.08 2.99 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.516 -0.74 . . . . 0.0 109.99 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 19.1 t -160.07 166.81 29.18 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.613 -0.679 . . . . 0.0 109.807 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.838 HD11 ' NE1' ' A' ' 315' ' ' TRP . 0.0 OUTLIER -99.56 42.72 1.09 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.445 -0.785 . . . . 0.0 110.814 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 420' ' ' ILE . 50.1 mm -119.07 39.08 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.576 -0.702 . . . . 0.0 109.31 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -80.02 123.79 28.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.0 110.386 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -95.21 -164.01 1.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.532 -0.73 . . . . 0.0 110.073 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 9.8 t -68.24 75.49 0.24 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.637 -0.664 . . . . 0.0 110.167 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.4 p -85.45 149.28 25.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.522 -0.736 . . . . 0.0 110.235 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -159.95 82.1 0.72 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 110.017 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 82.9 mt -83.42 107.78 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.547 -0.721 . . . . 0.0 109.97 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -151.72 42.16 0.7 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.803 HG23 ' HB2' ' A' ' 397' ' ' TYR . 5.7 m -61.67 -28.06 69.13 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.519 -0.738 . . . . 0.0 110.219 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 6.1 m -135.25 136.44 41.7 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.56 -0.712 . . . . 0.0 110.247 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -62.87 -28.31 69.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.553 -0.717 . . . . 0.0 110.291 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 9.0 tt -73.36 134.32 44.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.479 -0.763 . . . . 0.0 110.205 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 60.4 m -117.61 -74.22 0.61 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.628 -0.67 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -145.63 59.87 6.15 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.615 -0.678 . . . . 0.0 110.344 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.73 -28.35 13.95 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 O-C-N 123.338 1.178 . . . . 0.0 110.267 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 82.1 mt -80.9 81.74 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.641 -0.662 . . . . 0.0 109.914 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.186 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.098 0.475 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.64 169.86 18.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.596 -0.69 . . . . 0.0 110.282 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -71.54 161.73 54.23 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.21 176.18 12.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.631 -0.923 . . . . 0.0 110.135 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -130.15 71.39 1.45 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.549 -0.72 . . . . 0.0 110.257 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . 0.404 ' CD2' ' O ' ' A' ' -5' ' ' HIS . 2.2 p-80 -119.11 -167.68 1.44 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.519 -0.738 . . . . 0.0 110.294 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -63.84 -73.36 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' -7' ' ' HIS . 23.1 p80 -143.39 -172.9 3.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.505 -0.747 . . . . 0.0 110.26 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -62.6 122.54 16.08 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.645 -0.659 . . . . 0.0 110.154 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -130.14 -44.5 1.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.142 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -109.8 42.04 2.07 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 47.8 m -114.11 -64.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.693 -0.886 . . . . 0.0 110.151 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 24.7 t30 -88.34 -29.78 20.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.594 -0.691 . . . . 0.0 110.137 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -120.84 -167.51 1.49 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.513 -0.742 . . . . 0.0 110.243 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 14.3 mtpt -148.41 29.1 0.87 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.48 -0.763 . . . . 0.0 110.154 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 323' ' ' ILE . 1.9 t80 -113.52 86.21 2.35 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.665 . . . . 0.0 110.133 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -125.87 126.34 5.81 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 322' ' ' ASP . 0.5 OUTLIER -129.76 161.34 30.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.534 -0.98 . . . . 0.0 110.438 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.435 ' CH2' ' HB3' ' A' ' 320' ' ' CYS . 0.0 OUTLIER -57.56 168.85 0.75 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.612 -0.68 . . . . 0.0 110.332 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 317' ' ' ASP . 59.1 t -65.04 163.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.598 -0.689 . . . . 0.0 109.954 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 316' ' ' VAL . 5.8 t0 -61.43 91.55 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.589 -0.694 . . . . 0.0 110.205 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -96.38 -93.33 1.82 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -123.19 25.51 8.4 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.564 -0.962 . . . . 0.0 110.429 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . 0.435 ' HB3' ' CH2' ' A' ' 315' ' ' TRP . 0.1 OUTLIER -150.06 154.61 38.44 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.515 -0.741 . . . . 0.0 110.112 179.912 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -79.01 170.24 16.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.56 -0.713 . . . . 0.0 110.019 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.607 ' HA ' HD13 ' A' ' 314' ' ' LEU . 1.6 m-20 -55.59 140.71 40.09 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.483 -0.76 . . . . 0.0 110.613 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.429 HG13 ' CE1' ' A' ' 312' ' ' PHE . 33.7 pt -58.23 149.94 55.43 Favored Pre-proline 0 N--CA 1.498 1.958 0 O-C-N 121.587 -0.696 . . . . 0.0 110.497 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.4 -165.48 0.22 Allowed 'Trans proline' 0 C--N 1.315 -1.186 0 O-C-N 123.416 1.219 . . . . 0.0 110.421 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -97.64 93.95 6.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.58 -0.7 . . . . 0.0 110.288 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.725 HG12 ' CG ' ' A' ' 412' ' ' PHE . 34.7 m -93.01 160.31 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.564 -0.71 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -91.44 105.51 17.82 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.641 -0.662 . . . . 0.0 110.038 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -91.13 142.64 27.53 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.649 -0.657 . . . . 0.0 110.439 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -109.19 119.18 49.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.585 -0.697 . . . . 0.0 109.835 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.85 -50.51 0.21 Allowed 'Trans proline' 0 N--CA 1.485 1.015 0 O-C-N 123.226 1.119 . . . . 0.0 110.66 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.407 ' O ' ' CD1' ' A' ' 329' ' ' PHE . . . -147.53 -168.95 3.2 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.54 -0.725 . . . . 0.0 110.387 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.65 132.74 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.618 -0.676 . . . . 0.0 109.915 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -123.0 -38.14 2.64 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.578 -0.701 . . . . 0.0 110.491 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 4.8 tp -104.09 -65.55 1.01 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.527 -0.733 . . . . 0.0 110.283 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -132.95 -74.58 0.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.542 -0.724 . . . . 0.0 110.115 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -154.35 -155.87 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.714 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 27.5 p -112.49 29.68 7.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.491 -0.756 . . . . 0.0 110.265 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . 0.403 ' OD1' ' CE2' ' A' ' 402' ' ' TYR . 56.6 m-80 -117.62 41.35 2.86 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.651 -0.655 . . . . 0.0 109.753 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.23 -37.46 4.39 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.644 -0.66 . . . . 0.0 110.485 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.78 ' HB3' HG21 ' A' ' 411' ' ' ILE . 4.0 mm? -58.94 146.11 39.05 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.398 -0.814 . . . . 0.0 110.373 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.72 HG23 ' H ' ' A' ' 343' ' ' GLU . 32.8 m -64.31 -141.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.65 -0.656 . . . . 0.0 109.892 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -113.88 20.82 15.47 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.747 -1.221 . . . . 0.0 110.028 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . 0.72 ' H ' HG23 ' A' ' 341' ' ' VAL . 10.6 tt0 -178.19 150.24 0.58 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.632 HD22 ' N ' ' A' ' 344' ' ' LEU . 1.6 mm? -92.12 6.75 45.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.528 -0.732 . . . . 0.0 109.972 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 3.9 t -97.8 -35.31 10.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.954 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.44 67.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 31.4 m -63.31 -28.41 69.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.506 -0.746 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.25 -65.78 1.02 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 110.329 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -158.37 155.48 25.7 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.566 -0.709 . . . . 0.0 110.298 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.97 122.64 7.82 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.396 1.208 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -121.98 -65.36 1.13 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.58 -0.7 . . . . 0.0 110.155 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -84.96 113.18 21.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.571 -0.705 . . . . 0.0 109.875 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.67 -48.19 3.02 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.594 -0.691 . . . . 0.0 110.305 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.74 65.99 1.42 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.601 -0.687 . . . . 0.0 110.507 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -61.78 -160.13 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.476 -0.765 . . . . 0.0 110.038 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -90.54 18.35 6.39 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.32 -0.862 . . . . 0.0 111.349 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.483 ' O ' HD13 ' A' ' 357' ' ' LEU . 0.2 OUTLIER -98.73 -26.7 14.26 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.328 -0.857 . . . . 0.0 110.198 179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 60.3 m -89.46 -24.33 21.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.49 -0.756 . . . . 0.0 110.584 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -75.11 -28.73 60.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.424 -0.798 . . . . 0.0 110.483 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -74.66 -39.62 61.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.578 -0.702 . . . . 0.0 110.239 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -84.65 6.64 23.26 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.627 -0.671 . . . . 0.0 111.135 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 3.2 mmmt -78.46 -27.26 46.36 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.146 -0.971 . . . . 0.0 110.663 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 364' ' ' LYS . 31.0 pt -100.14 -28.26 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.423 -0.798 . . . . 0.0 111.099 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.409 ' N ' HG13 ' A' ' 363' ' ' ILE . 8.6 ptmt -100.63 -26.53 13.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.484 -0.76 . . . . 0.0 110.307 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 367' ' ' PHE . 5.4 tt0 -111.76 -4.29 14.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.553 -0.717 . . . . 0.0 111.763 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 365' ' ' GLU . . . 4.89 56.8 0.0 OUTLIER Glycine 1 N--CA 1.523 4.471 0 C-N-CA 124.422 1.01 . . . . 0.0 114.403 -179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 365' ' ' GLU . 43.7 p90 -61.53 102.11 0.22 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.965 0.888 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -23.39 12.1 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.281 -0.887 . . . . 0.0 110.501 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -106.26 40.9 1.51 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.425 -0.797 . . . . 0.0 110.528 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 2.9 mmtm -104.65 -76.6 0.6 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.55 -0.719 . . . . 0.0 110.137 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -85.37 -39.04 18.06 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.583 -0.698 . . . . 0.0 110.154 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.49 -21.94 60.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.713 -0.617 . . . . 0.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 18.2 t -76.83 -52.06 10.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.495 -0.753 . . . . 0.0 109.989 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.512 ' O ' HG23 ' A' ' 375' ' ' ILE . 0.4 OUTLIER -66.77 -67.85 0.42 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.615 -0.678 . . . . 0.0 109.731 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 374' ' ' MET . 4.5 pt -152.06 -110.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.555 -0.715 . . . . 0.0 109.529 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -115.17 -33.88 5.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.674 -1.266 . . . . 0.0 109.951 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.39 107.29 3.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.749 -0.594 . . . . 0.0 109.717 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -60.1 86.26 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.655 -0.653 . . . . 0.0 110.758 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.403 ' O ' ' CD2' ' A' ' 379' ' ' PHE . 60.0 t80 -138.77 94.26 2.81 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 380' ' ' LEU . 7.6 mp -103.22 96.87 8.85 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.544 -0.723 . . . . 0.0 110.682 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.44 -26.8 16.6 Favored 'Trans proline' 0 C--N 1.316 -1.14 0 O-C-N 123.381 1.201 . . . . 0.0 110.194 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.582 ' O ' HG23 ' A' ' 382' ' ' THR . 6.3 t -128.67 77.34 1.77 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.529 -0.732 . . . . 0.0 109.809 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -93.56 48.34 2.33 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -60.06 -17.57 40.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.951 . . . . 0.0 110.315 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -55.47 -26.68 43.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.298 -0.876 . . . . 0.0 110.55 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -65.74 -13.95 60.35 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.576 -0.703 . . . . 0.0 110.734 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -55.95 -20.9 18.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.205 -0.934 . . . . 0.0 111.038 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.13 -23.75 8.88 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.304 -0.872 . . . . 0.0 111.041 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.85 153.48 17.04 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.488 -0.757 . . . . 0.0 110.331 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -80.34 -74.93 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.535 -0.728 . . . . 0.0 110.406 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -114.52 159.65 20.13 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.575 -0.703 . . . . 0.0 110.324 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 2.1 m -90.21 49.88 1.77 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.597 -0.689 . . . . 0.0 110.084 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -86.96 80.33 8.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.489 -0.757 . . . . 0.0 110.316 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 81.12 45.97 7.27 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.75 15.69 2.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.589 -0.948 . . . . 0.0 110.9 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -137.9 69.67 0.49 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 397' ' ' TYR . 6.7 p90 -170.54 100.79 0.25 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.459 -1.024 . . . . 0.0 110.15 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.54 ' ND2' HG23 ' A' ' 428' ' ' THR . 3.2 p30 -169.65 -40.22 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.119 -0.988 . . . . 0.0 110.507 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.43 ' CZ2' ' O ' ' A' ' 340' ' ' LEU . 0.5 OUTLIER -76.3 3.91 9.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.659 -0.651 . . . . 0.0 112.044 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -143.53 177.18 22.5 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -108.47 132.74 53.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.347 -1.09 . . . . 0.0 110.024 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 60.3 m-85 -117.81 154.42 31.81 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.424 -0.797 . . . . 0.0 111.14 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -133.43 110.83 10.27 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 7.0 m -89.5 84.92 6.41 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -121.81 -65.79 1.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 10.3 p -121.57 -67.74 0.95 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.496 0.665 . . . . 0.0 109.398 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -172.49 72.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.627 -0.671 . . . . 0.0 109.694 179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -146.61 160.82 41.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.413 -0.805 . . . . 0.0 110.728 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.5 m -145.05 165.78 27.24 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.555 -0.716 . . . . 0.0 109.885 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -146.89 145.8 29.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.437 -0.79 . . . . 0.0 110.534 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.78 HG21 ' HB3' ' A' ' 340' ' ' LEU . 4.9 mp -132.51 130.7 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.368 -0.832 . . . . 0.0 110.104 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.725 ' CG ' HG12 ' A' ' 326' ' ' VAL . 2.0 t80 -174.12 -163.14 0.15 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.676 -0.64 . . . . 0.0 109.625 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . 0.412 ' OD1' ' CD2' ' A' ' 412' ' ' PHE . 1.8 p-10 -75.3 -167.9 0.71 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.425 -0.797 . . . . 0.0 110.541 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 415' ' ' LYS . 8.8 p -58.04 166.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.538 -0.726 . . . . 0.0 110.742 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . 0.475 ' N ' HG22 ' A' ' 414' ' ' VAL . 4.5 ttpm? -70.0 125.69 92.1 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.645 -0.66 . . . . 0.0 110.06 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.2 -174.67 1.86 Allowed 'Trans proline' 0 N--CA 1.485 0.987 0 O-C-N 123.131 1.069 . . . . 0.0 110.31 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.406 ' H ' HG22 ' A' ' 417' ' ' THR . 7.9 t -103.2 50.82 0.8 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 110.133 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 66.2 m -115.8 -168.93 1.49 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.58 -0.7 . . . . 0.0 109.929 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.434 ' HA ' HD13 ' A' ' 419' ' ' LEU . 1.9 mm? -79.09 -25.26 43.07 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 0.0 110.424 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 50.7 mm -84.09 74.09 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.38 -0.825 . . . . 0.0 109.727 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -101.35 100.65 11.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.585 -0.697 . . . . 0.0 110.457 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -88.45 -168.83 2.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.631 -0.668 . . . . 0.0 110.205 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 82.2 p -82.45 86.62 6.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.438 -0.789 . . . . 0.0 110.329 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.26 115.86 28.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.511 -0.743 . . . . 0.0 110.388 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.13 110.4 3.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.597 -0.689 . . . . 0.0 110.026 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.49 ' O ' HG22 ' A' ' 426' ' ' ILE . 81.5 mt -77.07 61.29 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.328 -0.857 . . . . 0.0 110.307 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -156.81 77.5 0.9 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.456 -0.777 . . . . 0.0 110.367 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.54 HG23 ' ND2' ' A' ' 398' ' ' ASN . 0.2 OUTLIER -60.94 -34.9 75.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.437 -0.789 . . . . 0.0 110.024 179.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 21.5 p -146.59 93.91 2.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.587 -0.695 . . . . 0.0 110.242 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -123.38 -165.17 1.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.572 -0.705 . . . . 0.0 110.217 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.38 98.77 0.07 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.606 -0.684 . . . . 0.0 110.264 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 15.4 p -150.28 128.76 12.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.591 -0.693 . . . . 0.0 110.298 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 433' ' ' HIS . 4.5 p80 -150.71 67.06 7.8 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.596 -0.69 . . . . 0.0 110.215 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.29 -28.88 11.98 Favored 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.381 1.201 . . . . 0.0 110.508 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 11.4 mt -104.42 74.65 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.514 -0.741 . . . . 0.0 109.863 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.769 179.957 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 21.7 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.063 0.459 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 29.6 mtt180 -88.87 -64.81 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.589 -0.695 . . . . 0.0 110.112 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -75.36 103.41 1.6 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.37 -177.82 3.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.58 -0.953 . . . . 0.0 110.3 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -125.48 -169.53 2.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.58 -0.7 . . . . 0.0 110.211 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.93 91.04 2.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.478 -0.763 . . . . 0.0 110.147 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 14.3 m170 -88.5 95.54 10.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.614 -0.679 . . . . 0.0 110.231 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -120.26 72.9 0.96 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.595 -0.691 . . . . 0.0 110.239 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -114.46 -61.32 1.76 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.505 -0.747 . . . . 0.0 110.18 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -148.47 34.15 0.79 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.601 -0.687 . . . . 0.0 110.172 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -100.3 165.71 19.55 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 31.7 m -83.95 -57.67 3.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.556 -0.967 . . . . 0.0 110.129 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -86.21 136.36 33.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.525 -0.735 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.99 -73.25 0.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.501 -0.749 . . . . 0.0 110.196 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 6.5 mmtt -151.36 166.63 30.42 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.54 -0.725 . . . . 0.0 110.296 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.401 ' CE2' HD22 ' A' ' 314' ' ' LEU . 3.9 t80 -106.1 114.78 29.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.807 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -124.48 125.17 5.67 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.401 HD22 ' CE2' ' A' ' 312' ' ' PHE . 0.5 OUTLIER -150.05 157.91 43.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.654 -0.909 . . . . 0.0 110.248 179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.469 ' CE2' HD12 ' A' ' 419' ' ' LEU . 6.5 t-105 -74.92 103.14 5.02 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.494 -0.754 . . . . 0.0 109.087 179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 316' ' ' VAL . 33.8 m -86.01 117.5 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.693 -0.629 . . . . 0.0 110.714 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -168.13 -74.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.561 -0.712 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 179.58 38.64 0.07 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -149.85 -35.56 0.17 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.628 -0.925 . . . . 0.0 111.502 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 67.2 m -88.67 169.86 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.009 0.909 . . . . 0.0 111.368 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -130.01 172.51 11.66 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -44.92 107.23 0.09 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.54 -0.725 . . . . 0.0 111.441 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.647 HD13 ' O ' ' A' ' 324' ' ' PRO . 0.0 OUTLIER -144.72 124.94 7.35 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.691 -0.63 . . . . 0.0 109.837 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . 0.647 ' O ' HD13 ' A' ' 323' ' ' ILE . 46.4 Cg_endo -69.75 -160.87 0.07 OUTLIER 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 123.165 1.087 . . . . 0.0 111.96 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -84.41 139.43 32.23 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.131 -0.981 . . . . 0.0 110.681 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 326' ' ' VAL . 35.6 m -80.17 161.51 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.69 -0.631 . . . . 0.0 110.145 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -89.01 130.95 35.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.615 -0.678 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -109.88 160.45 16.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.615 -0.678 . . . . 0.0 110.482 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.427 ' CZ ' ' HG3' ' A' ' 336' ' ' GLU . 0.2 OUTLIER -126.5 113.47 23.07 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.575 -0.703 . . . . 0.0 110.066 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.44 64.83 2.89 Favored 'Trans proline' 0 N--CA 1.486 1.07 0 O-C-N 123.179 1.094 . . . . 0.0 110.314 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -168.96 -169.47 0.99 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.582 -0.699 . . . . 0.0 109.987 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 1.7 tt -157.94 27.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.557 -0.715 . . . . 0.0 110.372 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.13 177.06 1.11 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.465 -0.772 . . . . 0.0 110.073 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.07 -65.67 0.97 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.557 -0.714 . . . . 0.0 110.164 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -96.92 82.09 3.19 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 110.1 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 329' ' ' PHE . 2.1 tp10 -148.06 -43.87 0.16 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.553 -0.717 . . . . 0.0 110.476 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 73.6 m -59.55 -32.1 70.03 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.462 -0.774 . . . . 0.0 110.536 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 46.7 p-10 -96.84 39.23 1.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 110.339 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -136.67 80.54 1.82 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.663 -0.648 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 1.4 mt -146.96 149.23 32.76 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.557 -0.715 . . . . 0.0 110.455 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 342' ' ' PHE . 60.3 t -59.7 169.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.644 -0.66 . . . . 0.0 109.532 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . 0.488 ' O ' ' CD2' ' A' ' 342' ' ' PHE . 55.2 p90 -71.38 59.33 0.28 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.343 -0.848 . . . . 0.0 110.867 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -87.62 10.92 16.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.881 -1.137 . . . . 0.0 110.931 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 412' ' ' PHE . 1.7 mm? -103.16 4.33 36.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 0.0 110.81 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 8.5 t -52.83 -26.87 15.9 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.094 -1.004 . . . . 0.0 110.737 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.51 -22.37 64.53 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.56 -0.712 . . . . 0.0 110.232 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 412' ' ' PHE . 60.7 p -86.35 10.06 16.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.411 -0.806 . . . . 0.0 111.199 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -87.45 9.32 21.19 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.168 -0.958 . . . . 0.0 111.041 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -50.73 167.26 0.27 Allowed Pre-proline 0 N--CA 1.502 2.156 0 O-C-N 121.063 -1.023 . . . . 0.0 110.929 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.74 -167.18 0.33 Allowed 'Trans proline' 0 C--N 1.317 -1.107 0 O-C-N 123.425 1.224 . . . . 0.0 110.316 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -92.54 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.673 -0.642 . . . . 0.0 110.336 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -61.38 -26.58 67.93 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.558 -0.714 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -56.77 -24.57 51.24 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.492 -0.755 . . . . 0.0 110.705 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -110.2 69.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.489 -0.757 . . . . 0.0 110.248 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.28 49.05 0.83 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.43 -0.794 . . . . 0.0 110.286 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -108.88 18.93 20.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.495 -0.753 . . . . 0.0 110.819 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.63 -38.73 82.14 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.358 -0.839 . . . . 0.0 110.242 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 15.2 m -62.54 -28.44 69.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.504 -0.747 . . . . 0.0 110.261 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -97.58 -18.1 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.597 -0.689 . . . . 0.0 110.702 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.448 ' HA ' HD12 ' A' ' 363' ' ' ILE . 0.0 OUTLIER -86.41 1.03 52.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.104 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -57.28 -23.84 50.98 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.058 -1.026 . . . . 0.0 110.709 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -89.07 -19.52 25.5 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.393 -0.817 . . . . 0.0 110.727 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 360' ' ' TYR . 81.9 mt -75.66 -22.15 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.33 -0.856 . . . . 0.0 110.599 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -27.08 65.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.08 -20.77 21.69 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.562 -0.711 . . . . 0.0 110.747 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -75.93 85.53 0.89 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -73.8 -5.6 41.84 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.593 -0.946 . . . . 0.0 111.458 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -26.39 68.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.258 -0.901 . . . . 0.0 110.193 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -147.51 92.67 2.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.509 -0.745 . . . . 0.0 110.237 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.94 128.83 34.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.205 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -100.21 -4.24 29.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.643 -0.661 . . . . 0.0 111.129 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.36 -35.15 73.35 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.115 -0.991 . . . . 0.0 110.423 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 2.4 t -105.22 12.97 31.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.61 -0.681 . . . . 0.0 111.12 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 18.5 ttt -105.21 -29.81 10.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.225 -0.922 . . . . 0.0 110.557 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 84.9 mt -118.79 -54.32 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.514 -0.741 . . . . 0.0 110.319 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -57.33 -25.9 60.1 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.607 -0.683 . . . . 0.0 110.692 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 1.2 m -84.34 -25.93 28.83 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.532 -0.73 . . . . 0.0 110.319 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -99.73 97.73 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.527 -0.733 . . . . 0.0 110.418 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.58 -77.15 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.715 -0.616 . . . . 0.0 109.705 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.459 ' CB ' ' CD ' ' A' ' 381' ' ' PRO . 13.9 mt -107.55 -65.73 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.482 -0.761 . . . . 0.0 111.161 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 380' ' ' LEU . 55.4 Cg_endo -73.81 76.6 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 O-C-N 122.619 0.799 . . . . 0.0 110.131 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.413 ' O ' HG23 ' A' ' 382' ' ' THR . 8.4 t -80.88 57.26 2.98 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.487 -0.758 . . . . 0.0 110.447 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -148.0 74.17 0.29 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.406 ' HA ' ' HB3' ' A' ' 387' ' ' ALA . . . -56.73 -21.36 27.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.557 -0.967 . . . . 0.0 110.852 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -60.22 -69.9 0.2 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.402 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -78.74 -22.24 46.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.635 -0.666 . . . . 0.0 110.739 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 384' ' ' ALA . . . -61.95 -16.3 50.03 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.411 -0.806 . . . . 0.0 110.664 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.62 -73.76 0.08 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.189 -0.945 . . . . 0.0 110.413 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.29 65.88 1.24 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.606 -0.684 . . . . 0.0 110.135 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 390' ' ' TYR . 26.4 p90 -81.78 145.01 30.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.5 -0.75 . . . . 0.0 110.268 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.09 -167.08 1.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.672 . . . . 0.0 110.417 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.91 52.92 2.4 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 0.0 109.963 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.13 -22.43 13.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.577 -0.702 . . . . 0.0 110.619 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -59.52 -50.17 70.66 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -60.54 134.85 57.48 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.535 -0.979 . . . . 0.0 110.302 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -165.7 -45.35 0.02 OUTLIER Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -91.48 177.85 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.569 -0.96 . . . . 0.0 110.184 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.495 ' O ' HD11 ' A' ' 426' ' ' ILE . 7.9 m120 -74.62 130.0 38.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.573 -0.704 . . . . 0.0 109.987 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.801 ' HB3' HG21 ' A' ' 428' ' ' THR . 48.7 p-90 -135.27 45.8 2.46 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.599 -0.688 . . . . 0.0 110.45 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -145.06 166.07 27.6 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -100.18 160.61 14.19 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.615 -0.932 . . . . 0.0 109.933 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -133.0 139.99 47.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.479 -0.763 . . . . 0.0 110.4 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -134.18 108.25 8.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.648 -0.658 . . . . 0.0 109.507 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . . . . . . . . . 30.3 p -89.55 84.77 6.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.497 -0.752 . . . . 0.0 110.692 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.6 -65.16 1.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 407' ' ' GLN . 0.0 OUTLIER -121.28 -73.86 0.63 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.57 -0.706 . . . . 0.0 109.716 179.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . 0.479 ' H ' HG23 ' A' ' 406' ' ' THR . 16.6 tt0 -167.58 65.86 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -149.83 167.13 27.43 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.473 -0.767 . . . . 0.0 110.433 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 1.8 t -138.87 179.72 6.32 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.624 -0.673 . . . . 0.0 109.936 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.425 ' C ' HD12 ' A' ' 411' ' ' ILE . 3.8 mt-10 -145.93 149.4 34.15 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.52 -0.738 . . . . 0.0 110.4 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.483 ' N ' HD12 ' A' ' 411' ' ' ILE . 5.1 mp -140.83 136.84 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.567 -0.708 . . . . 0.0 110.015 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.577 ' HA ' HD11 ' A' ' 344' ' ' LEU . 80.5 t80 -167.91 -74.68 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.533 -0.729 . . . . 0.0 110.213 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -171.11 -165.5 0.42 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.402 -0.811 . . . . 0.0 110.169 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 427' ' ' ALA . 61.3 t -63.06 156.78 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.617 -0.677 . . . . 0.0 109.609 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -50.79 105.33 0.51 Allowed Pre-proline 0 N--CA 1.502 2.138 0 O-C-N 121.48 -0.762 . . . . 0.0 111.044 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -89.05 155.36 5.77 Favored 'Trans proline' 0 C--N 1.318 -1.075 0 O-C-N 123.24 1.127 . . . . 0.0 110.016 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 40.5 p -69.76 74.93 0.44 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 109.304 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 45.4 t -158.75 138.55 11.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.585 -0.697 . . . . 0.0 110.175 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . 0.469 HD12 ' CE2' ' A' ' 315' ' ' TRP . 55.2 mt -79.81 57.85 2.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.47 -0.769 . . . . 0.0 110.27 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 9.1 tp -124.48 -36.32 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.363 -0.836 . . . . 0.0 110.472 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -79.52 172.31 13.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.45 -0.781 . . . . 0.0 110.386 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -113.71 -76.16 0.59 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.223 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.0 m -123.38 122.79 39.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.438 -0.789 . . . . 0.0 109.986 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 23.2 p -92.69 130.02 38.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.484 -0.76 . . . . 0.0 110.155 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.44 ' C ' HG23 ' A' ' 426' ' ' ILE . 3.0 t80 -76.18 -60.41 2.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.582 -0.699 . . . . 0.0 110.18 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 427' ' ' ALA . 2.8 pp -148.44 -162.6 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.583 -0.698 . . . . 0.0 110.132 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . 0.713 ' N ' HD12 ' A' ' 426' ' ' ILE . . . -127.98 100.49 5.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.141 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.801 HG21 ' HB3' ' A' ' 399' ' ' TRP . 9.9 p -60.73 -38.08 83.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 0.0 110.06 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 429' ' ' THR . 8.0 t -144.66 116.66 8.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.598 -0.689 . . . . 0.0 110.245 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -57.89 165.46 1.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.523 -0.736 . . . . 0.0 110.41 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 6.8 mt -88.65 -165.67 1.39 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.58 -0.7 . . . . 0.0 110.184 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 33.9 t -81.15 -155.65 0.13 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.597 -0.689 . . . . 0.0 110.174 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -58.5 156.57 22.21 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.437 -0.789 . . . . 0.0 110.411 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.44 -29.91 10.63 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.377 1.199 . . . . 0.0 110.417 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 81.0 mt -72.97 79.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.622 -0.674 . . . . 0.0 110.055 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.302 -179.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 4.7 ptp . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.079 0.466 . . . . 0.0 110.302 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 40.3 mtm-85 -123.01 -177.4 3.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.592 -0.692 . . . . 0.0 110.155 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -151.18 125.48 1.9 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 6.9 m -110.21 -29.95 7.95 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.587 -0.949 . . . . 0.0 110.183 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . 0.459 ' CD2' ' N ' ' A' ' -8' ' ' HIS . 0.4 OUTLIER -62.0 -164.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.583 -0.698 . . . . 0.0 110.367 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -57.91 -56.36 23.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.558 -0.714 . . . . 0.0 110.693 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.31 91.64 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.515 -0.74 . . . . 0.0 110.28 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -79.13 -50.51 10.89 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.601 -0.687 . . . . 0.0 110.302 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -119.72 -169.13 1.72 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.537 -0.727 . . . . 0.0 110.285 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -125.13 46.97 2.24 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.258 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -150.41 158.94 27.9 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 43.9 t -88.82 171.96 9.55 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.597 -0.943 . . . . 0.0 110.187 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -114.84 115.93 27.77 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 110.344 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 311' ' ' LYS . . . -170.15 164.58 9.21 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.62 -0.675 . . . . 0.0 109.959 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 310' ' ' ALA . 0.3 OUTLIER 0.75 71.34 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.193 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.69 ' CE2' HG21 ' A' ' 323' ' ' ILE . 8.5 t80 -146.83 -61.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.668 -0.645 . . . . 0.0 109.379 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -150.72 23.56 1.04 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 6.8 mt -123.48 157.82 32.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -1.09 . . . . 0.0 110.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.414 ' CZ2' ' HA3' ' A' ' 318' ' ' GLY . 7.3 p-90 -165.3 173.7 10.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.659 -0.65 . . . . 0.0 109.654 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 317' ' ' ASP . 90.8 t -45.75 167.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 O-C-N 121.692 -0.63 . . . . 0.0 111.23 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . 0.479 ' N ' HG12 ' A' ' 316' ' ' VAL . 8.5 t70 -43.78 112.14 0.36 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.526 -0.734 . . . . 0.0 112.147 -178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.414 ' HA3' ' CZ2' ' A' ' 315' ' ' TRP . . . -128.62 -115.39 1.85 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -150.22 30.59 0.69 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.558 -0.966 . . . . 0.0 110.454 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 26.3 p -140.19 137.88 34.7 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.516 -0.74 . . . . 0.0 110.823 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -75.53 171.29 14.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.66 -0.65 . . . . 0.0 109.457 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -49.83 160.24 0.33 Allowed 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.467 -0.771 . . . . 0.0 110.845 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 312' ' ' PHE . 3.1 mp -56.14 124.61 60.65 Favored Pre-proline 0 N--CA 1.5 2.064 0 O-C-N 121.433 -0.792 . . . . 0.0 110.26 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.42 -175.29 1.27 Allowed 'Trans proline' 0 C--N 1.319 -0.99 0 O-C-N 123.286 1.151 . . . . 0.0 109.874 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . 0.404 ' O ' ' CE1' ' A' ' 412' ' ' PHE . 34.1 t60 -88.35 89.09 7.85 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.482 -0.762 . . . . 0.0 110.415 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.653 HG12 ' CD2' ' A' ' 412' ' ' PHE . 29.1 m -107.78 154.15 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.57 -0.707 . . . . 0.0 109.497 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -89.47 128.36 35.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.0 110.548 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -110.0 138.53 46.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.674 -0.641 . . . . 0.0 109.604 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -109.04 89.69 6.98 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.53 -0.731 . . . . 0.0 110.513 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.46 68.56 6.09 Favored 'Trans proline' 0 C--N 1.317 -1.118 0 O-C-N 123.558 1.293 . . . . 0.0 109.954 179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.752 ' HB3' ' CG ' ' A' ' 407' ' ' GLN . . . -57.88 118.51 5.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.405 -0.809 . . . . 0.0 110.569 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 5.5 tp -99.1 -22.19 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.649 -0.657 . . . . 0.0 110.335 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -144.41 -60.4 0.38 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.427 -0.796 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.93 -178.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -156.96 89.42 1.08 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.604 -0.685 . . . . 0.0 110.327 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.85 89.28 0.28 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.466 -0.771 . . . . 0.0 110.462 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 72.3 m -58.37 -21.46 50.18 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.587 -0.696 . . . . 0.0 110.669 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . 0.766 ' OD1' HG11 ' A' ' 341' ' ' VAL . 16.8 t30 -95.31 33.94 1.5 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.355 -0.84 . . . . 0.0 110.64 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . 0.669 ' C ' HD13 ' A' ' 340' ' ' LEU . 2.2 ttpt -95.46 20.73 9.06 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.536 -0.728 . . . . 0.0 110.848 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 340' ' ' LEU . 0.0 OUTLIER -158.84 29.26 0.22 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.3 -0.875 . . . . 0.0 110.553 179.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.766 HG11 ' OD1' ' A' ' 338' ' ' ASN . 35.0 m -90.89 100.36 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 121.511 0.672 . . . . 0.0 110.417 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.34 -45.79 0.1 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.346 -0.846 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -154.7 126.63 7.65 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.72 -0.613 . . . . 0.0 109.766 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . . . . . . . . . 6.6 mt -81.32 4.87 19.1 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.601 -0.687 . . . . 0.0 110.689 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 5.5 p -89.83 -43.32 10.71 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 110.169 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -94.34 -26.1 16.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.522 -0.736 . . . . 0.0 110.356 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 3.1 t -78.97 -19.56 51.37 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.561 -0.712 . . . . 0.0 110.841 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -57.05 -31.62 65.37 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.288 -0.882 . . . . 0.0 110.645 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 132.63 78.02 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.521 -0.737 . . . . 0.0 110.108 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.18 157.59 46.04 Favored 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.18 1.095 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -103.33 -58.55 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.582 -0.699 . . . . 0.0 110.121 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -127.05 105.81 8.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.608 -0.683 . . . . 0.0 110.25 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -150.62 28.04 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 110.354 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -114.73 -29.48 6.76 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.549 -0.72 . . . . 0.0 110.344 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -87.56 -24.73 23.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.513 -0.742 . . . . 0.0 110.569 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -92.12 18.34 8.23 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.416 -0.802 . . . . 0.0 110.913 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . . . . . . . . . 3.1 tp -76.4 -19.87 57.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.285 -0.884 . . . . 0.0 110.666 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.96 -26.04 14.38 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.388 -0.82 . . . . 0.0 110.646 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.69 -19.0 46.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.531 -0.731 . . . . 0.0 111.08 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 363' ' ' ILE . 8.1 p90 -56.24 -24.59 43.36 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.213 -0.929 . . . . 0.0 110.816 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.61 -53.79 42.0 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.438 -0.788 . . . . 0.0 111.064 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -59.26 -15.48 15.79 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.706 -0.621 . . . . 0.0 111.968 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 360' ' ' TYR . 47.0 mm -57.21 -37.64 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.979 -1.076 . . . . 0.0 110.597 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.1 -29.72 70.52 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.443 -0.785 . . . . 0.0 110.095 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -97.8 21.02 11.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.672 -0.642 . . . . 0.0 110.443 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -56.01 -26.69 49.35 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.35 53.17 2.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.518 -0.989 . . . . 0.0 110.381 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 369' ' ' ASN . 4.7 pttm -103.19 56.96 0.75 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.641 -0.662 . . . . 0.0 109.265 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 368' ' ' LYS . 5.8 t30 2.09 68.31 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.09 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -139.69 -50.87 0.5 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.588 -0.695 . . . . 0.0 109.936 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -58.42 -27.9 64.75 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.888 -0.507 . . . . 0.0 110.601 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -58.59 -30.45 67.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.577 -0.702 . . . . 0.0 110.459 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 3.4 t -105.19 14.48 29.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 0.0 110.865 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.83 -26.85 12.07 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.272 -0.892 . . . . 0.0 110.347 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 71.0 mt -102.79 -63.71 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.47 -0.769 . . . . 0.0 110.115 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.27 58.84 3.19 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.64 -0.662 . . . . 0.0 110.424 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 16.9 t -169.97 -40.84 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.616 -0.677 . . . . 0.0 110.152 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . . . . . . . . . . . -75.24 -59.58 2.68 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.672 -0.642 . . . . 0.0 110.305 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -124.98 71.13 1.17 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.601 -0.687 . . . . 0.0 110.222 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . . . . . . . . . 8.5 mt -58.83 110.86 2.96 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.515 -0.74 . . . . 0.0 110.089 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -76.22 -55.45 0.06 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 O-C-N 123.215 1.113 . . . . 0.0 110.736 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.585 ' O ' HG23 ' A' ' 382' ' ' THR . 6.6 t -170.64 78.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.646 -0.659 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -60.81 -30.51 73.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . . . . . . . . . . . -61.64 -24.06 66.46 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.569 -0.959 . . . . 0.0 110.51 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -90.82 22.92 3.34 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.391 -0.818 . . . . 0.0 111.105 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -84.02 5.08 27.13 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.29 -0.881 . . . . 0.0 111.153 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -60.22 -23.63 64.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.132 -0.98 . . . . 0.0 110.649 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -55.36 -24.1 27.67 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.378 -0.826 . . . . 0.0 110.946 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -56.66 -24.21 47.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.468 -0.77 . . . . 0.0 110.772 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -58.2 -75.28 0.05 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.441 -0.787 . . . . 0.0 110.538 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 16.8 mtpt -129.46 -39.95 1.46 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.632 -0.667 . . . . 0.0 110.711 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 1.5 m -84.83 53.79 2.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.418 -0.801 . . . . 0.0 110.72 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . 0.405 ' O ' ' CD2' ' A' ' 393' ' ' HIS . 0.7 OUTLIER -89.01 61.63 5.95 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.244 179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 117.32 39.36 0.8 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -58.49 -25.21 62.09 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.637 -0.92 . . . . 0.0 110.756 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . 0.4 ' O ' ' CG ' ' A' ' 397' ' ' TYR . . . -97.49 27.14 20.03 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 396' ' ' GLY . 64.1 m-85 -153.77 27.76 0.48 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.467 -1.019 . . . . 0.0 110.302 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . 0.413 ' HB3' ' CD2' ' A' ' 425' ' ' TYR . 98.3 m-20 -87.98 76.2 8.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.506 -0.746 . . . . 0.0 110.085 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.496 ' HB3' HG23 ' A' ' 428' ' ' THR . 67.8 p-90 -152.93 21.98 0.58 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.593 -0.692 . . . . 0.0 110.647 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA3' HG22 ' A' ' 411' ' ' ILE . . . -160.29 -155.82 7.91 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -113.43 117.29 31.32 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.683 -0.892 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 402' ' ' TYR . 53.1 m-85 -120.25 109.96 16.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.393 -0.817 . . . . 0.0 110.343 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -152.45 90.72 1.52 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.536 -0.728 . . . . 0.0 109.734 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.418 HG21 ' H ' ' A' ' 408' ' ' LYS . 8.9 t -150.69 159.66 44.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.449 -0.782 . . . . 0.0 111.196 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -104.69 -25.57 12.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.786 -0.571 . . . . 0.0 109.507 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 78.0 p -116.72 -65.12 1.22 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.586 -0.696 . . . . 0.0 110.13 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . 0.752 ' CG ' ' HB3' ' A' ' 331' ' ' ALA . 73.5 tp60 -170.63 80.78 0.09 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.467 -0.771 . . . . 0.0 110.894 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.418 ' H ' HG21 ' A' ' 404' ' ' THR . 22.6 ttmt -141.51 103.21 4.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.471 -0.768 . . . . 0.0 109.673 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.14 158.81 15.58 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.535 -0.728 . . . . 0.0 110.775 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -150.28 136.1 18.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.691 -0.63 . . . . 0.0 109.931 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 411' ' ' ILE . 0.2 OUTLIER -137.98 142.39 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.493 -0.755 . . . . 0.0 110.225 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.653 ' CD2' HG12 ' A' ' 326' ' ' VAL . 8.8 t80 -173.14 174.28 3.45 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.49 -0.756 . . . . 0.0 110.082 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -69.71 -65.09 0.76 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 0.0 110.644 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.98 173.11 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.478 -0.764 . . . . 0.0 110.618 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.38 153.92 44.76 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.658 -0.651 . . . . 0.0 110.234 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -169.79 0.58 Allowed 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.493 1.259 . . . . 0.0 110.59 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 417' ' ' THR . 7.6 t -102.0 69.28 1.16 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.606 -0.684 . . . . 0.0 110.162 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.49 -168.12 1.32 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.713 . . . . 0.0 110.398 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 84.9 mt -78.27 -19.44 53.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.562 -0.711 . . . . 0.0 110.922 -179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.473 ' O ' HG23 ' A' ' 420' ' ' ILE . 1.1 tp -84.0 58.89 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.203 -0.936 . . . . 0.0 109.881 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.95 100.53 12.04 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.147 0.498 . . . . 0.0 110.227 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -88.24 -173.12 4.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.65 -0.656 . . . . 0.0 109.725 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 60.0 p -68.97 106.65 2.82 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 59.7 m -101.19 120.59 40.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.625 -0.672 . . . . 0.0 110.276 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . 0.413 ' CD2' ' HB3' ' A' ' 398' ' ' ASN . 41.5 t80 -168.28 98.11 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.606 -0.683 . . . . 0.0 110.089 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.0 mt -93.09 95.71 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.536 -0.727 . . . . 0.0 109.922 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -166.75 69.76 0.11 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 110.109 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . 0.496 HG23 ' HB3' ' A' ' 399' ' ' TRP . 3.9 p -75.74 124.83 27.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.511 -0.743 . . . . 0.0 110.074 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . . . . . . . . . 24.9 p -63.58 89.68 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.631 -0.668 . . . . 0.0 109.931 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -138.07 151.05 47.46 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.566 -0.708 . . . . 0.0 110.164 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . . . . . . . . . 27.3 mt -85.28 -45.87 11.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.571 -0.706 . . . . 0.0 110.171 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 77.5 p -168.26 -41.14 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.715 . . . . 0.0 110.423 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -105.95 126.49 30.53 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.583 -0.698 . . . . 0.0 110.206 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . 0.494 ' N ' HD12 ' A' ' 435' ' ' ILE . 51.9 Cg_endo -76.94 59.43 6.45 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 O-C-N 123.127 1.067 . . . . 0.0 110.651 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 434' ' ' PRO . 4.6 mp -140.51 -44.18 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.322 -0.861 . . . . 0.0 109.936 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.515 -179.96 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -12' ' ' MET . . . . . . . . . . . . . 6.3 ttt . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.253 0.549 . . . . 0.0 110.214 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -11' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -117.41 38.08 3.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -10' ' ' GLY . . . . . . . . . . . . . . . -125.95 61.69 0.62 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -9' ' ' SER . . . . . . . . . . . . . 18.4 p -124.8 151.82 44.69 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.53 -0.982 . . . . 0.0 110.265 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -8' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -164.22 -178.33 5.46 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.589 -0.694 . . . . 0.0 110.239 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.18 123.26 42.84 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.536 -0.728 . . . . 0.0 110.183 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -88.19 135.82 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.566 -0.709 . . . . 0.0 110.143 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -116.53 144.74 43.97 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.501 -0.749 . . . . 0.0 110.252 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 53.1 t60 -130.37 46.85 2.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.172 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -146.78 155.14 42.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.657 -0.652 . . . . 0.0 110.178 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -166.97 -68.56 0.03 OUTLIER Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 57.8 m -105.09 156.91 17.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.601 -0.941 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.78 -51.78 5.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.147 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ALA . . . . . . . . . . . . . . . -129.15 140.26 51.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.644 -0.66 . . . . 0.0 110.097 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 4.7 tttt -156.14 128.42 7.6 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 0.0 110.254 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -94.32 44.46 1.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.565 -0.709 . . . . 0.0 110.231 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -126.63 -173.88 13.67 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.577 ' O ' HD12 ' A' ' 314' ' ' LEU . 2.0 pp -150.15 117.59 6.1 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.646 -0.914 . . . . 0.0 110.198 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' TRP . . . . . 0.413 ' O ' ' CD1' ' A' ' 315' ' ' TRP . 1.0 OUTLIER -55.86 125.44 21.37 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.601 -0.687 . . . . 0.0 110.731 -179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' VAL . . . . . . . . . . . . . 59.4 t -82.49 90.09 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.542 -0.724 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -149.75 -62.84 0.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.72 . . . . 0.0 110.324 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -77.36 -112.11 0.16 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.36 27.85 0.66 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.905 . . . . 0.0 110.179 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' CYS . . . . . . . . . . . . . 8.6 t -96.93 95.6 7.94 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 110.689 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 89.23 2.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.685 -0.635 . . . . 0.0 109.961 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.52 -38.71 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.523 -0.736 . . . . 0.0 109.97 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.408 HD11 HD23 ' A' ' 314' ' ' LEU . 78.5 mt 55.63 72.72 0.97 Allowed Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.433 -0.792 . . . . 0.0 110.405 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.62 -165.09 0.21 Allowed 'Trans proline' 0 C--N 1.316 -1.153 0 O-C-N 123.403 1.212 . . . . 0.0 110.339 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -131.9 133.99 45.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.613 -0.679 . . . . 0.0 110.342 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 412' ' ' PHE . 29.6 m -80.02 160.96 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.659 -0.65 . . . . 0.0 110.096 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -89.1 112.51 23.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.584 -0.698 . . . . 0.0 110.066 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -75.4 154.56 37.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.627 -0.671 . . . . 0.0 110.275 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.18 116.21 1.47 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.688 -0.633 . . . . 0.0 110.346 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.75 66.68 3.9 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 123.158 1.083 . . . . 0.0 109.837 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.459 ' HB1' ' HA ' ' A' ' 336' ' ' GLU . . . -54.82 94.39 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.592 -0.692 . . . . 0.0 110.907 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 2.4 pt -134.09 27.65 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.575 -0.703 . . . . 0.0 110.23 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -126.46 -163.01 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.549 -0.72 . . . . 0.0 110.255 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LEU . . . . . . . . . . . . . 16.1 tp -60.3 -27.45 67.32 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.514 -0.741 . . . . 0.0 110.377 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -103.21 161.22 13.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.571 -0.705 . . . . 0.0 110.355 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.459 ' HA ' ' HB1' ' A' ' 331' ' ' ALA . 0.2 OUTLIER -114.34 -152.42 0.5 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.562 -0.711 . . . . 0.0 110.044 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.37 57.49 3.27 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.285 -0.885 . . . . 0.0 110.146 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -145.83 27.33 1.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.53 -0.731 . . . . 0.0 110.335 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -119.0 -44.43 2.61 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 4.3 mt -82.87 72.87 9.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.646 -0.658 . . . . 0.0 110.143 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 341' ' ' VAL . 8.6 p -145.56 51.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.536 -0.728 . . . . 0.0 110.208 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -95.43 -35.04 11.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.518 -0.739 . . . . 0.0 110.22 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -82.61 -26.76 31.97 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.567 -0.708 . . . . 0.0 110.287 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' LEU . . . . . 0.513 HD13 HD12 ' A' ' 411' ' ' ILE . 5.5 mt -77.83 -29.63 50.66 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.51 -0.744 . . . . 0.0 110.204 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -25.59 65.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.589 -0.694 . . . . 0.0 110.412 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -84.76 -32.28 23.51 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.47 -0.769 . . . . 0.0 110.256 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' SER . . . . . . . . . . . . . 1.4 t -72.52 -21.5 61.18 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.6 -0.688 . . . . 0.0 110.585 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.28 -20.63 29.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.318 -0.864 . . . . 0.0 110.955 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -51.74 149.5 8.44 Favored Pre-proline 0 N--CA 1.502 2.172 0 O-C-N 121.263 -0.898 . . . . 0.0 110.946 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.93 -166.98 0.32 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.414 1.218 . . . . 0.0 110.573 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' LYS . . . . . . . . . . . . . 20.6 mmtt -98.53 -168.68 1.68 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.561 -0.712 . . . . 0.0 110.237 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -77.99 117.94 19.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.543 -0.723 . . . . 0.0 110.2 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -155.47 30.09 0.38 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.529 -0.732 . . . . 0.0 110.117 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -133.05 -64.44 0.74 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.2 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -145.07 -169.52 3.21 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.605 -0.684 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -109.69 -30.78 7.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.656 -0.653 . . . . 0.0 110.284 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.474 ' HA ' HD13 ' A' ' 357' ' ' LEU . 2.8 mm? -91.37 -29.44 17.09 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.516 -0.74 . . . . 0.0 110.321 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' THR . . . . . . . . . . . . . 10.7 m -58.36 -26.18 62.87 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.586 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -80.78 -20.45 42.57 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.514 -0.741 . . . . 0.0 110.66 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -92.57 -25.93 18.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.328 -0.857 . . . . 0.0 110.683 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -90.73 -20.29 22.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.45 -0.781 . . . . 0.0 110.968 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -63.08 -18.05 62.96 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.343 -0.848 . . . . 0.0 110.791 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ILE . . . . . . . . . . . . . 49.2 mm -66.11 -26.92 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.314 -0.866 . . . . 0.0 109.917 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 17.2 mmtt -91.56 -30.86 16.15 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 109.946 179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.08 20.53 18.59 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.729 -0.607 . . . . 0.0 110.531 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -78.92 83.46 1.27 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -80.11 80.95 6.46 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.552 -0.969 . . . . 0.0 110.071 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -156.46 28.85 0.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.614 -0.679 . . . . 0.0 110.435 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -87.09 -39.44 15.57 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.576 -0.703 . . . . 0.0 110.518 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -168.87 -67.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.561 -0.712 . . . . 0.0 110.321 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -53.91 -23.84 14.12 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.698 -0.626 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ALA . . . . . . . . . . . . . . . -59.78 -34.84 73.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.477 -0.764 . . . . 0.0 110.302 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' SER . . . . . . . . . . . . . 73.2 m -104.93 13.09 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.633 -0.667 . . . . 0.0 110.782 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.613 ' O ' ' HB2' ' A' ' 378' ' ' ALA . 12.7 mmt -104.48 -12.44 16.5 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.297 -0.877 . . . . 0.0 110.817 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.18 -31.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.278 -0.889 . . . . 0.0 109.931 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -94.71 -32.62 13.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.604 -0.685 . . . . 0.0 110.004 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 56.9 p -114.36 33.8 5.08 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.772 -0.58 . . . . 0.0 109.968 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 374' ' ' MET . . . -57.63 113.22 1.72 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.715 -0.616 . . . . 0.0 110.727 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' PHE . . . . . 0.626 ' CE2' ' HB1' ' A' ' 384' ' ' ALA . 3.1 t80 -84.31 86.05 7.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.584 -0.698 . . . . 0.0 109.802 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' LEU . . . . . 0.698 ' O ' ' HB2' ' A' ' 384' ' ' ALA . 9.4 mt -53.57 124.15 40.27 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.538 -0.726 . . . . 0.0 110.757 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.22 -26.89 17.25 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 O-C-N 123.127 1.067 . . . . 0.0 110.686 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 36.8 p -61.03 -29.16 69.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.619 -0.675 . . . . 0.0 110.227 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLY . . . . . . . . . . . . . . . -143.5 42.64 1.06 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 380' ' ' LEU . . . -85.46 -28.22 25.19 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.981 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.62 -39.97 90.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.521 -0.737 . . . . 0.0 110.229 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' LYS . . . . . . . . . . . . . 25.8 mttt -90.29 -20.88 22.43 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.705 -0.622 . . . . 0.0 110.727 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ALA . . . . . . . . . . . . . . . -58.71 -19.24 38.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.355 -0.841 . . . . 0.0 110.716 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.77 142.75 52.65 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.337 -0.852 . . . . 0.0 110.424 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -124.09 -157.46 0.76 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.666 -0.646 . . . . 0.0 110.312 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.47 179.33 6.59 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.509 -0.744 . . . . 0.0 110.073 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -107.28 -38.02 6.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.612 -0.68 . . . . 0.0 110.339 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' SER . . . . . . . . . . . . . 59.7 p -85.63 -28.11 24.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.729 . . . . 0.0 110.235 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -85.13 82.01 8.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.586 -0.696 . . . . 0.0 110.199 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . 110.58 34.67 2.21 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt -61.72 126.72 28.36 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.545 -0.973 . . . . 0.0 110.326 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLY . . . . . . . . . . . . . . . -173.79 56.29 0.14 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -150.1 32.24 0.67 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.603 -0.94 . . . . 0.0 110.189 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -135.67 129.93 33.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.592 -0.693 . . . . 0.0 110.067 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' TRP . . . . . 0.456 ' N ' ' CD1' ' A' ' 399' ' ' TRP . 10.2 p-90 -167.64 31.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.485 -0.76 . . . . 0.0 110.659 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . -99.56 -125.86 5.55 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -146.93 138.55 24.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.555 -0.968 . . . . 0.0 110.109 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' TYR . . . . . 0.446 ' CD2' ' CB ' ' A' ' 409' ' ' CYS . 52.4 m-85 -125.56 126.94 45.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 110.271 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -151.37 90.17 1.56 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' THR . . . . . 0.644 HG21 ' H ' ' A' ' 408' ' ' LYS . 7.6 t -151.18 167.74 26.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.513 -0.742 . . . . 0.0 111.314 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -108.25 -23.32 11.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' THR . . . . . . . . . . . . . 17.8 p -113.35 -73.66 0.65 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.417 -0.802 . . . . 0.0 110.48 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -167.55 80.34 0.19 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.433 -0.792 . . . . 0.0 110.991 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LYS . . . . . 0.644 ' H ' HG21 ' A' ' 404' ' ' THR . 0.1 OUTLIER -150.68 131.77 14.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 0.0 109.437 179.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' CYS . . . . . 0.446 ' CB ' ' CD2' ' A' ' 402' ' ' TYR . 26.5 p -132.44 170.12 15.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.329 -0.857 . . . . 0.0 111.095 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . 0.701 ' OE2' HG21 ' A' ' 326' ' ' VAL . 3.6 pt-20 -149.48 170.19 19.17 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.798 -0.564 . . . . 0.0 109.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 412' ' ' PHE . 0.0 OUTLIER -137.73 136.32 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.458 -0.777 . . . . 0.0 110.147 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.793 ' CB ' HG12 ' A' ' 326' ' ' VAL . 40.7 t80 -172.35 63.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.537 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -58.38 136.84 57.51 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.604 -0.685 . . . . 0.0 110.855 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 412' ' ' PHE . 36.0 m -140.4 172.41 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.562 -0.712 . . . . 0.0 109.984 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' LYS . . . . . . . . . . . . . 22.2 mttp -67.36 153.7 94.32 Favored Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.541 -0.724 . . . . 0.0 110.168 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.37 74.75 2.54 Favored 'Trans proline' 0 C--N 1.317 -1.127 0 O-C-N 123.444 1.234 . . . . 0.0 110.439 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' THR . . . . . . . . . . . . . 7.0 t -164.95 30.31 0.06 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.476 -0.765 . . . . 0.0 110.257 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 169.87 22.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.547 -0.72 . . . . 0.0 110.198 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' LEU . . . . . . . . . . . . . 89.9 mt -134.13 85.75 2.22 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.602 -0.686 . . . . 0.0 110.241 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 420' ' ' ILE . 64.5 mt -139.84 43.79 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.522 -0.736 . . . . 0.0 109.525 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -155.31 172.16 18.66 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.603 -0.686 . . . . 0.0 110.297 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.65 -68.62 0.84 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.599 -0.688 . . . . 0.0 110.321 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 3.0 m -103.17 101.42 11.38 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 41.3 m -99.91 106.7 18.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.56 -0.712 . . . . 0.0 110.108 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -104.94 59.95 0.69 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.64 -0.663 . . . . 0.0 110.173 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ILE . . . . . . . . . . . . . 85.1 mt -76.27 85.78 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.492 -0.755 . . . . 0.0 109.893 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ALA . . . . . . . . . . . . . . . -129.31 58.1 1.63 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.532 -0.73 . . . . 0.0 110.17 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' THR . . . . . . . . . . . . . 73.5 p -124.89 -46.34 1.84 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.553 -0.717 . . . . 0.0 110.129 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' THR . . . . . 0.6 ' O ' HG23 ' A' ' 429' ' ' THR . 6.4 t -151.67 104.22 3.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.58 -0.7 . . . . 0.0 110.183 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.02 151.83 20.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.0 110.186 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LEU . . . . . 0.433 ' H ' HD23 ' A' ' 431' ' ' LEU . 0.6 OUTLIER -116.59 -20.15 9.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.566 -0.709 . . . . 0.0 110.776 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.26 -26.83 13.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.319 -0.863 . . . . 0.0 110.304 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' HIS . . . . . 0.402 ' N ' ' HD2' ' A' ' 434' ' ' PRO . 1.8 m-70 -70.36 -56.74 6.41 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.742 . . . . 0.0 110.445 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 433' ' ' HIS . 46.3 Cg_endo -72.82 171.85 16.54 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 O-C-N 123.155 1.082 . . . . 0.0 110.363 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 16.7 tt -60.56 -27.74 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.614 -0.679 . . . . 0.0 110.306 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.275 -179.97 . . . . . . . . 0 0 . 1 stop_ save_